symptom	biologicalSystem	effect	efoId	ensemblId	pmid	ref	target	uberonCode	url
arteriolar dilation/hypotension	cardiovascular system	activation_general	EFO_0005251	ENSG00000168398	""	Urban et al. (2012)	BDKRB2	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
cardiomyopathy	cardiovascular system	inhibition_general	EFO_0000318	ENSG00000168398	""	Urban et al. (2012)	BDKRB2	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
hypertension	cardiovascular system	inhibition_general	EFO_0000537	ENSG00000168398	""	Urban et al. (2012)	BDKRB2	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
arrhythmia	cardiovascular system	inhibition_general	EFO_0004269	ENSG00000168398	""	Urban et al. (2012)	BDKRB2	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
smooth-muscle contraction	cardiovascular system	activation_general	GO_0006939	ENSG00000168398	""	Urban et al. (2012)	BDKRB2	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
cough	cardiovascular system	activation_general	HP_0012735	ENSG00000168398	""	Urban et al. (2012)	BDKRB2	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
nociception	cardiovascular system	activation_general	EFO_0003843	ENSG00000168398	""	Urban et al. (2012)	BDKRB2	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
angiogenesis	cardiovascular system	activation_general	""	ENSG00000168398	""	Urban et al. (2012)	BDKRB2	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
acute allergic inflammation	cardiovascular system	activation_general	""	ENSG00000168398	""	Urban et al. (2012)	BDKRB2	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
analgesia	cardiovascular system	activation_general	EFO_1001484	ENSG00000082556	""	Urban et al. (2012)	OPRK1	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
sedation	cardiovascular system	activation_general	EFO_0009868	ENSG00000082556	""	Urban et al. (2012)	OPRK1	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
hypotension	cardiovascular system	activation_general	EFO_0005251	ENSG00000082556	""	Urban et al. (2012)	OPRK1	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
tachycardia	cardiovascular system	activation_general	HP_0001649	ENSG00000082556	""	Urban et al. (2012)	OPRK1	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
diuresis	cardiovascular system	activation_general	HP_0000103	ENSG00000082556	""	Urban et al. (2012)	OPRK1	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
dysphoria	cardiovascular system	activation_general	EFO_0009867	ENSG00000082556	""	Urban et al. (2012)	OPRK1	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
dizziness	cardiovascular system	activation_general	EFO_0009847	ENSG00000082556	""	Urban et al. (2012)	OPRK1	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
paresthesia	cardiovascular system	activation_general	HP_0003401	ENSG00000082556	""	Urban et al. (2012)	OPRK1	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
antipruritic effects	cardiovascular system	activation_general	""	ENSG00000082556	""	Urban et al. (2012)	OPRK1	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
interaction with dopaminergic transmission and hallucination	cardiovascular system	activation_general	""	ENSG00000082556	""	Urban et al. (2012)	OPRK1	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
psychotomimetic effects	cardiovascular system	activation_general	""	ENSG00000082556	""	Urban et al. (2012)	OPRK1	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
analgesia	nervous system	activation_general	EFO_1001484	ENSG00000082556	""	Urban et al. (2012)	OPRK1	UBERON_0001016	https://doi.org/10.1002/9781118098141.ch2
sedation	nervous system	activation_general	EFO_0009868	ENSG00000082556	""	Urban et al. (2012)	OPRK1	UBERON_0001016	https://doi.org/10.1002/9781118098141.ch2
hypotension	nervous system	activation_general	EFO_0005251	ENSG00000082556	""	Urban et al. (2012)	OPRK1	UBERON_0001016	https://doi.org/10.1002/9781118098141.ch2
tachycardia	nervous system	activation_general	HP_0001649	ENSG00000082556	""	Urban et al. (2012)	OPRK1	UBERON_0001016	https://doi.org/10.1002/9781118098141.ch2
diuresis	nervous system	activation_general	HP_0000103	ENSG00000082556	""	Urban et al. (2012)	OPRK1	UBERON_0001016	https://doi.org/10.1002/9781118098141.ch2
dysphoria	nervous system	activation_general	EFO_0009867	ENSG00000082556	""	Urban et al. (2012)	OPRK1	UBERON_0001016	https://doi.org/10.1002/9781118098141.ch2
dizziness	nervous system	activation_general	EFO_0009847	ENSG00000082556	""	Urban et al. (2012)	OPRK1	UBERON_0001016	https://doi.org/10.1002/9781118098141.ch2
paresthesia	nervous system	activation_general	HP_0003401	ENSG00000082556	""	Urban et al. (2012)	OPRK1	UBERON_0001016	https://doi.org/10.1002/9781118098141.ch2
antipruritic effects	nervous system	activation_general	""	ENSG00000082556	""	Urban et al. (2012)	OPRK1	UBERON_0001016	https://doi.org/10.1002/9781118098141.ch2
interaction with dopaminergic transmission and hallucination	nervous system	activation_general	""	ENSG00000082556	""	Urban et al. (2012)	OPRK1	UBERON_0001016	https://doi.org/10.1002/9781118098141.ch2
psychotomimetic effects	nervous system	activation_general	""	ENSG00000082556	""	Urban et al. (2012)	OPRK1	UBERON_0001016	https://doi.org/10.1002/9781118098141.ch2
analgesia	nervous system	activation_general	EFO_1001484	ENSG00000116329	""	Urban et al. (2012)	OPRD1	UBERON_0001016	https://doi.org/10.1002/9781118098141.ch2
increased blood pressure	nervous system	inhibition_general	""	ENSG00000116329	""	Urban et al. (2012)	OPRD1	UBERON_0001016	https://doi.org/10.1002/9781118098141.ch2
increased cardiac output	nervous system	inhibition_general	""	ENSG00000116329	""	Urban et al. (2012)	OPRD1	UBERON_0001016	https://doi.org/10.1002/9781118098141.ch2
increased contractility	nervous system	inhibition_general	""	ENSG00000116329	""	Urban et al. (2012)	OPRD1	UBERON_0001016	https://doi.org/10.1002/9781118098141.ch2
increased bloodflow to the heart	nervous system	inhibition_general	""	ENSG00000116329	""	Urban et al. (2012)	OPRD1	UBERON_0001016	https://doi.org/10.1002/9781118098141.ch2
increased bloodflow to the kidneys	nervous system	inhibition_general	""	ENSG00000116329	""	Urban et al. (2012)	OPRD1	UBERON_0001016	https://doi.org/10.1002/9781118098141.ch2
increased bloodflow to the gastrointestinal tract	nervous system	inhibition_general	""	ENSG00000116329	""	Urban et al. (2012)	OPRD1	UBERON_0001016	https://doi.org/10.1002/9781118098141.ch2
increased bloodflow to the skeletal muscle	nervous system	inhibition_general	""	ENSG00000116329	""	Urban et al. (2012)	OPRD1	UBERON_0001016	https://doi.org/10.1002/9781118098141.ch2
dysphoria	nervous system	activation_general	EFO_0009867	ENSG00000116329	""	Urban et al. (2012)	OPRD1	UBERON_0001016	https://doi.org/10.1002/9781118098141.ch2
psychomimetic effects	nervous system	activation_general	EFO_1000902	ENSG00000116329	""	Urban et al. (2012)	OPRD1	UBERON_0001016	https://doi.org/10.1002/9781118098141.ch2
cardiovascular effects	nervous system	activation_general	EFO_0000319	ENSG00000116329	""	Urban et al. (2012)	OPRD1	UBERON_0001016	https://doi.org/10.1002/9781118098141.ch2
convulsion	nervous system	activation_general	EFO_0009853	ENSG00000116329	""	Urban et al. (2012)	OPRD1	UBERON_0001016	https://doi.org/10.1002/9781118098141.ch2
seizure	nervous system	activation_general	EFO_0009853	ENSG00000116329	""	Urban et al. (2012)	OPRD1	UBERON_0001016	https://doi.org/10.1002/9781118098141.ch2
convulsion	nervous system	activation_general	EFO_0009853	ENSG00000116329	""	Urban et al. (2012)	OPRD1	UBERON_0001016	https://doi.org/10.1002/9781118098141.ch2
heart effects	nervous system	activation_general	""	ENSG00000116329	""	Urban et al. (2012)	OPRD1	UBERON_0001016	https://doi.org/10.1002/9781118098141.ch2
respiratory depression	nervous system	activation_general	EFO_0009842	ENSG00000116329	""	Urban et al. (2012)	OPRD1	UBERON_0001016	https://doi.org/10.1002/9781118098141.ch2
analgesia	cardiovascular system	activation_general	EFO_1001484	ENSG00000116329	""	Urban et al. (2012)	OPRD1	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
increased blood pressure	cardiovascular system	inhibition_general	""	ENSG00000116329	""	Urban et al. (2012)	OPRD1	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
increased cardiac output	cardiovascular system	inhibition_general	""	ENSG00000116329	""	Urban et al. (2012)	OPRD1	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
increased contractility	cardiovascular system	inhibition_general	""	ENSG00000116329	""	Urban et al. (2012)	OPRD1	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
increased bloodflow to the heart	cardiovascular system	inhibition_general	""	ENSG00000116329	""	Urban et al. (2012)	OPRD1	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
increased bloodflow to the kidneys	cardiovascular system	inhibition_general	""	ENSG00000116329	""	Urban et al. (2012)	OPRD1	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
increased bloodflow to the gastrointestinal tract	cardiovascular system	inhibition_general	""	ENSG00000116329	""	Urban et al. (2012)	OPRD1	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
increased bloodflow to the skeletal muscle	cardiovascular system	inhibition_general	""	ENSG00000116329	""	Urban et al. (2012)	OPRD1	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
dysphoria	cardiovascular system	activation_general	EFO_0009867	ENSG00000116329	""	Urban et al. (2012)	OPRD1	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
psychomimetic effects	cardiovascular system	activation_general	EFO_1000902	ENSG00000116329	""	Urban et al. (2012)	OPRD1	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
cardiovascular effects	cardiovascular system	activation_general	EFO_0000319	ENSG00000116329	""	Urban et al. (2012)	OPRD1	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
convulsion	cardiovascular system	activation_general	EFO_0009853	ENSG00000116329	""	Urban et al. (2012)	OPRD1	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
seizure	cardiovascular system	activation_general	EFO_0009853	ENSG00000116329	""	Urban et al. (2012)	OPRD1	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
convulsion	cardiovascular system	activation_general	EFO_0009853	ENSG00000116329	""	Urban et al. (2012)	OPRD1	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
heart effects	cardiovascular system	activation_general	""	ENSG00000116329	""	Urban et al. (2012)	OPRD1	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
respiratory depression	cardiovascular system	activation_general	EFO_0009842	ENSG00000116329	""	Urban et al. (2012)	OPRD1	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
vasoconstriction	cardiovascular system	activation_general	""	ENSG00000006638	""	Urban et al. (2012)	TBXA2R	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
inhibition platelet aggregation	cardiovascular system	inhibition_general	GO_0090331	ENSG00000006638	""	Urban et al. (2012)	TBXA2R	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
bronchoconstriction	cardiovascular system	activation_general	EFO_0009836	ENSG00000006638	""	Urban et al. (2012)	TBXA2R	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
platelet aggregation	cardiovascular system	activation_general	GO_0070527	ENSG00000006638	""	Urban et al. (2012)	TBXA2R	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
myocardial ischemia	cardiovascular system	activation_general	EFO_1001375	ENSG00000006638	""	Urban et al. (2012)	TBXA2R	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
heart failure	cardiovascular system	activation_general	EFO_0003144	ENSG00000006638	""	Urban et al. (2012)	TBXA2R	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
sedation	cardiovascular system	activation_general	EFO_0009868	ENSG00000150594	""	Urban et al. (2012)	ADRA2A	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
gastrointestinal prokinetic effects	cardiovascular system	inhibition_general	HP_0030895	ENSG00000150594	""	Urban et al. (2012)	ADRA2A	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
analgesia	cardiovascular system	activation_general	EFO_1001484	ENSG00000150594	""	Urban et al. (2012)	ADRA2A	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
anesthetic-sparing effect	cardiovascular system	activation_general	""	ENSG00000150594	""	Urban et al. (2012)	ADRA2A	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
central hypotension (reduction of blood pressure and heart rate)	cardiovascular system	activation_general	EFO_0005251	ENSG00000150594	""	Urban et al. (2012)	ADRA2A	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
hypothermia	cardiovascular system	activation_general	HP_0002045	ENSG00000150594	""	Urban et al. (2012)	ADRA2A	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
hyperglycemia	cardiovascular system	activation_general	HP_0003074	ENSG00000150594	""	Urban et al. (2012)	ADRA2A	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
memory impairment	cardiovascular system	activation_general	EFO_0001072	ENSG00000150594	""	Urban et al. (2012)	ADRA2A	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
weight gain	cardiovascular system	activation_general	EFO_0004566	ENSG00000150594	""	Urban et al. (2012)	ADRA2A	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
sedation	nervous system	activation_general	EFO_0009868	ENSG00000150594	""	Urban et al. (2012)	ADRA2A	UBERON_0001016	https://doi.org/10.1002/9781118098141.ch2
gastrointestinal prokinetic effects	nervous system	inhibition_general	HP_0030895	ENSG00000150594	""	Urban et al. (2012)	ADRA2A	UBERON_0001016	https://doi.org/10.1002/9781118098141.ch2
analgesia	nervous system	activation_general	EFO_1001484	ENSG00000150594	""	Urban et al. (2012)	ADRA2A	UBERON_0001016	https://doi.org/10.1002/9781118098141.ch2
anesthetic-sparing effect	nervous system	activation_general	""	ENSG00000150594	""	Urban et al. (2012)	ADRA2A	UBERON_0001016	https://doi.org/10.1002/9781118098141.ch2
central hypotension (reduction of blood pressure and heart rate)	nervous system	activation_general	EFO_0005251	ENSG00000150594	""	Urban et al. (2012)	ADRA2A	UBERON_0001016	https://doi.org/10.1002/9781118098141.ch2
hypothermia	nervous system	activation_general	HP_0002045	ENSG00000150594	""	Urban et al. (2012)	ADRA2A	UBERON_0001016	https://doi.org/10.1002/9781118098141.ch2
hyperglycemia	nervous system	activation_general	HP_0003074	ENSG00000150594	""	Urban et al. (2012)	ADRA2A	UBERON_0001016	https://doi.org/10.1002/9781118098141.ch2
memory impairment	nervous system	activation_general	EFO_0001072	ENSG00000150594	""	Urban et al. (2012)	ADRA2A	UBERON_0001016	https://doi.org/10.1002/9781118098141.ch2
weight gain	nervous system	activation_general	EFO_0004566	ENSG00000150594	""	Urban et al. (2012)	ADRA2A	UBERON_0001016	https://doi.org/10.1002/9781118098141.ch2
energy homeostasis	endocrine	activation_general	""	ENSG00000121853	""	Urban et al. (2012)	GHSR	UBERON_0000949	https://doi.org/10.1002/9781118098141.ch2
cardiovascular effects (reduced rates of left ventricular contraction and relaxation, hypertension, tachycardia)	endocrine	inhibition_general	EFO_0000319	ENSG00000121853	""	Urban et al. (2012)	GHSR	UBERON_0000949	https://doi.org/10.1002/9781118098141.ch2
gastric motility	endocrine	inhibition_general	HP_0002579	ENSG00000121853	""	Urban et al. (2012)	GHSR	UBERON_0000949	https://doi.org/10.1002/9781118098141.ch2
growth hormone release	endocrine	activation_general	GO_0030252	ENSG00000121853	""	Urban et al. (2012)	GHSR	UBERON_0000949	https://doi.org/10.1002/9781118098141.ch2
adrenocorticotropic hormone release	endocrine	activation_general	HP_0003154	ENSG00000121853	""	Urban et al. (2012)	GHSR	UBERON_0000949	https://doi.org/10.1002/9781118098141.ch2
cortisol release	endocrine	activation_general	GO_0043400	ENSG00000121853	""	Urban et al. (2012)	GHSR	UBERON_0000949	https://doi.org/10.1002/9781118098141.ch2
appetite stimulation	endocrine	activation_general	HP_0100738	ENSG00000121853	""	Urban et al. (2012)	GHSR	UBERON_0000949	https://doi.org/10.1002/9781118098141.ch2
hyperglycemia	endocrine	activation_general	HP_0003074	ENSG00000121853	""	Urban et al. (2012)	GHSR	UBERON_0000949	https://doi.org/10.1002/9781118098141.ch2
reduced insulin secretion	endocrine	activation_general	HP_0040216	ENSG00000121853	""	Urban et al. (2012)	GHSR	UBERON_0000949	https://doi.org/10.1002/9781118098141.ch2
hypotension	endocrine	activation_general	EFO_0005251	ENSG00000121853	""	Urban et al. (2012)	GHSR	UBERON_0000949	https://doi.org/10.1002/9781118098141.ch2
energy homeostasis	cardiovascular system	activation_general	""	ENSG00000121853	""	Urban et al. (2012)	GHSR	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
cardiovascular effects (reduced rates of left ventricular contraction and relaxation, hypertension, tachycardia)	cardiovascular system	inhibition_general	EFO_0000319	ENSG00000121853	""	Urban et al. (2012)	GHSR	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
gastric motility	cardiovascular system	inhibition_general	HP_0002579	ENSG00000121853	""	Urban et al. (2012)	GHSR	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
growth hormone release	cardiovascular system	activation_general	GO_0030252	ENSG00000121853	""	Urban et al. (2012)	GHSR	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
adrenocorticotropic hormone release	cardiovascular system	activation_general	HP_0003154	ENSG00000121853	""	Urban et al. (2012)	GHSR	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
cortisol release	cardiovascular system	activation_general	GO_0043400	ENSG00000121853	""	Urban et al. (2012)	GHSR	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
appetite stimulation	cardiovascular system	activation_general	HP_0100738	ENSG00000121853	""	Urban et al. (2012)	GHSR	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
hyperglycemia	cardiovascular system	activation_general	HP_0003074	ENSG00000121853	""	Urban et al. (2012)	GHSR	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
reduced insulin secretion	cardiovascular system	activation_general	HP_0040216	ENSG00000121853	""	Urban et al. (2012)	GHSR	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
hypotension	cardiovascular system	activation_general	EFO_0005251	ENSG00000121853	""	Urban et al. (2012)	GHSR	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
increased mortality in heart failure patients	cardiovascular system	inhibition_chronic	""	ENSG00000172572	""	Urban et al. (2012)	PDE3A	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
ventricular arrhythmias	cardiovascular system	inhibition_general	HP_0004308	ENSG00000172572	""	Urban et al. (2012)	PDE3A	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
tachycardia	cardiovascular system	inhibition_general	HP_0001649	ENSG00000172572	""	Urban et al. (2012)	PDE3A	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
hypotension	cardiovascular system	inhibition_general	EFO_0005251	ENSG00000172572	""	Urban et al. (2012)	PDE3A	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
thrombocytopenia	cardiovascular system	inhibition_chronic	HP_0001873	ENSG00000172572	""	Urban et al. (2012)	PDE3A	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
smooth-muscle contraction (prostate in particular, effects on the lower urinary tract)	gastrointestinal	activation_general	GO_0006939	ENSG00000120907	""	Urban et al. (2012)	ADRA1A	UBERON_0005409	https://doi.org/10.1002/9781118098141.ch2
orthostatic hypotension	gastrointestinal	inhibition_general	EFO_0005252	ENSG00000120907	""	Urban et al. (2012)	ADRA1A	UBERON_0005409	https://doi.org/10.1002/9781118098141.ch2
blood pressure events	gastrointestinal	inhibition_general	""	ENSG00000120907	""	Urban et al. (2012)	ADRA1A	UBERON_0005409	https://doi.org/10.1002/9781118098141.ch2
sexual function	gastrointestinal	inhibition_general	EFO_0004714	ENSG00000120907	""	Urban et al. (2012)	ADRA1A	UBERON_0005409	https://doi.org/10.1002/9781118098141.ch2
cardiac positive ionotropy	gastrointestinal	activation_general	GO_0045823	ENSG00000120907	""	Urban et al. (2012)	ADRA1A	UBERON_0005409	https://doi.org/10.1002/9781118098141.ch2
arrhythmia	gastrointestinal	activation_general	EFO_0004269	ENSG00000120907	""	Urban et al. (2012)	ADRA1A	UBERON_0005409	https://doi.org/10.1002/9781118098141.ch2
smooth-muscle contraction (prostate in particular, effects on the lower urinary tract)	cardiovascular system	activation_general	GO_0006939	ENSG00000120907	""	Urban et al. (2012)	ADRA1A	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
orthostatic hypotension	cardiovascular system	inhibition_general	EFO_0005252	ENSG00000120907	""	Urban et al. (2012)	ADRA1A	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
blood pressure events	cardiovascular system	inhibition_general	""	ENSG00000120907	""	Urban et al. (2012)	ADRA1A	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
sexual function	cardiovascular system	inhibition_general	EFO_0004714	ENSG00000120907	""	Urban et al. (2012)	ADRA1A	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
cardiac positive ionotropy	cardiovascular system	activation_general	GO_0045823	ENSG00000120907	""	Urban et al. (2012)	ADRA1A	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
arrhythmia	cardiovascular system	activation_general	EFO_0004269	ENSG00000120907	""	Urban et al. (2012)	ADRA1A	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
peripheral and central vasodilation	cardiovascular system	inhibition_general	""	ENSG00000112759	""	Urban et al. (2012)	SLC29A1	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
inhibition of platelet aggregation	cardiovascular system	inhibition_general	GO_0090331	ENSG00000112759	""	Urban et al. (2012)	SLC29A1	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
promotion of sleep	cardiovascular system	inhibition_general	EFO_0009843	ENSG00000112759	""	Urban et al. (2012)	SLC29A1	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
angina pectoris	cardiovascular system	inhibition_general	EFO_0003913	ENSG00000112759	""	Urban et al. (2012)	SLC29A1	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
dizziness	cardiovascular system	inhibition_general	EFO_0009847	ENSG00000112759	""	Urban et al. (2012)	SLC29A1	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
hypotension	cardiovascular system	inhibition_general	EFO_0005251	ENSG00000112759	""	Urban et al. (2012)	SLC29A1	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
cardiac death	cardiovascular system	inhibition_general	""	ENSG00000112759	""	Urban et al. (2012)	SLC29A1	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
myocardial infarction	cardiovascular system	inhibition_general	""	ENSG00000112759	""	Urban et al. (2012)	SLC29A1	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
ventricular fibrillation	cardiovascular system	inhibition_general	""	ENSG00000112759	""	Urban et al. (2012)	SLC29A1	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
ventricular tachycardia	cardiovascular system	inhibition_general	""	ENSG00000112759	""	Urban et al. (2012)	SLC29A1	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
stroke	cardiovascular system	inhibition_general	""	ENSG00000112759	""	Urban et al. (2012)	SLC29A1	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
transient cerebral ischemia	cardiovascular system	inhibition_general	""	ENSG00000112759	""	Urban et al. (2012)	SLC29A1	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
seizure	cardiovascular system	inhibition_general	""	ENSG00000112759	""	Urban et al. (2012)	SLC29A1	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
anaphylactoid reaction	cardiovascular system	inhibition_general	""	ENSG00000112759	""	Urban et al. (2012)	SLC29A1	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
bronchospasm	cardiovascular system	inhibition_general	""	ENSG00000112759	""	Urban et al. (2012)	SLC29A1	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
"hypertensive when combined with pressor amines such as tyramine present in cheese: inhibitors may induce severe hypertensive crisis (known as \"cheese reaction\")"	cardiovascular system	inhibition_general	""	ENSG00000189221	""	Urban et al. (2012)	MAOA	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
serotonin syndrome	cardiovascular system	inhibition_general	""	ENSG00000189221	""	Urban et al. (2012)	MAOA	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
dizziness	cardiovascular system	inhibition_general	""	ENSG00000189221	""	Urban et al. (2012)	MAOA	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
blurred vision	cardiovascular system	inhibition_general	""	ENSG00000189221	""	Urban et al. (2012)	MAOA	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
weakness	cardiovascular system	inhibition_general	""	ENSG00000189221	""	Urban et al. (2012)	MAOA	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
hypomania	cardiovascular system	inhibition_general	""	ENSG00000189221	""	Urban et al. (2012)	MAOA	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
"hypertensive when combined with pressor amines such as tyramine present in cheese: inhibitors may induce severe hypertensive crisis (known as \"cheese reaction\")"	central nervous system	inhibition_general	""	ENSG00000189221	""	Urban et al. (2012)	MAOA	UBERON_0001017	https://doi.org/10.1002/9781118098141.ch2
serotonin syndrome	central nervous system	inhibition_general	""	ENSG00000189221	""	Urban et al. (2012)	MAOA	UBERON_0001017	https://doi.org/10.1002/9781118098141.ch2
dizziness	central nervous system	inhibition_general	""	ENSG00000189221	""	Urban et al. (2012)	MAOA	UBERON_0001017	https://doi.org/10.1002/9781118098141.ch2
blurred vision	central nervous system	inhibition_general	""	ENSG00000189221	""	Urban et al. (2012)	MAOA	UBERON_0001017	https://doi.org/10.1002/9781118098141.ch2
weakness	central nervous system	inhibition_general	""	ENSG00000189221	""	Urban et al. (2012)	MAOA	UBERON_0001017	https://doi.org/10.1002/9781118098141.ch2
hypomania	central nervous system	inhibition_general	""	ENSG00000189221	""	Urban et al. (2012)	MAOA	UBERON_0001017	https://doi.org/10.1002/9781118098141.ch2
atrial fibrillation	cardiovascular system	activation_general	EFO_0000275	ENSG00000053918	""	Urban et al. (2012)	KCNQ1	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
long QT syndrome	cardiovascular system	inhibition_general	MONDO_0002442	ENSG00000053918	""	Urban et al. (2012)	KCNQ1	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
hearing impairment	cardiovascular system	inhibition_general	EFO_0004238	ENSG00000053918	""	Urban et al. (2012)	KCNQ1	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
deafness	cardiovascular system	inhibition_general	EFO_0001063	ENSG00000053918	""	Urban et al. (2012)	KCNQ1	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
gastrointestinal symptoms	cardiovascular system	inhibition_general	HP_0012719	ENSG00000053918	""	Urban et al. (2012)	KCNQ1	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
inhibition of platelet aggregation	cardiovascular system	activation_general	GO_0090331	ENSG00000128271	""	Urban et al. (2012)	ADORA2A	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
increased platelet aggregation	cardiovascular system	inhibition_general	GO_1901731	ENSG00000128271	""	Urban et al. (2012)	ADORA2A	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
hypertension	cardiovascular system	inhibition_general	EFO_0000537	ENSG00000128271	""	Urban et al. (2012)	ADORA2A	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
tremors	cardiovascular system	inhibition_general	NCIT_C74532	ENSG00000128271	""	Urban et al. (2012)	ADORA2A	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
agitation	cardiovascular system	inhibition_general	NCIT_C74532	ENSG00000128271	""	Urban et al. (2012)	ADORA2A	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
arousal	cardiovascular system	inhibition_general	EFO_0009849	ENSG00000128271	""	Urban et al. (2012)	ADORA2A	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
insomnia	cardiovascular system	inhibition_general	EFO_0004698	ENSG00000128271	""	Urban et al. (2012)	ADORA2A	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
cerebral and coronary vasodilation (in microvessels only)	cardiovascular system	inhibition_general	""	ENSG00000128271	""	Urban et al. (2012)	ADORA2A	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
antiinflammation	cardiovascular system	activation_general	GO_0050728	ENSG00000128271	""	Urban et al. (2012)	ADORA2A	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
neuroprotective effects	cardiovascular system	activation_general	""	ENSG00000128271	""	Urban et al. (2012)	ADORA2A	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
coronary vasodilation	cardiovascular system	activation_general	""	ENSG00000128271	""	Urban et al. (2012)	ADORA2A	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
decreased blood pressure	cardiovascular system	activation_general	EFO_0005251	ENSG00000128271	""	Urban et al. (2012)	ADORA2A	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
increased plasma renin activity	cardiovascular system	activation_general	GO_1900135	ENSG00000128271	""	Urban et al. (2012)	ADORA2A	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
sleep induction	cardiovascular system	activation_general	EFO_0009843	ENSG00000128271	""	Urban et al. (2012)	ADORA2A	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
inhibition of platelet aggregation	nervous system	activation_general	GO_0090331	ENSG00000128271	""	Urban et al. (2012)	ADORA2A	UBERON_0001016	https://doi.org/10.1002/9781118098141.ch2
increased platelet aggregation	nervous system	inhibition_general	GO_1901731	ENSG00000128271	""	Urban et al. (2012)	ADORA2A	UBERON_0001016	https://doi.org/10.1002/9781118098141.ch2
hypertension	nervous system	inhibition_general	EFO_0000537	ENSG00000128271	""	Urban et al. (2012)	ADORA2A	UBERON_0001016	https://doi.org/10.1002/9781118098141.ch2
tremors	nervous system	inhibition_general	NCIT_C74532	ENSG00000128271	""	Urban et al. (2012)	ADORA2A	UBERON_0001016	https://doi.org/10.1002/9781118098141.ch2
agitation	nervous system	inhibition_general	NCIT_C74532	ENSG00000128271	""	Urban et al. (2012)	ADORA2A	UBERON_0001016	https://doi.org/10.1002/9781118098141.ch2
arousal	nervous system	inhibition_general	EFO_0009849	ENSG00000128271	""	Urban et al. (2012)	ADORA2A	UBERON_0001016	https://doi.org/10.1002/9781118098141.ch2
insomnia	nervous system	inhibition_general	EFO_0004698	ENSG00000128271	""	Urban et al. (2012)	ADORA2A	UBERON_0001016	https://doi.org/10.1002/9781118098141.ch2
cerebral and coronary vasodilation (in microvessels only)	nervous system	inhibition_general	""	ENSG00000128271	""	Urban et al. (2012)	ADORA2A	UBERON_0001016	https://doi.org/10.1002/9781118098141.ch2
antiinflammation	nervous system	activation_general	GO_0050728	ENSG00000128271	""	Urban et al. (2012)	ADORA2A	UBERON_0001016	https://doi.org/10.1002/9781118098141.ch2
neuroprotective effects	nervous system	activation_general	""	ENSG00000128271	""	Urban et al. (2012)	ADORA2A	UBERON_0001016	https://doi.org/10.1002/9781118098141.ch2
coronary vasodilation	nervous system	activation_general	""	ENSG00000128271	""	Urban et al. (2012)	ADORA2A	UBERON_0001016	https://doi.org/10.1002/9781118098141.ch2
decreased blood pressure	nervous system	activation_general	EFO_0005251	ENSG00000128271	""	Urban et al. (2012)	ADORA2A	UBERON_0001016	https://doi.org/10.1002/9781118098141.ch2
increased plasma renin activity	nervous system	activation_general	GO_1900135	ENSG00000128271	""	Urban et al. (2012)	ADORA2A	UBERON_0001016	https://doi.org/10.1002/9781118098141.ch2
sleep induction	nervous system	activation_general	EFO_0009843	ENSG00000128271	""	Urban et al. (2012)	ADORA2A	UBERON_0001016	https://doi.org/10.1002/9781118098141.ch2
long QT	cardiovascular system	inhibition_general	MONDO_0002442	ENSG00000183873	""	Urban et al. (2012)	SCN5A	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
arrhythmias	cardiovascular system	inhibition_general	EFO_0004269	ENSG00000183873	""	Urban et al. (2012)	SCN5A	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
TdP	cardiovascular system	inhibition_general	EFO_0005307	ENSG00000183873	""	Urban et al. (2012)	SCN5A	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
polymorphic ventricular tachycardia	cardiovascular system	inhibition_general	MONDO_0020575	ENSG00000183873	""	Urban et al. (2012)	SCN5A	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
hemorrhagic events	cardiovascular system	inhibition_general	""	ENSG00000180210	""	Urban et al. (2012)	F2	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
congestive heart failure	cardiovascular system	inhibition_general	EFO_0000373	ENSG00000103546	""	Urban et al. (2012)	SLC6A2	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
hypertension (supine)	cardiovascular system	inhibition_general	EFO_0000537	ENSG00000103546	""	Urban et al. (2012)	SLC6A2	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
tachycardia	cardiovascular system	inhibition_general	HP_0001649	ENSG00000103546	""	Urban et al. (2012)	SLC6A2	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
vasocontriction	cardiovascular system	activation_general	""	ENSG00000144891	""	Urban et al. (2012)	AGTR1	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
antihypertensive and cardioprotective agent	cardiovascular system	inhibition_general	""	ENSG00000144891	""	Urban et al. (2012)	AGTR1	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
hypotension	cardiovascular system	inhibition_general	EFO_0005251	ENSG00000144891	""	Urban et al. (2012)	AGTR1	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
dry mouth	cardiovascular system	inhibition_general	EFO_0009869	ENSG00000144891	""	Urban et al. (2012)	AGTR1	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
excessive thirst	cardiovascular system	inhibition_general	HP_0001959	ENSG00000144891	""	Urban et al. (2012)	AGTR1	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
dizziness	cardiovascular system	inhibition_general	EFO_0009847	ENSG00000144891	""	Urban et al. (2012)	AGTR1	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
slow or irregular heartbeat	cardiovascular system	inhibition_general	HP_0031860	ENSG00000144891	""	Urban et al. (2012)	AGTR1	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
positive inotropy	cardiovascular system	activation_general	GO_0045823	ENSG00000144891	""	Urban et al. (2012)	AGTR1	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
cell proliferation and migration	cardiovascular system	activation_general	GO_0008283	ENSG00000144891	""	Urban et al. (2012)	AGTR1	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
cardioprotection	nervous system	activation_general	""	ENSG00000163485	""	Urban et al. (2012)	ADORA1	UBERON_0001016	https://doi.org/10.1002/9781118098141.ch2
vasodilation	nervous system	inhibition_general	""	ENSG00000163485	""	Urban et al. (2012)	ADORA1	UBERON_0001016	https://doi.org/10.1002/9781118098141.ch2
diuresis	nervous system	inhibition_general	HP_0000103	ENSG00000163485	""	Urban et al. (2012)	ADORA1	UBERON_0001016	https://doi.org/10.1002/9781118098141.ch2
natriuresis	nervous system	inhibition_general	GO_0035812	ENSG00000163485	""	Urban et al. (2012)	ADORA1	UBERON_0001016	https://doi.org/10.1002/9781118098141.ch2
bradycardia	nervous system	activation_general	HP_0001662	ENSG00000163485	""	Urban et al. (2012)	ADORA1	UBERON_0001016	https://doi.org/10.1002/9781118098141.ch2
vasoconstriction	nervous system	activation_general	""	ENSG00000163485	""	Urban et al. (2012)	ADORA1	UBERON_0001016	https://doi.org/10.1002/9781118098141.ch2
bronchoconstriction	nervous system	activation_general	EFO_0009836	ENSG00000163485	""	Urban et al. (2012)	ADORA1	UBERON_0001016	https://doi.org/10.1002/9781118098141.ch2
induction of sleep	nervous system	activation_general	EFO_0009843	ENSG00000163485	""	Urban et al. (2012)	ADORA1	UBERON_0001016	https://doi.org/10.1002/9781118098141.ch2
cardioprotection	renal	activation_general	""	ENSG00000163485	""	Urban et al. (2012)	ADORA1	UBERON_0001008	https://doi.org/10.1002/9781118098141.ch2
vasodilation	renal	inhibition_general	""	ENSG00000163485	""	Urban et al. (2012)	ADORA1	UBERON_0001008	https://doi.org/10.1002/9781118098141.ch2
diuresis	renal	inhibition_general	HP_0000103	ENSG00000163485	""	Urban et al. (2012)	ADORA1	UBERON_0001008	https://doi.org/10.1002/9781118098141.ch2
natriuresis	renal	inhibition_general	GO_0035812	ENSG00000163485	""	Urban et al. (2012)	ADORA1	UBERON_0001008	https://doi.org/10.1002/9781118098141.ch2
bradycardia	renal	activation_general	HP_0001662	ENSG00000163485	""	Urban et al. (2012)	ADORA1	UBERON_0001008	https://doi.org/10.1002/9781118098141.ch2
vasoconstriction	renal	activation_general	""	ENSG00000163485	""	Urban et al. (2012)	ADORA1	UBERON_0001008	https://doi.org/10.1002/9781118098141.ch2
bronchoconstriction	renal	activation_general	EFO_0009836	ENSG00000163485	""	Urban et al. (2012)	ADORA1	UBERON_0001008	https://doi.org/10.1002/9781118098141.ch2
induction of sleep	renal	activation_general	EFO_0009843	ENSG00000163485	""	Urban et al. (2012)	ADORA1	UBERON_0001008	https://doi.org/10.1002/9781118098141.ch2
cardioprotection	cardiovascular system	activation_general	""	ENSG00000163485	""	Urban et al. (2012)	ADORA1	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
vasodilation	cardiovascular system	inhibition_general	""	ENSG00000163485	""	Urban et al. (2012)	ADORA1	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
diuresis	cardiovascular system	inhibition_general	HP_0000103	ENSG00000163485	""	Urban et al. (2012)	ADORA1	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
natriuresis	cardiovascular system	inhibition_general	GO_0035812	ENSG00000163485	""	Urban et al. (2012)	ADORA1	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
bradycardia	cardiovascular system	activation_general	HP_0001662	ENSG00000163485	""	Urban et al. (2012)	ADORA1	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
vasoconstriction	cardiovascular system	activation_general	""	ENSG00000163485	""	Urban et al. (2012)	ADORA1	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
bronchoconstriction	cardiovascular system	activation_general	EFO_0009836	ENSG00000163485	""	Urban et al. (2012)	ADORA1	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
induction of sleep	cardiovascular system	activation_general	EFO_0009843	ENSG00000163485	""	Urban et al. (2012)	ADORA1	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
increased mortality of heart failure patients	nervous system	activation_general	""	ENSG00000151067	""	Urban et al. (2012)	CACNA1C	UBERON_0001016	https://doi.org/10.1002/9781118098141.ch2
hypotension	nervous system	inhibition_general	EFO_0005251	ENSG00000151067	""	Urban et al. (2012)	CACNA1C	UBERON_0001016	https://doi.org/10.1002/9781118098141.ch2
reflex tachycardia	nervous system	inhibition_general	""	ENSG00000151067	""	Urban et al. (2012)	CACNA1C	UBERON_0001016	https://doi.org/10.1002/9781118098141.ch2
arrhythmia	nervous system	inhibition_general	EFO_0004269	ENSG00000151067	""	Urban et al. (2012)	CACNA1C	UBERON_0001016	https://doi.org/10.1002/9781118098141.ch2
dizziness	nervous system	inhibition_general	EFO_0009847	ENSG00000151067	""	Urban et al. (2012)	CACNA1C	UBERON_0001016	https://doi.org/10.1002/9781118098141.ch2
headache	nervous system	inhibition_general	HP_0002315	ENSG00000151067	""	Urban et al. (2012)	CACNA1C	UBERON_0001016	https://doi.org/10.1002/9781118098141.ch2
redness in the face	nervous system	inhibition_general	HP_0031284	ENSG00000151067	""	Urban et al. (2012)	CACNA1C	UBERON_0001016	https://doi.org/10.1002/9781118098141.ch2
fluid buildup in the legs	nervous system	inhibition_general	""	ENSG00000151067	""	Urban et al. (2012)	CACNA1C	UBERON_0001016	https://doi.org/10.1002/9781118098141.ch2
effect on heart rate	nervous system	inhibition_general	HP_0031860	ENSG00000151067	""	Urban et al. (2012)	CACNA1C	UBERON_0001016	https://doi.org/10.1002/9781118098141.ch2
constipation	nervous system	inhibition_general	HP_0002019	ENSG00000151067	""	Urban et al. (2012)	CACNA1C	UBERON_0001016	https://doi.org/10.1002/9781118098141.ch2
induction of seizures	nervous system	activation_general	HP_0001250	ENSG00000151067	""	Urban et al. (2012)	CACNA1C	UBERON_0001016	https://doi.org/10.1002/9781118098141.ch2
increases in peripheral vascular resistance	nervous system	activation_general	""	ENSG00000151067	""	Urban et al. (2012)	CACNA1C	UBERON_0001016	https://doi.org/10.1002/9781118098141.ch2
increased systolic blood pressure	nervous system	activation_general	HP_0032263	ENSG00000151067	""	Urban et al. (2012)	CACNA1C	UBERON_0001016	https://doi.org/10.1002/9781118098141.ch2
arrhythmia	nervous system	activation_general	EFO_0004269	ENSG00000151067	""	Urban et al. (2012)	CACNA1C	UBERON_0001016	https://doi.org/10.1002/9781118098141.ch2
increased mortality of heart failure patients	cardiovascular system	activation_general	""	ENSG00000151067	""	Urban et al. (2012)	CACNA1C	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
hypotension	cardiovascular system	inhibition_general	EFO_0005251	ENSG00000151067	""	Urban et al. (2012)	CACNA1C	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
reflex tachycardia	cardiovascular system	inhibition_general	""	ENSG00000151067	""	Urban et al. (2012)	CACNA1C	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
arrhythmia	cardiovascular system	inhibition_general	EFO_0004269	ENSG00000151067	""	Urban et al. (2012)	CACNA1C	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
dizziness	cardiovascular system	inhibition_general	EFO_0009847	ENSG00000151067	""	Urban et al. (2012)	CACNA1C	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
headache	cardiovascular system	inhibition_general	HP_0002315	ENSG00000151067	""	Urban et al. (2012)	CACNA1C	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
redness in the face	cardiovascular system	inhibition_general	HP_0031284	ENSG00000151067	""	Urban et al. (2012)	CACNA1C	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
fluid buildup in the legs	cardiovascular system	inhibition_general	""	ENSG00000151067	""	Urban et al. (2012)	CACNA1C	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
effect on heart rate	cardiovascular system	inhibition_general	HP_0031860	ENSG00000151067	""	Urban et al. (2012)	CACNA1C	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
constipation	cardiovascular system	inhibition_general	HP_0002019	ENSG00000151067	""	Urban et al. (2012)	CACNA1C	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
induction of seizures	cardiovascular system	activation_general	HP_0001250	ENSG00000151067	""	Urban et al. (2012)	CACNA1C	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
increases in peripheral vascular resistance	cardiovascular system	activation_general	""	ENSG00000151067	""	Urban et al. (2012)	CACNA1C	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
increased systolic blood pressure	cardiovascular system	activation_general	HP_0032263	ENSG00000151067	""	Urban et al. (2012)	CACNA1C	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
arrhythmia	cardiovascular system	activation_general	EFO_0004269	ENSG00000151067	""	Urban et al. (2012)	CACNA1C	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
increased mortality of heart failure patients	gastrointestinal	activation_general	""	ENSG00000151067	""	Urban et al. (2012)	CACNA1C	UBERON_0005409	https://doi.org/10.1002/9781118098141.ch2
hypotension	gastrointestinal	inhibition_general	EFO_0005251	ENSG00000151067	""	Urban et al. (2012)	CACNA1C	UBERON_0005409	https://doi.org/10.1002/9781118098141.ch2
reflex tachycardia	gastrointestinal	inhibition_general	""	ENSG00000151067	""	Urban et al. (2012)	CACNA1C	UBERON_0005409	https://doi.org/10.1002/9781118098141.ch2
arrhythmia	gastrointestinal	inhibition_general	EFO_0004269	ENSG00000151067	""	Urban et al. (2012)	CACNA1C	UBERON_0005409	https://doi.org/10.1002/9781118098141.ch2
dizziness	gastrointestinal	inhibition_general	EFO_0009847	ENSG00000151067	""	Urban et al. (2012)	CACNA1C	UBERON_0005409	https://doi.org/10.1002/9781118098141.ch2
headache	gastrointestinal	inhibition_general	HP_0002315	ENSG00000151067	""	Urban et al. (2012)	CACNA1C	UBERON_0005409	https://doi.org/10.1002/9781118098141.ch2
redness in the face	gastrointestinal	inhibition_general	HP_0031284	ENSG00000151067	""	Urban et al. (2012)	CACNA1C	UBERON_0005409	https://doi.org/10.1002/9781118098141.ch2
fluid buildup in the legs	gastrointestinal	inhibition_general	""	ENSG00000151067	""	Urban et al. (2012)	CACNA1C	UBERON_0005409	https://doi.org/10.1002/9781118098141.ch2
effect on heart rate	gastrointestinal	inhibition_general	HP_0031860	ENSG00000151067	""	Urban et al. (2012)	CACNA1C	UBERON_0005409	https://doi.org/10.1002/9781118098141.ch2
constipation	gastrointestinal	inhibition_general	HP_0002019	ENSG00000151067	""	Urban et al. (2012)	CACNA1C	UBERON_0005409	https://doi.org/10.1002/9781118098141.ch2
induction of seizures	gastrointestinal	activation_general	HP_0001250	ENSG00000151067	""	Urban et al. (2012)	CACNA1C	UBERON_0005409	https://doi.org/10.1002/9781118098141.ch2
increases in peripheral vascular resistance	gastrointestinal	activation_general	""	ENSG00000151067	""	Urban et al. (2012)	CACNA1C	UBERON_0005409	https://doi.org/10.1002/9781118098141.ch2
increased systolic blood pressure	gastrointestinal	activation_general	HP_0032263	ENSG00000151067	""	Urban et al. (2012)	CACNA1C	UBERON_0005409	https://doi.org/10.1002/9781118098141.ch2
arrhythmia	gastrointestinal	activation_general	EFO_0004269	ENSG00000151067	""	Urban et al. (2012)	CACNA1C	UBERON_0005409	https://doi.org/10.1002/9781118098141.ch2
dopaminergic modulation	cardiovascular system	activation_general	""	ENSG00000138435	""	Urban et al. (2012)	CHRNA1	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
serotoninergic modulation	cardiovascular system	activation_general	""	ENSG00000138435	""	Urban et al. (2012)	CHRNA1	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
glutamatergic modulation	cardiovascular system	activation_general	""	ENSG00000138435	""	Urban et al. (2012)	CHRNA1	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
cognitive effects	cardiovascular system	activation_general	""	ENSG00000138435	""	Urban et al. (2012)	CHRNA1	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
motor effects	cardiovascular system	activation_general	""	ENSG00000138435	""	Urban et al. (2012)	CHRNA1	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
analgesic effects	cardiovascular system	activation_general	""	ENSG00000138435	""	Urban et al. (2012)	CHRNA1	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
autonomic effects	cardiovascular system	activation_general	""	ENSG00000138435	""	Urban et al. (2012)	CHRNA1	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
respiratory effects	cardiovascular system	activation_general	""	ENSG00000138435	""	Urban et al. (2012)	CHRNA1	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
cardiovascular effects	cardiovascular system	activation_general	""	ENSG00000138435	""	Urban et al. (2012)	CHRNA1	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
gastrointestinal effects	cardiovascular system	activation_general	""	ENSG00000138435	""	Urban et al. (2012)	CHRNA1	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
muscle relaxant	cardiovascular system	inhibition_general	""	ENSG00000138435	""	Urban et al. (2012)	CHRNA1	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
antihypertensive agent	cardiovascular system	inhibition_general	""	ENSG00000138435	""	Urban et al. (2012)	CHRNA1	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
dopaminergic modulation	respiratory	activation_general	""	ENSG00000138435	""	Urban et al. (2012)	CHRNA1	UBERON_0001004	https://doi.org/10.1002/9781118098141.ch2
serotoninergic modulation	respiratory	activation_general	""	ENSG00000138435	""	Urban et al. (2012)	CHRNA1	UBERON_0001004	https://doi.org/10.1002/9781118098141.ch2
glutamatergic modulation	respiratory	activation_general	""	ENSG00000138435	""	Urban et al. (2012)	CHRNA1	UBERON_0001004	https://doi.org/10.1002/9781118098141.ch2
cognitive effects	respiratory	activation_general	""	ENSG00000138435	""	Urban et al. (2012)	CHRNA1	UBERON_0001004	https://doi.org/10.1002/9781118098141.ch2
motor effects	respiratory	activation_general	""	ENSG00000138435	""	Urban et al. (2012)	CHRNA1	UBERON_0001004	https://doi.org/10.1002/9781118098141.ch2
analgesic effects	respiratory	activation_general	""	ENSG00000138435	""	Urban et al. (2012)	CHRNA1	UBERON_0001004	https://doi.org/10.1002/9781118098141.ch2
autonomic effects	respiratory	activation_general	""	ENSG00000138435	""	Urban et al. (2012)	CHRNA1	UBERON_0001004	https://doi.org/10.1002/9781118098141.ch2
respiratory effects	respiratory	activation_general	""	ENSG00000138435	""	Urban et al. (2012)	CHRNA1	UBERON_0001004	https://doi.org/10.1002/9781118098141.ch2
cardiovascular effects	respiratory	activation_general	""	ENSG00000138435	""	Urban et al. (2012)	CHRNA1	UBERON_0001004	https://doi.org/10.1002/9781118098141.ch2
gastrointestinal effects	respiratory	activation_general	""	ENSG00000138435	""	Urban et al. (2012)	CHRNA1	UBERON_0001004	https://doi.org/10.1002/9781118098141.ch2
muscle relaxant	respiratory	inhibition_general	""	ENSG00000138435	""	Urban et al. (2012)	CHRNA1	UBERON_0001004	https://doi.org/10.1002/9781118098141.ch2
antihypertensive agent	respiratory	inhibition_general	""	ENSG00000138435	""	Urban et al. (2012)	CHRNA1	UBERON_0001004	https://doi.org/10.1002/9781118098141.ch2
dopaminergic modulation	nervous system	activation_general	""	ENSG00000138435	""	Urban et al. (2012)	CHRNA1	UBERON_0001016	https://doi.org/10.1002/9781118098141.ch2
serotoninergic modulation	nervous system	activation_general	""	ENSG00000138435	""	Urban et al. (2012)	CHRNA1	UBERON_0001016	https://doi.org/10.1002/9781118098141.ch2
glutamatergic modulation	nervous system	activation_general	""	ENSG00000138435	""	Urban et al. (2012)	CHRNA1	UBERON_0001016	https://doi.org/10.1002/9781118098141.ch2
cognitive effects	nervous system	activation_general	""	ENSG00000138435	""	Urban et al. (2012)	CHRNA1	UBERON_0001016	https://doi.org/10.1002/9781118098141.ch2
motor effects	nervous system	activation_general	""	ENSG00000138435	""	Urban et al. (2012)	CHRNA1	UBERON_0001016	https://doi.org/10.1002/9781118098141.ch2
analgesic effects	nervous system	activation_general	""	ENSG00000138435	""	Urban et al. (2012)	CHRNA1	UBERON_0001016	https://doi.org/10.1002/9781118098141.ch2
autonomic effects	nervous system	activation_general	""	ENSG00000138435	""	Urban et al. (2012)	CHRNA1	UBERON_0001016	https://doi.org/10.1002/9781118098141.ch2
respiratory effects	nervous system	activation_general	""	ENSG00000138435	""	Urban et al. (2012)	CHRNA1	UBERON_0001016	https://doi.org/10.1002/9781118098141.ch2
cardiovascular effects	nervous system	activation_general	""	ENSG00000138435	""	Urban et al. (2012)	CHRNA1	UBERON_0001016	https://doi.org/10.1002/9781118098141.ch2
gastrointestinal effects	nervous system	activation_general	""	ENSG00000138435	""	Urban et al. (2012)	CHRNA1	UBERON_0001016	https://doi.org/10.1002/9781118098141.ch2
muscle relaxant	nervous system	inhibition_general	""	ENSG00000138435	""	Urban et al. (2012)	CHRNA1	UBERON_0001016	https://doi.org/10.1002/9781118098141.ch2
antihypertensive agent	nervous system	inhibition_general	""	ENSG00000138435	""	Urban et al. (2012)	CHRNA1	UBERON_0001016	https://doi.org/10.1002/9781118098141.ch2
dopaminergic modulation	gastrointestinal	activation_general	""	ENSG00000138435	""	Urban et al. (2012)	CHRNA1	UBERON_0005409	https://doi.org/10.1002/9781118098141.ch2
serotoninergic modulation	gastrointestinal	activation_general	""	ENSG00000138435	""	Urban et al. (2012)	CHRNA1	UBERON_0005409	https://doi.org/10.1002/9781118098141.ch2
glutamatergic modulation	gastrointestinal	activation_general	""	ENSG00000138435	""	Urban et al. (2012)	CHRNA1	UBERON_0005409	https://doi.org/10.1002/9781118098141.ch2
cognitive effects	gastrointestinal	activation_general	""	ENSG00000138435	""	Urban et al. (2012)	CHRNA1	UBERON_0005409	https://doi.org/10.1002/9781118098141.ch2
motor effects	gastrointestinal	activation_general	""	ENSG00000138435	""	Urban et al. (2012)	CHRNA1	UBERON_0005409	https://doi.org/10.1002/9781118098141.ch2
analgesic effects	gastrointestinal	activation_general	""	ENSG00000138435	""	Urban et al. (2012)	CHRNA1	UBERON_0005409	https://doi.org/10.1002/9781118098141.ch2
autonomic effects	gastrointestinal	activation_general	""	ENSG00000138435	""	Urban et al. (2012)	CHRNA1	UBERON_0005409	https://doi.org/10.1002/9781118098141.ch2
respiratory effects	gastrointestinal	activation_general	""	ENSG00000138435	""	Urban et al. (2012)	CHRNA1	UBERON_0005409	https://doi.org/10.1002/9781118098141.ch2
cardiovascular effects	gastrointestinal	activation_general	""	ENSG00000138435	""	Urban et al. (2012)	CHRNA1	UBERON_0005409	https://doi.org/10.1002/9781118098141.ch2
gastrointestinal effects	gastrointestinal	activation_general	""	ENSG00000138435	""	Urban et al. (2012)	CHRNA1	UBERON_0005409	https://doi.org/10.1002/9781118098141.ch2
muscle relaxant	gastrointestinal	inhibition_general	""	ENSG00000138435	""	Urban et al. (2012)	CHRNA1	UBERON_0005409	https://doi.org/10.1002/9781118098141.ch2
antihypertensive agent	gastrointestinal	inhibition_general	""	ENSG00000138435	""	Urban et al. (2012)	CHRNA1	UBERON_0005409	https://doi.org/10.1002/9781118098141.ch2
vasoconstriction	cardiovascular system	activation_general	""	ENSG00000151617	""	Urban et al. (2012)	EDNRA	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
teratogenicity	cardiovascular system	inhibition_developmental toxicity	EFO_0009880	ENSG00000151617	""	Urban et al. (2012)	EDNRA	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
bronchoconstriction	cardiovascular system	activation_general	EFO_0009836	ENSG00000151617	""	Urban et al. (2012)	EDNRA	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
aldosterone secretion	cardiovascular system	activation_general	GO_0035932	ENSG00000151617	""	Urban et al. (2012)	EDNRA	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
osteoblast proliferation	cardiovascular system	activation_general	GO_0033687	ENSG00000151617	""	Urban et al. (2012)	EDNRA	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
hyperglycemia	cardiovascular system	inhibition_general	HP_0003074	ENSG00000142208	""	Urban et al. (2012)	AKT1	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
apoptototic cell death in cancer cells	cardiovascular system	inhibition_general	""	ENSG00000142208	""	Urban et al. (2012)	AKT1	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
antiinflammatory	cardiovascular system	inhibition_general	GO_0050728	ENSG00000073756	""	Urban et al. (2012)	PTGS2	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
inhibits some mitogenic actions	cardiovascular system	inhibition_general	GO_0045839	ENSG00000073756	""	Urban et al. (2012)	PTGS2	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
heart failure	cardiovascular system	inhibition_general	EFO_0000319	ENSG00000073756	""	Urban et al. (2012)	PTGS2	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
clotting	cardiovascular system	inhibition_general	EFO_0000319	ENSG00000073756	""	Urban et al. (2012)	PTGS2	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
increased risk of wound infections	cardiovascular system	inhibition_general	""	ENSG00000073756	""	Urban et al. (2012)	PTGS2	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
supraventricular tachycardia	cardiovascular system	inhibition_general	HP_0004755	ENSG00000073756	""	Urban et al. (2012)	PTGS2	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
hypotension	cardiovascular system	inhibition_general	EFO_0005251	ENSG00000073756	""	Urban et al. (2012)	PTGS2	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
myocardial infarction	cardiovascular system	inhibition_general	EFO_0000612	ENSG00000073756	""	Urban et al. (2012)	PTGS2	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
cerebrovascular events	cardiovascular system	inhibition_general	""	ENSG00000073756	""	Urban et al. (2012)	PTGS2	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
increased blood pressure	nervous system	activation_general	HP_0032263	ENSG00000168539	""	Urban et al. (2012)	CHRM1	UBERON_0001016	https://doi.org/10.1002/9781118098141.ch2
disruption of cognitive functions such as learning and memory	nervous system	inhibition_general	HP_0100543	ENSG00000168539	""	Urban et al. (2012)	CHRM1	UBERON_0001016	https://doi.org/10.1002/9781118098141.ch2
increased heart rate	nervous system	activation_general	HP_0001649	ENSG00000168539	""	Urban et al. (2012)	CHRM1	UBERON_0001016	https://doi.org/10.1002/9781118098141.ch2
increased sympathetic outflow	nervous system	activation_general	""	ENSG00000168539	""	Urban et al. (2012)	CHRM1	UBERON_0001016	https://doi.org/10.1002/9781118098141.ch2
gastrointestinal side effects	nervous system	activation_general	HP_0012719	ENSG00000168539	""	Urban et al. (2012)	CHRM1	UBERON_0001016	https://doi.org/10.1002/9781118098141.ch2
regulation of circadian rhythm	nervous system	activation_general	GO_0042752	ENSG00000168539	""	Urban et al. (2012)	CHRM1	UBERON_0001016	https://doi.org/10.1002/9781118098141.ch2
increased blood pressure	gastrointestinal	activation_general	HP_0032263	ENSG00000168539	""	Urban et al. (2012)	CHRM1	UBERON_0005409	https://doi.org/10.1002/9781118098141.ch2
disruption of cognitive functions such as learning and memory	gastrointestinal	inhibition_general	HP_0100543	ENSG00000168539	""	Urban et al. (2012)	CHRM1	UBERON_0005409	https://doi.org/10.1002/9781118098141.ch2
increased heart rate	gastrointestinal	activation_general	HP_0001649	ENSG00000168539	""	Urban et al. (2012)	CHRM1	UBERON_0005409	https://doi.org/10.1002/9781118098141.ch2
increased sympathetic outflow	gastrointestinal	activation_general	""	ENSG00000168539	""	Urban et al. (2012)	CHRM1	UBERON_0005409	https://doi.org/10.1002/9781118098141.ch2
gastrointestinal side effects	gastrointestinal	activation_general	HP_0012719	ENSG00000168539	""	Urban et al. (2012)	CHRM1	UBERON_0005409	https://doi.org/10.1002/9781118098141.ch2
regulation of circadian rhythm	gastrointestinal	activation_general	GO_0042752	ENSG00000168539	""	Urban et al. (2012)	CHRM1	UBERON_0005409	https://doi.org/10.1002/9781118098141.ch2
increased blood pressure	cardiovascular system	activation_general	HP_0032263	ENSG00000168539	""	Urban et al. (2012)	CHRM1	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
disruption of cognitive functions such as learning and memory	cardiovascular system	inhibition_general	HP_0100543	ENSG00000168539	""	Urban et al. (2012)	CHRM1	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
increased heart rate	cardiovascular system	activation_general	HP_0001649	ENSG00000168539	""	Urban et al. (2012)	CHRM1	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
increased sympathetic outflow	cardiovascular system	activation_general	""	ENSG00000168539	""	Urban et al. (2012)	CHRM1	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
gastrointestinal side effects	cardiovascular system	activation_general	HP_0012719	ENSG00000168539	""	Urban et al. (2012)	CHRM1	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
regulation of circadian rhythm	cardiovascular system	activation_general	GO_0042752	ENSG00000168539	""	Urban et al. (2012)	CHRM1	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
startle reflex	cardiovascular system	activation_general	""	ENSG00000184160	""	Urban et al. (2012)	ADRA2C	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
stress response	cardiovascular system	activation_general	""	ENSG00000184160	""	Urban et al. (2012)	ADRA2C	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
locomotion	cardiovascular system	activation_general	""	ENSG00000184160	""	Urban et al. (2012)	ADRA2C	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
venous contraction (contraction of human saphenous vein)	cardiovascular system	activation_general	""	ENSG00000184160	""	Urban et al. (2012)	ADRA2C	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
hypertension	cardiovascular system	activation_general	EFO_0000537	ENSG00000184160	""	Urban et al. (2012)	ADRA2C	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
cardiac ischemia	cardiovascular system	activation_general	EFO_1001375	ENSG00000184160	""	Urban et al. (2012)	ADRA2C	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
startle reflex	central nervous system	activation_general	""	ENSG00000184160	""	Urban et al. (2012)	ADRA2C	UBERON_0001017	https://doi.org/10.1002/9781118098141.ch2
stress response	central nervous system	activation_general	""	ENSG00000184160	""	Urban et al. (2012)	ADRA2C	UBERON_0001017	https://doi.org/10.1002/9781118098141.ch2
locomotion	central nervous system	activation_general	""	ENSG00000184160	""	Urban et al. (2012)	ADRA2C	UBERON_0001017	https://doi.org/10.1002/9781118098141.ch2
venous contraction (contraction of human saphenous vein)	central nervous system	activation_general	""	ENSG00000184160	""	Urban et al. (2012)	ADRA2C	UBERON_0001017	https://doi.org/10.1002/9781118098141.ch2
hypertension	central nervous system	activation_general	EFO_0000537	ENSG00000184160	""	Urban et al. (2012)	ADRA2C	UBERON_0001017	https://doi.org/10.1002/9781118098141.ch2
cardiac ischemia	central nervous system	activation_general	EFO_1001375	ENSG00000184160	""	Urban et al. (2012)	ADRA2C	UBERON_0001017	https://doi.org/10.1002/9781118098141.ch2
immunosuppression	immune	activation_general	GO_0050777	ENSG00000282608	""	Urban et al. (2012)	ADORA3	UBERON_0002405	https://doi.org/10.1002/9781118098141.ch2
myocardial ischemia (inferred by author)	immune	inhibition_general	EFO_1001375	ENSG00000282608	""	Urban et al. (2012)	ADORA3	UBERON_0002405	https://doi.org/10.1002/9781118098141.ch2
proinflammatory effects (inferred by author)	immune	inhibition_general	GO_0050729	ENSG00000282608	""	Urban et al. (2012)	ADORA3	UBERON_0002405	https://doi.org/10.1002/9781118098141.ch2
hypertension (inferred by author)	immune	inhibition_general	EFO_0000537	ENSG00000282608	""	Urban et al. (2012)	ADORA3	UBERON_0002405	https://doi.org/10.1002/9781118098141.ch2
interference with the regulation of cell growth (inferred by author)	immune	inhibition_general	""	ENSG00000282608	""	Urban et al. (2012)	ADORA3	UBERON_0002405	https://doi.org/10.1002/9781118098141.ch2
hypotension	immune	activation_general	EFO_0005251	ENSG00000282608	""	Urban et al. (2012)	ADORA3	UBERON_0002405	https://doi.org/10.1002/9781118098141.ch2
antiischaemic (cardioprotective)	immune	activation_general	""	ENSG00000282608	""	Urban et al. (2012)	ADORA3	UBERON_0002405	https://doi.org/10.1002/9781118098141.ch2
proischemic (cerebral)	immune	activation_general	""	ENSG00000282608	""	Urban et al. (2012)	ADORA3	UBERON_0002405	https://doi.org/10.1002/9781118098141.ch2
cell necrosis	immune	activation_general	EFO_0009426	ENSG00000282608	""	Urban et al. (2012)	ADORA3	UBERON_0002405	https://doi.org/10.1002/9781118098141.ch2
cell proliferation	immune	activation_general	GO_0008283	ENSG00000282608	""	Urban et al. (2012)	ADORA3	UBERON_0002405	https://doi.org/10.1002/9781118098141.ch2
angiogenesis	immune	activation_general	""	ENSG00000282608	""	Urban et al. (2012)	ADORA3	UBERON_0002405	https://doi.org/10.1002/9781118098141.ch2
immunosuppression	cardiovascular system	activation_general	GO_0050777	ENSG00000282608	""	Urban et al. (2012)	ADORA3	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
myocardial ischemia (inferred by author)	cardiovascular system	inhibition_general	EFO_1001375	ENSG00000282608	""	Urban et al. (2012)	ADORA3	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
proinflammatory effects (inferred by author)	cardiovascular system	inhibition_general	GO_0050729	ENSG00000282608	""	Urban et al. (2012)	ADORA3	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
hypertension (inferred by author)	cardiovascular system	inhibition_general	EFO_0000537	ENSG00000282608	""	Urban et al. (2012)	ADORA3	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
interference with the regulation of cell growth (inferred by author)	cardiovascular system	inhibition_general	""	ENSG00000282608	""	Urban et al. (2012)	ADORA3	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
hypotension	cardiovascular system	activation_general	EFO_0005251	ENSG00000282608	""	Urban et al. (2012)	ADORA3	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
antiischaemic (cardioprotective)	cardiovascular system	activation_general	""	ENSG00000282608	""	Urban et al. (2012)	ADORA3	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
proischemic (cerebral)	cardiovascular system	activation_general	""	ENSG00000282608	""	Urban et al. (2012)	ADORA3	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
cell necrosis	cardiovascular system	activation_general	EFO_0009426	ENSG00000282608	""	Urban et al. (2012)	ADORA3	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
cell proliferation	cardiovascular system	activation_general	GO_0008283	ENSG00000282608	""	Urban et al. (2012)	ADORA3	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
angiogenesis	cardiovascular system	activation_general	""	ENSG00000282608	""	Urban et al. (2012)	ADORA3	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
bradycardia	cardiovascular system	activation_general	HP_0001662	ENSG00000181072	""	Urban et al. (2012)	CHRM2	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
palpitations	cardiovascular system	inhibition_general	HP_0001962	ENSG00000181072	""	Urban et al. (2012)	CHRM2	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
dysrhythmia	cardiovascular system	inhibition_general	EFO_0004269	ENSG00000181072	""	Urban et al. (2012)	CHRM2	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
peripheral edema	cardiovascular system	inhibition_general	""	ENSG00000181072	""	Urban et al. (2012)	CHRM2	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
tachycardia	cardiovascular system	inhibition_general	HP_0001649	ENSG00000181072	""	Urban et al. (2012)	CHRM2	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
vagal effects (key role in control of heart rate and smooth muscle activity)	cardiovascular system	activation_general	""	ENSG00000181072	""	Urban et al. (2012)	CHRM2	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
smooth muscle relaxation	cardiovascular system	activation_general	""	ENSG00000169252	""	Urban et al. (2012)	ADRB2	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
bradycardia	cardiovascular system	inhibition_general	HP_0001662	ENSG00000169252	""	Urban et al. (2012)	ADRB2	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
cardiovascular performance	cardiovascular system	inhibition_general	EFO_0000319	ENSG00000169252	""	Urban et al. (2012)	ADRB2	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
cardiac contractility	cardiovascular system	activation_general	GO_0045823	ENSG00000169252	""	Urban et al. (2012)	ADRB2	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
hypotonia	cardiovascular system	activation_general	HP_0001252	ENSG00000169252	""	Urban et al. (2012)	ADRB2	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
vasodilatation of the vascular beds of skeletal muscle	cardiovascular system	activation_general	""	ENSG00000169252	""	Urban et al. (2012)	ADRB2	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
insomnia	gastrointestinal	inhibition_general	EFO_0004698	ENSG00000108576	""	Urban et al. (2012)	SLC6A4	UBERON_0005409	https://doi.org/10.1002/9781118098141.ch2
anxiety	gastrointestinal	inhibition_general	EFO_0005230	ENSG00000108576	""	Urban et al. (2012)	SLC6A4	UBERON_0005409	https://doi.org/10.1002/9781118098141.ch2
nausea and vomiting	gastrointestinal	inhibition_general	HP_0002017	ENSG00000108576	""	Urban et al. (2012)	SLC6A4	UBERON_0005409	https://doi.org/10.1002/9781118098141.ch2
sexual dysfunction	gastrointestinal	inhibition_general	EFO_0004714	ENSG00000108576	""	Urban et al. (2012)	SLC6A4	UBERON_0005409	https://doi.org/10.1002/9781118098141.ch2
gastrointestinal cramps	gastrointestinal	inhibition_general	HP_0032155	ENSG00000108576	""	Urban et al. (2012)	SLC6A4	UBERON_0005409	https://doi.org/10.1002/9781118098141.ch2
diarrhea	gastrointestinal	inhibition_general	HP_0002014	ENSG00000108576	""	Urban et al. (2012)	SLC6A4	UBERON_0005409	https://doi.org/10.1002/9781118098141.ch2
headache	gastrointestinal	inhibition_general	HP_0002315	ENSG00000108576	""	Urban et al. (2012)	SLC6A4	UBERON_0005409	https://doi.org/10.1002/9781118098141.ch2
valvular heart disease	gastrointestinal	inhibition_general	EFO_0009551	ENSG00000108576	""	Urban et al. (2012)	SLC6A4	UBERON_0005409	https://doi.org/10.1002/9781118098141.ch2
primary pulmonary hypertension	gastrointestinal	inhibition_general	MONDO_0001999	ENSG00000108576	""	Urban et al. (2012)	SLC6A4	UBERON_0005409	https://doi.org/10.1002/9781118098141.ch2
insomnia	cardiovascular system	inhibition_general	EFO_0004698	ENSG00000108576	""	Urban et al. (2012)	SLC6A4	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
anxiety	cardiovascular system	inhibition_general	EFO_0005230	ENSG00000108576	""	Urban et al. (2012)	SLC6A4	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
nausea and vomiting	cardiovascular system	inhibition_general	HP_0002017	ENSG00000108576	""	Urban et al. (2012)	SLC6A4	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
sexual dysfunction	cardiovascular system	inhibition_general	EFO_0004714	ENSG00000108576	""	Urban et al. (2012)	SLC6A4	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
gastrointestinal cramps	cardiovascular system	inhibition_general	HP_0032155	ENSG00000108576	""	Urban et al. (2012)	SLC6A4	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
diarrhea	cardiovascular system	inhibition_general	HP_0002014	ENSG00000108576	""	Urban et al. (2012)	SLC6A4	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
headache	cardiovascular system	inhibition_general	HP_0002315	ENSG00000108576	""	Urban et al. (2012)	SLC6A4	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
valvular heart disease	cardiovascular system	inhibition_general	EFO_0009551	ENSG00000108576	""	Urban et al. (2012)	SLC6A4	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
primary pulmonary hypertension	cardiovascular system	inhibition_general	MONDO_0001999	ENSG00000108576	""	Urban et al. (2012)	SLC6A4	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
insomnia	nervous system	inhibition_general	EFO_0004698	ENSG00000108576	""	Urban et al. (2012)	SLC6A4	UBERON_0001016	https://doi.org/10.1002/9781118098141.ch2
anxiety	nervous system	inhibition_general	EFO_0005230	ENSG00000108576	""	Urban et al. (2012)	SLC6A4	UBERON_0001016	https://doi.org/10.1002/9781118098141.ch2
nausea and vomiting	nervous system	inhibition_general	HP_0002017	ENSG00000108576	""	Urban et al. (2012)	SLC6A4	UBERON_0001016	https://doi.org/10.1002/9781118098141.ch2
sexual dysfunction	nervous system	inhibition_general	EFO_0004714	ENSG00000108576	""	Urban et al. (2012)	SLC6A4	UBERON_0001016	https://doi.org/10.1002/9781118098141.ch2
gastrointestinal cramps	nervous system	inhibition_general	HP_0032155	ENSG00000108576	""	Urban et al. (2012)	SLC6A4	UBERON_0001016	https://doi.org/10.1002/9781118098141.ch2
diarrhea	nervous system	inhibition_general	HP_0002014	ENSG00000108576	""	Urban et al. (2012)	SLC6A4	UBERON_0001016	https://doi.org/10.1002/9781118098141.ch2
headache	nervous system	inhibition_general	HP_0002315	ENSG00000108576	""	Urban et al. (2012)	SLC6A4	UBERON_0001016	https://doi.org/10.1002/9781118098141.ch2
valvular heart disease	nervous system	inhibition_general	EFO_0009551	ENSG00000108576	""	Urban et al. (2012)	SLC6A4	UBERON_0001016	https://doi.org/10.1002/9781118098141.ch2
primary pulmonary hypertension	nervous system	inhibition_general	MONDO_0001999	ENSG00000108576	""	Urban et al. (2012)	SLC6A4	UBERON_0001016	https://doi.org/10.1002/9781118098141.ch2
cardiac valvulopathy	cardiovascular system	activation_general	""	ENSG00000135914	""	Urban et al. (2012)	HTR2B	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
cardiac development effect leading to cardiomyopathy (based on knockout mouse data)	cardiovascular system	inhibition_developmental toxicity	EFO_0000318	ENSG00000135914	""	Urban et al. (2012)	HTR2B	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
hypertension	cardiovascular system	activation_general	EFO_0000537	ENSG00000135914	""	Urban et al. (2012)	HTR2B	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
increased mortality in heart failure patients	cardiovascular system	inhibition_chronic	""	ENSG00000152270	""	Urban et al. (2012)	PDE3B	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
ventricular arrhythmias	cardiovascular system	inhibition_general	HP_0004308	ENSG00000152270	""	Urban et al. (2012)	PDE3B	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
tachycardia	cardiovascular system	inhibition_general	HP_0001649	ENSG00000152270	""	Urban et al. (2012)	PDE3B	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
hypotension	cardiovascular system	inhibition_general	EFO_0005251	ENSG00000152270	""	Urban et al. (2012)	PDE3B	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
thrombocytopenia	cardiovascular system	inhibition_chronic	HP_0001873	ENSG00000152270	""	Urban et al. (2012)	PDE3B	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
cardiac muscle stimulation	cardiovascular system	activation_general	GO_0045823	ENSG00000043591	""	Urban et al. (2012)	ADRB1	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
increased heart rate	cardiovascular system	activation_general	GO_0045823	ENSG00000043591	""	Urban et al. (2012)	ADRB1	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
increased force of contraction	cardiovascular system	activation_general	GO_0045823	ENSG00000043591	""	Urban et al. (2012)	ADRB1	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
cardiovascular performance	cardiovascular system	inhibition_general	EFO_0000319	ENSG00000043591	""	Urban et al. (2012)	ADRB1	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
bradycardia	cardiovascular system	inhibition_general	HP_0001662	ENSG00000043591	""	Urban et al. (2012)	ADRB1	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
relaxation of blood vessels	cardiovascular system	activation_general	GO_0060087	ENSG00000043591	""	Urban et al. (2012)	ADRB1	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
anxiolytic effects	nervous system	activation_general	EFO_0009874	ENSG00000164128	""	Urban et al. (2012)	NPY1R	UBERON_0001016	https://doi.org/10.1002/9781118098141.ch2
vasodilation (especially venous)	nervous system	inhibition_general	""	ENSG00000164128	""	Urban et al. (2012)	NPY1R	UBERON_0001016	https://doi.org/10.1002/9781118098141.ch2
increase in anxiety-related effects	nervous system	inhibition_general	EFO_0005230	ENSG00000164128	""	Urban et al. (2012)	NPY1R	UBERON_0001016	https://doi.org/10.1002/9781118098141.ch2
vasoconstriction	nervous system	activation_general	""	ENSG00000164128	""	Urban et al. (2012)	NPY1R	UBERON_0001016	https://doi.org/10.1002/9781118098141.ch2
vasodilation in subcutaneous arteries	nervous system	activation_general	""	ENSG00000164128	""	Urban et al. (2012)	NPY1R	UBERON_0001016	https://doi.org/10.1002/9781118098141.ch2
smooth-muscle cell growth	nervous system	activation_general	EFO_0009829	ENSG00000164128	""	Urban et al. (2012)	NPY1R	UBERON_0001016	https://doi.org/10.1002/9781118098141.ch2
atherosclerosis	nervous system	activation_general	EFO_0009829	ENSG00000164128	""	Urban et al. (2012)	NPY1R	UBERON_0001016	https://doi.org/10.1002/9781118098141.ch2
restenosis	nervous system	activation_general	EFO_0009829	ENSG00000164128	""	Urban et al. (2012)	NPY1R	UBERON_0001016	https://doi.org/10.1002/9781118098141.ch2
stroke	nervous system	activation_general	EFO_0009829	ENSG00000164128	""	Urban et al. (2012)	NPY1R	UBERON_0001016	https://doi.org/10.1002/9781118098141.ch2
stimulation of feeding behavior	nervous system	activation_general	HP_0100738	ENSG00000164128	""	Urban et al. (2012)	NPY1R	UBERON_0001016	https://doi.org/10.1002/9781118098141.ch2
anxiolytic effects	cardiovascular system	activation_general	EFO_0009874	ENSG00000164128	""	Urban et al. (2012)	NPY1R	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
vasodilation (especially venous)	cardiovascular system	inhibition_general	""	ENSG00000164128	""	Urban et al. (2012)	NPY1R	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
increase in anxiety-related effects	cardiovascular system	inhibition_general	EFO_0005230	ENSG00000164128	""	Urban et al. (2012)	NPY1R	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
vasoconstriction	cardiovascular system	activation_general	""	ENSG00000164128	""	Urban et al. (2012)	NPY1R	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
vasodilation in subcutaneous arteries	cardiovascular system	activation_general	""	ENSG00000164128	""	Urban et al. (2012)	NPY1R	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
smooth-muscle cell growth	cardiovascular system	activation_general	EFO_0009829	ENSG00000164128	""	Urban et al. (2012)	NPY1R	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
atherosclerosis	cardiovascular system	activation_general	EFO_0009829	ENSG00000164128	""	Urban et al. (2012)	NPY1R	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
restenosis	cardiovascular system	activation_general	EFO_0009829	ENSG00000164128	""	Urban et al. (2012)	NPY1R	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
stroke	cardiovascular system	activation_general	EFO_0009829	ENSG00000164128	""	Urban et al. (2012)	NPY1R	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
stimulation of feeding behavior	cardiovascular system	activation_general	HP_0100738	ENSG00000164128	""	Urban et al. (2012)	NPY1R	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
myocardial fibrosis	cardiovascular system	activation_general	HP_0001685	ENSG00000166148	""	Urban et al. (2012)	AVPR1A	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
hypertrophy	cardiovascular system	activation_general	EFO_0002503	ENSG00000166148	""	Urban et al. (2012)	AVPR1A	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
vasoconstriction	cardiovascular system	activation_general	""	ENSG00000166148	""	Urban et al. (2012)	AVPR1A	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
heart failure	cardiovascular system	activation_general	EFO_0003144	ENSG00000166148	""	Urban et al. (2012)	AVPR1A	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
stimulation of gastric acid secretion	gastrointestinal	activation_general	GO_0060454	ENSG00000113749	""	Urban et al. (2012)	HRH2	UBERON_0005409	https://doi.org/10.1002/9781118098141.ch2
reduction of gastric acid secretion	gastrointestinal	inhibition_general	GO_0060455	ENSG00000113749	""	Urban et al. (2012)	HRH2	UBERON_0005409	https://doi.org/10.1002/9781118098141.ch2
positive inotropic effect on the human ventricle	gastrointestinal	activation_general	GO_0045823	ENSG00000113749	""	Urban et al. (2012)	HRH2	UBERON_0005409	https://doi.org/10.1002/9781118098141.ch2
emesis	gastrointestinal	activation_general	HP_0002017	ENSG00000113749	""	Urban et al. (2012)	HRH2	UBERON_0005409	https://doi.org/10.1002/9781118098141.ch2
stimulation of gastric acid secretion	cardiovascular system	activation_general	GO_0060454	ENSG00000113749	""	Urban et al. (2012)	HRH2	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
reduction of gastric acid secretion	cardiovascular system	inhibition_general	GO_0060455	ENSG00000113749	""	Urban et al. (2012)	HRH2	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
positive inotropic effect on the human ventricle	cardiovascular system	activation_general	GO_0045823	ENSG00000113749	""	Urban et al. (2012)	HRH2	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
emesis	cardiovascular system	activation_general	HP_0002017	ENSG00000113749	""	Urban et al. (2012)	HRH2	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
cardiomyocyte hyperproliferation	cardiovascular system	activation_general	""	ENSG00000123374	""	Urban et al. (2012)	CDK2	UBERON_0004535	https://doi.org/10.1002/9781118098141.ch2
bronchoconstriction	gastrointestinal	activation_general	EFO_0009836	ENSG00000133019	23197038	Bowes et al. (2012)	CHRM3	UBERON_0005409	""
constipation	gastrointestinal	inhibition_general	HP_0002019	ENSG00000133019	23197038	Bowes et al. (2012)	CHRM3	UBERON_0005409	""
blurred vision	gastrointestinal	inhibition_general	HP_0000622	ENSG00000133019	23197038	Bowes et al. (2012)	CHRM3	UBERON_0005409	""
pupil dilation	gastrointestinal	inhibition_general	HP_0011499	ENSG00000133019	23197038	Bowes et al. (2012)	CHRM3	UBERON_0005409	""
dry mouth	gastrointestinal	inhibition_general	EFO_0009869	ENSG00000133019	23197038	Bowes et al. (2012)	CHRM3	UBERON_0005409	""
increased salivation	gastrointestinal	activation_general	GO_0046878	ENSG00000133019	23197038	Bowes et al. (2012)	CHRM3	UBERON_0005409	""
gastrointestinal smooth muscle constriction	gastrointestinal	activation_general	GO_0014831	ENSG00000133019	23197038	Bowes et al. (2012)	CHRM3	UBERON_0005409	""
urinary smooth muscle constriction	gastrointestinal	activation_general	GO_0014848	ENSG00000133019	23197038	Bowes et al. (2012)	CHRM3	UBERON_0005409	""
bronchoconstriction	pulmonary	activation_general	EFO_0009836	ENSG00000133019	23197038	Bowes et al. (2012)	CHRM3	UBERON_0002048	""
constipation	pulmonary	inhibition_general	HP_0002019	ENSG00000133019	23197038	Bowes et al. (2012)	CHRM3	UBERON_0002048	""
blurred vision	pulmonary	inhibition_general	HP_0000622	ENSG00000133019	23197038	Bowes et al. (2012)	CHRM3	UBERON_0002048	""
pupil dilation	pulmonary	inhibition_general	HP_0011499	ENSG00000133019	23197038	Bowes et al. (2012)	CHRM3	UBERON_0002048	""
dry mouth	pulmonary	inhibition_general	EFO_0009869	ENSG00000133019	23197038	Bowes et al. (2012)	CHRM3	UBERON_0002048	""
increased salivation	pulmonary	activation_general	GO_0046878	ENSG00000133019	23197038	Bowes et al. (2012)	CHRM3	UBERON_0002048	""
gastrointestinal smooth muscle constriction	pulmonary	activation_general	GO_0014831	ENSG00000133019	23197038	Bowes et al. (2012)	CHRM3	UBERON_0002048	""
urinary smooth muscle constriction	pulmonary	activation_general	GO_0014848	ENSG00000133019	23197038	Bowes et al. (2012)	CHRM3	UBERON_0002048	""
vascular relaxation	cardiovascular system	activation_general	GO_0060087	ENSG00000184845	23197038	Bowes et al. (2012)	DRD1	UBERON_0004535	""
dyskinesia	cardiovascular system	inhibition_general	EFO_1000904	ENSG00000184845	23197038	Bowes et al. (2012)	DRD1	UBERON_0004535	""
parkinsonian symptoms (tremors)	cardiovascular system	inhibition_general	HP_0001300	ENSG00000184845	23197038	Bowes et al. (2012)	DRD1	UBERON_0004535	""
anti-emetic effects	cardiovascular system	inhibition_general	EFO_0009848	ENSG00000184845	23197038	Bowes et al. (2012)	DRD1	UBERON_0004535	""
depression	cardiovascular system	inhibition_general	MONDO_0002050	ENSG00000184845	23197038	Bowes et al. (2012)	DRD1	UBERON_0004535	""
anxiety	cardiovascular system	inhibition_general	EFO_0005230	ENSG00000184845	23197038	Bowes et al. (2012)	DRD1	UBERON_0004535	""
suicidal intent	cardiovascular system	inhibition_general	EFO_0004320	ENSG00000184845	23197038	Bowes et al. (2012)	DRD1	UBERON_0004535	""
decreased blood pressure	cardiovascular system	activation_general	EFO_0005251	ENSG00000184845	23197038	Bowes et al. (2012)	DRD1	UBERON_0004535	""
headaches	cardiovascular system	activation_general	HP_0002315	ENSG00000184845	23197038	Bowes et al. (2012)	DRD1	UBERON_0004535	""
dizziness	cardiovascular system	activation_general	EFO_0009847	ENSG00000184845	23197038	Bowes et al. (2012)	DRD1	UBERON_0004535	""
nausea	cardiovascular system	activation_general	HP_0002018	ENSG00000184845	23197038	Bowes et al. (2012)	DRD1	UBERON_0004535	""
natriuresis	cardiovascular system	activation_general	GO_0035812	ENSG00000184845	23197038	Bowes et al. (2012)	DRD1	UBERON_0004535	""
abuse potential	cardiovascular system	activation_general	EFO_0003890	ENSG00000184845	23197038	Bowes et al. (2012)	DRD1	UBERON_0004535	""
vascular relaxation	central nervous system	activation_general	GO_0060087	ENSG00000184845	23197038	Bowes et al. (2012)	DRD1	UBERON_0001017	""
dyskinesia	central nervous system	inhibition_general	EFO_1000904	ENSG00000184845	23197038	Bowes et al. (2012)	DRD1	UBERON_0001017	""
parkinsonian symptoms (tremors)	central nervous system	inhibition_general	HP_0001300	ENSG00000184845	23197038	Bowes et al. (2012)	DRD1	UBERON_0001017	""
anti-emetic effects	central nervous system	inhibition_general	EFO_0009848	ENSG00000184845	23197038	Bowes et al. (2012)	DRD1	UBERON_0001017	""
depression	central nervous system	inhibition_general	MONDO_0002050	ENSG00000184845	23197038	Bowes et al. (2012)	DRD1	UBERON_0001017	""
anxiety	central nervous system	inhibition_general	EFO_0005230	ENSG00000184845	23197038	Bowes et al. (2012)	DRD1	UBERON_0001017	""
suicidal intent	central nervous system	inhibition_general	EFO_0004320	ENSG00000184845	23197038	Bowes et al. (2012)	DRD1	UBERON_0001017	""
decreased blood pressure	central nervous system	activation_general	EFO_0005251	ENSG00000184845	23197038	Bowes et al. (2012)	DRD1	UBERON_0001017	""
headaches	central nervous system	activation_general	HP_0002315	ENSG00000184845	23197038	Bowes et al. (2012)	DRD1	UBERON_0001017	""
dizziness	central nervous system	activation_general	EFO_0009847	ENSG00000184845	23197038	Bowes et al. (2012)	DRD1	UBERON_0001017	""
nausea	central nervous system	activation_general	HP_0002018	ENSG00000184845	23197038	Bowes et al. (2012)	DRD1	UBERON_0001017	""
natriuresis	central nervous system	activation_general	GO_0035812	ENSG00000184845	23197038	Bowes et al. (2012)	DRD1	UBERON_0001017	""
abuse potential	central nervous system	activation_general	EFO_0003890	ENSG00000184845	23197038	Bowes et al. (2012)	DRD1	UBERON_0001017	""
convulsions	nervous system	activation_acute	EFO_0009853	ENSG00000177098	28216264	Lynch et al. (2017)	SCN4B	UBERON_0001016	""
decreased pain	nervous system	inhibition_acute	GO_1904057	ENSG00000177098	28216264	Lynch et al. (2017)	SCN4B	UBERON_0001016	""
agitation	nervous system	inhibition_acute	NCIT_C74532	ENSG00000177098	28216264	Lynch et al. (2017)	SCN4B	UBERON_0001016	""
decreased sweating	nervous system	inhibition_acute	EFO_1000712	ENSG00000177098	28216264	Lynch et al. (2017)	SCN4B	UBERON_0001016	""
increased pupil diameter	nervous system	inhibition_acute	HP_0011499	ENSG00000177098	28216264	Lynch et al. (2017)	SCN4B	UBERON_0001016	""
decreased/increased convulsions	nervous system	inhibition_acute	EFO_0009853	ENSG00000177098	28216264	Lynch et al. (2017)	SCN4B	UBERON_0001016	""
decreased/increased heart rate	nervous system	inhibition_acute	HP_0031860	ENSG00000177098	28216264	Lynch et al. (2017)	SCN4B	UBERON_0001016	""
decreased blood pressure	nervous system	inhibition_acute	EFO_0005251	ENSG00000177098	28216264	Lynch et al. (2017)	SCN4B	UBERON_0001016	""
decreased cardiac contractility	nervous system	inhibition_acute	GO_0045822	ENSG00000177098	28216264	Lynch et al. (2017)	SCN4B	UBERON_0001016	""
decreased cardiac conduction	nervous system	inhibition_acute	EFO_1001497	ENSG00000177098	28216264	Lynch et al. (2017)	SCN4B	UBERON_0001016	""
increased QRS complex	nervous system	inhibition_acute	HP_0006677	ENSG00000177098	28216264	Lynch et al. (2017)	SCN4B	UBERON_0001016	""
cardiac arrhythmia	nervous system	inhibition_acute	EFO_0004269	ENSG00000177098	28216264	Lynch et al. (2017)	SCN4B	UBERON_0001016	""
decreased respiratory rate	nervous system	inhibition_acute	EFO_0009839	ENSG00000177098	28216264	Lynch et al. (2017)	SCN4B	UBERON_0001016	""
decreased gastrointestinal transit	nervous system	inhibition_acute	HP_0030897	ENSG00000177098	28216264	Lynch et al. (2017)	SCN4B	UBERON_0001016	""
decreased urine excretion	nervous system	inhibition_acute	HP_0011037	ENSG00000177098	28216264	Lynch et al. (2017)	SCN4B	UBERON_0001016	""
coma	nervous system	inhibition_acute	HP_0001259	ENSG00000177098	28216264	Lynch et al. (2017)	SCN4B	UBERON_0001016	""
dyspnea	cardiovascular	activation_acute	HP_0002094	ENSG00000177098	28216264	Lynch et al. (2017)	SCN4B	UBERON_0004535	""
decreased pain	cardiovascular	inhibition_acute	GO_1904057	ENSG00000177098	28216264	Lynch et al. (2017)	SCN4B	UBERON_0004535	""
agitation	cardiovascular	inhibition_acute	NCIT_C74532	ENSG00000177098	28216264	Lynch et al. (2017)	SCN4B	UBERON_0004535	""
decreased sweating	cardiovascular	inhibition_acute	EFO_1000712	ENSG00000177098	28216264	Lynch et al. (2017)	SCN4B	UBERON_0004535	""
increased pupil diameter	cardiovascular	inhibition_acute	HP_0011499	ENSG00000177098	28216264	Lynch et al. (2017)	SCN4B	UBERON_0004535	""
decreased/increased convulsions	cardiovascular	inhibition_acute	EFO_0009853	ENSG00000177098	28216264	Lynch et al. (2017)	SCN4B	UBERON_0004535	""
decreased/increased heart rate	cardiovascular	inhibition_acute	HP_0031860	ENSG00000177098	28216264	Lynch et al. (2017)	SCN4B	UBERON_0004535	""
decreased blood pressure	cardiovascular	inhibition_acute	EFO_0005251	ENSG00000177098	28216264	Lynch et al. (2017)	SCN4B	UBERON_0004535	""
decreased cardiac contractility	cardiovascular	inhibition_acute	GO_0045822	ENSG00000177098	28216264	Lynch et al. (2017)	SCN4B	UBERON_0004535	""
decreased cardiac conduction	cardiovascular	inhibition_acute	EFO_1001497	ENSG00000177098	28216264	Lynch et al. (2017)	SCN4B	UBERON_0004535	""
increased QRS complex	cardiovascular	inhibition_acute	HP_0006677	ENSG00000177098	28216264	Lynch et al. (2017)	SCN4B	UBERON_0004535	""
cardiac arrhythmia	cardiovascular	inhibition_acute	EFO_0004269	ENSG00000177098	28216264	Lynch et al. (2017)	SCN4B	UBERON_0004535	""
decreased respiratory rate	cardiovascular	inhibition_acute	EFO_0009839	ENSG00000177098	28216264	Lynch et al. (2017)	SCN4B	UBERON_0004535	""
decreased gastrointestinal transit	cardiovascular	inhibition_acute	HP_0030897	ENSG00000177098	28216264	Lynch et al. (2017)	SCN4B	UBERON_0004535	""
decreased urine excretion	cardiovascular	inhibition_acute	HP_0011037	ENSG00000177098	28216264	Lynch et al. (2017)	SCN4B	UBERON_0004535	""
coma	cardiovascular	inhibition_acute	HP_0001259	ENSG00000177098	28216264	Lynch et al. (2017)	SCN4B	UBERON_0004535	""
convulsions	cardiovascular	activation_acute	EFO_0009853	ENSG00000177098	28216264	Lynch et al. (2017)	SCN4B	UBERON_0004535	""
dyspnea	respiratory	activation_acute	HP_0002094	ENSG00000177098	28216264	Lynch et al. (2017)	SCN4B	UBERON_0001004	""
decreased pain	respiratory	inhibition_acute	GO_1904057	ENSG00000177098	28216264	Lynch et al. (2017)	SCN4B	UBERON_0001004	""
agitation	respiratory	inhibition_acute	NCIT_C74532	ENSG00000177098	28216264	Lynch et al. (2017)	SCN4B	UBERON_0001004	""
decreased sweating	respiratory	inhibition_acute	EFO_1000712	ENSG00000177098	28216264	Lynch et al. (2017)	SCN4B	UBERON_0001004	""
increased pupil diameter	respiratory	inhibition_acute	HP_0011499	ENSG00000177098	28216264	Lynch et al. (2017)	SCN4B	UBERON_0001004	""
decreased/increased convulsions	respiratory	inhibition_acute	EFO_0009853	ENSG00000177098	28216264	Lynch et al. (2017)	SCN4B	UBERON_0001004	""
decreased/increased heart rate	respiratory	inhibition_acute	HP_0031860	ENSG00000177098	28216264	Lynch et al. (2017)	SCN4B	UBERON_0001004	""
decreased blood pressure	respiratory	inhibition_acute	EFO_0005251	ENSG00000177098	28216264	Lynch et al. (2017)	SCN4B	UBERON_0001004	""
decreased cardiac contractility	respiratory	inhibition_acute	GO_0045822	ENSG00000177098	28216264	Lynch et al. (2017)	SCN4B	UBERON_0001004	""
decreased cardiac conduction	respiratory	inhibition_acute	EFO_1001497	ENSG00000177098	28216264	Lynch et al. (2017)	SCN4B	UBERON_0001004	""
increased QRS complex	respiratory	inhibition_acute	HP_0006677	ENSG00000177098	28216264	Lynch et al. (2017)	SCN4B	UBERON_0001004	""
cardiac arrhythmia	respiratory	inhibition_acute	EFO_0004269	ENSG00000177098	28216264	Lynch et al. (2017)	SCN4B	UBERON_0001004	""
decreased respiratory rate	respiratory	inhibition_acute	EFO_0009839	ENSG00000177098	28216264	Lynch et al. (2017)	SCN4B	UBERON_0001004	""
decreased gastrointestinal transit	respiratory	inhibition_acute	HP_0030897	ENSG00000177098	28216264	Lynch et al. (2017)	SCN4B	UBERON_0001004	""
decreased urine excretion	respiratory	inhibition_acute	HP_0011037	ENSG00000177098	28216264	Lynch et al. (2017)	SCN4B	UBERON_0001004	""
coma	respiratory	inhibition_acute	HP_0001259	ENSG00000177098	28216264	Lynch et al. (2017)	SCN4B	UBERON_0001004	""
decreased locomotor activity	cardiovascular	activation_acute	GO_0040013	ENSG00000177098	28216264	Lynch et al. (2017)	SCN4B	UBERON_0004535	""
cardiac arrhythmia	nervous system	activation_acute	EFO_0004269	ENSG00000177098	28216264	Lynch et al. (2017)	SCN4B	UBERON_0001016	""
increased heart rate	nervous system	activation_acute	HP_0001649	ENSG00000177098	28216264	Lynch et al. (2017)	SCN4B	UBERON_0001016	""
increased heart rate	respiratory	activation_acute	HP_0001649	ENSG00000177098	28216264	Lynch et al. (2017)	SCN4B	UBERON_0001004	""
dyspnea	nervous system	activation_acute	HP_0002094	ENSG00000177098	28216264	Lynch et al. (2017)	SCN4B	UBERON_0001016	""
decreased locomotor activity	respiratory	activation_acute	GO_0040013	ENSG00000177098	28216264	Lynch et al. (2017)	SCN4B	UBERON_0001004	""
decreased locomotor activity	nervous system	activation_acute	GO_0040013	ENSG00000177098	28216264	Lynch et al. (2017)	SCN4B	UBERON_0001016	""
cardiac arrhythmia	cardiovascular	activation_acute	EFO_0004269	ENSG00000177098	28216264	Lynch et al. (2017)	SCN4B	UBERON_0004535	""
increased heart rate	cardiovascular	activation_acute	HP_0001649	ENSG00000177098	28216264	Lynch et al. (2017)	SCN4B	UBERON_0004535	""
cardiac arrhythmia	respiratory	activation_acute	EFO_0004269	ENSG00000177098	28216264	Lynch et al. (2017)	SCN4B	UBERON_0001004	""
convulsions	respiratory	activation_acute	EFO_0009853	ENSG00000177098	28216264	Lynch et al. (2017)	SCN4B	UBERON_0001004	""
increased blood glucose	blood	activation_acute	HP_0003074	ENSG00000169252	28216264	Lynch et al. (2017)	ADRB2	UBERON_0000178	""
increased blood pressure	blood	inhibition_acute	HP_0032263	ENSG00000169252	28216264	Lynch et al. (2017)	ADRB2	UBERON_0000178	""
heart failure	cardiovascular	activation_acute	EFO_0003144	ENSG00000169252	28216264	Lynch et al. (2017)	ADRB2	UBERON_0004535	""
increased blood pressure	cardiovascular	inhibition_acute	HP_0032263	ENSG00000169252	28216264	Lynch et al. (2017)	ADRB2	UBERON_0004535	""
decreased blood potassium	cardiovascular	activation_acute	HP_0002900	ENSG00000169252	28216264	Lynch et al. (2017)	ADRB2	UBERON_0004535	""
increased QTc interval	blood	activation_acute	HP_0005184	ENSG00000169252	28216264	Lynch et al. (2017)	ADRB2	UBERON_0000178	""
bronchospasm	blood	activation_acute	HP_0025428	ENSG00000169252	28216264	Lynch et al. (2017)	ADRB2	UBERON_0000178	""
increased heart rate	blood	activation_acute	HP_0001649	ENSG00000169252	28216264	Lynch et al. (2017)	ADRB2	UBERON_0000178	""
increased blood glucose	cardiovascular	activation_acute	HP_0003074	ENSG00000169252	28216264	Lynch et al. (2017)	ADRB2	UBERON_0004535	""
increased heart rate	cardiovascular	activation_acute	HP_0001649	ENSG00000169252	28216264	Lynch et al. (2017)	ADRB2	UBERON_0004535	""
bronchospasm	cardiovascular	activation_acute	HP_0025428	ENSG00000169252	28216264	Lynch et al. (2017)	ADRB2	UBERON_0004535	""
heart failure	blood	activation_acute	EFO_0003144	ENSG00000169252	28216264	Lynch et al. (2017)	ADRB2	UBERON_0000178	""
increased QTc interval	cardiovascular	activation_acute	HP_0005184	ENSG00000169252	28216264	Lynch et al. (2017)	ADRB2	UBERON_0004535	""
increased cardiac contractility	cardiovascular	activation_acute	GO_0045823	ENSG00000169252	28216264	Lynch et al. (2017)	ADRB2	UBERON_0004535	""
increased cardiac contractility	blood	activation_acute	GO_0045823	ENSG00000169252	28216264	Lynch et al. (2017)	ADRB2	UBERON_0000178	""
decreased blood potassium	blood	activation_acute	HP_0002900	ENSG00000169252	28216264	Lynch et al. (2017)	ADRB2	UBERON_0000178	""
decreased platelet aggregation	respiratory	activation_acute	GO_0090331	ENSG00000136160	28216264	Lynch et al. (2017)	EDNRB	UBERON_0001004	""
increased blood pressure	respiratory	inhibition_acute	HP_0032263	ENSG00000136160	28216264	Lynch et al. (2017)	EDNRB	UBERON_0001004	""
cardiovascular malformations	respiratory	inhibition_developmental toxicity	EFO_0005269	ENSG00000136160	28216264	Lynch et al. (2017)	EDNRB	UBERON_0001004	""
craniofacial abnormalities	respiratory	inhibition_developmental toxicity	HP_0000234	ENSG00000136160	28216264	Lynch et al. (2017)	EDNRB	UBERON_0001004	""
decreased urine excretion	respiratory	inhibition_acute	HP_0011037	ENSG00000136160	28216264	Lynch et al. (2017)	EDNRB	UBERON_0001004	""
decreased gastric emptying	respiratory	inhibition_acute	GO_0120061	ENSG00000136160	28216264	Lynch et al. (2017)	EDNRB	UBERON_0001004	""
decreased intestinal transit	respiratory	inhibition_acute	HP_0030897	ENSG00000136160	28216264	Lynch et al. (2017)	EDNRB	UBERON_0001004	""
decreased pain	respiratory	inhibition_acute	GO_1904057	ENSG00000136160	28216264	Lynch et al. (2017)	EDNRB	UBERON_0001004	""
bronchoconstriction	cardiovascular	activation_acute	EFO_0009836	ENSG00000136160	28216264	Lynch et al. (2017)	EDNRB	UBERON_0004535	""
increased blood pressure	cardiovascular	inhibition_acute	HP_0032263	ENSG00000136160	28216264	Lynch et al. (2017)	EDNRB	UBERON_0004535	""
cardiovascular malformations	cardiovascular	inhibition_developmental toxicity	EFO_0005269	ENSG00000136160	28216264	Lynch et al. (2017)	EDNRB	UBERON_0004535	""
craniofacial abnormalities	cardiovascular	inhibition_developmental toxicity	HP_0000234	ENSG00000136160	28216264	Lynch et al. (2017)	EDNRB	UBERON_0004535	""
decreased urine excretion	cardiovascular	inhibition_acute	HP_0011037	ENSG00000136160	28216264	Lynch et al. (2017)	EDNRB	UBERON_0004535	""
decreased gastric emptying	cardiovascular	inhibition_acute	GO_0120061	ENSG00000136160	28216264	Lynch et al. (2017)	EDNRB	UBERON_0004535	""
decreased intestinal transit	cardiovascular	inhibition_acute	HP_0030897	ENSG00000136160	28216264	Lynch et al. (2017)	EDNRB	UBERON_0004535	""
decreased pain	cardiovascular	inhibition_acute	GO_1904057	ENSG00000136160	28216264	Lynch et al. (2017)	EDNRB	UBERON_0004535	""
left ventricular hypertrophy	renal	activation_acute	EFO_0003896	ENSG00000136160	28216264	Lynch et al. (2017)	EDNRB	UBERON_0001008	""
increased blood pressure	renal	inhibition_acute	HP_0032263	ENSG00000136160	28216264	Lynch et al. (2017)	EDNRB	UBERON_0001008	""
cardiovascular malformations	renal	inhibition_developmental toxicity	EFO_0005269	ENSG00000136160	28216264	Lynch et al. (2017)	EDNRB	UBERON_0001008	""
craniofacial abnormalities	renal	inhibition_developmental toxicity	HP_0000234	ENSG00000136160	28216264	Lynch et al. (2017)	EDNRB	UBERON_0001008	""
decreased urine excretion	renal	inhibition_acute	HP_0011037	ENSG00000136160	28216264	Lynch et al. (2017)	EDNRB	UBERON_0001008	""
decreased gastric emptying	renal	inhibition_acute	GO_0120061	ENSG00000136160	28216264	Lynch et al. (2017)	EDNRB	UBERON_0001008	""
decreased intestinal transit	renal	inhibition_acute	HP_0030897	ENSG00000136160	28216264	Lynch et al. (2017)	EDNRB	UBERON_0001008	""
decreased pain	renal	inhibition_acute	GO_1904057	ENSG00000136160	28216264	Lynch et al. (2017)	EDNRB	UBERON_0001008	""
cell proliferation	renal	activation_acute	GO_0008283	ENSG00000136160	28216264	Lynch et al. (2017)	EDNRB	UBERON_0001008	""
pulmonary hypertension	cardiovascular	activation_acute	EFO_0001361	ENSG00000136160	28216264	Lynch et al. (2017)	EDNRB	UBERON_0004535	""
increased then decreased heart rate	renal	activation_acute	HP_0031860	ENSG00000136160	28216264	Lynch et al. (2017)	EDNRB	UBERON_0001008	""
left ventricular hypertrophy	blood	activation_acute	EFO_0003896	ENSG00000136160	28216264	Lynch et al. (2017)	EDNRB	UBERON_0000178	""
increased blood pressure	blood	inhibition_acute	HP_0032263	ENSG00000136160	28216264	Lynch et al. (2017)	EDNRB	UBERON_0000178	""
cardiovascular malformations	blood	inhibition_developmental toxicity	EFO_0005269	ENSG00000136160	28216264	Lynch et al. (2017)	EDNRB	UBERON_0000178	""
craniofacial abnormalities	blood	inhibition_developmental toxicity	HP_0000234	ENSG00000136160	28216264	Lynch et al. (2017)	EDNRB	UBERON_0000178	""
decreased urine excretion	blood	inhibition_acute	HP_0011037	ENSG00000136160	28216264	Lynch et al. (2017)	EDNRB	UBERON_0000178	""
decreased gastric emptying	blood	inhibition_acute	GO_0120061	ENSG00000136160	28216264	Lynch et al. (2017)	EDNRB	UBERON_0000178	""
decreased intestinal transit	blood	inhibition_acute	HP_0030897	ENSG00000136160	28216264	Lynch et al. (2017)	EDNRB	UBERON_0000178	""
decreased pain	blood	inhibition_acute	GO_1904057	ENSG00000136160	28216264	Lynch et al. (2017)	EDNRB	UBERON_0000178	""
increased then decreased heart rate	blood	activation_acute	HP_0031860	ENSG00000136160	28216264	Lynch et al. (2017)	EDNRB	UBERON_0000178	""
left ventricular hypertrophy	cardiovascular	activation_acute	EFO_0003896	ENSG00000136160	28216264	Lynch et al. (2017)	EDNRB	UBERON_0004535	""
left ventricular hypertrophy	respiratory	activation_acute	EFO_0003896	ENSG00000136160	28216264	Lynch et al. (2017)	EDNRB	UBERON_0001004	""
pulmonary hypertension	respiratory	activation_acute	EFO_0001361	ENSG00000136160	28216264	Lynch et al. (2017)	EDNRB	UBERON_0001004	""
cell proliferation	blood	activation_acute	GO_0008283	ENSG00000136160	28216264	Lynch et al. (2017)	EDNRB	UBERON_0000178	""
glomerular and tubulointerstitial structural injury	respiratory	activation_acute	EFO_0009833	ENSG00000136160	28216264	Lynch et al. (2017)	EDNRB	UBERON_0001004	""
cell proliferation	respiratory	activation_acute	GO_0008283	ENSG00000136160	28216264	Lynch et al. (2017)	EDNRB	UBERON_0001004	""
decreased platelet aggregation	renal	activation_acute	GO_0090331	ENSG00000136160	28216264	Lynch et al. (2017)	EDNRB	UBERON_0001008	""
pulmonary hypertension	renal	activation_acute	EFO_0001361	ENSG00000136160	28216264	Lynch et al. (2017)	EDNRB	UBERON_0001008	""
decreased platelet aggregation	gastrointestinal	activation_acute	GO_0090331	ENSG00000136160	28216264	Lynch et al. (2017)	EDNRB	UBERON_0005409	""
increased blood pressure	gastrointestinal	inhibition_acute	HP_0032263	ENSG00000136160	28216264	Lynch et al. (2017)	EDNRB	UBERON_0005409	""
cardiovascular malformations	gastrointestinal	inhibition_developmental toxicity	EFO_0005269	ENSG00000136160	28216264	Lynch et al. (2017)	EDNRB	UBERON_0005409	""
craniofacial abnormalities	gastrointestinal	inhibition_developmental toxicity	HP_0000234	ENSG00000136160	28216264	Lynch et al. (2017)	EDNRB	UBERON_0005409	""
decreased urine excretion	gastrointestinal	inhibition_acute	HP_0011037	ENSG00000136160	28216264	Lynch et al. (2017)	EDNRB	UBERON_0005409	""
decreased gastric emptying	gastrointestinal	inhibition_acute	GO_0120061	ENSG00000136160	28216264	Lynch et al. (2017)	EDNRB	UBERON_0005409	""
decreased intestinal transit	gastrointestinal	inhibition_acute	HP_0030897	ENSG00000136160	28216264	Lynch et al. (2017)	EDNRB	UBERON_0005409	""
decreased pain	gastrointestinal	inhibition_acute	GO_1904057	ENSG00000136160	28216264	Lynch et al. (2017)	EDNRB	UBERON_0005409	""
increased then decreased heart rate	gastrointestinal	activation_acute	HP_0031860	ENSG00000136160	28216264	Lynch et al. (2017)	EDNRB	UBERON_0005409	""
cell proliferation	gastrointestinal	activation_acute	GO_0008283	ENSG00000136160	28216264	Lynch et al. (2017)	EDNRB	UBERON_0005409	""
decreased platelet aggregation	cardiovascular	activation_acute	GO_0090331	ENSG00000136160	28216264	Lynch et al. (2017)	EDNRB	UBERON_0004535	""
decreased then increased blood pressure	blood	activation_acute	HP_0030972	ENSG00000136160	28216264	Lynch et al. (2017)	EDNRB	UBERON_0000178	""
glomerular and tubulointerstitial structural injury	renal	activation_acute	EFO_0009833	ENSG00000136160	28216264	Lynch et al. (2017)	EDNRB	UBERON_0001008	""
left ventricular hypertrophy	gastrointestinal	activation_acute	EFO_0003896	ENSG00000136160	28216264	Lynch et al. (2017)	EDNRB	UBERON_0005409	""
glomerular and tubulointerstitial structural injury	cardiovascular	activation_acute	EFO_0009833	ENSG00000136160	28216264	Lynch et al. (2017)	EDNRB	UBERON_0004535	""
decreased then increased blood pressure	gastrointestinal	activation_acute	HP_0030972	ENSG00000136160	28216264	Lynch et al. (2017)	EDNRB	UBERON_0005409	""
bronchoconstriction	blood	activation_acute	EFO_0009836	ENSG00000136160	28216264	Lynch et al. (2017)	EDNRB	UBERON_0000178	""
glomerular and tubulointerstitial structural injury	blood	activation_acute	EFO_0009833	ENSG00000136160	28216264	Lynch et al. (2017)	EDNRB	UBERON_0000178	""
cell proliferation	cardiovascular	activation_acute	GO_0008283	ENSG00000136160	28216264	Lynch et al. (2017)	EDNRB	UBERON_0004535	""
pulmonary hypertension	gastrointestinal	activation_acute	EFO_0001361	ENSG00000136160	28216264	Lynch et al. (2017)	EDNRB	UBERON_0005409	""
bronchoconstriction	respiratory	activation_acute	EFO_0009836	ENSG00000136160	28216264	Lynch et al. (2017)	EDNRB	UBERON_0001004	""
increased then decreased heart rate	cardiovascular	activation_acute	HP_0031860	ENSG00000136160	28216264	Lynch et al. (2017)	EDNRB	UBERON_0004535	""
glomerular and tubulointerstitial structural injury	gastrointestinal	activation_acute	EFO_0009833	ENSG00000136160	28216264	Lynch et al. (2017)	EDNRB	UBERON_0005409	""
bronchoconstriction	renal	activation_acute	EFO_0009836	ENSG00000136160	28216264	Lynch et al. (2017)	EDNRB	UBERON_0001008	""
increased then decreased heart rate	respiratory	activation_acute	HP_0031860	ENSG00000136160	28216264	Lynch et al. (2017)	EDNRB	UBERON_0001004	""
decreased then increased blood pressure	cardiovascular	activation_acute	HP_0030972	ENSG00000136160	28216264	Lynch et al. (2017)	EDNRB	UBERON_0004535	""
bronchoconstriction	gastrointestinal	activation_acute	EFO_0009836	ENSG00000136160	28216264	Lynch et al. (2017)	EDNRB	UBERON_0005409	""
decreased then increased blood pressure	renal	activation_acute	HP_0030972	ENSG00000136160	28216264	Lynch et al. (2017)	EDNRB	UBERON_0001008	""
pulmonary hypertension	blood	activation_acute	EFO_0001361	ENSG00000136160	28216264	Lynch et al. (2017)	EDNRB	UBERON_0000178	""
decreased then increased blood pressure	respiratory	activation_acute	HP_0030972	ENSG00000136160	28216264	Lynch et al. (2017)	EDNRB	UBERON_0001004	""
decreased platelet aggregation	blood	activation_acute	GO_0090331	ENSG00000136160	28216264	Lynch et al. (2017)	EDNRB	UBERON_0000178	""
increased urinary sodium excretion	renal	activation_acute	GO_0035815	ENSG00000180772	28216264	Lynch et al. (2017)	AGTR2	UBERON_0001008	""
decreased pain	renal	inhibition_acute	GO_1904057	ENSG00000180772	28216264	Lynch et al. (2017)	AGTR2	UBERON_0001008	""
death	renal	inhibition_developmental toxicity	EFO_0000480	ENSG00000180772	28216264	Lynch et al. (2017)	AGTR2	UBERON_0001008	""
oligoamnios	renal	inhibition_developmental toxicity	EFO_0007401	ENSG00000180772	28216264	Lynch et al. (2017)	AGTR2	UBERON_0001008	""
renal failure	renal	inhibition_developmental toxicity	EFO_1002048	ENSG00000180772	28216264	Lynch et al. (2017)	AGTR2	UBERON_0001008	""
decreased blood pressure	renal	inhibition_developmental toxicity	EFO_0005251	ENSG00000180772	28216264	Lynch et al. (2017)	AGTR2	UBERON_0001008	""
pulmonary hypoplasia	renal	inhibition_developmental toxicity	HP_0002089	ENSG00000180772	28216264	Lynch et al. (2017)	AGTR2	UBERON_0001008	""
respiratory distress syndrome	renal	inhibition_developmental toxicity	EFO_1000644	ENSG00000180772	28216264	Lynch et al. (2017)	AGTR2	UBERON_0001008	""
persistent patent ductus arteriosus	renal	inhibition_developmental toxicity	HP_0001643	ENSG00000180772	28216264	Lynch et al. (2017)	AGTR2	UBERON_0001008	""
hypocalvaria	renal	inhibition_developmental toxicity	HP_0010539	ENSG00000180772	28216264	Lynch et al. (2017)	AGTR2	UBERON_0001008	""
limb defects	renal	inhibition_developmental toxicity	MONDO_0019054	ENSG00000180772	28216264	Lynch et al. (2017)	AGTR2	UBERON_0001008	""
intrauterine growth retardation	renal	inhibition_developmental toxicity	EFO_0000495	ENSG00000180772	28216264	Lynch et al. (2017)	AGTR2	UBERON_0001008	""
cerebral complications	renal	inhibition_developmental toxicity	MONDO_0016054	ENSG00000180772	28216264	Lynch et al. (2017)	AGTR2	UBERON_0001008	""
increased urine excretion	renal	activation_acute	HP_0000103	ENSG00000180772	28216264	Lynch et al. (2017)	AGTR2	UBERON_0001008	""
pain	cardiovascular	activation_acute	EFO_0003843	ENSG00000116032	28216264	Lynch et al. (2017)	GRIN3B	UBERON_0004535	""
decreased pain	cardiovascular	inhibition_acute	GO_1904057	ENSG00000116032	28216264	Lynch et al. (2017)	GRIN3B	UBERON_0004535	""
impaired social interactions	cardiovascular	inhibition_chronic	HP_0000735	ENSG00000116032	28216264	Lynch et al. (2017)	GRIN3B	UBERON_0004535	""
stereotypy	cardiovascular	inhibition_chronic	HP_0000733	ENSG00000116032	28216264	Lynch et al. (2017)	GRIN3B	UBERON_0004535	""
psychosis	cardiovascular	inhibition_chronic	EFO_0005407	ENSG00000116032	28216264	Lynch et al. (2017)	GRIN3B	UBERON_0004535	""
neurodegeneration	cardiovascular	inhibition_chronic	HP_0002180	ENSG00000116032	28216264	Lynch et al. (2017)	GRIN3B	UBERON_0004535	""
increased locomotor activity	cardiovascular	inhibition_acute	GO_0040017	ENSG00000116032	28216264	Lynch et al. (2017)	GRIN3B	UBERON_0004535	""
ataxia	cardiovascular	inhibition_acute	MONDO_0000437	ENSG00000116032	28216264	Lynch et al. (2017)	GRIN3B	UBERON_0004535	""
dizziness	cardiovascular	inhibition_acute	EFO_0009847	ENSG00000116032	28216264	Lynch et al. (2017)	GRIN3B	UBERON_0004535	""
decreased memory	cardiovascular	inhibition_acute	EFO_0001072	ENSG00000116032	28216264	Lynch et al. (2017)	GRIN3B	UBERON_0004535	""
psychosis	cardiovascular	inhibition_acute	EFO_0005407	ENSG00000116032	28216264	Lynch et al. (2017)	GRIN3B	UBERON_0004535	""
decreased convulsions	cardiovascular	inhibition_acute	EFO_0009853	ENSG00000116032	28216264	Lynch et al. (2017)	GRIN3B	UBERON_0004535	""
drug abuse/dependence	cardiovascular	inhibition_acute	EFO_0003890	ENSG00000116032	28216264	Lynch et al. (2017)	GRIN3B	UBERON_0004535	""
neurotoxicity	cardiovascular	inhibition_acute	EFO_0005595	ENSG00000116032	28216264	Lynch et al. (2017)	GRIN3B	UBERON_0004535	""
increased blood pressure	cardiovascular	inhibition_acute	HP_0032263	ENSG00000116032	28216264	Lynch et al. (2017)	GRIN3B	UBERON_0004535	""
increased heart rate	cardiovascular	inhibition_acute	HP_0001649	ENSG00000116032	28216264	Lynch et al. (2017)	GRIN3B	UBERON_0004535	""
increased blood pressure	central nervous system	activation_acute	HP_0032263	ENSG00000116032	28216264	Lynch et al. (2017)	GRIN3B	UBERON_0001017	""
decreased pain	central nervous system	inhibition_acute	GO_1904057	ENSG00000116032	28216264	Lynch et al. (2017)	GRIN3B	UBERON_0001017	""
impaired social interactions	central nervous system	inhibition_chronic	HP_0000735	ENSG00000116032	28216264	Lynch et al. (2017)	GRIN3B	UBERON_0001017	""
stereotypy	central nervous system	inhibition_chronic	HP_0000733	ENSG00000116032	28216264	Lynch et al. (2017)	GRIN3B	UBERON_0001017	""
psychosis	central nervous system	inhibition_chronic	EFO_0005407	ENSG00000116032	28216264	Lynch et al. (2017)	GRIN3B	UBERON_0001017	""
neurodegeneration	central nervous system	inhibition_chronic	HP_0002180	ENSG00000116032	28216264	Lynch et al. (2017)	GRIN3B	UBERON_0001017	""
increased locomotor activity	central nervous system	inhibition_acute	GO_0040017	ENSG00000116032	28216264	Lynch et al. (2017)	GRIN3B	UBERON_0001017	""
ataxia	central nervous system	inhibition_acute	MONDO_0000437	ENSG00000116032	28216264	Lynch et al. (2017)	GRIN3B	UBERON_0001017	""
dizziness	central nervous system	inhibition_acute	EFO_0009847	ENSG00000116032	28216264	Lynch et al. (2017)	GRIN3B	UBERON_0001017	""
decreased memory	central nervous system	inhibition_acute	EFO_0001072	ENSG00000116032	28216264	Lynch et al. (2017)	GRIN3B	UBERON_0001017	""
psychosis	central nervous system	inhibition_acute	EFO_0005407	ENSG00000116032	28216264	Lynch et al. (2017)	GRIN3B	UBERON_0001017	""
decreased convulsions	central nervous system	inhibition_acute	EFO_0009853	ENSG00000116032	28216264	Lynch et al. (2017)	GRIN3B	UBERON_0001017	""
drug abuse/dependence	central nervous system	inhibition_acute	EFO_0003890	ENSG00000116032	28216264	Lynch et al. (2017)	GRIN3B	UBERON_0001017	""
neurotoxicity	central nervous system	inhibition_acute	EFO_0005595	ENSG00000116032	28216264	Lynch et al. (2017)	GRIN3B	UBERON_0001017	""
increased blood pressure	central nervous system	inhibition_acute	HP_0032263	ENSG00000116032	28216264	Lynch et al. (2017)	GRIN3B	UBERON_0001017	""
increased heart rate	central nervous system	inhibition_acute	HP_0001649	ENSG00000116032	28216264	Lynch et al. (2017)	GRIN3B	UBERON_0001017	""
increased then decreased heart rate	cardiovascular	activation_acute	HP_0031860	ENSG00000116032	28216264	Lynch et al. (2017)	GRIN3B	UBERON_0004535	""
pain	central nervous system	activation_acute	EFO_0003843	ENSG00000116032	28216264	Lynch et al. (2017)	GRIN3B	UBERON_0001017	""
convulsions	cardiovascular	activation_acute	EFO_0009853	ENSG00000116032	28216264	Lynch et al. (2017)	GRIN3B	UBERON_0004535	""
increased then decreased heart rate	central nervous system	activation_acute	HP_0031860	ENSG00000116032	28216264	Lynch et al. (2017)	GRIN3B	UBERON_0001017	""
convulsions	central nervous system	activation_acute	EFO_0009853	ENSG00000116032	28216264	Lynch et al. (2017)	GRIN3B	UBERON_0001017	""
increased blood pressure	cardiovascular	activation_acute	HP_0032263	ENSG00000116032	28216264	Lynch et al. (2017)	GRIN3B	UBERON_0004535	""
irritability	cardiovascular	activation_acute	HP_0000737	ENSG00000180720	28216264	Lynch et al. (2017)	CHRM4	UBERON_0004535	""
decreased blood pressure	nervous system	activation_acute	EFO_0005251	ENSG00000180720	28216264	Lynch et al. (2017)	CHRM4	UBERON_0001016	""
exhaustion	nervous system	activation_acute	EFO_0009852	ENSG00000180720	28216264	Lynch et al. (2017)	CHRM4	UBERON_0001016	""
ptosis	nervous system	activation_acute	Orphanet_98578	ENSG00000180720	28216264	Lynch et al. (2017)	CHRM4	UBERON_0001016	""
catalepsy	nervous system	activation_acute	EFO_0009845	ENSG00000180720	28216264	Lynch et al. (2017)	CHRM4	UBERON_0001016	""
lacrimation	nervous system	activation_acute	HP_0000632	ENSG00000180720	28216264	Lynch et al. (2017)	CHRM4	UBERON_0001016	""
decreased blood pressure	cardiovascular	activation_acute	EFO_0005251	ENSG00000180720	28216264	Lynch et al. (2017)	CHRM4	UBERON_0004535	""
catalepsy	cardiovascular	activation_acute	EFO_0009845	ENSG00000180720	28216264	Lynch et al. (2017)	CHRM4	UBERON_0004535	""
frothing	nervous system	activation_acute	""	ENSG00000180720	28216264	Lynch et al. (2017)	CHRM4	UBERON_0001016	""
ptosis	cardiovascular	activation_acute	Orphanet_98578	ENSG00000180720	28216264	Lynch et al. (2017)	CHRM4	UBERON_0004535	""
decreased heart rate	cardiovascular	activation_acute	HP_0001662	ENSG00000180720	28216264	Lynch et al. (2017)	CHRM4	UBERON_0004535	""
frothing	cardiovascular	activation_acute	""	ENSG00000180720	28216264	Lynch et al. (2017)	CHRM4	UBERON_0004535	""
decreased pupil diameter	cardiovascular	activation_acute	HP_0000616	ENSG00000180720	28216264	Lynch et al. (2017)	CHRM4	UBERON_0004535	""
muscle cramps	cardiovascular	activation_acute	EFO_0009846	ENSG00000180720	28216264	Lynch et al. (2017)	CHRM4	UBERON_0004535	""
blurred vision	cardiovascular	activation_acute	HP_0000622	ENSG00000180720	28216264	Lynch et al. (2017)	CHRM4	UBERON_0004535	""
decreased heart rate	nervous system	activation_acute	HP_0001662	ENSG00000180720	28216264	Lynch et al. (2017)	CHRM4	UBERON_0001016	""
decreased pupil diameter	nervous system	activation_acute	HP_0000616	ENSG00000180720	28216264	Lynch et al. (2017)	CHRM4	UBERON_0001016	""
sweating	cardiovascular	activation_acute	HP_0000975	ENSG00000180720	28216264	Lynch et al. (2017)	CHRM4	UBERON_0004535	""
blurred vision	nervous system	activation_acute	HP_0000622	ENSG00000180720	28216264	Lynch et al. (2017)	CHRM4	UBERON_0001016	""
exhaustion	cardiovascular	activation_acute	EFO_0009852	ENSG00000180720	28216264	Lynch et al. (2017)	CHRM4	UBERON_0004535	""
irritability	nervous system	activation_acute	HP_0000737	ENSG00000180720	28216264	Lynch et al. (2017)	CHRM4	UBERON_0001016	""
sweating	nervous system	activation_acute	HP_0000975	ENSG00000180720	28216264	Lynch et al. (2017)	CHRM4	UBERON_0001016	""
increased salivation	cardiovascular	activation_acute	GO_0046878	ENSG00000180720	28216264	Lynch et al. (2017)	CHRM4	UBERON_0004535	""
muscle cramps	nervous system	activation_acute	EFO_0009846	ENSG00000180720	28216264	Lynch et al. (2017)	CHRM4	UBERON_0001016	""
increased salivation	nervous system	activation_acute	GO_0046878	ENSG00000180720	28216264	Lynch et al. (2017)	CHRM4	UBERON_0001016	""
lacrimation	cardiovascular	activation_acute	HP_0000632	ENSG00000180720	28216264	Lynch et al. (2017)	CHRM4	UBERON_0004535	""
increased pupil diameter	blood	activation_acute	HP_0011499	ENSG00000102468	28216264	Lynch et al. (2017)	HTR2A	UBERON_0000178	""
decreased platelet aggregation	blood	inhibition_acute	GO_0090331	ENSG00000102468	28216264	Lynch et al. (2017)	HTR2A	UBERON_0000178	""
decreased body temperature	blood	inhibition_acute	HP_0002045	ENSG00000102468	28216264	Lynch et al. (2017)	HTR2A	UBERON_0000178	""
decreased pain	blood	inhibition_acute	GO_1904057	ENSG00000102468	28216264	Lynch et al. (2017)	HTR2A	UBERON_0000178	""
decreased inflammation	blood	inhibition_acute	GO_0050728	ENSG00000102468	28216264	Lynch et al. (2017)	HTR2A	UBERON_0000178	""
increased sleep	blood	inhibition_acute	EFO_0008568	ENSG00000102468	28216264	Lynch et al. (2017)	HTR2A	UBERON_0000178	""
stereotypy	cardiovascular	activation_acute	HP_0000733	ENSG00000102468	28216264	Lynch et al. (2017)	HTR2A	UBERON_0004535	""
decreased platelet aggregation	cardiovascular	inhibition_acute	GO_0090331	ENSG00000102468	28216264	Lynch et al. (2017)	HTR2A	UBERON_0004535	""
decreased body temperature	cardiovascular	inhibition_acute	HP_0002045	ENSG00000102468	28216264	Lynch et al. (2017)	HTR2A	UBERON_0004535	""
decreased pain	cardiovascular	inhibition_acute	GO_1904057	ENSG00000102468	28216264	Lynch et al. (2017)	HTR2A	UBERON_0004535	""
decreased inflammation	cardiovascular	inhibition_acute	GO_0050728	ENSG00000102468	28216264	Lynch et al. (2017)	HTR2A	UBERON_0004535	""
increased sleep	cardiovascular	inhibition_acute	EFO_0008568	ENSG00000102468	28216264	Lynch et al. (2017)	HTR2A	UBERON_0004535	""
increased pupil diameter	cardiovascular	activation_acute	HP_0011499	ENSG00000102468	28216264	Lynch et al. (2017)	HTR2A	UBERON_0004535	""
increased heart rate	blood	activation_acute	HP_0001649	ENSG00000102468	28216264	Lynch et al. (2017)	HTR2A	UBERON_0000178	""
hypervigilance	blood	activation_acute	""	ENSG00000102468	28216264	Lynch et al. (2017)	HTR2A	UBERON_0000178	""
increased pain	cardiovascular	activation_acute	GO_1904058	ENSG00000102468	28216264	Lynch et al. (2017)	HTR2A	UBERON_0004535	""
sweating	cardiovascular	activation_acute	HP_0000975	ENSG00000102468	28216264	Lynch et al. (2017)	HTR2A	UBERON_0004535	""
agitation	nervous system	activation_acute	NCIT_C74532	ENSG00000102468	28216264	Lynch et al. (2017)	HTR2A	UBERON_0001016	""
decreased platelet aggregation	nervous system	inhibition_acute	GO_0090331	ENSG00000102468	28216264	Lynch et al. (2017)	HTR2A	UBERON_0001016	""
decreased body temperature	nervous system	inhibition_acute	HP_0002045	ENSG00000102468	28216264	Lynch et al. (2017)	HTR2A	UBERON_0001016	""
decreased pain	nervous system	inhibition_acute	GO_1904057	ENSG00000102468	28216264	Lynch et al. (2017)	HTR2A	UBERON_0001016	""
decreased inflammation	nervous system	inhibition_acute	GO_0050728	ENSG00000102468	28216264	Lynch et al. (2017)	HTR2A	UBERON_0001016	""
increased sleep	nervous system	inhibition_acute	EFO_0008568	ENSG00000102468	28216264	Lynch et al. (2017)	HTR2A	UBERON_0001016	""
platelet aggregation	nervous system	activation_acute	GO_0070527	ENSG00000102468	28216264	Lynch et al. (2017)	HTR2A	UBERON_0001016	""
platelet aggregation	blood	activation_acute	GO_0070527	ENSG00000102468	28216264	Lynch et al. (2017)	HTR2A	UBERON_0000178	""
increased body temperature	cardiovascular	activation_acute	HP_0001945	ENSG00000102468	28216264	Lynch et al. (2017)	HTR2A	UBERON_0004535	""
increased pupil diameter	nervous system	activation_acute	HP_0011499	ENSG00000102468	28216264	Lynch et al. (2017)	HTR2A	UBERON_0001016	""
hypervigilance	cardiovascular	activation_acute	""	ENSG00000102468	28216264	Lynch et al. (2017)	HTR2A	UBERON_0004535	""
decreased memory	blood	activation_acute	EFO_0001072	ENSG00000102468	28216264	Lynch et al. (2017)	HTR2A	UBERON_0000178	""
hyperreflexia	blood	activation_acute	HP_0001347	ENSG00000102468	28216264	Lynch et al. (2017)	HTR2A	UBERON_0000178	""
stereotypy	nervous system	activation_acute	HP_0000733	ENSG00000102468	28216264	Lynch et al. (2017)	HTR2A	UBERON_0001016	""
myoclonus	blood	activation_acute	HP_0001336	ENSG00000102468	28216264	Lynch et al. (2017)	HTR2A	UBERON_0000178	""
psychosis	nervous system	activation_acute	EFO_0005407	ENSG00000102468	28216264	Lynch et al. (2017)	HTR2A	UBERON_0001016	""
increased pain	blood	activation_acute	GO_1904058	ENSG00000102468	28216264	Lynch et al. (2017)	HTR2A	UBERON_0000178	""
hyperreflexia	cardiovascular	activation_acute	HP_0001347	ENSG00000102468	28216264	Lynch et al. (2017)	HTR2A	UBERON_0004535	""
myoclonus	nervous system	activation_acute	HP_0001336	ENSG00000102468	28216264	Lynch et al. (2017)	HTR2A	UBERON_0001016	""
decreased memory	cardiovascular	activation_acute	EFO_0001072	ENSG00000102468	28216264	Lynch et al. (2017)	HTR2A	UBERON_0004535	""
drug abuse/dependence	nervous system	activation_acute	EFO_0003890	ENSG00000102468	28216264	Lynch et al. (2017)	HTR2A	UBERON_0001016	""
sweating	nervous system	activation_acute	HP_0000975	ENSG00000102468	28216264	Lynch et al. (2017)	HTR2A	UBERON_0001016	""
increased body temperature	blood	activation_acute	HP_0001945	ENSG00000102468	28216264	Lynch et al. (2017)	HTR2A	UBERON_0000178	""
psychosis	blood	activation_acute	EFO_0005407	ENSG00000102468	28216264	Lynch et al. (2017)	HTR2A	UBERON_0000178	""
increased blood pressure	nervous system	activation_acute	HP_0032263	ENSG00000102468	28216264	Lynch et al. (2017)	HTR2A	UBERON_0001016	""
hallucinations	cardiovascular	activation_acute	HP_0000738	ENSG00000102468	28216264	Lynch et al. (2017)	HTR2A	UBERON_0004535	""
hyperreflexia	nervous system	activation_acute	HP_0001347	ENSG00000102468	28216264	Lynch et al. (2017)	HTR2A	UBERON_0001016	""
platelet aggregation	cardiovascular	activation_acute	GO_0070527	ENSG00000102468	28216264	Lynch et al. (2017)	HTR2A	UBERON_0004535	""
increased pain	nervous system	activation_acute	GO_1904058	ENSG00000102468	28216264	Lynch et al. (2017)	HTR2A	UBERON_0001016	""
increased heart rate	cardiovascular	activation_acute	HP_0001649	ENSG00000102468	28216264	Lynch et al. (2017)	HTR2A	UBERON_0004535	""
sweating	blood	activation_acute	HP_0000975	ENSG00000102468	28216264	Lynch et al. (2017)	HTR2A	UBERON_0000178	""
myoclonus	cardiovascular	activation_acute	HP_0001336	ENSG00000102468	28216264	Lynch et al. (2017)	HTR2A	UBERON_0004535	""
increased heart rate	nervous system	activation_acute	HP_0001649	ENSG00000102468	28216264	Lynch et al. (2017)	HTR2A	UBERON_0001016	""
psychosis	cardiovascular	activation_acute	EFO_0005407	ENSG00000102468	28216264	Lynch et al. (2017)	HTR2A	UBERON_0004535	""
drug abuse/dependence	blood	activation_acute	EFO_0003890	ENSG00000102468	28216264	Lynch et al. (2017)	HTR2A	UBERON_0000178	""
hallucinations	blood	activation_acute	HP_0000738	ENSG00000102468	28216264	Lynch et al. (2017)	HTR2A	UBERON_0000178	""
increased body temperature	nervous system	activation_acute	HP_0001945	ENSG00000102468	28216264	Lynch et al. (2017)	HTR2A	UBERON_0001016	""
hypervigilance	nervous system	activation_acute	""	ENSG00000102468	28216264	Lynch et al. (2017)	HTR2A	UBERON_0001016	""
hallucinations	nervous system	activation_acute	HP_0000738	ENSG00000102468	28216264	Lynch et al. (2017)	HTR2A	UBERON_0001016	""
drug abuse/dependence	cardiovascular	activation_acute	EFO_0003890	ENSG00000102468	28216264	Lynch et al. (2017)	HTR2A	UBERON_0004535	""
increased blood pressure	cardiovascular	activation_acute	HP_0032263	ENSG00000102468	28216264	Lynch et al. (2017)	HTR2A	UBERON_0004535	""
stereotypy	blood	activation_acute	HP_0000733	ENSG00000102468	28216264	Lynch et al. (2017)	HTR2A	UBERON_0000178	""
increased blood pressure	blood	activation_acute	HP_0032263	ENSG00000102468	28216264	Lynch et al. (2017)	HTR2A	UBERON_0000178	""
decreased memory	nervous system	activation_acute	EFO_0001072	ENSG00000102468	28216264	Lynch et al. (2017)	HTR2A	UBERON_0001016	""
agitation	blood	activation_acute	NCIT_C74532	ENSG00000102468	28216264	Lynch et al. (2017)	HTR2A	UBERON_0000178	""
agitation	cardiovascular	activation_acute	NCIT_C74532	ENSG00000102468	28216264	Lynch et al. (2017)	HTR2A	UBERON_0004535	""
increased heart rate	pulmonary	activation_general	HP_0001649	ENSG00000169252	23197038	Bowes et al. (2012)	ADRB2	UBERON_0002048	""
decreased blood pressure	pulmonary	inhibition_general	EFO_0005251	ENSG00000169252	23197038	Bowes et al. (2012)	ADRB2	UBERON_0002048	""
bronchodilation	pulmonary	activation_general	EFO_0009837	ENSG00000169252	23197038	Bowes et al. (2012)	ADRB2	UBERON_0002048	""
peripheral vasodilation	pulmonary	activation_general	""	ENSG00000169252	23197038	Bowes et al. (2012)	ADRB2	UBERON_0002048	""
skeletal muscle tremor	pulmonary	activation_general	HP_0001337	ENSG00000169252	23197038	Bowes et al. (2012)	ADRB2	UBERON_0002048	""
increased glycogenolysis and glucagon release	pulmonary	activation_general	GO_0070094	ENSG00000169252	23197038	Bowes et al. (2012)	ADRB2	UBERON_0002048	""
increased heart rate	cardiovascular system	activation_general	HP_0001649	ENSG00000169252	23197038	Bowes et al. (2012)	ADRB2	UBERON_0004535	""
decreased blood pressure	cardiovascular system	inhibition_general	EFO_0005251	ENSG00000169252	23197038	Bowes et al. (2012)	ADRB2	UBERON_0004535	""
bronchodilation	cardiovascular system	activation_general	EFO_0009837	ENSG00000169252	23197038	Bowes et al. (2012)	ADRB2	UBERON_0004535	""
peripheral vasodilation	cardiovascular system	activation_general	""	ENSG00000169252	23197038	Bowes et al. (2012)	ADRB2	UBERON_0004535	""
skeletal muscle tremor	cardiovascular system	activation_general	HP_0001337	ENSG00000169252	23197038	Bowes et al. (2012)	ADRB2	UBERON_0004535	""
increased glycogenolysis and glucagon release	cardiovascular system	activation_general	GO_0070094	ENSG00000169252	23197038	Bowes et al. (2012)	ADRB2	UBERON_0004535	""
pain	nervous system	activation_acute	EFO_0003843	ENSG00000115353	28216264	Lynch et al. (2017)	TACR1	UBERON_0001016	""
decreased pain	nervous system	inhibition_acute	GO_1904057	ENSG00000115353	28216264	Lynch et al. (2017)	TACR1	UBERON_0001016	""
decreased inflammation	nervous system	inhibition_acute	GO_0050728	ENSG00000115353	28216264	Lynch et al. (2017)	TACR1	UBERON_0001016	""
decreased locomotor activity	nervous system	inhibition_acute	GO_0040013	ENSG00000115353	28216264	Lynch et al. (2017)	TACR1	UBERON_0001016	""
decreased anxiety	nervous system	inhibition_acute	EFO_0009874	ENSG00000115353	28216264	Lynch et al. (2017)	TACR1	UBERON_0001016	""
decreased gonadotrophic hormones	nervous system	inhibition_acute	GO_0032277	ENSG00000115353	28216264	Lynch et al. (2017)	TACR1	UBERON_0001016	""
testicular degeneration	nervous system	inhibition_acute	HP_0000029	ENSG00000115353	28216264	Lynch et al. (2017)	TACR1	UBERON_0001016	""
delayed/absent sexual maturity	nervous system	inhibition_acute	HP_0000823	ENSG00000115353	28216264	Lynch et al. (2017)	TACR1	UBERON_0001016	""
vomiting	gastrointestinal	activation_acute	HP_0002017	ENSG00000115353	28216264	Lynch et al. (2017)	TACR1	UBERON_0005409	""
decreased pain	gastrointestinal	inhibition_acute	GO_1904057	ENSG00000115353	28216264	Lynch et al. (2017)	TACR1	UBERON_0005409	""
decreased inflammation	gastrointestinal	inhibition_acute	GO_0050728	ENSG00000115353	28216264	Lynch et al. (2017)	TACR1	UBERON_0005409	""
decreased locomotor activity	gastrointestinal	inhibition_acute	GO_0040013	ENSG00000115353	28216264	Lynch et al. (2017)	TACR1	UBERON_0005409	""
decreased anxiety	gastrointestinal	inhibition_acute	EFO_0009874	ENSG00000115353	28216264	Lynch et al. (2017)	TACR1	UBERON_0005409	""
decreased gonadotrophic hormones	gastrointestinal	inhibition_acute	GO_0032277	ENSG00000115353	28216264	Lynch et al. (2017)	TACR1	UBERON_0005409	""
testicular degeneration	gastrointestinal	inhibition_acute	HP_0000029	ENSG00000115353	28216264	Lynch et al. (2017)	TACR1	UBERON_0005409	""
delayed/absent sexual maturity	gastrointestinal	inhibition_acute	HP_0000823	ENSG00000115353	28216264	Lynch et al. (2017)	TACR1	UBERON_0005409	""
decreased blood pressure	gastrointestinal	activation_acute	EFO_0005251	ENSG00000115353	28216264	Lynch et al. (2017)	TACR1	UBERON_0005409	""
inflammation	nervous system	activation_acute	GO_0006954	ENSG00000115353	28216264	Lynch et al. (2017)	TACR1	UBERON_0001016	""
increased intestinal transit	immune	activation_acute	HP_0410204	ENSG00000115353	28216264	Lynch et al. (2017)	TACR1	UBERON_0002405	""
decreased pain	immune	inhibition_acute	GO_1904057	ENSG00000115353	28216264	Lynch et al. (2017)	TACR1	UBERON_0002405	""
decreased inflammation	immune	inhibition_acute	GO_0050728	ENSG00000115353	28216264	Lynch et al. (2017)	TACR1	UBERON_0002405	""
decreased locomotor activity	immune	inhibition_acute	GO_0040013	ENSG00000115353	28216264	Lynch et al. (2017)	TACR1	UBERON_0002405	""
decreased anxiety	immune	inhibition_acute	EFO_0009874	ENSG00000115353	28216264	Lynch et al. (2017)	TACR1	UBERON_0002405	""
decreased gonadotrophic hormones	immune	inhibition_acute	GO_0032277	ENSG00000115353	28216264	Lynch et al. (2017)	TACR1	UBERON_0002405	""
testicular degeneration	immune	inhibition_acute	HP_0000029	ENSG00000115353	28216264	Lynch et al. (2017)	TACR1	UBERON_0002405	""
delayed/absent sexual maturity	immune	inhibition_acute	HP_0000823	ENSG00000115353	28216264	Lynch et al. (2017)	TACR1	UBERON_0002405	""
inflammation	gonad	activation_acute	GO_0006954	ENSG00000115353	28216264	Lynch et al. (2017)	TACR1	UBERON_0000991	""
decreased pain	gonad	inhibition_acute	GO_1904057	ENSG00000115353	28216264	Lynch et al. (2017)	TACR1	UBERON_0000991	""
decreased inflammation	gonad	inhibition_acute	GO_0050728	ENSG00000115353	28216264	Lynch et al. (2017)	TACR1	UBERON_0000991	""
decreased locomotor activity	gonad	inhibition_acute	GO_0040013	ENSG00000115353	28216264	Lynch et al. (2017)	TACR1	UBERON_0000991	""
decreased anxiety	gonad	inhibition_acute	EFO_0009874	ENSG00000115353	28216264	Lynch et al. (2017)	TACR1	UBERON_0000991	""
decreased gonadotrophic hormones	gonad	inhibition_acute	GO_0032277	ENSG00000115353	28216264	Lynch et al. (2017)	TACR1	UBERON_0000991	""
testicular degeneration	gonad	inhibition_acute	HP_0000029	ENSG00000115353	28216264	Lynch et al. (2017)	TACR1	UBERON_0000991	""
delayed/absent sexual maturity	gonad	inhibition_acute	HP_0000823	ENSG00000115353	28216264	Lynch et al. (2017)	TACR1	UBERON_0000991	""
decreased blood pressure	nervous system	activation_acute	EFO_0005251	ENSG00000115353	28216264	Lynch et al. (2017)	TACR1	UBERON_0001016	""
increased intestinal transit	nervous system	activation_acute	HP_0410204	ENSG00000115353	28216264	Lynch et al. (2017)	TACR1	UBERON_0001016	""
decreased gastric emptying	nervous system	activation_acute	GO_0120061	ENSG00000115353	28216264	Lynch et al. (2017)	TACR1	UBERON_0001016	""
inflammation	gastrointestinal	activation_acute	GO_0006954	ENSG00000115353	28216264	Lynch et al. (2017)	TACR1	UBERON_0005409	""
bronchoconstriction	immune	activation_acute	EFO_0009836	ENSG00000115353	28216264	Lynch et al. (2017)	TACR1	UBERON_0002405	""
bronchoconstriction	nervous system	activation_acute	EFO_0009836	ENSG00000115353	28216264	Lynch et al. (2017)	TACR1	UBERON_0001016	""
pain	gastrointestinal	activation_acute	EFO_0003843	ENSG00000115353	28216264	Lynch et al. (2017)	TACR1	UBERON_0005409	""
bronchoconstriction	gonad	activation_acute	EFO_0009836	ENSG00000115353	28216264	Lynch et al. (2017)	TACR1	UBERON_0000991	""
decreased gastric emptying	gastrointestinal	activation_acute	GO_0120061	ENSG00000115353	28216264	Lynch et al. (2017)	TACR1	UBERON_0005409	""
increased intestinal transit	gonad	activation_acute	HP_0410204	ENSG00000115353	28216264	Lynch et al. (2017)	TACR1	UBERON_0000991	""
vomiting	gonad	activation_acute	HP_0002017	ENSG00000115353	28216264	Lynch et al. (2017)	TACR1	UBERON_0000991	""
inflammation	immune	activation_acute	GO_0006954	ENSG00000115353	28216264	Lynch et al. (2017)	TACR1	UBERON_0002405	""
increased intestinal transit	gastrointestinal	activation_acute	HP_0410204	ENSG00000115353	28216264	Lynch et al. (2017)	TACR1	UBERON_0005409	""
decreased blood pressure	gonad	activation_acute	EFO_0005251	ENSG00000115353	28216264	Lynch et al. (2017)	TACR1	UBERON_0000991	""
pain	gonad	activation_acute	EFO_0003843	ENSG00000115353	28216264	Lynch et al. (2017)	TACR1	UBERON_0000991	""
decreased gastric emptying	immune	activation_acute	GO_0120061	ENSG00000115353	28216264	Lynch et al. (2017)	TACR1	UBERON_0002405	""
pain	immune	activation_acute	EFO_0003843	ENSG00000115353	28216264	Lynch et al. (2017)	TACR1	UBERON_0002405	""
vomiting	immune	activation_acute	HP_0002017	ENSG00000115353	28216264	Lynch et al. (2017)	TACR1	UBERON_0002405	""
bronchoconstriction	gastrointestinal	activation_acute	EFO_0009836	ENSG00000115353	28216264	Lynch et al. (2017)	TACR1	UBERON_0005409	""
decreased gastric emptying	gonad	activation_acute	GO_0120061	ENSG00000115353	28216264	Lynch et al. (2017)	TACR1	UBERON_0000991	""
decreased blood pressure	immune	activation_acute	EFO_0005251	ENSG00000115353	28216264	Lynch et al. (2017)	TACR1	UBERON_0002405	""
vomiting	nervous system	activation_acute	HP_0002017	ENSG00000115353	28216264	Lynch et al. (2017)	TACR1	UBERON_0001016	""
increased gastric acid secretion	gastrointestinal	activation_general	GO_0060454	ENSG00000113749	23197038	Bowes et al. (2012)	HRH2	UBERON_0005409	""
decreased gastric acid secretion	gastrointestinal	inhibition_general	GO_0060455	ENSG00000113749	23197038	Bowes et al. (2012)	HRH2	UBERON_0005409	""
emesis	gastrointestinal	activation_general	HP_0002017	ENSG00000113749	23197038	Bowes et al. (2012)	HRH2	UBERON_0005409	""
positive inotropy	gastrointestinal	activation_general	GO_0045823	ENSG00000113749	23197038	Bowes et al. (2012)	HRH2	UBERON_0005409	""
increased gastric acid secretion	cardiovascular system	activation_general	GO_0060454	ENSG00000113749	23197038	Bowes et al. (2012)	HRH2	UBERON_0004535	""
decreased gastric acid secretion	cardiovascular system	inhibition_general	GO_0060455	ENSG00000113749	23197038	Bowes et al. (2012)	HRH2	UBERON_0004535	""
emesis	cardiovascular system	activation_general	HP_0002017	ENSG00000113749	23197038	Bowes et al. (2012)	HRH2	UBERON_0004535	""
positive inotropy	cardiovascular system	activation_general	GO_0045823	ENSG00000113749	23197038	Bowes et al. (2012)	HRH2	UBERON_0004535	""
anti-inflammatory activities	immune	inhibition_general	GO_0050728	ENSG00000113448	23197038	Bowes et al. (2012)	PDE4D	UBERON_0002405	""
antidepressant-like activities	immune	inhibition_general	GO_0036276	ENSG00000113448	23197038	Bowes et al. (2012)	PDE4D	UBERON_0002405	""
emesis	immune	inhibition_general	HP_0002017	ENSG00000113448	23197038	Bowes et al. (2012)	PDE4D	UBERON_0002405	""
vasculitis	immune	inhibition_general	EFO_0006803	ENSG00000113448	23197038	Bowes et al. (2012)	PDE4D	UBERON_0002405	""
arteritis	immune	inhibition_general	EFO_0009011	ENSG00000113448	23197038	Bowes et al. (2012)	PDE4D	UBERON_0002405	""
possible thymus atrophy	immune	inhibition_general	EFO_0009875	ENSG00000113448	23197038	Bowes et al. (2012)	PDE4D	UBERON_0002405	""
anti-inflammatory activities	central nervous system	inhibition_general	GO_0050728	ENSG00000113448	23197038	Bowes et al. (2012)	PDE4D	UBERON_0001017	""
antidepressant-like activities	central nervous system	inhibition_general	GO_0036276	ENSG00000113448	23197038	Bowes et al. (2012)	PDE4D	UBERON_0001017	""
emesis	central nervous system	inhibition_general	HP_0002017	ENSG00000113448	23197038	Bowes et al. (2012)	PDE4D	UBERON_0001017	""
vasculitis	central nervous system	inhibition_general	EFO_0006803	ENSG00000113448	23197038	Bowes et al. (2012)	PDE4D	UBERON_0001017	""
arteritis	central nervous system	inhibition_general	EFO_0009011	ENSG00000113448	23197038	Bowes et al. (2012)	PDE4D	UBERON_0001017	""
possible thymus atrophy	central nervous system	inhibition_general	EFO_0009875	ENSG00000113448	23197038	Bowes et al. (2012)	PDE4D	UBERON_0001017	""
decreased motor strength	nervous system	activation_acute	HP_0001324	ENSG00000142319	28216264	Lynch et al. (2017)	SLC6A3	UBERON_0001016	""
increased locomotor activity	nervous system	inhibition_acute	GO_0040017	ENSG00000142319	28216264	Lynch et al. (2017)	SLC6A3	UBERON_0001016	""
stereotypy	nervous system	inhibition_acute	HP_0000733	ENSG00000142319	28216264	Lynch et al. (2017)	SLC6A3	UBERON_0001016	""
psychostimulation	nervous system	inhibition_acute	""	ENSG00000142319	28216264	Lynch et al. (2017)	SLC6A3	UBERON_0001016	""
drug abuse/dependence	nervous system	inhibition_acute	EFO_0003890	ENSG00000142319	28216264	Lynch et al. (2017)	SLC6A3	UBERON_0001016	""
convulsions	nervous system	inhibition_acute	EFO_0009853	ENSG00000142319	28216264	Lynch et al. (2017)	SLC6A3	UBERON_0001016	""
depression	nervous system	inhibition_acute	MONDO_0002050	ENSG00000142319	28216264	Lynch et al. (2017)	SLC6A3	UBERON_0001016	""
parkinsonism	nervous system	inhibition_acute	HP_0001300	ENSG00000142319	28216264	Lynch et al. (2017)	SLC6A3	UBERON_0001016	""
dyskinesia	nervous system	inhibition_acute	EFO_1000904	ENSG00000142319	28216264	Lynch et al. (2017)	SLC6A3	UBERON_0001016	""
dystonia	nervous system	inhibition_acute	HP_0001332	ENSG00000142319	28216264	Lynch et al. (2017)	SLC6A3	UBERON_0001016	""
acne	nervous system	inhibition_acute	EFO_0003894	ENSG00000142319	28216264	Lynch et al. (2017)	SLC6A3	UBERON_0001016	""
decreased motor coordination	nervous system	activation_acute	HP_0002275	ENSG00000142319	28216264	Lynch et al. (2017)	SLC6A3	UBERON_0001016	""
decreased convulsions	cardiovascular	activation_acute	EFO_0009853	ENSG00000069431	28216264	Lynch et al. (2017)	ABCC9	UBERON_0004535	""
decreased heart rate	cardiovascular	inhibition_acute	HP_0001662	ENSG00000069431	28216264	Lynch et al. (2017)	ABCC9	UBERON_0004535	""
atrioventricular block	cardiovascular	inhibition_acute	MONDO_0000465	ENSG00000069431	28216264	Lynch et al. (2017)	ABCC9	UBERON_0004535	""
increased blood insulin	cardiovascular	inhibition_acute	HP_0000842	ENSG00000069431	28216264	Lynch et al. (2017)	ABCC9	UBERON_0004535	""
decreased blood glucose	cardiovascular	inhibition_acute	HP_0001943	ENSG00000069431	28216264	Lynch et al. (2017)	ABCC9	UBERON_0004535	""
increased urine excretion	cardiovascular	inhibition_acute	HP_0000103	ENSG00000069431	28216264	Lynch et al. (2017)	ABCC9	UBERON_0004535	""
increased urinary sodium excretion	cardiovascular	inhibition_acute	GO_0035815	ENSG00000069431	28216264	Lynch et al. (2017)	ABCC9	UBERON_0004535	""
abnormal pulse	cardiovascular	activation_acute	HP_0031860	ENSG00000069431	28216264	Lynch et al. (2017)	ABCC9	UBERON_0004535	""
decreased convulsions	renal	activation_acute	EFO_0009853	ENSG00000069431	28216264	Lynch et al. (2017)	ABCC9	UBERON_0001008	""
decreased heart rate	renal	inhibition_acute	HP_0001662	ENSG00000069431	28216264	Lynch et al. (2017)	ABCC9	UBERON_0001008	""
atrioventricular block	renal	inhibition_acute	MONDO_0000465	ENSG00000069431	28216264	Lynch et al. (2017)	ABCC9	UBERON_0001008	""
increased blood insulin	renal	inhibition_acute	HP_0000842	ENSG00000069431	28216264	Lynch et al. (2017)	ABCC9	UBERON_0001008	""
decreased blood glucose	renal	inhibition_acute	HP_0001943	ENSG00000069431	28216264	Lynch et al. (2017)	ABCC9	UBERON_0001008	""
increased urine excretion	renal	inhibition_acute	HP_0000103	ENSG00000069431	28216264	Lynch et al. (2017)	ABCC9	UBERON_0001008	""
increased urinary sodium excretion	renal	inhibition_acute	GO_0035815	ENSG00000069431	28216264	Lynch et al. (2017)	ABCC9	UBERON_0001008	""
increased/decreased blood glucose	renal	activation_acute	HP_0011015	ENSG00000069431	28216264	Lynch et al. (2017)	ABCC9	UBERON_0001008	""
decreased blood insulin	pancreas	activation_acute	HP_0040216	ENSG00000069431	28216264	Lynch et al. (2017)	ABCC9	UBERON_0001264	""
decreased heart rate	pancreas	inhibition_acute	HP_0001662	ENSG00000069431	28216264	Lynch et al. (2017)	ABCC9	UBERON_0001264	""
atrioventricular block	pancreas	inhibition_acute	MONDO_0000465	ENSG00000069431	28216264	Lynch et al. (2017)	ABCC9	UBERON_0001264	""
increased blood insulin	pancreas	inhibition_acute	HP_0000842	ENSG00000069431	28216264	Lynch et al. (2017)	ABCC9	UBERON_0001264	""
decreased blood glucose	pancreas	inhibition_acute	HP_0001943	ENSG00000069431	28216264	Lynch et al. (2017)	ABCC9	UBERON_0001264	""
increased urine excretion	pancreas	inhibition_acute	HP_0000103	ENSG00000069431	28216264	Lynch et al. (2017)	ABCC9	UBERON_0001264	""
increased urinary sodium excretion	pancreas	inhibition_acute	GO_0035815	ENSG00000069431	28216264	Lynch et al. (2017)	ABCC9	UBERON_0001264	""
cardiac arrhythmia	cardiovascular	activation_acute	EFO_0004269	ENSG00000069431	28216264	Lynch et al. (2017)	ABCC9	UBERON_0004535	""
cardiac lesions	renal	activation_acute	""	ENSG00000069431	28216264	Lynch et al. (2017)	ABCC9	UBERON_0001008	""
cardiac lesions	cardiovascular	activation_acute	""	ENSG00000069431	28216264	Lynch et al. (2017)	ABCC9	UBERON_0004535	""
decreased blood pressure	renal	activation_acute	EFO_0005251	ENSG00000069431	28216264	Lynch et al. (2017)	ABCC9	UBERON_0001008	""
decreased blood insulin	renal	activation_acute	HP_0040216	ENSG00000069431	28216264	Lynch et al. (2017)	ABCC9	UBERON_0001008	""
increased heart rate	cardiovascular	activation_acute	HP_0001649	ENSG00000069431	28216264	Lynch et al. (2017)	ABCC9	UBERON_0004535	""
cardiac lesions	pancreas	activation_acute	""	ENSG00000069431	28216264	Lynch et al. (2017)	ABCC9	UBERON_0001264	""
decreased convulsions	pancreas	activation_acute	EFO_0009853	ENSG00000069431	28216264	Lynch et al. (2017)	ABCC9	UBERON_0001264	""
increased/decreased blood glucose	pancreas	activation_acute	HP_0011015	ENSG00000069431	28216264	Lynch et al. (2017)	ABCC9	UBERON_0001264	""
cardiac arrhythmia	renal	activation_acute	EFO_0004269	ENSG00000069431	28216264	Lynch et al. (2017)	ABCC9	UBERON_0001008	""
increased/decreased blood glucose	cardiovascular	activation_acute	HP_0011015	ENSG00000069431	28216264	Lynch et al. (2017)	ABCC9	UBERON_0004535	""
abnormal pulse	renal	activation_acute	HP_0031860	ENSG00000069431	28216264	Lynch et al. (2017)	ABCC9	UBERON_0001008	""
decreased blood insulin	cardiovascular	activation_acute	HP_0040216	ENSG00000069431	28216264	Lynch et al. (2017)	ABCC9	UBERON_0004535	""
increased heart rate	renal	activation_acute	HP_0001649	ENSG00000069431	28216264	Lynch et al. (2017)	ABCC9	UBERON_0001008	""
increased heart rate	pancreas	activation_acute	HP_0001649	ENSG00000069431	28216264	Lynch et al. (2017)	ABCC9	UBERON_0001264	""
abnormal pulse	pancreas	activation_acute	HP_0031860	ENSG00000069431	28216264	Lynch et al. (2017)	ABCC9	UBERON_0001264	""
decreased blood pressure	pancreas	activation_acute	EFO_0005251	ENSG00000069431	28216264	Lynch et al. (2017)	ABCC9	UBERON_0001264	""
decreased blood pressure	cardiovascular	activation_acute	EFO_0005251	ENSG00000069431	28216264	Lynch et al. (2017)	ABCC9	UBERON_0004535	""
cardiac arrhythmia	pancreas	activation_acute	EFO_0004269	ENSG00000069431	28216264	Lynch et al. (2017)	ABCC9	UBERON_0001264	""
analgesia	central nervous system	activation_general	EFO_1001484	ENSG00000116329	23197038	Bowes et al. (2012)	OPRD1	UBERON_0001017	""
increased blood pressure	central nervous system	inhibition_general	HP_0032263	ENSG00000116329	23197038	Bowes et al. (2012)	OPRD1	UBERON_0001017	""
increased cardiac contractility	central nervous system	inhibition_general	GO_0045823	ENSG00000116329	23197038	Bowes et al. (2012)	OPRD1	UBERON_0001017	""
dysphoria	central nervous system	activation_general	EFO_0009867	ENSG00000116329	23197038	Bowes et al. (2012)	OPRD1	UBERON_0001017	""
psychomimetic effects	central nervous system	activation_general	EFO_1000902	ENSG00000116329	23197038	Bowes et al. (2012)	OPRD1	UBERON_0001017	""
cardiovascular effects	central nervous system	activation_general	EFO_0000319	ENSG00000116329	23197038	Bowes et al. (2012)	OPRD1	UBERON_0001017	""
convulsion	central nervous system	activation_general	EFO_0009853	ENSG00000116329	23197038	Bowes et al. (2012)	OPRD1	UBERON_0001017	""
analgesia	cardiovascular system	activation_general	EFO_1001484	ENSG00000116329	23197038	Bowes et al. (2012)	OPRD1	UBERON_0004535	""
increased blood pressure	cardiovascular system	inhibition_general	HP_0032263	ENSG00000116329	23197038	Bowes et al. (2012)	OPRD1	UBERON_0004535	""
increased cardiac contractility	cardiovascular system	inhibition_general	GO_0045823	ENSG00000116329	23197038	Bowes et al. (2012)	OPRD1	UBERON_0004535	""
dysphoria	cardiovascular system	activation_general	EFO_0009867	ENSG00000116329	23197038	Bowes et al. (2012)	OPRD1	UBERON_0004535	""
psychomimetic effects	cardiovascular system	activation_general	EFO_1000902	ENSG00000116329	23197038	Bowes et al. (2012)	OPRD1	UBERON_0004535	""
cardiovascular effects	cardiovascular system	activation_general	EFO_0000319	ENSG00000116329	23197038	Bowes et al. (2012)	OPRD1	UBERON_0004535	""
convulsion	cardiovascular system	activation_general	EFO_0009853	ENSG00000116329	23197038	Bowes et al. (2012)	OPRD1	UBERON_0004535	""
increased locomotor activity	central nervous system	activation_acute	GO_0040017	ENSG00000116329	28216264	Lynch et al. (2017)	OPRD1	UBERON_0001017	""
increased pain	central nervous system	inhibition_acute	GO_1904058	ENSG00000116329	28216264	Lynch et al. (2017)	OPRD1	UBERON_0001017	""
increased anxiety	central nervous system	inhibition_acute	EFO_0005230	ENSG00000116329	28216264	Lynch et al. (2017)	OPRD1	UBERON_0001017	""
convulsions	central nervous system	activation_acute	EFO_0009853	ENSG00000116329	28216264	Lynch et al. (2017)	OPRD1	UBERON_0001017	""
decreased gastrointestinal transit	central nervous system	activation_acute	HP_0030897	ENSG00000116329	28216264	Lynch et al. (2017)	OPRD1	UBERON_0001017	""
respiratory depression	central nervous system	activation_acute	EFO_0009842	ENSG00000116329	28216264	Lynch et al. (2017)	OPRD1	UBERON_0001017	""
decreased pain	central nervous system	activation_acute	GO_1904057	ENSG00000116329	28216264	Lynch et al. (2017)	OPRD1	UBERON_0001017	""
euphoria	central nervous system	activation_acute	HP_0031844	ENSG00000116329	28216264	Lynch et al. (2017)	OPRD1	UBERON_0001017	""
decreased body temperature	central nervous system	activation_acute	HP_0002045	ENSG00000116329	28216264	Lynch et al. (2017)	OPRD1	UBERON_0001017	""
acidosis	nervous system	activation_acute	EFO_1000014	ENSG00000181072	28216264	Lynch et al. (2017)	CHRM2	UBERON_0001016	""
increased heart rate	nervous system	inhibition_acute	HP_0001649	ENSG00000181072	28216264	Lynch et al. (2017)	CHRM2	UBERON_0001016	""
bronchoconstriction	nervous system	inhibition_acute	EFO_0009836	ENSG00000181072	28216264	Lynch et al. (2017)	CHRM2	UBERON_0001016	""
tremors	nervous system	inhibition_acute	HP_0001337	ENSG00000181072	28216264	Lynch et al. (2017)	CHRM2	UBERON_0001016	""
cough	cardiovascular	activation_acute	HP_0012735	ENSG00000181072	28216264	Lynch et al. (2017)	CHRM2	UBERON_0004535	""
increased heart rate	cardiovascular	inhibition_acute	HP_0001649	ENSG00000181072	28216264	Lynch et al. (2017)	CHRM2	UBERON_0004535	""
bronchoconstriction	cardiovascular	inhibition_acute	EFO_0009836	ENSG00000181072	28216264	Lynch et al. (2017)	CHRM2	UBERON_0004535	""
tremors	cardiovascular	inhibition_acute	HP_0001337	ENSG00000181072	28216264	Lynch et al. (2017)	CHRM2	UBERON_0004535	""
blurred vision	cardiovascular	activation_acute	HP_0000622	ENSG00000181072	28216264	Lynch et al. (2017)	CHRM2	UBERON_0004535	""
irritability	respiratory	activation_acute	HP_0000737	ENSG00000181072	28216264	Lynch et al. (2017)	CHRM2	UBERON_0001004	""
increased heart rate	respiratory	inhibition_acute	HP_0001649	ENSG00000181072	28216264	Lynch et al. (2017)	CHRM2	UBERON_0001004	""
bronchoconstriction	respiratory	inhibition_acute	EFO_0009836	ENSG00000181072	28216264	Lynch et al. (2017)	CHRM2	UBERON_0001004	""
tremors	respiratory	inhibition_acute	HP_0001337	ENSG00000181072	28216264	Lynch et al. (2017)	CHRM2	UBERON_0001004	""
decreased/increased heart rate	nervous system	activation_acute	HP_0031860	ENSG00000181072	28216264	Lynch et al. (2017)	CHRM2	UBERON_0001016	""
exhaustion	nervous system	activation_acute	EFO_0009852	ENSG00000181072	28216264	Lynch et al. (2017)	CHRM2	UBERON_0001016	""
lacrimation	nervous system	activation_acute	HP_0000632	ENSG00000181072	28216264	Lynch et al. (2017)	CHRM2	UBERON_0001016	""
increased/decreased blood pressure	nervous system	activation_acute	HP_0030972	ENSG00000181072	28216264	Lynch et al. (2017)	CHRM2	UBERON_0001016	""
pulmonary hemorrhage	cardiovascular	activation_acute	HP_0040223	ENSG00000181072	28216264	Lynch et al. (2017)	CHRM2	UBERON_0004535	""
decreased PR interval	cardiovascular	activation_acute	HP_0005165	ENSG00000181072	28216264	Lynch et al. (2017)	CHRM2	UBERON_0004535	""
pulmonary congestion	nervous system	activation_acute	EFO_0009866	ENSG00000181072	28216264	Lynch et al. (2017)	CHRM2	UBERON_0001016	""
decreased/increased heart rate	cardiovascular	activation_acute	HP_0031860	ENSG00000181072	28216264	Lynch et al. (2017)	CHRM2	UBERON_0004535	""
ptosis	respiratory	activation_acute	Orphanet_98578	ENSG00000181072	28216264	Lynch et al. (2017)	CHRM2	UBERON_0001004	""
blurred vision	respiratory	activation_acute	HP_0000622	ENSG00000181072	28216264	Lynch et al. (2017)	CHRM2	UBERON_0001004	""
pulmonary hemorrhage	respiratory	activation_acute	HP_0040223	ENSG00000181072	28216264	Lynch et al. (2017)	CHRM2	UBERON_0001004	""
frothing	nervous system	activation_acute	""	ENSG00000181072	28216264	Lynch et al. (2017)	CHRM2	UBERON_0001016	""
frothing	respiratory	activation_acute	""	ENSG00000181072	28216264	Lynch et al. (2017)	CHRM2	UBERON_0001004	""
increased salivation	nervous system	activation_acute	GO_0046878	ENSG00000181072	28216264	Lynch et al. (2017)	CHRM2	UBERON_0001016	""
acidosis	cardiovascular	activation_acute	EFO_1000014	ENSG00000181072	28216264	Lynch et al. (2017)	CHRM2	UBERON_0004535	""
bronchorrhea	cardiovascular	activation_acute	""	ENSG00000181072	28216264	Lynch et al. (2017)	CHRM2	UBERON_0004535	""
pulmonary congestion	cardiovascular	activation_acute	EFO_0009866	ENSG00000181072	28216264	Lynch et al. (2017)	CHRM2	UBERON_0004535	""
acidosis	respiratory	activation_acute	EFO_1000014	ENSG00000181072	28216264	Lynch et al. (2017)	CHRM2	UBERON_0001004	""
increased/decreased blood pressure	respiratory	activation_acute	HP_0030972	ENSG00000181072	28216264	Lynch et al. (2017)	CHRM2	UBERON_0001004	""
exhaustion	cardiovascular	activation_acute	EFO_0009852	ENSG00000181072	28216264	Lynch et al. (2017)	CHRM2	UBERON_0004535	""
decreased pupil diameter	respiratory	activation_acute	HP_0000616	ENSG00000181072	28216264	Lynch et al. (2017)	CHRM2	UBERON_0001004	""
decreased pupil diameter	nervous system	activation_acute	HP_0000616	ENSG00000181072	28216264	Lynch et al. (2017)	CHRM2	UBERON_0001016	""
irritability	cardiovascular	activation_acute	HP_0000737	ENSG00000181072	28216264	Lynch et al. (2017)	CHRM2	UBERON_0004535	""
cough	respiratory	activation_acute	HP_0012735	ENSG00000181072	28216264	Lynch et al. (2017)	CHRM2	UBERON_0001004	""
increased body temperature	cardiovascular	activation_acute	HP_0001945	ENSG00000181072	28216264	Lynch et al. (2017)	CHRM2	UBERON_0004535	""
bronchorrhea	respiratory	activation_acute	""	ENSG00000181072	28216264	Lynch et al. (2017)	CHRM2	UBERON_0001004	""
exhaustion	respiratory	activation_acute	EFO_0009852	ENSG00000181072	28216264	Lynch et al. (2017)	CHRM2	UBERON_0001004	""
increased body temperature	respiratory	activation_acute	HP_0001945	ENSG00000181072	28216264	Lynch et al. (2017)	CHRM2	UBERON_0001004	""
pulmonary congestion	respiratory	activation_acute	EFO_0009866	ENSG00000181072	28216264	Lynch et al. (2017)	CHRM2	UBERON_0001004	""
bronchospasm	cardiovascular	activation_acute	HP_0025428	ENSG00000181072	28216264	Lynch et al. (2017)	CHRM2	UBERON_0004535	""
increased body temperature	nervous system	activation_acute	HP_0001945	ENSG00000181072	28216264	Lynch et al. (2017)	CHRM2	UBERON_0001016	""
sweating	nervous system	activation_acute	HP_0000975	ENSG00000181072	28216264	Lynch et al. (2017)	CHRM2	UBERON_0001016	""
cough	nervous system	activation_acute	HP_0012735	ENSG00000181072	28216264	Lynch et al. (2017)	CHRM2	UBERON_0001016	""
bronchorrhea	nervous system	activation_acute	""	ENSG00000181072	28216264	Lynch et al. (2017)	CHRM2	UBERON_0001016	""
sweating	cardiovascular	activation_acute	HP_0000975	ENSG00000181072	28216264	Lynch et al. (2017)	CHRM2	UBERON_0004535	""
increased salivation	respiratory	activation_acute	GO_0046878	ENSG00000181072	28216264	Lynch et al. (2017)	CHRM2	UBERON_0001004	""
sweating	respiratory	activation_acute	HP_0000975	ENSG00000181072	28216264	Lynch et al. (2017)	CHRM2	UBERON_0001004	""
decreased PR interval	nervous system	activation_acute	HP_0005165	ENSG00000181072	28216264	Lynch et al. (2017)	CHRM2	UBERON_0001016	""
lacrimation	cardiovascular	activation_acute	HP_0000632	ENSG00000181072	28216264	Lynch et al. (2017)	CHRM2	UBERON_0004535	""
lacrimation	respiratory	activation_acute	HP_0000632	ENSG00000181072	28216264	Lynch et al. (2017)	CHRM2	UBERON_0001004	""
muscle cramps	cardiovascular	activation_acute	EFO_0009846	ENSG00000181072	28216264	Lynch et al. (2017)	CHRM2	UBERON_0004535	""
pulmonary hemorrhage	nervous system	activation_acute	HP_0040223	ENSG00000181072	28216264	Lynch et al. (2017)	CHRM2	UBERON_0001016	""
ptosis	cardiovascular	activation_acute	Orphanet_98578	ENSG00000181072	28216264	Lynch et al. (2017)	CHRM2	UBERON_0004535	""
muscle cramps	nervous system	activation_acute	EFO_0009846	ENSG00000181072	28216264	Lynch et al. (2017)	CHRM2	UBERON_0001016	""
increased salivation	cardiovascular	activation_acute	GO_0046878	ENSG00000181072	28216264	Lynch et al. (2017)	CHRM2	UBERON_0004535	""
irritability	nervous system	activation_acute	HP_0000737	ENSG00000181072	28216264	Lynch et al. (2017)	CHRM2	UBERON_0001016	""
ptosis	nervous system	activation_acute	Orphanet_98578	ENSG00000181072	28216264	Lynch et al. (2017)	CHRM2	UBERON_0001016	""
muscle cramps	respiratory	activation_acute	EFO_0009846	ENSG00000181072	28216264	Lynch et al. (2017)	CHRM2	UBERON_0001004	""
bronchospasm	respiratory	activation_acute	HP_0025428	ENSG00000181072	28216264	Lynch et al. (2017)	CHRM2	UBERON_0001004	""
decreased PR interval	respiratory	activation_acute	HP_0005165	ENSG00000181072	28216264	Lynch et al. (2017)	CHRM2	UBERON_0001004	""
decreased/increased respiratory rate	nervous system	activation_acute	EFO_0009841	ENSG00000181072	28216264	Lynch et al. (2017)	CHRM2	UBERON_0001016	""
bronchospasm	nervous system	activation_acute	HP_0025428	ENSG00000181072	28216264	Lynch et al. (2017)	CHRM2	UBERON_0001016	""
decreased/increased respiratory rate	respiratory	activation_acute	EFO_0009841	ENSG00000181072	28216264	Lynch et al. (2017)	CHRM2	UBERON_0001004	""
decreased/increased heart rate	respiratory	activation_acute	HP_0031860	ENSG00000181072	28216264	Lynch et al. (2017)	CHRM2	UBERON_0001004	""
decreased/increased respiratory rate	cardiovascular	activation_acute	EFO_0009841	ENSG00000181072	28216264	Lynch et al. (2017)	CHRM2	UBERON_0004535	""
frothing	cardiovascular	activation_acute	""	ENSG00000181072	28216264	Lynch et al. (2017)	CHRM2	UBERON_0004535	""
increased/decreased blood pressure	cardiovascular	activation_acute	HP_0030972	ENSG00000181072	28216264	Lynch et al. (2017)	CHRM2	UBERON_0004535	""
decreased pupil diameter	cardiovascular	activation_acute	HP_0000616	ENSG00000181072	28216264	Lynch et al. (2017)	CHRM2	UBERON_0004535	""
blurred vision	nervous system	activation_acute	HP_0000622	ENSG00000181072	28216264	Lynch et al. (2017)	CHRM2	UBERON_0001016	""
convulsions	respiratory	activation_acute	EFO_0009853	ENSG00000166257	28216264	Lynch et al. (2017)	SCN3B	UBERON_0001004	""
decreased pain	respiratory	inhibition_acute	GO_1904057	ENSG00000166257	28216264	Lynch et al. (2017)	SCN3B	UBERON_0001004	""
agitation	respiratory	inhibition_acute	NCIT_C74532	ENSG00000166257	28216264	Lynch et al. (2017)	SCN3B	UBERON_0001004	""
decreased sweating	respiratory	inhibition_acute	EFO_1000712	ENSG00000166257	28216264	Lynch et al. (2017)	SCN3B	UBERON_0001004	""
increased pupil diameter	respiratory	inhibition_acute	HP_0011499	ENSG00000166257	28216264	Lynch et al. (2017)	SCN3B	UBERON_0001004	""
decreased/increased convulsions	respiratory	inhibition_acute	EFO_0009853	ENSG00000166257	28216264	Lynch et al. (2017)	SCN3B	UBERON_0001004	""
decreased/increased heart rate	respiratory	inhibition_acute	HP_0031860	ENSG00000166257	28216264	Lynch et al. (2017)	SCN3B	UBERON_0001004	""
decreased blood pressure	respiratory	inhibition_acute	EFO_0005251	ENSG00000166257	28216264	Lynch et al. (2017)	SCN3B	UBERON_0001004	""
decreased cardiac contractility	respiratory	inhibition_acute	GO_0045822	ENSG00000166257	28216264	Lynch et al. (2017)	SCN3B	UBERON_0001004	""
decreased cardiac conduction	respiratory	inhibition_acute	EFO_1001497	ENSG00000166257	28216264	Lynch et al. (2017)	SCN3B	UBERON_0001004	""
increased QRS complex	respiratory	inhibition_acute	HP_0006677	ENSG00000166257	28216264	Lynch et al. (2017)	SCN3B	UBERON_0001004	""
cardiac arrhythmia	respiratory	inhibition_acute	EFO_0004269	ENSG00000166257	28216264	Lynch et al. (2017)	SCN3B	UBERON_0001004	""
decreased respiratory rate	respiratory	inhibition_acute	EFO_0009839	ENSG00000166257	28216264	Lynch et al. (2017)	SCN3B	UBERON_0001004	""
decreased gastrointestinal transit	respiratory	inhibition_acute	HP_0030897	ENSG00000166257	28216264	Lynch et al. (2017)	SCN3B	UBERON_0001004	""
decreased urine excretion	respiratory	inhibition_acute	HP_0011037	ENSG00000166257	28216264	Lynch et al. (2017)	SCN3B	UBERON_0001004	""
coma	respiratory	inhibition_acute	HP_0001259	ENSG00000166257	28216264	Lynch et al. (2017)	SCN3B	UBERON_0001004	""
increased heart rate	nervous system	activation_acute	HP_0001649	ENSG00000166257	28216264	Lynch et al. (2017)	SCN3B	UBERON_0001016	""
decreased pain	nervous system	inhibition_acute	GO_1904057	ENSG00000166257	28216264	Lynch et al. (2017)	SCN3B	UBERON_0001016	""
agitation	nervous system	inhibition_acute	NCIT_C74532	ENSG00000166257	28216264	Lynch et al. (2017)	SCN3B	UBERON_0001016	""
decreased sweating	nervous system	inhibition_acute	EFO_1000712	ENSG00000166257	28216264	Lynch et al. (2017)	SCN3B	UBERON_0001016	""
increased pupil diameter	nervous system	inhibition_acute	HP_0011499	ENSG00000166257	28216264	Lynch et al. (2017)	SCN3B	UBERON_0001016	""
decreased/increased convulsions	nervous system	inhibition_acute	EFO_0009853	ENSG00000166257	28216264	Lynch et al. (2017)	SCN3B	UBERON_0001016	""
decreased/increased heart rate	nervous system	inhibition_acute	HP_0031860	ENSG00000166257	28216264	Lynch et al. (2017)	SCN3B	UBERON_0001016	""
decreased blood pressure	nervous system	inhibition_acute	EFO_0005251	ENSG00000166257	28216264	Lynch et al. (2017)	SCN3B	UBERON_0001016	""
decreased cardiac contractility	nervous system	inhibition_acute	GO_0045822	ENSG00000166257	28216264	Lynch et al. (2017)	SCN3B	UBERON_0001016	""
decreased cardiac conduction	nervous system	inhibition_acute	EFO_1001497	ENSG00000166257	28216264	Lynch et al. (2017)	SCN3B	UBERON_0001016	""
increased QRS complex	nervous system	inhibition_acute	HP_0006677	ENSG00000166257	28216264	Lynch et al. (2017)	SCN3B	UBERON_0001016	""
cardiac arrhythmia	nervous system	inhibition_acute	EFO_0004269	ENSG00000166257	28216264	Lynch et al. (2017)	SCN3B	UBERON_0001016	""
decreased respiratory rate	nervous system	inhibition_acute	EFO_0009839	ENSG00000166257	28216264	Lynch et al. (2017)	SCN3B	UBERON_0001016	""
decreased gastrointestinal transit	nervous system	inhibition_acute	HP_0030897	ENSG00000166257	28216264	Lynch et al. (2017)	SCN3B	UBERON_0001016	""
decreased urine excretion	nervous system	inhibition_acute	HP_0011037	ENSG00000166257	28216264	Lynch et al. (2017)	SCN3B	UBERON_0001016	""
coma	nervous system	inhibition_acute	HP_0001259	ENSG00000166257	28216264	Lynch et al. (2017)	SCN3B	UBERON_0001016	""
increased heart rate	respiratory	activation_acute	HP_0001649	ENSG00000166257	28216264	Lynch et al. (2017)	SCN3B	UBERON_0001004	""
increased heart rate	cardiovascular	activation_acute	HP_0001649	ENSG00000166257	28216264	Lynch et al. (2017)	SCN3B	UBERON_0004535	""
decreased pain	cardiovascular	inhibition_acute	GO_1904057	ENSG00000166257	28216264	Lynch et al. (2017)	SCN3B	UBERON_0004535	""
agitation	cardiovascular	inhibition_acute	NCIT_C74532	ENSG00000166257	28216264	Lynch et al. (2017)	SCN3B	UBERON_0004535	""
decreased sweating	cardiovascular	inhibition_acute	EFO_1000712	ENSG00000166257	28216264	Lynch et al. (2017)	SCN3B	UBERON_0004535	""
increased pupil diameter	cardiovascular	inhibition_acute	HP_0011499	ENSG00000166257	28216264	Lynch et al. (2017)	SCN3B	UBERON_0004535	""
decreased/increased convulsions	cardiovascular	inhibition_acute	EFO_0009853	ENSG00000166257	28216264	Lynch et al. (2017)	SCN3B	UBERON_0004535	""
decreased/increased heart rate	cardiovascular	inhibition_acute	HP_0031860	ENSG00000166257	28216264	Lynch et al. (2017)	SCN3B	UBERON_0004535	""
decreased blood pressure	cardiovascular	inhibition_acute	EFO_0005251	ENSG00000166257	28216264	Lynch et al. (2017)	SCN3B	UBERON_0004535	""
decreased cardiac contractility	cardiovascular	inhibition_acute	GO_0045822	ENSG00000166257	28216264	Lynch et al. (2017)	SCN3B	UBERON_0004535	""
decreased cardiac conduction	cardiovascular	inhibition_acute	EFO_1001497	ENSG00000166257	28216264	Lynch et al. (2017)	SCN3B	UBERON_0004535	""
increased QRS complex	cardiovascular	inhibition_acute	HP_0006677	ENSG00000166257	28216264	Lynch et al. (2017)	SCN3B	UBERON_0004535	""
cardiac arrhythmia	cardiovascular	inhibition_acute	EFO_0004269	ENSG00000166257	28216264	Lynch et al. (2017)	SCN3B	UBERON_0004535	""
decreased respiratory rate	cardiovascular	inhibition_acute	EFO_0009839	ENSG00000166257	28216264	Lynch et al. (2017)	SCN3B	UBERON_0004535	""
decreased gastrointestinal transit	cardiovascular	inhibition_acute	HP_0030897	ENSG00000166257	28216264	Lynch et al. (2017)	SCN3B	UBERON_0004535	""
decreased urine excretion	cardiovascular	inhibition_acute	HP_0011037	ENSG00000166257	28216264	Lynch et al. (2017)	SCN3B	UBERON_0004535	""
coma	cardiovascular	inhibition_acute	HP_0001259	ENSG00000166257	28216264	Lynch et al. (2017)	SCN3B	UBERON_0004535	""
dyspnea	nervous system	activation_acute	HP_0002094	ENSG00000166257	28216264	Lynch et al. (2017)	SCN3B	UBERON_0001016	""
decreased locomotor activity	cardiovascular	activation_acute	GO_0040013	ENSG00000166257	28216264	Lynch et al. (2017)	SCN3B	UBERON_0004535	""
decreased locomotor activity	respiratory	activation_acute	GO_0040013	ENSG00000166257	28216264	Lynch et al. (2017)	SCN3B	UBERON_0001004	""
convulsions	nervous system	activation_acute	EFO_0009853	ENSG00000166257	28216264	Lynch et al. (2017)	SCN3B	UBERON_0001016	""
decreased locomotor activity	nervous system	activation_acute	GO_0040013	ENSG00000166257	28216264	Lynch et al. (2017)	SCN3B	UBERON_0001016	""
dyspnea	respiratory	activation_acute	HP_0002094	ENSG00000166257	28216264	Lynch et al. (2017)	SCN3B	UBERON_0001004	""
convulsions	cardiovascular	activation_acute	EFO_0009853	ENSG00000166257	28216264	Lynch et al. (2017)	SCN3B	UBERON_0004535	""
cardiac arrhythmia	nervous system	activation_acute	EFO_0004269	ENSG00000166257	28216264	Lynch et al. (2017)	SCN3B	UBERON_0001016	""
cardiac arrhythmia	cardiovascular	activation_acute	EFO_0004269	ENSG00000166257	28216264	Lynch et al. (2017)	SCN3B	UBERON_0004535	""
dyspnea	cardiovascular	activation_acute	HP_0002094	ENSG00000166257	28216264	Lynch et al. (2017)	SCN3B	UBERON_0004535	""
cardiac arrhythmia	respiratory	activation_acute	EFO_0004269	ENSG00000166257	28216264	Lynch et al. (2017)	SCN3B	UBERON_0001004	""
platelet aggregation	cardiovascular	activation_acute	GO_0070527	ENSG00000169403	28216264	Lynch et al. (2017)	PTAFR	UBERON_0004535	""
decreased inflammation	cardiovascular	inhibition_acute	GO_0050728	ENSG00000169403	28216264	Lynch et al. (2017)	PTAFR	UBERON_0004535	""
decreased pain	cardiovascular	inhibition_acute	GO_1904057	ENSG00000169403	28216264	Lynch et al. (2017)	PTAFR	UBERON_0004535	""
decreased blood pressure	blood	activation_acute	EFO_0005251	ENSG00000169403	28216264	Lynch et al. (2017)	PTAFR	UBERON_0000178	""
decreased inflammation	blood	inhibition_acute	GO_0050728	ENSG00000169403	28216264	Lynch et al. (2017)	PTAFR	UBERON_0000178	""
decreased pain	blood	inhibition_acute	GO_1904057	ENSG00000169403	28216264	Lynch et al. (2017)	PTAFR	UBERON_0000178	""
platelet aggregation	blood	activation_acute	GO_0070527	ENSG00000169403	28216264	Lynch et al. (2017)	PTAFR	UBERON_0000178	""
decreased blood pressure	respiratory	activation_acute	EFO_0005251	ENSG00000169403	28216264	Lynch et al. (2017)	PTAFR	UBERON_0001004	""
decreased inflammation	respiratory	inhibition_acute	GO_0050728	ENSG00000169403	28216264	Lynch et al. (2017)	PTAFR	UBERON_0001004	""
decreased pain	respiratory	inhibition_acute	GO_1904057	ENSG00000169403	28216264	Lynch et al. (2017)	PTAFR	UBERON_0001004	""
decreased cardiac contractility	respiratory	activation_acute	GO_0045822	ENSG00000169403	28216264	Lynch et al. (2017)	PTAFR	UBERON_0001004	""
inflammation	renal	activation_acute	GO_0006954	ENSG00000169403	28216264	Lynch et al. (2017)	PTAFR	UBERON_0001008	""
decreased inflammation	renal	inhibition_acute	GO_0050728	ENSG00000169403	28216264	Lynch et al. (2017)	PTAFR	UBERON_0001008	""
decreased pain	renal	inhibition_acute	GO_1904057	ENSG00000169403	28216264	Lynch et al. (2017)	PTAFR	UBERON_0001008	""
pain	cardiovascular	activation_acute	EFO_0003843	ENSG00000169403	28216264	Lynch et al. (2017)	PTAFR	UBERON_0004535	""
inflammation	respiratory	activation_acute	GO_0006954	ENSG00000169403	28216264	Lynch et al. (2017)	PTAFR	UBERON_0001004	""
decreased blood pressure	cardiovascular	activation_acute	EFO_0005251	ENSG00000169403	28216264	Lynch et al. (2017)	PTAFR	UBERON_0004535	""
decreased urinary sodium excretion	cardiovascular	activation_acute	GO_0035814	ENSG00000169403	28216264	Lynch et al. (2017)	PTAFR	UBERON_0004535	""
decreased heart rate	renal	activation_acute	HP_0001662	ENSG00000169403	28216264	Lynch et al. (2017)	PTAFR	UBERON_0001008	""
decreased cardiac contractility	renal	activation_acute	GO_0045822	ENSG00000169403	28216264	Lynch et al. (2017)	PTAFR	UBERON_0001008	""
decreased urine excretion	renal	activation_acute	HP_0011037	ENSG00000169403	28216264	Lynch et al. (2017)	PTAFR	UBERON_0001008	""
decreased cardiac contractility	immune	activation_acute	GO_0045822	ENSG00000169403	28216264	Lynch et al. (2017)	PTAFR	UBERON_0002405	""
decreased inflammation	immune	inhibition_acute	GO_0050728	ENSG00000169403	28216264	Lynch et al. (2017)	PTAFR	UBERON_0002405	""
decreased pain	immune	inhibition_acute	GO_1904057	ENSG00000169403	28216264	Lynch et al. (2017)	PTAFR	UBERON_0002405	""
pain	renal	activation_acute	EFO_0003843	ENSG00000169403	28216264	Lynch et al. (2017)	PTAFR	UBERON_0001008	""
decreased urinary sodium excretion	immune	activation_acute	GO_0035814	ENSG00000169403	28216264	Lynch et al. (2017)	PTAFR	UBERON_0002405	""
decreased urine excretion	cardiovascular	activation_acute	HP_0011037	ENSG00000169403	28216264	Lynch et al. (2017)	PTAFR	UBERON_0004535	""
decreased urine excretion	immune	activation_acute	HP_0011037	ENSG00000169403	28216264	Lynch et al. (2017)	PTAFR	UBERON_0002405	""
decreased cardiac contractility	cardiovascular	activation_acute	GO_0045822	ENSG00000169403	28216264	Lynch et al. (2017)	PTAFR	UBERON_0004535	""
platelet aggregation	respiratory	activation_acute	GO_0070527	ENSG00000169403	28216264	Lynch et al. (2017)	PTAFR	UBERON_0001004	""
increased airway responsiveness to antigens	immune	activation_acute	EFO_0005414	ENSG00000169403	28216264	Lynch et al. (2017)	PTAFR	UBERON_0002405	""
decreased urine excretion	respiratory	activation_acute	HP_0011037	ENSG00000169403	28216264	Lynch et al. (2017)	PTAFR	UBERON_0001004	""
decreased urine excretion	blood	activation_acute	HP_0011037	ENSG00000169403	28216264	Lynch et al. (2017)	PTAFR	UBERON_0000178	""
pain	immune	activation_acute	EFO_0003843	ENSG00000169403	28216264	Lynch et al. (2017)	PTAFR	UBERON_0002405	""
decreased urinary sodium excretion	respiratory	activation_acute	GO_0035814	ENSG00000169403	28216264	Lynch et al. (2017)	PTAFR	UBERON_0001004	""
increased airway responsiveness to antigens	blood	activation_acute	EFO_0005414	ENSG00000169403	28216264	Lynch et al. (2017)	PTAFR	UBERON_0000178	""
inflammation	cardiovascular	activation_acute	GO_0006954	ENSG00000169403	28216264	Lynch et al. (2017)	PTAFR	UBERON_0004535	""
bronchoconstriction	blood	activation_acute	EFO_0009836	ENSG00000169403	28216264	Lynch et al. (2017)	PTAFR	UBERON_0000178	""
decreased heart rate	blood	activation_acute	HP_0001662	ENSG00000169403	28216264	Lynch et al. (2017)	PTAFR	UBERON_0000178	""
increased airway responsiveness to antigens	renal	activation_acute	EFO_0005414	ENSG00000169403	28216264	Lynch et al. (2017)	PTAFR	UBERON_0001008	""
bronchoconstriction	renal	activation_acute	EFO_0009836	ENSG00000169403	28216264	Lynch et al. (2017)	PTAFR	UBERON_0001008	""
increased airway responsiveness to antigens	respiratory	activation_acute	EFO_0005414	ENSG00000169403	28216264	Lynch et al. (2017)	PTAFR	UBERON_0001004	""
bronchoconstriction	respiratory	activation_acute	EFO_0009836	ENSG00000169403	28216264	Lynch et al. (2017)	PTAFR	UBERON_0001004	""
bronchoconstriction	cardiovascular	activation_acute	EFO_0009836	ENSG00000169403	28216264	Lynch et al. (2017)	PTAFR	UBERON_0004535	""
inflammation	immune	activation_acute	GO_0006954	ENSG00000169403	28216264	Lynch et al. (2017)	PTAFR	UBERON_0002405	""
decreased cardiac contractility	blood	activation_acute	GO_0045822	ENSG00000169403	28216264	Lynch et al. (2017)	PTAFR	UBERON_0000178	""
platelet aggregation	renal	activation_acute	GO_0070527	ENSG00000169403	28216264	Lynch et al. (2017)	PTAFR	UBERON_0001008	""
decreased urinary sodium excretion	blood	activation_acute	GO_0035814	ENSG00000169403	28216264	Lynch et al. (2017)	PTAFR	UBERON_0000178	""
decreased blood pressure	renal	activation_acute	EFO_0005251	ENSG00000169403	28216264	Lynch et al. (2017)	PTAFR	UBERON_0001008	""
decreased heart rate	immune	activation_acute	HP_0001662	ENSG00000169403	28216264	Lynch et al. (2017)	PTAFR	UBERON_0002405	""
pain	respiratory	activation_acute	EFO_0003843	ENSG00000169403	28216264	Lynch et al. (2017)	PTAFR	UBERON_0001004	""
pain	blood	activation_acute	EFO_0003843	ENSG00000169403	28216264	Lynch et al. (2017)	PTAFR	UBERON_0000178	""
decreased heart rate	cardiovascular	activation_acute	HP_0001662	ENSG00000169403	28216264	Lynch et al. (2017)	PTAFR	UBERON_0004535	""
increased airway responsiveness to antigens	cardiovascular	activation_acute	EFO_0005414	ENSG00000169403	28216264	Lynch et al. (2017)	PTAFR	UBERON_0004535	""
decreased heart rate	respiratory	activation_acute	HP_0001662	ENSG00000169403	28216264	Lynch et al. (2017)	PTAFR	UBERON_0001004	""
decreased blood pressure	immune	activation_acute	EFO_0005251	ENSG00000169403	28216264	Lynch et al. (2017)	PTAFR	UBERON_0002405	""
platelet aggregation	immune	activation_acute	GO_0070527	ENSG00000169403	28216264	Lynch et al. (2017)	PTAFR	UBERON_0002405	""
decreased urinary sodium excretion	renal	activation_acute	GO_0035814	ENSG00000169403	28216264	Lynch et al. (2017)	PTAFR	UBERON_0001008	""
inflammation	blood	activation_acute	GO_0006954	ENSG00000169403	28216264	Lynch et al. (2017)	PTAFR	UBERON_0000178	""
bronchoconstriction	immune	activation_acute	EFO_0009836	ENSG00000169403	28216264	Lynch et al. (2017)	PTAFR	UBERON_0002405	""
increased memory	nervous system	activation_acute	EFO_0004874	ENSG00000147955	28216264	Lynch et al. (2017)	SIGMAR1	UBERON_0001016	""
decreased pain	nervous system	inhibition_acute	GO_1904057	ENSG00000147955	28216264	Lynch et al. (2017)	SIGMAR1	UBERON_0001016	""
drug abuse/dependence	nervous system	activation_acute	EFO_0003890	ENSG00000147955	28216264	Lynch et al. (2017)	SIGMAR1	UBERON_0001016	""
decreased anxiety	nervous system	activation_acute	EFO_0009874	ENSG00000147955	28216264	Lynch et al. (2017)	SIGMAR1	UBERON_0001016	""
hallucinations	nervous system	activation_acute	HP_0000738	ENSG00000147955	28216264	Lynch et al. (2017)	SIGMAR1	UBERON_0001016	""
decreased convulsions	nervous system	activation_acute	EFO_0009853	ENSG00000147955	28216264	Lynch et al. (2017)	SIGMAR1	UBERON_0001016	""
anxiolysis	central nervous system	activation_general	EFO_0009874	ENSG00000022355	23197038	Bowes et al. (2012)	GABRA1	UBERON_0001017	""
seizure (when used as a BZD antidote)	central nervous system	inhibition_general	HP_0001250	ENSG00000022355	23197038	Bowes et al. (2012)	GABRA1	UBERON_0001017	""
muscle relaxation	central nervous system	activation_general	""	ENSG00000022355	23197038	Bowes et al. (2012)	GABRA1	UBERON_0001017	""
ataxia	central nervous system	activation_general	MONDO_0000437	ENSG00000022355	23197038	Bowes et al. (2012)	GABRA1	UBERON_0001017	""
anticonvulsant	central nervous system	activation_general	GO_0036277	ENSG00000022355	23197038	Bowes et al. (2012)	GABRA1	UBERON_0001017	""
abuse potential	central nervous system	activation_general	EFO_0003890	ENSG00000022355	23197038	Bowes et al. (2012)	GABRA1	UBERON_0001017	""
sedation	central nervous system	activation_general	EFO_0009868	ENSG00000022355	23197038	Bowes et al. (2012)	GABRA1	UBERON_0001017	""
dizziness	central nervous system	activation_general	EFO_0009847	ENSG00000022355	23197038	Bowes et al. (2012)	GABRA1	UBERON_0001017	""
depression	central nervous system	activation_general	MONDO_0002050	ENSG00000022355	23197038	Bowes et al. (2012)	GABRA1	UBERON_0001017	""
anterograde amnesia	central nervous system	activation_general	EFO_1001454	ENSG00000022355	23197038	Bowes et al. (2012)	GABRA1	UBERON_0001017	""
potential cardiac valvulopathy	pulmonary	activation_general	""	ENSG00000135914	23197038	Bowes et al. (2012)	HTR2B	UBERON_0002048	""
possible cardiac effects, especially during embryonic development	pulmonary	inhibition_developmental toxicity	EFO_0005269	ENSG00000135914	23197038	Bowes et al. (2012)	HTR2B	UBERON_0002048	""
pulmonary hypertension	pulmonary	activation_general	EFO_0001361	ENSG00000135914	23197038	Bowes et al. (2012)	HTR2B	UBERON_0002048	""
potential cardiac valvulopathy	development	activation_general	""	ENSG00000135914	23197038	Bowes et al. (2012)	HTR2B	""	""
possible cardiac effects, especially during embryonic development	development	inhibition_developmental toxicity	EFO_0005269	ENSG00000135914	23197038	Bowes et al. (2012)	HTR2B	""	""
pulmonary hypertension	development	activation_general	EFO_0001361	ENSG00000135914	23197038	Bowes et al. (2012)	HTR2B	""	""
potential cardiac valvulopathy	cardiovascular system	activation_general	""	ENSG00000135914	23197038	Bowes et al. (2012)	HTR2B	UBERON_0004535	""
possible cardiac effects, especially during embryonic development	cardiovascular system	inhibition_developmental toxicity	EFO_0005269	ENSG00000135914	23197038	Bowes et al. (2012)	HTR2B	UBERON_0004535	""
pulmonary hypertension	cardiovascular system	activation_general	EFO_0001361	ENSG00000135914	23197038	Bowes et al. (2012)	HTR2B	UBERON_0004535	""
increased cardiac contractility	cardiovascular	inhibition_acute	GO_0045823	ENSG00000105409	28216264	Lynch et al. (2017)	ATP1A3	UBERON_0004535	""
decreased heart rate	cardiovascular	inhibition_acute	HP_0001662	ENSG00000105409	28216264	Lynch et al. (2017)	ATP1A3	UBERON_0004535	""
atrioventricular block	cardiovascular	inhibition_acute	MONDO_0000465	ENSG00000105409	28216264	Lynch et al. (2017)	ATP1A3	UBERON_0004535	""
cardiac arrhythmia	cardiovascular	inhibition_acute	EFO_0004269	ENSG00000105409	28216264	Lynch et al. (2017)	ATP1A3	UBERON_0004535	""
ventricular fibrillation	cardiovascular	inhibition_acute	EFO_0004287	ENSG00000105409	28216264	Lynch et al. (2017)	ATP1A3	UBERON_0004535	""
increased urine excretion	cardiovascular	inhibition_acute	HP_0000103	ENSG00000105409	28216264	Lynch et al. (2017)	ATP1A3	UBERON_0004535	""
increased urinary sodium excretion	cardiovascular	inhibition_acute	GO_0035815	ENSG00000105409	28216264	Lynch et al. (2017)	ATP1A3	UBERON_0004535	""
vomiting	cardiovascular	inhibition_acute	HP_0002017	ENSG00000105409	28216264	Lynch et al. (2017)	ATP1A3	UBERON_0004535	""
increased cardiac contractility	renal	inhibition_acute	GO_0045823	ENSG00000105409	28216264	Lynch et al. (2017)	ATP1A3	UBERON_0001008	""
decreased heart rate	renal	inhibition_acute	HP_0001662	ENSG00000105409	28216264	Lynch et al. (2017)	ATP1A3	UBERON_0001008	""
atrioventricular block	renal	inhibition_acute	MONDO_0000465	ENSG00000105409	28216264	Lynch et al. (2017)	ATP1A3	UBERON_0001008	""
cardiac arrhythmia	renal	inhibition_acute	EFO_0004269	ENSG00000105409	28216264	Lynch et al. (2017)	ATP1A3	UBERON_0001008	""
ventricular fibrillation	renal	inhibition_acute	EFO_0004287	ENSG00000105409	28216264	Lynch et al. (2017)	ATP1A3	UBERON_0001008	""
increased urine excretion	renal	inhibition_acute	HP_0000103	ENSG00000105409	28216264	Lynch et al. (2017)	ATP1A3	UBERON_0001008	""
increased urinary sodium excretion	renal	inhibition_acute	GO_0035815	ENSG00000105409	28216264	Lynch et al. (2017)	ATP1A3	UBERON_0001008	""
vomiting	renal	inhibition_acute	HP_0002017	ENSG00000105409	28216264	Lynch et al. (2017)	ATP1A3	UBERON_0001008	""
atrial fibrillation	cardiovascular system	activation_general	EFO_0000275	ENSG00000180509	23197038	Bowes et al. (2012)	KCNE1	UBERON_0004535	""
long QT syndrome	cardiovascular system	inhibition_general	MONDO_0002442	ENSG00000180509	23197038	Bowes et al. (2012)	KCNE1	UBERON_0004535	""
potential hearing impairment	cardiovascular system	inhibition_general	EFO_0004238	ENSG00000180509	23197038	Bowes et al. (2012)	KCNE1	UBERON_0004535	""
deafness	cardiovascular system	inhibition_general	EFO_0001063	ENSG00000180509	23197038	Bowes et al. (2012)	KCNE1	UBERON_0004535	""
gastrointestinal symptoms	cardiovascular system	inhibition_general	HP_0012719	ENSG00000180509	23197038	Bowes et al. (2012)	KCNE1	UBERON_0004535	""
atrial fibrillation	cardiovascular system	activation_general	EFO_0000275	ENSG00000053918	23197038	Bowes et al. (2012)	KCNQ1	UBERON_0004535	""
long QT syndrome	cardiovascular system	inhibition_general	MONDO_0002442	ENSG00000053918	23197038	Bowes et al. (2012)	KCNQ1	UBERON_0004535	""
potential hearing impairment	cardiovascular system	inhibition_general	EFO_0004238	ENSG00000053918	23197038	Bowes et al. (2012)	KCNQ1	UBERON_0004535	""
deafness	cardiovascular system	inhibition_general	EFO_0001063	ENSG00000053918	23197038	Bowes et al. (2012)	KCNQ1	UBERON_0004535	""
gastrointestinal symptoms	cardiovascular system	inhibition_general	HP_0012719	ENSG00000053918	23197038	Bowes et al. (2012)	KCNQ1	UBERON_0004535	""
increased pupil diameter	nervous system	activation_acute	HP_0011499	ENSG00000150594	28216264	Lynch et al. (2017)	ADRA2A	UBERON_0001016	""
increased heart rate	nervous system	inhibition_acute	HP_0001649	ENSG00000150594	28216264	Lynch et al. (2017)	ADRA2A	UBERON_0001016	""
increased gastrointestinal transit	nervous system	inhibition_acute	HP_0410204	ENSG00000150594	28216264	Lynch et al. (2017)	ADRA2A	UBERON_0001016	""
increased convulsions	nervous system	inhibition_acute	EFO_0009853	ENSG00000150594	28216264	Lynch et al. (2017)	ADRA2A	UBERON_0001016	""
increased blood insulin	nervous system	inhibition_acute	HP_0000842	ENSG00000150594	28216264	Lynch et al. (2017)	ADRA2A	UBERON_0001016	""
decreased blood pressure	cardiovascular	activation_acute	EFO_0005251	ENSG00000150594	28216264	Lynch et al. (2017)	ADRA2A	UBERON_0004535	""
increased heart rate	cardiovascular	inhibition_acute	HP_0001649	ENSG00000150594	28216264	Lynch et al. (2017)	ADRA2A	UBERON_0004535	""
increased gastrointestinal transit	cardiovascular	inhibition_acute	HP_0410204	ENSG00000150594	28216264	Lynch et al. (2017)	ADRA2A	UBERON_0004535	""
increased convulsions	cardiovascular	inhibition_acute	EFO_0009853	ENSG00000150594	28216264	Lynch et al. (2017)	ADRA2A	UBERON_0004535	""
increased blood insulin	cardiovascular	inhibition_acute	HP_0000842	ENSG00000150594	28216264	Lynch et al. (2017)	ADRA2A	UBERON_0004535	""
decreased blood insulin	pancreas	activation_acute	HP_0040216	ENSG00000150594	28216264	Lynch et al. (2017)	ADRA2A	UBERON_0001264	""
increased heart rate	pancreas	inhibition_acute	HP_0001649	ENSG00000150594	28216264	Lynch et al. (2017)	ADRA2A	UBERON_0001264	""
increased gastrointestinal transit	pancreas	inhibition_acute	HP_0410204	ENSG00000150594	28216264	Lynch et al. (2017)	ADRA2A	UBERON_0001264	""
increased convulsions	pancreas	inhibition_acute	EFO_0009853	ENSG00000150594	28216264	Lynch et al. (2017)	ADRA2A	UBERON_0001264	""
increased blood insulin	pancreas	inhibition_acute	HP_0000842	ENSG00000150594	28216264	Lynch et al. (2017)	ADRA2A	UBERON_0001264	""
decreased gastric emptying	nervous system	activation_acute	GO_0120061	ENSG00000150594	28216264	Lynch et al. (2017)	ADRA2A	UBERON_0001016	""
decreased memory	pancreas	activation_acute	EFO_0001072	ENSG00000150594	28216264	Lynch et al. (2017)	ADRA2A	UBERON_0001264	""
decreased blood insulin	nervous system	activation_acute	HP_0040216	ENSG00000150594	28216264	Lynch et al. (2017)	ADRA2A	UBERON_0001016	""
decreased heart rate	gastrointestinal	activation_acute	HP_0001662	ENSG00000150594	28216264	Lynch et al. (2017)	ADRA2A	UBERON_0005409	""
increased heart rate	gastrointestinal	inhibition_acute	HP_0001649	ENSG00000150594	28216264	Lynch et al. (2017)	ADRA2A	UBERON_0005409	""
increased gastrointestinal transit	gastrointestinal	inhibition_acute	HP_0410204	ENSG00000150594	28216264	Lynch et al. (2017)	ADRA2A	UBERON_0005409	""
increased convulsions	gastrointestinal	inhibition_acute	EFO_0009853	ENSG00000150594	28216264	Lynch et al. (2017)	ADRA2A	UBERON_0005409	""
increased blood insulin	gastrointestinal	inhibition_acute	HP_0000842	ENSG00000150594	28216264	Lynch et al. (2017)	ADRA2A	UBERON_0005409	""
sedation	gastrointestinal	activation_acute	EFO_0009868	ENSG00000150594	28216264	Lynch et al. (2017)	ADRA2A	UBERON_0005409	""
decreased blood insulin	cardiovascular	activation_acute	HP_0040216	ENSG00000150594	28216264	Lynch et al. (2017)	ADRA2A	UBERON_0004535	""
decreased gastric emptying	gastrointestinal	activation_acute	GO_0120061	ENSG00000150594	28216264	Lynch et al. (2017)	ADRA2A	UBERON_0005409	""
decreased pain	cardiovascular	activation_acute	GO_1904057	ENSG00000150594	28216264	Lynch et al. (2017)	ADRA2A	UBERON_0004535	""
sedation	cardiovascular	activation_acute	EFO_0009868	ENSG00000150594	28216264	Lynch et al. (2017)	ADRA2A	UBERON_0004535	""
decreased gastric emptying	pancreas	activation_acute	GO_0120061	ENSG00000150594	28216264	Lynch et al. (2017)	ADRA2A	UBERON_0001264	""
decreased memory	nervous system	activation_acute	EFO_0001072	ENSG00000150594	28216264	Lynch et al. (2017)	ADRA2A	UBERON_0001016	""
decreased blood pressure	nervous system	activation_acute	EFO_0005251	ENSG00000150594	28216264	Lynch et al. (2017)	ADRA2A	UBERON_0001016	""
decreased pain	pancreas	activation_acute	GO_1904057	ENSG00000150594	28216264	Lynch et al. (2017)	ADRA2A	UBERON_0001264	""
decreased body temperature	nervous system	activation_acute	HP_0002045	ENSG00000150594	28216264	Lynch et al. (2017)	ADRA2A	UBERON_0001016	""
decreased pain	gastrointestinal	activation_acute	GO_1904057	ENSG00000150594	28216264	Lynch et al. (2017)	ADRA2A	UBERON_0005409	""
increased pupil diameter	pancreas	activation_acute	HP_0011499	ENSG00000150594	28216264	Lynch et al. (2017)	ADRA2A	UBERON_0001264	""
decreased heart rate	cardiovascular	activation_acute	HP_0001662	ENSG00000150594	28216264	Lynch et al. (2017)	ADRA2A	UBERON_0004535	""
decreased blood insulin	gastrointestinal	activation_acute	HP_0040216	ENSG00000150594	28216264	Lynch et al. (2017)	ADRA2A	UBERON_0005409	""
decreased body temperature	gastrointestinal	activation_acute	HP_0002045	ENSG00000150594	28216264	Lynch et al. (2017)	ADRA2A	UBERON_0005409	""
sedation	pancreas	activation_acute	EFO_0009868	ENSG00000150594	28216264	Lynch et al. (2017)	ADRA2A	UBERON_0001264	""
decreased blood pressure	pancreas	activation_acute	EFO_0005251	ENSG00000150594	28216264	Lynch et al. (2017)	ADRA2A	UBERON_0001264	""
decreased blood pressure	gastrointestinal	activation_acute	EFO_0005251	ENSG00000150594	28216264	Lynch et al. (2017)	ADRA2A	UBERON_0005409	""
sedation	nervous system	activation_acute	EFO_0009868	ENSG00000150594	28216264	Lynch et al. (2017)	ADRA2A	UBERON_0001016	""
decreased gastric emptying	cardiovascular	activation_acute	GO_0120061	ENSG00000150594	28216264	Lynch et al. (2017)	ADRA2A	UBERON_0004535	""
increased pupil diameter	cardiovascular	activation_acute	HP_0011499	ENSG00000150594	28216264	Lynch et al. (2017)	ADRA2A	UBERON_0004535	""
decreased memory	gastrointestinal	activation_acute	EFO_0001072	ENSG00000150594	28216264	Lynch et al. (2017)	ADRA2A	UBERON_0005409	""
decreased memory	cardiovascular	activation_acute	EFO_0001072	ENSG00000150594	28216264	Lynch et al. (2017)	ADRA2A	UBERON_0004535	""
decreased heart rate	nervous system	activation_acute	HP_0001662	ENSG00000150594	28216264	Lynch et al. (2017)	ADRA2A	UBERON_0001016	""
decreased body temperature	pancreas	activation_acute	HP_0002045	ENSG00000150594	28216264	Lynch et al. (2017)	ADRA2A	UBERON_0001264	""
decreased heart rate	pancreas	activation_acute	HP_0001662	ENSG00000150594	28216264	Lynch et al. (2017)	ADRA2A	UBERON_0001264	""
decreased body temperature	cardiovascular	activation_acute	HP_0002045	ENSG00000150594	28216264	Lynch et al. (2017)	ADRA2A	UBERON_0004535	""
increased pupil diameter	gastrointestinal	activation_acute	HP_0011499	ENSG00000150594	28216264	Lynch et al. (2017)	ADRA2A	UBERON_0005409	""
decreased pain	nervous system	activation_acute	GO_1904057	ENSG00000150594	28216264	Lynch et al. (2017)	ADRA2A	UBERON_0001016	""
increased pain	renal	activation_acute	GO_1904058	ENSG00000109991	28216264	Lynch et al. (2017)	P2RX3	UBERON_0001008	""
neurodegeneration	renal	activation_chronic	HP_0002180	ENSG00000109991	28216264	Lynch et al. (2017)	P2RX3	UBERON_0001008	""
decreased pain	renal	inhibition_acute	GO_1904057	ENSG00000109991	28216264	Lynch et al. (2017)	P2RX3	UBERON_0001008	""
decreased inflammation	renal	inhibition_acute	GO_0050728	ENSG00000109991	28216264	Lynch et al. (2017)	P2RX3	UBERON_0001008	""
decreased convulsions	renal	inhibition_acute	EFO_0009853	ENSG00000109991	28216264	Lynch et al. (2017)	P2RX3	UBERON_0001008	""
increased urine excretion	nervous system	activation_acute	HP_0000103	ENSG00000109991	28216264	Lynch et al. (2017)	P2RX3	UBERON_0001016	""
neurodegeneration	nervous system	activation_chronic	HP_0002180	ENSG00000109991	28216264	Lynch et al. (2017)	P2RX3	UBERON_0001016	""
decreased pain	nervous system	inhibition_acute	GO_1904057	ENSG00000109991	28216264	Lynch et al. (2017)	P2RX3	UBERON_0001016	""
decreased inflammation	nervous system	inhibition_acute	GO_0050728	ENSG00000109991	28216264	Lynch et al. (2017)	P2RX3	UBERON_0001016	""
decreased convulsions	nervous system	inhibition_acute	EFO_0009853	ENSG00000109991	28216264	Lynch et al. (2017)	P2RX3	UBERON_0001016	""
increased pain	immune	activation_acute	GO_1904058	ENSG00000109991	28216264	Lynch et al. (2017)	P2RX3	UBERON_0002405	""
neurodegeneration	immune	activation_chronic	HP_0002180	ENSG00000109991	28216264	Lynch et al. (2017)	P2RX3	UBERON_0002405	""
decreased pain	immune	inhibition_acute	GO_1904057	ENSG00000109991	28216264	Lynch et al. (2017)	P2RX3	UBERON_0002405	""
decreased inflammation	immune	inhibition_acute	GO_0050728	ENSG00000109991	28216264	Lynch et al. (2017)	P2RX3	UBERON_0002405	""
decreased convulsions	immune	inhibition_acute	EFO_0009853	ENSG00000109991	28216264	Lynch et al. (2017)	P2RX3	UBERON_0002405	""
increased urine excretion	renal	activation_acute	HP_0000103	ENSG00000109991	28216264	Lynch et al. (2017)	P2RX3	UBERON_0001008	""
hemolysis	nervous system	activation_acute	EFO_0009473	ENSG00000109991	28216264	Lynch et al. (2017)	P2RX3	UBERON_0001016	""
increased urine excretion	immune	activation_acute	HP_0000103	ENSG00000109991	28216264	Lynch et al. (2017)	P2RX3	UBERON_0002405	""
increased pain	nervous system	activation_acute	GO_1904058	ENSG00000109991	28216264	Lynch et al. (2017)	P2RX3	UBERON_0001016	""
hemolysis	immune	activation_acute	EFO_0009473	ENSG00000109991	28216264	Lynch et al. (2017)	P2RX3	UBERON_0002405	""
increased urinary sodium excretion	nervous system	activation_acute	GO_0035815	ENSG00000109991	28216264	Lynch et al. (2017)	P2RX3	UBERON_0001016	""
increased urinary sodium excretion	renal	activation_acute	GO_0035815	ENSG00000109991	28216264	Lynch et al. (2017)	P2RX3	UBERON_0001008	""
increased urinary sodium excretion	immune	activation_acute	GO_0035815	ENSG00000109991	28216264	Lynch et al. (2017)	P2RX3	UBERON_0002405	""
hemolysis	renal	activation_acute	EFO_0009473	ENSG00000109991	28216264	Lynch et al. (2017)	P2RX3	UBERON_0001008	""
increased prostate carcinoma	endocrine	activation_general	EFO_0001663	ENSG00000169083	23197038	Bowes et al. (2012)	AR	UBERON_0000949	""
decreased spermatogenesis	endocrine	inhibition_general	EFO_0000279	ENSG00000169083	23197038	Bowes et al. (2012)	AR	UBERON_0000949	""
impotence	endocrine	inhibition_general	EFO_0004234	ENSG00000169083	23197038	Bowes et al. (2012)	AR	UBERON_0000949	""
gynecomastia	endocrine	inhibition_general	HP_0000771	ENSG00000169083	23197038	Bowes et al. (2012)	AR	UBERON_0000949	""
mastodynia	endocrine	inhibition_general	EFO_1001366	ENSG00000169083	23197038	Bowes et al. (2012)	AR	UBERON_0000949	""
increased breast carcinoma	endocrine	inhibition_general	EFO_0000305	ENSG00000169083	23197038	Bowes et al. (2012)	AR	UBERON_0000949	""
oedema	endocrine	activation_general	EFO_0009373	ENSG00000169083	23197038	Bowes et al. (2012)	AR	UBERON_0000949	""
androgenicity females	endocrine	activation_general	EFO_0009850	ENSG00000169083	23197038	Bowes et al. (2012)	AR	UBERON_0000949	""
increased muscle mass	endocrine	activation_general	HP_0003720	ENSG00000169083	23197038	Bowes et al. (2012)	AR	UBERON_0000949	""
increased hostility	endocrine	activation_general	EFO_0003015	ENSG00000169083	23197038	Bowes et al. (2012)	AR	UBERON_0000949	""
sleep apnoea	endocrine	activation_general	EFO_0003877	ENSG00000169083	23197038	Bowes et al. (2012)	AR	UBERON_0000949	""
liver complications	endocrine	activation_general	EFO_0001421	ENSG00000169083	23197038	Bowes et al. (2012)	AR	UBERON_0000949	""
decreased pain	cardiovascular	activation_acute	GO_1904057	ENSG00000145863	28216264	Lynch et al. (2017)	GABRA6	UBERON_0004535	""
convulsions	cardiovascular	inhibition_acute	EFO_0009853	ENSG00000145863	28216264	Lynch et al. (2017)	GABRA6	UBERON_0004535	""
decreased sleep	cardiovascular	inhibition_acute	EFO_0008568	ENSG00000145863	28216264	Lynch et al. (2017)	GABRA6	UBERON_0004535	""
increased sleep	central nervous system	activation_acute	EFO_0008568	ENSG00000145863	28216264	Lynch et al. (2017)	GABRA6	UBERON_0001017	""
convulsions	central nervous system	inhibition_acute	EFO_0009853	ENSG00000145863	28216264	Lynch et al. (2017)	GABRA6	UBERON_0001017	""
decreased sleep	central nervous system	inhibition_acute	EFO_0008568	ENSG00000145863	28216264	Lynch et al. (2017)	GABRA6	UBERON_0001017	""
increased respiratory rate	central nervous system	activation_acute	EFO_0009840	ENSG00000145863	28216264	Lynch et al. (2017)	GABRA6	UBERON_0001017	""
decreased cardiac contractility	cardiovascular	activation_acute	GO_0045822	ENSG00000145863	28216264	Lynch et al. (2017)	GABRA6	UBERON_0004535	""
increased cardiac output	central nervous system	activation_acute	EFO_0009872	ENSG00000145863	28216264	Lynch et al. (2017)	GABRA6	UBERON_0001017	""
decreased cardiac contractility	central nervous system	activation_acute	GO_0045822	ENSG00000145863	28216264	Lynch et al. (2017)	GABRA6	UBERON_0001017	""
decreased body temperature	cardiovascular	activation_acute	HP_0002045	ENSG00000145863	28216264	Lynch et al. (2017)	GABRA6	UBERON_0004535	""
decreased body temperature	central nervous system	activation_acute	HP_0002045	ENSG00000145863	28216264	Lynch et al. (2017)	GABRA6	UBERON_0001017	""
decreased anxiety	cardiovascular	activation_acute	EFO_0009874	ENSG00000145863	28216264	Lynch et al. (2017)	GABRA6	UBERON_0004535	""
increased respiratory rate	cardiovascular	activation_acute	EFO_0009840	ENSG00000145863	28216264	Lynch et al. (2017)	GABRA6	UBERON_0004535	""
decreased pain	central nervous system	activation_acute	GO_1904057	ENSG00000145863	28216264	Lynch et al. (2017)	GABRA6	UBERON_0001017	""
decreased blood pressure	central nervous system	activation_acute	EFO_0005251	ENSG00000145863	28216264	Lynch et al. (2017)	GABRA6	UBERON_0001017	""
decreased locomotor activity	cardiovascular	activation_acute	GO_0040013	ENSG00000145863	28216264	Lynch et al. (2017)	GABRA6	UBERON_0004535	""
decreased convulsions	central nervous system	activation_acute	EFO_0009853	ENSG00000145863	28216264	Lynch et al. (2017)	GABRA6	UBERON_0001017	""
increased eating	cardiovascular	activation_acute	HP_0100738	ENSG00000145863	28216264	Lynch et al. (2017)	GABRA6	UBERON_0004535	""
muscle relaxation	cardiovascular	activation_acute	""	ENSG00000145863	28216264	Lynch et al. (2017)	GABRA6	UBERON_0004535	""
drug abuse/dependence	cardiovascular	activation_acute	EFO_0003890	ENSG00000145863	28216264	Lynch et al. (2017)	GABRA6	UBERON_0004535	""
increased sleep	cardiovascular	activation_acute	EFO_0008568	ENSG00000145863	28216264	Lynch et al. (2017)	GABRA6	UBERON_0004535	""
ataxia	central nervous system	activation_acute	MONDO_0000437	ENSG00000145863	28216264	Lynch et al. (2017)	GABRA6	UBERON_0001017	""
drug abuse/dependence	central nervous system	activation_acute	EFO_0003890	ENSG00000145863	28216264	Lynch et al. (2017)	GABRA6	UBERON_0001017	""
muscle relaxation	central nervous system	activation_acute	""	ENSG00000145863	28216264	Lynch et al. (2017)	GABRA6	UBERON_0001017	""
ataxia	cardiovascular	activation_acute	MONDO_0000437	ENSG00000145863	28216264	Lynch et al. (2017)	GABRA6	UBERON_0004535	""
decreased memory	cardiovascular	activation_acute	EFO_0001072	ENSG00000145863	28216264	Lynch et al. (2017)	GABRA6	UBERON_0004535	""
decreased convulsions	cardiovascular	activation_acute	EFO_0009853	ENSG00000145863	28216264	Lynch et al. (2017)	GABRA6	UBERON_0004535	""
decreased anxiety	central nervous system	activation_acute	EFO_0009874	ENSG00000145863	28216264	Lynch et al. (2017)	GABRA6	UBERON_0001017	""
decreased memory	central nervous system	activation_acute	EFO_0001072	ENSG00000145863	28216264	Lynch et al. (2017)	GABRA6	UBERON_0001017	""
decreased locomotor activity	central nervous system	activation_acute	GO_0040013	ENSG00000145863	28216264	Lynch et al. (2017)	GABRA6	UBERON_0001017	""
increased eating	central nervous system	activation_acute	HP_0100738	ENSG00000145863	28216264	Lynch et al. (2017)	GABRA6	UBERON_0001017	""
increased cardiac output	cardiovascular	activation_acute	EFO_0009872	ENSG00000145863	28216264	Lynch et al. (2017)	GABRA6	UBERON_0004535	""
decreased blood pressure	cardiovascular	activation_acute	EFO_0005251	ENSG00000145863	28216264	Lynch et al. (2017)	GABRA6	UBERON_0004535	""
apnea	nervous system	inhibition_acute	HP_0002104	ENSG00000087085	28216264	Lynch et al. (2017)	ACHE	UBERON_0001016	""
cognitive deficit	nervous system	inhibition_chronic	HP_0100543	ENSG00000087085	28216264	Lynch et al. (2017)	ACHE	UBERON_0001016	""
mood change	nervous system	inhibition_chronic	EFO_0004247	ENSG00000087085	28216264	Lynch et al. (2017)	ACHE	UBERON_0001016	""
autonomic dysfunction	nervous system	inhibition_chronic	HP_0012332	ENSG00000087085	28216264	Lynch et al. (2017)	ACHE	UBERON_0001016	""
peripheral neuropathy	nervous system	inhibition_chronic	EFO_0003100	ENSG00000087085	28216264	Lynch et al. (2017)	ACHE	UBERON_0001016	""
tingling/weakness in limbs	nervous system	inhibition_chronic	MONDO_0044967	ENSG00000087085	28216264	Lynch et al. (2017)	ACHE	UBERON_0001016	""
foot drop	nervous system	inhibition_chronic	HP_0009027	ENSG00000087085	28216264	Lynch et al. (2017)	ACHE	UBERON_0001016	""
bronchoconstriction	nervous system	inhibition_acute	EFO_0009836	ENSG00000087085	28216264	Lynch et al. (2017)	ACHE	UBERON_0001016	""
increased bronchial secretions	nervous system	inhibition_acute	EFO_0009835	ENSG00000087085	28216264	Lynch et al. (2017)	ACHE	UBERON_0001016	""
muscle relaxation	nervous system	inhibition_acute	""	ENSG00000087085	28216264	Lynch et al. (2017)	ACHE	UBERON_0001016	""
ataxia	nervous system	inhibition_acute	MONDO_0000437	ENSG00000087085	28216264	Lynch et al. (2017)	ACHE	UBERON_0001016	""
increased salivation	nervous system	inhibition_acute	GO_0046878	ENSG00000087085	28216264	Lynch et al. (2017)	ACHE	UBERON_0001016	""
lacrimation	nervous system	inhibition_acute	HP_0000632	ENSG00000087085	28216264	Lynch et al. (2017)	ACHE	UBERON_0001016	""
decreased pupil diameter	nervous system	inhibition_acute	HP_0000616	ENSG00000087085	28216264	Lynch et al. (2017)	ACHE	UBERON_0001016	""
blurred vision	nervous system	inhibition_acute	HP_0000622	ENSG00000087085	28216264	Lynch et al. (2017)	ACHE	UBERON_0001016	""
increased urine excretion	nervous system	inhibition_acute	HP_0000103	ENSG00000087085	28216264	Lynch et al. (2017)	ACHE	UBERON_0001016	""
increased defecation	nervous system	inhibition_acute	GO_2000294	ENSG00000087085	28216264	Lynch et al. (2017)	ACHE	UBERON_0001016	""
diarrhea	nervous system	inhibition_acute	HP_0002014	ENSG00000087085	28216264	Lynch et al. (2017)	ACHE	UBERON_0001016	""
vomiting	nervous system	inhibition_acute	HP_0002017	ENSG00000087085	28216264	Lynch et al. (2017)	ACHE	UBERON_0001016	""
increased then decreased blood pressure	nervous system	inhibition_acute	HP_0030972	ENSG00000087085	28216264	Lynch et al. (2017)	ACHE	UBERON_0001016	""
increased then decreased heart rate	nervous system	inhibition_acute	HP_0031860	ENSG00000087085	28216264	Lynch et al. (2017)	ACHE	UBERON_0001016	""
convulsions	nervous system	inhibition_acute	EFO_0009853	ENSG00000087085	28216264	Lynch et al. (2017)	ACHE	UBERON_0001016	""
coma	nervous system	inhibition_acute	HP_0001259	ENSG00000087085	28216264	Lynch et al. (2017)	ACHE	UBERON_0001016	""
death	nervous system	inhibition_acute	EFO_0000480	ENSG00000087085	28216264	Lynch et al. (2017)	ACHE	UBERON_0001016	""
apnea	cardiovascular	inhibition_acute	HP_0002104	ENSG00000087085	28216264	Lynch et al. (2017)	ACHE	UBERON_0004535	""
cognitive deficit	cardiovascular	inhibition_chronic	HP_0100543	ENSG00000087085	28216264	Lynch et al. (2017)	ACHE	UBERON_0004535	""
mood change	cardiovascular	inhibition_chronic	EFO_0004247	ENSG00000087085	28216264	Lynch et al. (2017)	ACHE	UBERON_0004535	""
autonomic dysfunction	cardiovascular	inhibition_chronic	HP_0012332	ENSG00000087085	28216264	Lynch et al. (2017)	ACHE	UBERON_0004535	""
peripheral neuropathy	cardiovascular	inhibition_chronic	EFO_0003100	ENSG00000087085	28216264	Lynch et al. (2017)	ACHE	UBERON_0004535	""
tingling/weakness in limbs	cardiovascular	inhibition_chronic	MONDO_0044967	ENSG00000087085	28216264	Lynch et al. (2017)	ACHE	UBERON_0004535	""
foot drop	cardiovascular	inhibition_chronic	HP_0009027	ENSG00000087085	28216264	Lynch et al. (2017)	ACHE	UBERON_0004535	""
bronchoconstriction	cardiovascular	inhibition_acute	EFO_0009836	ENSG00000087085	28216264	Lynch et al. (2017)	ACHE	UBERON_0004535	""
increased bronchial secretions	cardiovascular	inhibition_acute	EFO_0009835	ENSG00000087085	28216264	Lynch et al. (2017)	ACHE	UBERON_0004535	""
muscle relaxation	cardiovascular	inhibition_acute	""	ENSG00000087085	28216264	Lynch et al. (2017)	ACHE	UBERON_0004535	""
ataxia	cardiovascular	inhibition_acute	MONDO_0000437	ENSG00000087085	28216264	Lynch et al. (2017)	ACHE	UBERON_0004535	""
increased salivation	cardiovascular	inhibition_acute	GO_0046878	ENSG00000087085	28216264	Lynch et al. (2017)	ACHE	UBERON_0004535	""
lacrimation	cardiovascular	inhibition_acute	HP_0000632	ENSG00000087085	28216264	Lynch et al. (2017)	ACHE	UBERON_0004535	""
decreased pupil diameter	cardiovascular	inhibition_acute	HP_0000616	ENSG00000087085	28216264	Lynch et al. (2017)	ACHE	UBERON_0004535	""
blurred vision	cardiovascular	inhibition_acute	HP_0000622	ENSG00000087085	28216264	Lynch et al. (2017)	ACHE	UBERON_0004535	""
increased urine excretion	cardiovascular	inhibition_acute	HP_0000103	ENSG00000087085	28216264	Lynch et al. (2017)	ACHE	UBERON_0004535	""
increased defecation	cardiovascular	inhibition_acute	GO_2000294	ENSG00000087085	28216264	Lynch et al. (2017)	ACHE	UBERON_0004535	""
diarrhea	cardiovascular	inhibition_acute	HP_0002014	ENSG00000087085	28216264	Lynch et al. (2017)	ACHE	UBERON_0004535	""
vomiting	cardiovascular	inhibition_acute	HP_0002017	ENSG00000087085	28216264	Lynch et al. (2017)	ACHE	UBERON_0004535	""
increased then decreased blood pressure	cardiovascular	inhibition_acute	HP_0030972	ENSG00000087085	28216264	Lynch et al. (2017)	ACHE	UBERON_0004535	""
increased then decreased heart rate	cardiovascular	inhibition_acute	HP_0031860	ENSG00000087085	28216264	Lynch et al. (2017)	ACHE	UBERON_0004535	""
convulsions	cardiovascular	inhibition_acute	EFO_0009853	ENSG00000087085	28216264	Lynch et al. (2017)	ACHE	UBERON_0004535	""
coma	cardiovascular	inhibition_acute	HP_0001259	ENSG00000087085	28216264	Lynch et al. (2017)	ACHE	UBERON_0004535	""
death	cardiovascular	inhibition_acute	EFO_0000480	ENSG00000087085	28216264	Lynch et al. (2017)	ACHE	UBERON_0004535	""
apnea	gastrointestinal	inhibition_acute	HP_0002104	ENSG00000087085	28216264	Lynch et al. (2017)	ACHE	UBERON_0005409	""
cognitive deficit	gastrointestinal	inhibition_chronic	HP_0100543	ENSG00000087085	28216264	Lynch et al. (2017)	ACHE	UBERON_0005409	""
mood change	gastrointestinal	inhibition_chronic	EFO_0004247	ENSG00000087085	28216264	Lynch et al. (2017)	ACHE	UBERON_0005409	""
autonomic dysfunction	gastrointestinal	inhibition_chronic	HP_0012332	ENSG00000087085	28216264	Lynch et al. (2017)	ACHE	UBERON_0005409	""
peripheral neuropathy	gastrointestinal	inhibition_chronic	EFO_0003100	ENSG00000087085	28216264	Lynch et al. (2017)	ACHE	UBERON_0005409	""
tingling/weakness in limbs	gastrointestinal	inhibition_chronic	MONDO_0044967	ENSG00000087085	28216264	Lynch et al. (2017)	ACHE	UBERON_0005409	""
foot drop	gastrointestinal	inhibition_chronic	HP_0009027	ENSG00000087085	28216264	Lynch et al. (2017)	ACHE	UBERON_0005409	""
bronchoconstriction	gastrointestinal	inhibition_acute	EFO_0009836	ENSG00000087085	28216264	Lynch et al. (2017)	ACHE	UBERON_0005409	""
increased bronchial secretions	gastrointestinal	inhibition_acute	EFO_0009835	ENSG00000087085	28216264	Lynch et al. (2017)	ACHE	UBERON_0005409	""
muscle relaxation	gastrointestinal	inhibition_acute	""	ENSG00000087085	28216264	Lynch et al. (2017)	ACHE	UBERON_0005409	""
ataxia	gastrointestinal	inhibition_acute	MONDO_0000437	ENSG00000087085	28216264	Lynch et al. (2017)	ACHE	UBERON_0005409	""
increased salivation	gastrointestinal	inhibition_acute	GO_0046878	ENSG00000087085	28216264	Lynch et al. (2017)	ACHE	UBERON_0005409	""
lacrimation	gastrointestinal	inhibition_acute	HP_0000632	ENSG00000087085	28216264	Lynch et al. (2017)	ACHE	UBERON_0005409	""
decreased pupil diameter	gastrointestinal	inhibition_acute	HP_0000616	ENSG00000087085	28216264	Lynch et al. (2017)	ACHE	UBERON_0005409	""
blurred vision	gastrointestinal	inhibition_acute	HP_0000622	ENSG00000087085	28216264	Lynch et al. (2017)	ACHE	UBERON_0005409	""
increased urine excretion	gastrointestinal	inhibition_acute	HP_0000103	ENSG00000087085	28216264	Lynch et al. (2017)	ACHE	UBERON_0005409	""
increased defecation	gastrointestinal	inhibition_acute	GO_2000294	ENSG00000087085	28216264	Lynch et al. (2017)	ACHE	UBERON_0005409	""
diarrhea	gastrointestinal	inhibition_acute	HP_0002014	ENSG00000087085	28216264	Lynch et al. (2017)	ACHE	UBERON_0005409	""
vomiting	gastrointestinal	inhibition_acute	HP_0002017	ENSG00000087085	28216264	Lynch et al. (2017)	ACHE	UBERON_0005409	""
increased then decreased blood pressure	gastrointestinal	inhibition_acute	HP_0030972	ENSG00000087085	28216264	Lynch et al. (2017)	ACHE	UBERON_0005409	""
increased then decreased heart rate	gastrointestinal	inhibition_acute	HP_0031860	ENSG00000087085	28216264	Lynch et al. (2017)	ACHE	UBERON_0005409	""
convulsions	gastrointestinal	inhibition_acute	EFO_0009853	ENSG00000087085	28216264	Lynch et al. (2017)	ACHE	UBERON_0005409	""
coma	gastrointestinal	inhibition_acute	HP_0001259	ENSG00000087085	28216264	Lynch et al. (2017)	ACHE	UBERON_0005409	""
death	gastrointestinal	inhibition_acute	EFO_0000480	ENSG00000087085	28216264	Lynch et al. (2017)	ACHE	UBERON_0005409	""
apnea	respiratory	inhibition_acute	HP_0002104	ENSG00000087085	28216264	Lynch et al. (2017)	ACHE	UBERON_0001004	""
cognitive deficit	respiratory	inhibition_chronic	HP_0100543	ENSG00000087085	28216264	Lynch et al. (2017)	ACHE	UBERON_0001004	""
mood change	respiratory	inhibition_chronic	EFO_0004247	ENSG00000087085	28216264	Lynch et al. (2017)	ACHE	UBERON_0001004	""
autonomic dysfunction	respiratory	inhibition_chronic	HP_0012332	ENSG00000087085	28216264	Lynch et al. (2017)	ACHE	UBERON_0001004	""
peripheral neuropathy	respiratory	inhibition_chronic	EFO_0003100	ENSG00000087085	28216264	Lynch et al. (2017)	ACHE	UBERON_0001004	""
tingling/weakness in limbs	respiratory	inhibition_chronic	MONDO_0044967	ENSG00000087085	28216264	Lynch et al. (2017)	ACHE	UBERON_0001004	""
foot drop	respiratory	inhibition_chronic	HP_0009027	ENSG00000087085	28216264	Lynch et al. (2017)	ACHE	UBERON_0001004	""
bronchoconstriction	respiratory	inhibition_acute	EFO_0009836	ENSG00000087085	28216264	Lynch et al. (2017)	ACHE	UBERON_0001004	""
increased bronchial secretions	respiratory	inhibition_acute	EFO_0009835	ENSG00000087085	28216264	Lynch et al. (2017)	ACHE	UBERON_0001004	""
muscle relaxation	respiratory	inhibition_acute	""	ENSG00000087085	28216264	Lynch et al. (2017)	ACHE	UBERON_0001004	""
ataxia	respiratory	inhibition_acute	MONDO_0000437	ENSG00000087085	28216264	Lynch et al. (2017)	ACHE	UBERON_0001004	""
increased salivation	respiratory	inhibition_acute	GO_0046878	ENSG00000087085	28216264	Lynch et al. (2017)	ACHE	UBERON_0001004	""
lacrimation	respiratory	inhibition_acute	HP_0000632	ENSG00000087085	28216264	Lynch et al. (2017)	ACHE	UBERON_0001004	""
decreased pupil diameter	respiratory	inhibition_acute	HP_0000616	ENSG00000087085	28216264	Lynch et al. (2017)	ACHE	UBERON_0001004	""
blurred vision	respiratory	inhibition_acute	HP_0000622	ENSG00000087085	28216264	Lynch et al. (2017)	ACHE	UBERON_0001004	""
increased urine excretion	respiratory	inhibition_acute	HP_0000103	ENSG00000087085	28216264	Lynch et al. (2017)	ACHE	UBERON_0001004	""
increased defecation	respiratory	inhibition_acute	GO_2000294	ENSG00000087085	28216264	Lynch et al. (2017)	ACHE	UBERON_0001004	""
diarrhea	respiratory	inhibition_acute	HP_0002014	ENSG00000087085	28216264	Lynch et al. (2017)	ACHE	UBERON_0001004	""
vomiting	respiratory	inhibition_acute	HP_0002017	ENSG00000087085	28216264	Lynch et al. (2017)	ACHE	UBERON_0001004	""
increased then decreased blood pressure	respiratory	inhibition_acute	HP_0030972	ENSG00000087085	28216264	Lynch et al. (2017)	ACHE	UBERON_0001004	""
increased then decreased heart rate	respiratory	inhibition_acute	HP_0031860	ENSG00000087085	28216264	Lynch et al. (2017)	ACHE	UBERON_0001004	""
convulsions	respiratory	inhibition_acute	EFO_0009853	ENSG00000087085	28216264	Lynch et al. (2017)	ACHE	UBERON_0001004	""
coma	respiratory	inhibition_acute	HP_0001259	ENSG00000087085	28216264	Lynch et al. (2017)	ACHE	UBERON_0001004	""
death	respiratory	inhibition_acute	EFO_0000480	ENSG00000087085	28216264	Lynch et al. (2017)	ACHE	UBERON_0001004	""
diarrhea	respiratory	activation_acute	HP_0002014	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0001004	""
decreased gastric emptying	respiratory	inhibition_acute	GO_0120061	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0001004	""
decreased intestinal transit	respiratory	inhibition_acute	HP_0030897	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0001004	""
constipation	respiratory	inhibition_acute	HP_0002019	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0001004	""
decreased salivation	respiratory	inhibition_acute	GO_1905747	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0001004	""
dry mouth	respiratory	inhibition_acute	EFO_0009869	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0001004	""
increased pupil diameter	respiratory	inhibition_acute	HP_0011499	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0001004	""
blurred vision	respiratory	inhibition_acute	HP_0000622	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0001004	""
blurred vision	gastrointestinal	activation_acute	HP_0000622	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0005409	""
decreased gastric emptying	gastrointestinal	inhibition_acute	GO_0120061	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0005409	""
decreased intestinal transit	gastrointestinal	inhibition_acute	HP_0030897	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0005409	""
constipation	gastrointestinal	inhibition_acute	HP_0002019	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0005409	""
decreased salivation	gastrointestinal	inhibition_acute	GO_1905747	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0005409	""
dry mouth	gastrointestinal	inhibition_acute	EFO_0009869	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0005409	""
increased pupil diameter	gastrointestinal	inhibition_acute	HP_0011499	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0005409	""
blurred vision	gastrointestinal	inhibition_acute	HP_0000622	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0005409	""
acidosis	liver	activation_acute	EFO_1000014	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0002107	""
decreased gastric emptying	liver	inhibition_acute	GO_0120061	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0002107	""
decreased intestinal transit	liver	inhibition_acute	HP_0030897	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0002107	""
constipation	liver	inhibition_acute	HP_0002019	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0002107	""
decreased salivation	liver	inhibition_acute	GO_1905747	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0002107	""
dry mouth	liver	inhibition_acute	EFO_0009869	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0002107	""
increased pupil diameter	liver	inhibition_acute	HP_0011499	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0002107	""
blurred vision	liver	inhibition_acute	HP_0000622	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0002107	""
increased/decreased blood pressure	cardiovascular	activation_acute	HP_0030972	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0004535	""
decreased gastric emptying	cardiovascular	inhibition_acute	GO_0120061	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0004535	""
decreased intestinal transit	cardiovascular	inhibition_acute	HP_0030897	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0004535	""
constipation	cardiovascular	inhibition_acute	HP_0002019	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0004535	""
decreased salivation	cardiovascular	inhibition_acute	GO_1905747	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0004535	""
dry mouth	cardiovascular	inhibition_acute	EFO_0009869	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0004535	""
increased pupil diameter	cardiovascular	inhibition_acute	HP_0011499	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0004535	""
blurred vision	cardiovascular	inhibition_acute	HP_0000622	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0004535	""
liver failure	cardiovascular	activation_acute	HP_0001399	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0004535	""
bronchoconstriction	liver	activation_acute	EFO_0009836	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0002107	""
increased body temperature	nervous system	activation_acute	HP_0001945	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0001016	""
decreased gastric emptying	nervous system	inhibition_acute	GO_0120061	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0001016	""
decreased intestinal transit	nervous system	inhibition_acute	HP_0030897	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0001016	""
constipation	nervous system	inhibition_acute	HP_0002019	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0001016	""
decreased salivation	nervous system	inhibition_acute	GO_1905747	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0001016	""
dry mouth	nervous system	inhibition_acute	EFO_0009869	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0001016	""
increased pupil diameter	nervous system	inhibition_acute	HP_0011499	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0001016	""
blurred vision	nervous system	inhibition_acute	HP_0000622	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0001016	""
diarrhea	nervous system	activation_acute	HP_0002014	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0001016	""
bronchoconstriction	respiratory	activation_acute	EFO_0009836	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0001004	""
ptosis	cardiovascular	activation_acute	Orphanet_98578	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0004535	""
blurred vision	liver	activation_acute	HP_0000622	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0002107	""
ptosis	gastrointestinal	activation_acute	Orphanet_98578	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0005409	""
frothing	gastrointestinal	activation_acute	""	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0005409	""
neutrophil collection within the sinusoids	cardiovascular	activation_acute	GO_2000428	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0004535	""
sweating	respiratory	activation_acute	HP_0000975	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0001004	""
cough	respiratory	activation_acute	HP_0012735	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0001004	""
muscle cramps	cardiovascular	activation_acute	EFO_0009846	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0004535	""
abdominal cramps	liver	activation_acute	HP_0032155	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0002107	""
muscle cramps	liver	activation_acute	EFO_0009846	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0002107	""
acidosis	respiratory	activation_acute	EFO_1000014	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0001004	""
abdominal cramps	cardiovascular	activation_acute	HP_0032155	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0004535	""
frothing	cardiovascular	activation_acute	""	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0004535	""
abdominal cramps	gastrointestinal	activation_acute	HP_0032155	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0005409	""
increased respiratory rate	nervous system	activation_acute	EFO_0009840	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0001016	""
blurred vision	nervous system	activation_acute	HP_0000622	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0001016	""
diarrhea	liver	activation_acute	HP_0002014	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0002107	""
increased respiratory rate	cardiovascular	activation_acute	EFO_0009840	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0004535	""
increased/decreased blood pressure	gastrointestinal	activation_acute	HP_0030972	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0005409	""
increased body temperature	liver	activation_acute	HP_0001945	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0002107	""
increased respiratory rate	liver	activation_acute	EFO_0009840	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0002107	""
centrilobular liver congestion	nervous system	activation_acute	EFO_0001421	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0001016	""
centrilobular liver congestion	gastrointestinal	activation_acute	EFO_0001421	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0005409	""
bronchoconstriction	gastrointestinal	activation_acute	EFO_0009836	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0005409	""
irritability	liver	activation_acute	HP_0000737	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0002107	""
cough	nervous system	activation_acute	HP_0012735	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0001016	""
ptosis	respiratory	activation_acute	Orphanet_98578	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0001004	""
bronchospasm	gastrointestinal	activation_acute	HP_0025428	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0005409	""
increased respiratory rate	respiratory	activation_acute	EFO_0009840	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0001004	""
lacrimation	cardiovascular	activation_acute	HP_0000632	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0004535	""
lacrimation	liver	activation_acute	HP_0000632	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0002107	""
increased/decreased heart rate	respiratory	activation_acute	HP_0031860	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0001004	""
cough	gastrointestinal	activation_acute	HP_0012735	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0005409	""
cough	liver	activation_acute	HP_0012735	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0002107	""
ptosis	liver	activation_acute	Orphanet_98578	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0002107	""
lacrimation	respiratory	activation_acute	HP_0000632	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0001004	""
irritability	cardiovascular	activation_acute	HP_0000737	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0004535	""
diarrhea	gastrointestinal	activation_acute	HP_0002014	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0005409	""
sweating	liver	activation_acute	HP_0000975	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0002107	""
pleural effusions	nervous system	activation_acute	EFO_0009637	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0001016	""
bronchospasm	respiratory	activation_acute	HP_0025428	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0001004	""
frothing	respiratory	activation_acute	""	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0001004	""
exhaustion	liver	activation_acute	EFO_0009852	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0002107	""
increased salivation	cardiovascular	activation_acute	GO_0046878	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0004535	""
increased salivation	liver	activation_acute	GO_0046878	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0002107	""
increased/decreased heart rate	liver	activation_acute	HP_0031860	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0002107	""
liver failure	gastrointestinal	activation_acute	HP_0001399	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0005409	""
exhaustion	gastrointestinal	activation_acute	EFO_0009852	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0005409	""
increased/decreased heart rate	nervous system	activation_acute	HP_0031860	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0001016	""
centrilobular liver congestion	respiratory	activation_acute	EFO_0001421	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0001004	""
increased/decreased blood pressure	liver	activation_acute	HP_0030972	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0002107	""
frothing	liver	activation_acute	""	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0002107	""
blurred vision	respiratory	activation_acute	HP_0000622	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0001004	""
acidosis	cardiovascular	activation_acute	EFO_1000014	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0004535	""
acidosis	gastrointestinal	activation_acute	EFO_1000014	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0005409	""
ptosis	nervous system	activation_acute	Orphanet_98578	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0001016	""
abdominal cramps	nervous system	activation_acute	HP_0032155	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0001016	""
bronchorrhea	nervous system	activation_acute	""	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0001016	""
neutrophil collection within the sinusoids	nervous system	activation_acute	GO_2000428	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0001016	""
pleural effusions	respiratory	activation_acute	EFO_0009637	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0001004	""
centrilobular liver congestion	cardiovascular	activation_acute	EFO_0001421	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0004535	""
lacrimation	gastrointestinal	activation_acute	HP_0000632	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0005409	""
bronchoconstriction	cardiovascular	activation_acute	EFO_0009836	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0004535	""
liver failure	liver	activation_acute	HP_0001399	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0002107	""
bronchorrhea	respiratory	activation_acute	""	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0001004	""
muscle cramps	gastrointestinal	activation_acute	EFO_0009846	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0005409	""
exhaustion	respiratory	activation_acute	EFO_0009852	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0001004	""
lacrimation	nervous system	activation_acute	HP_0000632	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0001016	""
increased respiratory rate	gastrointestinal	activation_acute	EFO_0009840	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0005409	""
increased salivation	gastrointestinal	activation_acute	GO_0046878	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0005409	""
pleural effusions	liver	activation_acute	EFO_0009637	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0002107	""
irritability	gastrointestinal	activation_acute	HP_0000737	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0005409	""
neutrophil collection within the sinusoids	gastrointestinal	activation_acute	GO_2000428	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0005409	""
increased/decreased heart rate	gastrointestinal	activation_acute	HP_0031860	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0005409	""
increased body temperature	gastrointestinal	activation_acute	HP_0001945	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0005409	""
muscle cramps	nervous system	activation_acute	EFO_0009846	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0001016	""
increased body temperature	cardiovascular	activation_acute	HP_0001945	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0004535	""
sweating	gastrointestinal	activation_acute	HP_0000975	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0005409	""
bronchoconstriction	nervous system	activation_acute	EFO_0009836	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0001016	""
increased salivation	respiratory	activation_acute	GO_0046878	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0001004	""
bronchorrhea	cardiovascular	activation_acute	""	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0004535	""
decreased pupil diameter	nervous system	activation_acute	HP_0000616	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0001016	""
sweating	nervous system	activation_acute	HP_0000975	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0001016	""
blurred vision	cardiovascular	activation_acute	HP_0000622	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0004535	""
decreased pupil diameter	cardiovascular	activation_acute	HP_0000616	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0004535	""
decreased pupil diameter	liver	activation_acute	HP_0000616	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0002107	""
centrilobular liver congestion	liver	activation_acute	EFO_0001421	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0002107	""
increased body temperature	respiratory	activation_acute	HP_0001945	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0001004	""
frothing	nervous system	activation_acute	""	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0001016	""
liver failure	nervous system	activation_acute	HP_0001399	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0001016	""
increased/decreased blood pressure	nervous system	activation_acute	HP_0030972	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0001016	""
increased/decreased heart rate	cardiovascular	activation_acute	HP_0031860	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0004535	""
bronchospasm	cardiovascular	activation_acute	HP_0025428	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0004535	""
neutrophil collection within the sinusoids	liver	activation_acute	GO_2000428	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0002107	""
acidosis	nervous system	activation_acute	EFO_1000014	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0001016	""
decreased pupil diameter	gastrointestinal	activation_acute	HP_0000616	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0005409	""
bronchospasm	liver	activation_acute	HP_0025428	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0002107	""
pleural effusions	gastrointestinal	activation_acute	EFO_0009637	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0005409	""
irritability	nervous system	activation_acute	HP_0000737	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0001016	""
decreased pupil diameter	respiratory	activation_acute	HP_0000616	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0001004	""
increased/decreased blood pressure	respiratory	activation_acute	HP_0030972	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0001004	""
abdominal cramps	respiratory	activation_acute	HP_0032155	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0001004	""
muscle cramps	respiratory	activation_acute	EFO_0009846	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0001004	""
neutrophil collection within the sinusoids	respiratory	activation_acute	GO_2000428	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0001004	""
pleural effusions	cardiovascular	activation_acute	EFO_0009637	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0004535	""
increased salivation	nervous system	activation_acute	GO_0046878	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0001016	""
cough	cardiovascular	activation_acute	HP_0012735	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0004535	""
diarrhea	cardiovascular	activation_acute	HP_0002014	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0004535	""
exhaustion	cardiovascular	activation_acute	EFO_0009852	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0004535	""
bronchospasm	nervous system	activation_acute	HP_0025428	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0001016	""
liver failure	respiratory	activation_acute	HP_0001399	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0001004	""
exhaustion	nervous system	activation_acute	EFO_0009852	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0001016	""
sweating	cardiovascular	activation_acute	HP_0000975	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0004535	""
bronchorrhea	gastrointestinal	activation_acute	""	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0005409	""
bronchorrhea	liver	activation_acute	""	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0002107	""
irritability	respiratory	activation_acute	HP_0000737	ENSG00000133019	28216264	Lynch et al. (2017)	CHRM3	UBERON_0001004	""
T cell activation	Immune	activation_general	GO_0042110	ENSG00000182866	23197038	Bowes et al. (2012)	LCK	""	""
T cell inhibition	Immune	inhibition_general	""	ENSG00000182866	23197038	Bowes et al. (2012)	LCK	""	""
SCID-like immunodeficiency	Immune	inhibition_general	HP_0002721	ENSG00000182866	23197038	Bowes et al. (2012)	LCK	""	""
decreased platelet aggregation	immune	activation_acute	GO_0090331	ENSG00000132170	28216264	Lynch et al. (2017)	PPARG	UBERON_0002405	""
increased inflammation	immune	inhibition_acute	GO_0050729	ENSG00000132170	28216264	Lynch et al. (2017)	PPARG	UBERON_0002405	""
decreased blood glucose	cardiovascular	activation_acute	HP_0001943	ENSG00000132170	28216264	Lynch et al. (2017)	PPARG	UBERON_0004535	""
increased inflammation	cardiovascular	inhibition_acute	GO_0050729	ENSG00000132170	28216264	Lynch et al. (2017)	PPARG	UBERON_0004535	""
heart failure	immune	activation_acute	EFO_0003144	ENSG00000132170	28216264	Lynch et al. (2017)	PPARG	UBERON_0002405	""
increased heart weight	renal	activation_acute	EFO_0009871	ENSG00000132170	28216264	Lynch et al. (2017)	PPARG	UBERON_0001008	""
increased inflammation	renal	inhibition_acute	GO_0050729	ENSG00000132170	28216264	Lynch et al. (2017)	PPARG	UBERON_0001008	""
increased plasma volume	cardiovascular	activation_acute	HP_0011105	ENSG00000132170	28216264	Lynch et al. (2017)	PPARG	UBERON_0004535	""
decreased urinary sodium excretion	renal	activation_acute	GO_0035814	ENSG00000132170	28216264	Lynch et al. (2017)	PPARG	UBERON_0001008	""
increased plasma volume	immune	activation_acute	HP_0011105	ENSG00000132170	28216264	Lynch et al. (2017)	PPARG	UBERON_0002405	""
decreased inflammation	renal	activation_acute	GO_0050728	ENSG00000132170	28216264	Lynch et al. (2017)	PPARG	UBERON_0001008	""
increased water retention	immune	activation_acute	GO_0003092	ENSG00000132170	28216264	Lynch et al. (2017)	PPARG	UBERON_0002405	""
increased body weight	renal	activation_acute	EFO_0004566	ENSG00000132170	28216264	Lynch et al. (2017)	PPARG	UBERON_0001008	""
decreased platelet aggregation	renal	activation_acute	GO_0090331	ENSG00000132170	28216264	Lynch et al. (2017)	PPARG	UBERON_0001008	""
increased body weight	cardiovascular	activation_acute	EFO_0004566	ENSG00000132170	28216264	Lynch et al. (2017)	PPARG	UBERON_0004535	""
increased plasma volume	renal	activation_acute	HP_0011105	ENSG00000132170	28216264	Lynch et al. (2017)	PPARG	UBERON_0001008	""
heart failure	cardiovascular	activation_acute	EFO_0003144	ENSG00000132170	28216264	Lynch et al. (2017)	PPARG	UBERON_0004535	""
decreased urinary sodium excretion	immune	activation_acute	GO_0035814	ENSG00000132170	28216264	Lynch et al. (2017)	PPARG	UBERON_0002405	""
heart failure	renal	activation_acute	EFO_0003144	ENSG00000132170	28216264	Lynch et al. (2017)	PPARG	UBERON_0001008	""
increased water retention	cardiovascular	activation_acute	GO_0003092	ENSG00000132170	28216264	Lynch et al. (2017)	PPARG	UBERON_0004535	""
decreased urine excretion	renal	activation_acute	HP_0011037	ENSG00000132170	28216264	Lynch et al. (2017)	PPARG	UBERON_0001008	""
decreased urine excretion	cardiovascular	activation_acute	HP_0011037	ENSG00000132170	28216264	Lynch et al. (2017)	PPARG	UBERON_0004535	""
increased heart weight	immune	activation_acute	EFO_0009871	ENSG00000132170	28216264	Lynch et al. (2017)	PPARG	UBERON_0002405	""
decreased blood glucose	immune	activation_acute	HP_0001943	ENSG00000132170	28216264	Lynch et al. (2017)	PPARG	UBERON_0002405	""
decreased platelet aggregation	cardiovascular	activation_acute	GO_0090331	ENSG00000132170	28216264	Lynch et al. (2017)	PPARG	UBERON_0004535	""
increased water retention	renal	activation_acute	GO_0003092	ENSG00000132170	28216264	Lynch et al. (2017)	PPARG	UBERON_0001008	""
decreased blood glucose	renal	activation_acute	HP_0001943	ENSG00000132170	28216264	Lynch et al. (2017)	PPARG	UBERON_0001008	""
decreased inflammation	cardiovascular	activation_acute	GO_0050728	ENSG00000132170	28216264	Lynch et al. (2017)	PPARG	UBERON_0004535	""
increased heart weight	cardiovascular	activation_acute	EFO_0009871	ENSG00000132170	28216264	Lynch et al. (2017)	PPARG	UBERON_0004535	""
decreased inflammation	immune	activation_acute	GO_0050728	ENSG00000132170	28216264	Lynch et al. (2017)	PPARG	UBERON_0002405	""
increased body weight	immune	activation_acute	EFO_0004566	ENSG00000132170	28216264	Lynch et al. (2017)	PPARG	UBERON_0002405	""
decreased urinary sodium excretion	cardiovascular	activation_acute	GO_0035814	ENSG00000132170	28216264	Lynch et al. (2017)	PPARG	UBERON_0004535	""
decreased urine excretion	immune	activation_acute	HP_0011037	ENSG00000132170	28216264	Lynch et al. (2017)	PPARG	UBERON_0002405	""
increased heart rate	central nervous system	inhibition_general	HP_0001649	ENSG00000103546	23197038	Bowes et al. (2012)	SLC6A2	UBERON_0001017	""
increased blood pressure	central nervous system	inhibition_general	HP_0032263	ENSG00000103546	23197038	Bowes et al. (2012)	SLC6A2	UBERON_0001017	""
increased locomotor activity	central nervous system	inhibition_general	GO_0040017	ENSG00000103546	23197038	Bowes et al. (2012)	SLC6A2	UBERON_0001017	""
constipation	central nervous system	inhibition_general	HP_0002019	ENSG00000103546	23197038	Bowes et al. (2012)	SLC6A2	UBERON_0001017	""
abuse potential	central nervous system	inhibition_general	EFO_0003890	ENSG00000103546	23197038	Bowes et al. (2012)	SLC6A2	UBERON_0001017	""
increased heart rate	cardiovascular system	inhibition_general	HP_0001649	ENSG00000103546	23197038	Bowes et al. (2012)	SLC6A2	UBERON_0004535	""
increased blood pressure	cardiovascular system	inhibition_general	HP_0032263	ENSG00000103546	23197038	Bowes et al. (2012)	SLC6A2	UBERON_0004535	""
increased locomotor activity	cardiovascular system	inhibition_general	GO_0040017	ENSG00000103546	23197038	Bowes et al. (2012)	SLC6A2	UBERON_0004535	""
constipation	cardiovascular system	inhibition_general	HP_0002019	ENSG00000103546	23197038	Bowes et al. (2012)	SLC6A2	UBERON_0004535	""
abuse potential	cardiovascular system	inhibition_general	EFO_0003890	ENSG00000103546	23197038	Bowes et al. (2012)	SLC6A2	UBERON_0004535	""
increased/decreased inflammation	peripheral nervous system	activation_acute	GO_0050727	ENSG00000170425	28216264	Lynch et al. (2017)	ADORA2B	UBERON_0000010	""
increased/decreased inflammation	peripheral nervous system	inhibition_acute	GO_0050727	ENSG00000170425	28216264	Lynch et al. (2017)	ADORA2B	UBERON_0000010	""
decreased pain	peripheral nervous system	inhibition_acute	GO_1904057	ENSG00000170425	28216264	Lynch et al. (2017)	ADORA2B	UBERON_0000010	""
increased/decreased inflammation	immune	activation_acute	GO_0050727	ENSG00000170425	28216264	Lynch et al. (2017)	ADORA2B	UBERON_0002405	""
increased/decreased inflammation	immune	inhibition_acute	GO_0050727	ENSG00000170425	28216264	Lynch et al. (2017)	ADORA2B	UBERON_0002405	""
decreased pain	immune	inhibition_acute	GO_1904057	ENSG00000170425	28216264	Lynch et al. (2017)	ADORA2B	UBERON_0002405	""
ataxia	cardiovascular	activation_acute	MONDO_0000437	ENSG00000104783	28216264	Lynch et al. (2017)	KCNN4	UBERON_0004535	""
increased atrial refractory period	cardiovascular	inhibition_acute	""	ENSG00000104783	28216264	Lynch et al. (2017)	KCNN4	UBERON_0004535	""
convulsions	cardiovascular	inhibition_acute	EFO_0009853	ENSG00000104783	28216264	Lynch et al. (2017)	KCNN4	UBERON_0004535	""
neurotoxicity	cardiovascular	inhibition_acute	EFO_0005595	ENSG00000104783	28216264	Lynch et al. (2017)	KCNN4	UBERON_0004535	""
decreased convulsions	central nervous system	activation_acute	EFO_0009853	ENSG00000104783	28216264	Lynch et al. (2017)	KCNN4	UBERON_0001017	""
increased atrial refractory period	central nervous system	inhibition_acute	""	ENSG00000104783	28216264	Lynch et al. (2017)	KCNN4	UBERON_0001017	""
convulsions	central nervous system	inhibition_acute	EFO_0009853	ENSG00000104783	28216264	Lynch et al. (2017)	KCNN4	UBERON_0001017	""
neurotoxicity	central nervous system	inhibition_acute	EFO_0005595	ENSG00000104783	28216264	Lynch et al. (2017)	KCNN4	UBERON_0001017	""
ataxia	central nervous system	activation_acute	MONDO_0000437	ENSG00000104783	28216264	Lynch et al. (2017)	KCNN4	UBERON_0001017	""
decreased locomotor activity	central nervous system	activation_acute	GO_0040013	ENSG00000104783	28216264	Lynch et al. (2017)	KCNN4	UBERON_0001017	""
decreased convulsions	cardiovascular	activation_acute	EFO_0009853	ENSG00000104783	28216264	Lynch et al. (2017)	KCNN4	UBERON_0004535	""
decreased locomotor activity	cardiovascular	activation_acute	GO_0040013	ENSG00000104783	28216264	Lynch et al. (2017)	KCNN4	UBERON_0004535	""
psychosis (schizophrenia-like)	central nervous system	activation_general	EFO_0005407	ENSG00000176884	23197038	Bowes et al. (2012)	GRIN1	UBERON_0001017	""
hallucinations	central nervous system	activation_general	HP_0000738	ENSG00000176884	23197038	Bowes et al. (2012)	GRIN1	UBERON_0001017	""
delirium and disoriented behaviour	central nervous system	activation_general	EFO_0009267	ENSG00000176884	23197038	Bowes et al. (2012)	GRIN1	UBERON_0001017	""
seizures	central nervous system	activation_general	HP_0001250	ENSG00000176884	23197038	Bowes et al. (2012)	GRIN1	UBERON_0001017	""
neurotoxicity	central nervous system	activation_general	EFO_0005595	ENSG00000176884	23197038	Bowes et al. (2012)	GRIN1	UBERON_0001017	""
increased inflammation	Immune	inhibition_general	GO_0050729	ENSG00000188822	23197038	Bowes et al. (2012)	CNR2	""	""
decreased bone mass	Immune	inhibition_general	EFO_0009877	ENSG00000188822	23197038	Bowes et al. (2012)	CNR2	""	""
decreased memory	cardiovascular	activation_acute	EFO_0001072	ENSG00000186297	28216264	Lynch et al. (2017)	GABRA5	UBERON_0004535	""
convulsions	cardiovascular	inhibition_acute	EFO_0009853	ENSG00000186297	28216264	Lynch et al. (2017)	GABRA5	UBERON_0004535	""
decreased sleep	cardiovascular	inhibition_acute	EFO_0008568	ENSG00000186297	28216264	Lynch et al. (2017)	GABRA5	UBERON_0004535	""
ataxia	central nervous system	activation_acute	MONDO_0000437	ENSG00000186297	28216264	Lynch et al. (2017)	GABRA5	UBERON_0001017	""
convulsions	central nervous system	inhibition_acute	EFO_0009853	ENSG00000186297	28216264	Lynch et al. (2017)	GABRA5	UBERON_0001017	""
decreased sleep	central nervous system	inhibition_acute	EFO_0008568	ENSG00000186297	28216264	Lynch et al. (2017)	GABRA5	UBERON_0001017	""
decreased body temperature	cardiovascular	activation_acute	HP_0002045	ENSG00000186297	28216264	Lynch et al. (2017)	GABRA5	UBERON_0004535	""
decreased locomotor activity	central nervous system	activation_acute	GO_0040013	ENSG00000186297	28216264	Lynch et al. (2017)	GABRA5	UBERON_0001017	""
muscle relaxation	cardiovascular	activation_acute	""	ENSG00000186297	28216264	Lynch et al. (2017)	GABRA5	UBERON_0004535	""
decreased blood pressure	central nervous system	activation_acute	EFO_0005251	ENSG00000186297	28216264	Lynch et al. (2017)	GABRA5	UBERON_0001017	""
decreased convulsions	cardiovascular	activation_acute	EFO_0009853	ENSG00000186297	28216264	Lynch et al. (2017)	GABRA5	UBERON_0004535	""
increased sleep	central nervous system	activation_acute	EFO_0008568	ENSG00000186297	28216264	Lynch et al. (2017)	GABRA5	UBERON_0001017	""
increased respiratory rate	central nervous system	activation_acute	EFO_0009840	ENSG00000186297	28216264	Lynch et al. (2017)	GABRA5	UBERON_0001017	""
drug abuse/dependence	central nervous system	activation_acute	EFO_0003890	ENSG00000186297	28216264	Lynch et al. (2017)	GABRA5	UBERON_0001017	""
decreased cardiac contractility	cardiovascular	activation_acute	GO_0045822	ENSG00000186297	28216264	Lynch et al. (2017)	GABRA5	UBERON_0004535	""
decreased pain	central nervous system	activation_acute	GO_1904057	ENSG00000186297	28216264	Lynch et al. (2017)	GABRA5	UBERON_0001017	""
decreased cardiac contractility	central nervous system	activation_acute	GO_0045822	ENSG00000186297	28216264	Lynch et al. (2017)	GABRA5	UBERON_0001017	""
decreased blood pressure	cardiovascular	activation_acute	EFO_0005251	ENSG00000186297	28216264	Lynch et al. (2017)	GABRA5	UBERON_0004535	""
decreased anxiety	central nervous system	activation_acute	EFO_0009874	ENSG00000186297	28216264	Lynch et al. (2017)	GABRA5	UBERON_0001017	""
decreased locomotor activity	cardiovascular	activation_acute	GO_0040013	ENSG00000186297	28216264	Lynch et al. (2017)	GABRA5	UBERON_0004535	""
increased sleep	cardiovascular	activation_acute	EFO_0008568	ENSG00000186297	28216264	Lynch et al. (2017)	GABRA5	UBERON_0004535	""
increased respiratory rate	cardiovascular	activation_acute	EFO_0009840	ENSG00000186297	28216264	Lynch et al. (2017)	GABRA5	UBERON_0004535	""
increased cardiac output	central nervous system	activation_acute	EFO_0009872	ENSG00000186297	28216264	Lynch et al. (2017)	GABRA5	UBERON_0001017	""
drug abuse/dependence	cardiovascular	activation_acute	EFO_0003890	ENSG00000186297	28216264	Lynch et al. (2017)	GABRA5	UBERON_0004535	""
decreased memory	central nervous system	activation_acute	EFO_0001072	ENSG00000186297	28216264	Lynch et al. (2017)	GABRA5	UBERON_0001017	""
decreased body temperature	central nervous system	activation_acute	HP_0002045	ENSG00000186297	28216264	Lynch et al. (2017)	GABRA5	UBERON_0001017	""
increased cardiac output	cardiovascular	activation_acute	EFO_0009872	ENSG00000186297	28216264	Lynch et al. (2017)	GABRA5	UBERON_0004535	""
muscle relaxation	central nervous system	activation_acute	""	ENSG00000186297	28216264	Lynch et al. (2017)	GABRA5	UBERON_0001017	""
decreased pain	cardiovascular	activation_acute	GO_1904057	ENSG00000186297	28216264	Lynch et al. (2017)	GABRA5	UBERON_0004535	""
increased eating	central nervous system	activation_acute	HP_0100738	ENSG00000186297	28216264	Lynch et al. (2017)	GABRA5	UBERON_0001017	""
decreased convulsions	central nervous system	activation_acute	EFO_0009853	ENSG00000186297	28216264	Lynch et al. (2017)	GABRA5	UBERON_0001017	""
ataxia	cardiovascular	activation_acute	MONDO_0000437	ENSG00000186297	28216264	Lynch et al. (2017)	GABRA5	UBERON_0004535	""
decreased anxiety	cardiovascular	activation_acute	EFO_0009874	ENSG00000186297	28216264	Lynch et al. (2017)	GABRA5	UBERON_0004535	""
increased eating	cardiovascular	activation_acute	HP_0100738	ENSG00000186297	28216264	Lynch et al. (2017)	GABRA5	UBERON_0004535	""
frothing	liver	activation_acute	""	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0002107	""
increased locomotor activity	liver	inhibition_acute	GO_0040017	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0002107	""
decreased convulsions	liver	inhibition_acute	EFO_0009853	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0002107	""
decreased memory	liver	inhibition_acute	EFO_0001072	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0002107	""
decreased cognitive function	liver	inhibition_acute	HP_0100543	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0002107	""
blurred vision	liver	inhibition_acute	HP_0000622	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0002107	""
increased heart rate	liver	inhibition_acute	HP_0001649	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0002107	""
decreased gastric acid secretion	liver	inhibition_acute	GO_0060455	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0002107	""
increased salivation	liver	activation_acute	GO_0046878	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0002107	""
neutrophil collection within the sinusoids	liver	activation_acute	GO_2000428	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0002107	""
vomiting	gastrointestinal	activation_acute	HP_0002017	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0005409	""
increased locomotor activity	gastrointestinal	inhibition_acute	GO_0040017	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0005409	""
decreased convulsions	gastrointestinal	inhibition_acute	EFO_0009853	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0005409	""
decreased memory	gastrointestinal	inhibition_acute	EFO_0001072	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0005409	""
decreased cognitive function	gastrointestinal	inhibition_acute	HP_0100543	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0005409	""
blurred vision	gastrointestinal	inhibition_acute	HP_0000622	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0005409	""
increased heart rate	gastrointestinal	inhibition_acute	HP_0001649	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0005409	""
decreased gastric acid secretion	gastrointestinal	inhibition_acute	GO_0060455	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0005409	""
bronchorrhea	respiratory	activation_acute	""	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0001004	""
increased locomotor activity	respiratory	inhibition_acute	GO_0040017	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0001004	""
decreased convulsions	respiratory	inhibition_acute	EFO_0009853	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0001004	""
decreased memory	respiratory	inhibition_acute	EFO_0001072	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0001004	""
decreased cognitive function	respiratory	inhibition_acute	HP_0100543	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0001004	""
blurred vision	respiratory	inhibition_acute	HP_0000622	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0001004	""
increased heart rate	respiratory	inhibition_acute	HP_0001649	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0001004	""
decreased gastric acid secretion	respiratory	inhibition_acute	GO_0060455	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0001004	""
acidosis	liver	activation_acute	EFO_1000014	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0002107	""
increased/decreased blood pressure	respiratory	activation_acute	HP_0030972	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0001004	""
cough	cardiovascular	activation_acute	HP_0012735	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0004535	""
increased locomotor activity	cardiovascular	inhibition_acute	GO_0040017	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0004535	""
decreased convulsions	cardiovascular	inhibition_acute	EFO_0009853	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0004535	""
decreased memory	cardiovascular	inhibition_acute	EFO_0001072	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0004535	""
decreased cognitive function	cardiovascular	inhibition_acute	HP_0100543	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0004535	""
blurred vision	cardiovascular	inhibition_acute	HP_0000622	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0004535	""
increased heart rate	cardiovascular	inhibition_acute	HP_0001649	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0004535	""
decreased gastric acid secretion	cardiovascular	inhibition_acute	GO_0060455	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0004535	""
increased body temperature	gastrointestinal	activation_acute	HP_0001945	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0005409	""
exhaustion	respiratory	activation_acute	EFO_0009852	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0001004	""
sweating	cardiovascular	activation_acute	HP_0000975	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0004535	""
irritability	nervous system	activation_acute	HP_0000737	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0001016	""
increased locomotor activity	nervous system	inhibition_acute	GO_0040017	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0001016	""
decreased convulsions	nervous system	inhibition_acute	EFO_0009853	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0001016	""
decreased memory	nervous system	inhibition_acute	EFO_0001072	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0001016	""
decreased cognitive function	nervous system	inhibition_acute	HP_0100543	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0001016	""
blurred vision	nervous system	inhibition_acute	HP_0000622	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0001016	""
increased heart rate	nervous system	inhibition_acute	HP_0001649	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0001016	""
decreased gastric acid secretion	nervous system	inhibition_acute	GO_0060455	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0001016	""
bronchorrhea	nervous system	activation_acute	""	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0001016	""
neutrophil collection within the sinusoids	cardiovascular	activation_acute	GO_2000428	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0004535	""
increased convulsions	cardiovascular	activation_acute	EFO_0009853	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0004535	""
increased memory	nervous system	activation_acute	EFO_0004874	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0001016	""
abdominal cramps	liver	activation_acute	HP_0032155	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0002107	""
frothing	gastrointestinal	activation_acute	""	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0005409	""
centrilobular liver congestion	gastrointestinal	activation_acute	EFO_0001421	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0005409	""
bronchorrhea	cardiovascular	activation_acute	""	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0004535	""
cough	respiratory	activation_acute	HP_0012735	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0001004	""
increased/decreased heart rate	liver	activation_acute	HP_0031860	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0002107	""
irritability	gastrointestinal	activation_acute	HP_0000737	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0005409	""
ptosis	cardiovascular	activation_acute	Orphanet_98578	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0004535	""
exhaustion	liver	activation_acute	EFO_0009852	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0002107	""
bronchospasm	respiratory	activation_acute	HP_0025428	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0001004	""
irritability	cardiovascular	activation_acute	HP_0000737	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0004535	""
muscle cramps	nervous system	activation_acute	EFO_0009846	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0001016	""
liver failure	cardiovascular	activation_acute	HP_0001399	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0004535	""
lacrimation	respiratory	activation_acute	HP_0000632	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0001004	""
lacrimation	cardiovascular	activation_acute	HP_0000632	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0004535	""
ptosis	gastrointestinal	activation_acute	Orphanet_98578	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0005409	""
sweating	liver	activation_acute	HP_0000975	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0002107	""
abdominal cramps	gastrointestinal	activation_acute	HP_0032155	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0005409	""
increased body temperature	liver	activation_acute	HP_0001945	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0002107	""
increased/decreased blood pressure	liver	activation_acute	HP_0030972	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0002107	""
decreased locomotor activity	gastrointestinal	activation_acute	GO_0040013	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0005409	""
increased salivation	respiratory	activation_acute	GO_0046878	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0001004	""
increased respiratory rate	gastrointestinal	activation_acute	EFO_0009840	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0005409	""
increased memory	cardiovascular	activation_acute	EFO_0004874	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0004535	""
centrilobular liver congestion	respiratory	activation_acute	EFO_0001421	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0001004	""
increased/decreased heart rate	respiratory	activation_acute	HP_0031860	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0001004	""
muscle cramps	cardiovascular	activation_acute	EFO_0009846	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0004535	""
increased body temperature	respiratory	activation_acute	HP_0001945	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0001004	""
increased/decreased blood pressure	gastrointestinal	activation_acute	HP_0030972	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0005409	""
liver failure	liver	activation_acute	HP_0001399	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0002107	""
increased/decreased heart rate	nervous system	activation_acute	HP_0031860	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0001016	""
increased/decreased blood pressure	nervous system	activation_acute	HP_0030972	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0001016	""
liver failure	respiratory	activation_acute	HP_0001399	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0001004	""
centrilobular liver congestion	cardiovascular	activation_acute	EFO_0001421	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0004535	""
bronchospasm	liver	activation_acute	HP_0025428	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0002107	""
sweating	nervous system	activation_acute	HP_0000975	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0001016	""
increased convulsions	nervous system	activation_acute	EFO_0009853	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0001016	""
ptosis	respiratory	activation_acute	Orphanet_98578	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0001004	""
acidosis	cardiovascular	activation_acute	EFO_1000014	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0004535	""
centrilobular liver congestion	liver	activation_acute	EFO_0001421	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0002107	""
increased respiratory rate	respiratory	activation_acute	EFO_0009840	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0001004	""
decreased locomotor activity	liver	activation_acute	GO_0040013	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0002107	""
increased respiratory rate	nervous system	activation_acute	EFO_0009840	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0001016	""
bronchospasm	gastrointestinal	activation_acute	HP_0025428	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0005409	""
increased salivation	cardiovascular	activation_acute	GO_0046878	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0004535	""
frothing	cardiovascular	activation_acute	""	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0004535	""
irritability	liver	activation_acute	HP_0000737	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0002107	""
blurred vision	liver	activation_acute	HP_0000622	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0002107	""
abdominal cramps	cardiovascular	activation_acute	HP_0032155	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0004535	""
increased memory	gastrointestinal	activation_acute	EFO_0004874	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0005409	""
blurred vision	cardiovascular	activation_acute	HP_0000622	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0004535	""
vomiting	liver	activation_acute	HP_0002017	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0002107	""
muscle cramps	liver	activation_acute	EFO_0009846	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0002107	""
bronchorrhea	gastrointestinal	activation_acute	""	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0005409	""
decreased pupil diameter	gastrointestinal	activation_acute	HP_0000616	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0005409	""
blurred vision	nervous system	activation_acute	HP_0000622	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0001016	""
increased convulsions	respiratory	activation_acute	EFO_0009853	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0001004	""
abdominal cramps	nervous system	activation_acute	HP_0032155	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0001016	""
acidosis	gastrointestinal	activation_acute	EFO_1000014	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0005409	""
frothing	nervous system	activation_acute	""	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0001016	""
exhaustion	nervous system	activation_acute	EFO_0009852	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0001016	""
increased/decreased blood pressure	cardiovascular	activation_acute	HP_0030972	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0004535	""
increased memory	respiratory	activation_acute	EFO_0004874	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0001004	""
bronchospasm	cardiovascular	activation_acute	HP_0025428	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0004535	""
increased respiratory rate	cardiovascular	activation_acute	EFO_0009840	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0004535	""
vomiting	nervous system	activation_acute	HP_0002017	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0001016	""
ptosis	liver	activation_acute	Orphanet_98578	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0002107	""
decreased pupil diameter	nervous system	activation_acute	HP_0000616	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0001016	""
vomiting	cardiovascular	activation_acute	HP_0002017	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0004535	""
increased body temperature	nervous system	activation_acute	HP_0001945	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0001016	""
muscle cramps	respiratory	activation_acute	EFO_0009846	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0001004	""
decreased locomotor activity	nervous system	activation_acute	GO_0040013	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0001016	""
increased/decreased heart rate	cardiovascular	activation_acute	HP_0031860	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0004535	""
acidosis	respiratory	activation_acute	EFO_1000014	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0001004	""
irritability	respiratory	activation_acute	HP_0000737	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0001004	""
ptosis	nervous system	activation_acute	Orphanet_98578	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0001016	""
increased/decreased heart rate	gastrointestinal	activation_acute	HP_0031860	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0005409	""
lacrimation	gastrointestinal	activation_acute	HP_0000632	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0005409	""
acidosis	nervous system	activation_acute	EFO_1000014	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0001016	""
decreased pupil diameter	respiratory	activation_acute	HP_0000616	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0001004	""
sweating	gastrointestinal	activation_acute	HP_0000975	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0005409	""
muscle cramps	gastrointestinal	activation_acute	EFO_0009846	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0005409	""
increased salivation	nervous system	activation_acute	GO_0046878	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0001016	""
increased respiratory rate	liver	activation_acute	EFO_0009840	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0002107	""
decreased pupil diameter	cardiovascular	activation_acute	HP_0000616	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0004535	""
blurred vision	respiratory	activation_acute	HP_0000622	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0001004	""
decreased pupil diameter	liver	activation_acute	HP_0000616	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0002107	""
neutrophil collection within the sinusoids	respiratory	activation_acute	GO_2000428	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0001004	""
cough	liver	activation_acute	HP_0012735	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0002107	""
cough	gastrointestinal	activation_acute	HP_0012735	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0005409	""
lacrimation	nervous system	activation_acute	HP_0000632	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0001016	""
increased salivation	gastrointestinal	activation_acute	GO_0046878	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0005409	""
increased memory	liver	activation_acute	EFO_0004874	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0002107	""
vomiting	respiratory	activation_acute	HP_0002017	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0001004	""
centrilobular liver congestion	nervous system	activation_acute	EFO_0001421	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0001016	""
frothing	respiratory	activation_acute	""	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0001004	""
sweating	respiratory	activation_acute	HP_0000975	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0001004	""
decreased locomotor activity	respiratory	activation_acute	GO_0040013	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0001004	""
increased convulsions	gastrointestinal	activation_acute	EFO_0009853	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0005409	""
lacrimation	liver	activation_acute	HP_0000632	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0002107	""
exhaustion	cardiovascular	activation_acute	EFO_0009852	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0004535	""
increased body temperature	cardiovascular	activation_acute	HP_0001945	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0004535	""
increased gastric acid secretion	gastrointestinal	activation_acute	GO_0060454	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0005409	""
bronchospasm	nervous system	activation_acute	HP_0025428	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0001016	""
neutrophil collection within the sinusoids	gastrointestinal	activation_acute	GO_2000428	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0005409	""
increased convulsions	liver	activation_acute	EFO_0009853	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0002107	""
bronchorrhea	liver	activation_acute	""	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0002107	""
increased gastric acid secretion	nervous system	activation_acute	GO_0060454	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0001016	""
increased gastric acid secretion	respiratory	activation_acute	GO_0060454	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0001004	""
cough	nervous system	activation_acute	HP_0012735	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0001016	""
liver failure	nervous system	activation_acute	HP_0001399	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0001016	""
blurred vision	gastrointestinal	activation_acute	HP_0000622	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0005409	""
exhaustion	gastrointestinal	activation_acute	EFO_0009852	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0005409	""
abdominal cramps	respiratory	activation_acute	HP_0032155	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0001004	""
increased gastric acid secretion	cardiovascular	activation_acute	GO_0060454	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0004535	""
decreased locomotor activity	cardiovascular	activation_acute	GO_0040013	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0004535	""
liver failure	gastrointestinal	activation_acute	HP_0001399	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0005409	""
neutrophil collection within the sinusoids	nervous system	activation_acute	GO_2000428	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0001016	""
increased gastric acid secretion	liver	activation_acute	GO_0060454	ENSG00000168539	28216264	Lynch et al. (2017)	CHRM1	UBERON_0002107	""
increased blood pressure	nervous system	inhibition_acute	HP_0032263	ENSG00000103546	28216264	Lynch et al. (2017)	SLC6A2	UBERON_0001016	""
increased heart rate	nervous system	inhibition_acute	HP_0001649	ENSG00000103546	28216264	Lynch et al. (2017)	SLC6A2	UBERON_0001016	""
increased QTc interval	nervous system	inhibition_acute	HP_0005184	ENSG00000103546	28216264	Lynch et al. (2017)	SLC6A2	UBERON_0001016	""
increased cardiac output	nervous system	inhibition_acute	EFO_0009872	ENSG00000103546	28216264	Lynch et al. (2017)	SLC6A2	UBERON_0001016	""
orthostatic hypotension	nervous system	inhibition_acute	EFO_0005252	ENSG00000103546	28216264	Lynch et al. (2017)	SLC6A2	UBERON_0001016	""
ventricular hypertrophy	nervous system	inhibition_acute	EFO_0002503	ENSG00000103546	28216264	Lynch et al. (2017)	SLC6A2	UBERON_0001016	""
decreased eating	nervous system	inhibition_acute	HP_0100738	ENSG00000103546	28216264	Lynch et al. (2017)	SLC6A2	UBERON_0001016	""
constipation	nervous system	inhibition_acute	HP_0002019	ENSG00000103546	28216264	Lynch et al. (2017)	SLC6A2	UBERON_0001016	""
decreased salivation	nervous system	inhibition_acute	GO_1905747	ENSG00000103546	28216264	Lynch et al. (2017)	SLC6A2	UBERON_0001016	""
urinary hesitancy	nervous system	inhibition_acute	HP_0000019	ENSG00000103546	28216264	Lynch et al. (2017)	SLC6A2	UBERON_0001016	""
decreased pain	nervous system	inhibition_acute	GO_1904057	ENSG00000103546	28216264	Lynch et al. (2017)	SLC6A2	UBERON_0001016	""
decreased locomotor activity	nervous system	inhibition_acute	GO_0040013	ENSG00000103546	28216264	Lynch et al. (2017)	SLC6A2	UBERON_0001016	""
decreased sleep	nervous system	inhibition_acute	EFO_0008568	ENSG00000103546	28216264	Lynch et al. (2017)	SLC6A2	UBERON_0001016	""
sweating	nervous system	inhibition_acute	HP_0000975	ENSG00000103546	28216264	Lynch et al. (2017)	SLC6A2	UBERON_0001016	""
decreased pupillary reflex	nervous system	inhibition_acute	HP_0030211	ENSG00000103546	28216264	Lynch et al. (2017)	SLC6A2	UBERON_0001016	""
blurred vision	nervous system	inhibition_acute	HP_0000622	ENSG00000103546	28216264	Lynch et al. (2017)	SLC6A2	UBERON_0001016	""
drug abuse/dependence	nervous system	inhibition_acute	EFO_0003890	ENSG00000103546	28216264	Lynch et al. (2017)	SLC6A2	UBERON_0001016	""
increased blood pressure	cardiovascular	inhibition_acute	HP_0032263	ENSG00000103546	28216264	Lynch et al. (2017)	SLC6A2	UBERON_0004535	""
increased heart rate	cardiovascular	inhibition_acute	HP_0001649	ENSG00000103546	28216264	Lynch et al. (2017)	SLC6A2	UBERON_0004535	""
increased QTc interval	cardiovascular	inhibition_acute	HP_0005184	ENSG00000103546	28216264	Lynch et al. (2017)	SLC6A2	UBERON_0004535	""
increased cardiac output	cardiovascular	inhibition_acute	EFO_0009872	ENSG00000103546	28216264	Lynch et al. (2017)	SLC6A2	UBERON_0004535	""
orthostatic hypotension	cardiovascular	inhibition_acute	EFO_0005252	ENSG00000103546	28216264	Lynch et al. (2017)	SLC6A2	UBERON_0004535	""
ventricular hypertrophy	cardiovascular	inhibition_acute	EFO_0002503	ENSG00000103546	28216264	Lynch et al. (2017)	SLC6A2	UBERON_0004535	""
decreased eating	cardiovascular	inhibition_acute	HP_0100738	ENSG00000103546	28216264	Lynch et al. (2017)	SLC6A2	UBERON_0004535	""
constipation	cardiovascular	inhibition_acute	HP_0002019	ENSG00000103546	28216264	Lynch et al. (2017)	SLC6A2	UBERON_0004535	""
decreased salivation	cardiovascular	inhibition_acute	GO_1905747	ENSG00000103546	28216264	Lynch et al. (2017)	SLC6A2	UBERON_0004535	""
urinary hesitancy	cardiovascular	inhibition_acute	HP_0000019	ENSG00000103546	28216264	Lynch et al. (2017)	SLC6A2	UBERON_0004535	""
decreased pain	cardiovascular	inhibition_acute	GO_1904057	ENSG00000103546	28216264	Lynch et al. (2017)	SLC6A2	UBERON_0004535	""
decreased locomotor activity	cardiovascular	inhibition_acute	GO_0040013	ENSG00000103546	28216264	Lynch et al. (2017)	SLC6A2	UBERON_0004535	""
decreased sleep	cardiovascular	inhibition_acute	EFO_0008568	ENSG00000103546	28216264	Lynch et al. (2017)	SLC6A2	UBERON_0004535	""
sweating	cardiovascular	inhibition_acute	HP_0000975	ENSG00000103546	28216264	Lynch et al. (2017)	SLC6A2	UBERON_0004535	""
decreased pupillary reflex	cardiovascular	inhibition_acute	HP_0030211	ENSG00000103546	28216264	Lynch et al. (2017)	SLC6A2	UBERON_0004535	""
blurred vision	cardiovascular	inhibition_acute	HP_0000622	ENSG00000103546	28216264	Lynch et al. (2017)	SLC6A2	UBERON_0004535	""
drug abuse/dependence	cardiovascular	inhibition_acute	EFO_0003890	ENSG00000103546	28216264	Lynch et al. (2017)	SLC6A2	UBERON_0004535	""
drug-drug interactions	Pharmaco-kinetics	inhibition_acute	EFO_0009878	ENSG00000189221	28216264	Lynch et al. (2017)	MAOA	""	""
decreased anxiety	Pharmaco-kinetics	inhibition_acute	EFO_0009874	ENSG00000189221	28216264	Lynch et al. (2017)	MAOA	""	""
decreased aggression	Pharmaco-kinetics	inhibition_acute	EFO_0003015	ENSG00000189221	28216264	Lynch et al. (2017)	MAOA	""	""
dizziness	Pharmaco-kinetics	inhibition_acute	EFO_0009847	ENSG00000189221	28216264	Lynch et al. (2017)	MAOA	""	""
nausea	Pharmaco-kinetics	inhibition_acute	HP_0002018	ENSG00000189221	28216264	Lynch et al. (2017)	MAOA	""	""
sleep disturbances	Pharmaco-kinetics	inhibition_acute	EFO_0008568	ENSG00000189221	28216264	Lynch et al. (2017)	MAOA	""	""
fatigue	Pharmaco-kinetics	inhibition_acute	HP_0012378	ENSG00000189221	28216264	Lynch et al. (2017)	MAOA	""	""
weakness	Pharmaco-kinetics	inhibition_acute	HP_0001324	ENSG00000189221	28216264	Lynch et al. (2017)	MAOA	""	""
tremors	Pharmaco-kinetics	inhibition_acute	HP_0001337	ENSG00000189221	28216264	Lynch et al. (2017)	MAOA	""	""
drug-drug interactions	central nervous system	inhibition_acute	EFO_0009878	ENSG00000189221	28216264	Lynch et al. (2017)	MAOA	UBERON_0001017	""
decreased anxiety	central nervous system	inhibition_acute	EFO_0009874	ENSG00000189221	28216264	Lynch et al. (2017)	MAOA	UBERON_0001017	""
decreased aggression	central nervous system	inhibition_acute	EFO_0003015	ENSG00000189221	28216264	Lynch et al. (2017)	MAOA	UBERON_0001017	""
dizziness	central nervous system	inhibition_acute	EFO_0009847	ENSG00000189221	28216264	Lynch et al. (2017)	MAOA	UBERON_0001017	""
nausea	central nervous system	inhibition_acute	HP_0002018	ENSG00000189221	28216264	Lynch et al. (2017)	MAOA	UBERON_0001017	""
sleep disturbances	central nervous system	inhibition_acute	EFO_0008568	ENSG00000189221	28216264	Lynch et al. (2017)	MAOA	UBERON_0001017	""
fatigue	central nervous system	inhibition_acute	HP_0012378	ENSG00000189221	28216264	Lynch et al. (2017)	MAOA	UBERON_0001017	""
weakness	central nervous system	inhibition_acute	HP_0001324	ENSG00000189221	28216264	Lynch et al. (2017)	MAOA	UBERON_0001017	""
tremors	central nervous system	inhibition_acute	HP_0001337	ENSG00000189221	28216264	Lynch et al. (2017)	MAOA	UBERON_0001017	""
decreased gastric acid secretion	pancreas	activation_acute	GO_0060455	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0001264	""
pain	pancreas	inhibition_acute	EFO_0003843	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0001264	""
increased/decreased convulsions	pancreas	inhibition_acute	EFO_0009853	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0001264	""
increased heart rate	pancreas	inhibition_acute	HP_0001649	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0001264	""
increased blood pressure	pancreas	inhibition_acute	HP_0032263	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0001264	""
decreased gastric emptying	pancreas	inhibition_acute	GO_0120061	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0001264	""
increased gastrointestinal transit	pancreas	inhibition_acute	HP_0410204	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0001264	""
dyspepsia	pancreas	inhibition_acute	EFO_0008533	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0001264	""
gas	pancreas	inhibition_acute	EFO_0009669	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0001264	""
decreased/increased convulsions	pancreas	activation_acute	EFO_0009853	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0001264	""
decreased/increased body temperature	respiratory	activation_acute	HP_0004370	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0001004	""
pain	respiratory	inhibition_acute	EFO_0003843	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0001004	""
increased/decreased convulsions	respiratory	inhibition_acute	EFO_0009853	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0001004	""
increased heart rate	respiratory	inhibition_acute	HP_0001649	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0001004	""
increased blood pressure	respiratory	inhibition_acute	HP_0032263	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0001004	""
decreased gastric emptying	respiratory	inhibition_acute	GO_0120061	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0001004	""
increased gastrointestinal transit	respiratory	inhibition_acute	HP_0410204	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0001004	""
dyspepsia	respiratory	inhibition_acute	EFO_0008533	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0001004	""
gas	respiratory	inhibition_acute	EFO_0009669	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0001004	""
decreased gastric acid secretion	gastrointestinal	activation_acute	GO_0060455	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0005409	""
pain	gastrointestinal	inhibition_acute	EFO_0003843	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0005409	""
increased/decreased convulsions	gastrointestinal	inhibition_acute	EFO_0009853	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0005409	""
increased heart rate	gastrointestinal	inhibition_acute	HP_0001649	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0005409	""
increased blood pressure	gastrointestinal	inhibition_acute	HP_0032263	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0005409	""
decreased gastric emptying	gastrointestinal	inhibition_acute	GO_0120061	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0005409	""
increased gastrointestinal transit	gastrointestinal	inhibition_acute	HP_0410204	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0005409	""
dyspepsia	gastrointestinal	inhibition_acute	EFO_0008533	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0005409	""
gas	gastrointestinal	inhibition_acute	EFO_0009669	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0005409	""
decreased heart rate	respiratory	activation_acute	HP_0001662	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0001004	""
increased blood glucose	respiratory	activation_acute	HP_0003074	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0001004	""
decreased gastric acid secretion	respiratory	activation_acute	GO_0060455	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0001004	""
drug abuse/dependence	nervous system	activation_acute	EFO_0003890	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0001016	""
pain	nervous system	inhibition_acute	EFO_0003843	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0001016	""
increased/decreased convulsions	nervous system	inhibition_acute	EFO_0009853	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0001016	""
increased heart rate	nervous system	inhibition_acute	HP_0001649	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0001016	""
increased blood pressure	nervous system	inhibition_acute	HP_0032263	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0001016	""
decreased gastric emptying	nervous system	inhibition_acute	GO_0120061	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0001016	""
increased gastrointestinal transit	nervous system	inhibition_acute	HP_0410204	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0001016	""
dyspepsia	nervous system	inhibition_acute	EFO_0008533	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0001016	""
gas	nervous system	inhibition_acute	EFO_0009669	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0001016	""
decreased/increased body temperature	nervous system	activation_acute	HP_0004370	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0001016	""
decreased cardiac output	pancreas	activation_acute	EFO_0009872	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0001264	""
scratching	gastrointestinal	activation_acute	""	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0005409	""
increased blood insulin	renal	activation_acute	HP_0000842	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0001008	""
pain	renal	inhibition_acute	EFO_0003843	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0001008	""
increased/decreased convulsions	renal	inhibition_acute	EFO_0009853	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0001008	""
increased heart rate	renal	inhibition_acute	HP_0001649	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0001008	""
increased blood pressure	renal	inhibition_acute	HP_0032263	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0001008	""
decreased gastric emptying	renal	inhibition_acute	GO_0120061	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0001008	""
increased gastrointestinal transit	renal	inhibition_acute	HP_0410204	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0001008	""
dyspepsia	renal	inhibition_acute	EFO_0008533	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0001008	""
gas	renal	inhibition_acute	EFO_0009669	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0001008	""
decreased gastric acid secretion	renal	activation_acute	GO_0060455	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0001008	""
decreased heart rate	nervous system	activation_acute	HP_0001662	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0001016	""
decreased/increased pupil diameter	respiratory	activation_acute	HP_0007686	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0001004	""
decreased/increased blood pressure	renal	activation_acute	HP_0030972	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0001008	""
decreased cardiac output	renal	activation_acute	EFO_0009872	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0001008	""
decreased/increased blood pressure	respiratory	activation_acute	HP_0030972	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0001004	""
decreased respiratory rate	nervous system	activation_acute	EFO_0009839	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0001016	""
decreased gastrointestinal transit	respiratory	activation_acute	HP_0030897	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0001004	""
decreased heart rate	gastrointestinal	activation_acute	HP_0001662	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0005409	""
decreased pain	renal	activation_acute	GO_1904057	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0001008	""
decreased heart rate	pancreas	activation_acute	HP_0001662	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0001264	""
decreased pain	nervous system	activation_acute	GO_1904057	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0001016	""
decreased pain	respiratory	activation_acute	GO_1904057	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0001004	""
increased urine excretion	renal	activation_acute	HP_0000103	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0001008	""
increased/decreased memory	gastrointestinal	activation_acute	EFO_0004874	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0005409	""
decreased gastric emptying	cardiovascular	activation_acute	GO_0120061	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0004535	""
pain	cardiovascular	inhibition_acute	EFO_0003843	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0004535	""
increased/decreased convulsions	cardiovascular	inhibition_acute	EFO_0009853	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0004535	""
increased heart rate	cardiovascular	inhibition_acute	HP_0001649	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0004535	""
increased blood pressure	cardiovascular	inhibition_acute	HP_0032263	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0004535	""
decreased gastric emptying	cardiovascular	inhibition_acute	GO_0120061	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0004535	""
increased gastrointestinal transit	cardiovascular	inhibition_acute	HP_0410204	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0004535	""
dyspepsia	cardiovascular	inhibition_acute	EFO_0008533	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0004535	""
gas	cardiovascular	inhibition_acute	EFO_0009669	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0004535	""
decreased gastric emptying	pancreas	activation_acute	GO_0120061	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0001264	""
scratching	renal	activation_acute	""	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0001008	""
decreased/increased pupil diameter	renal	activation_acute	HP_0007686	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0001008	""
decreased/increased blood pressure	cardiovascular	activation_acute	HP_0030972	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0004535	""
decreased gastrointestinal transit	cardiovascular	activation_acute	HP_0030897	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0004535	""
decreased respiratory rate	respiratory	activation_acute	EFO_0009839	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0001004	""
increased urine excretion	respiratory	activation_acute	HP_0000103	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0001004	""
decreased respiratory rate	cardiovascular	activation_acute	EFO_0009839	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0004535	""
decreased anxiety	cardiovascular	activation_acute	EFO_0009874	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0004535	""
decreased/increased blood pressure	nervous system	activation_acute	HP_0030972	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0001016	""
increased urinary sodium excretion	renal	activation_acute	GO_0035815	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0001008	""
decreased/increased pupil diameter	pancreas	activation_acute	HP_0007686	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0001264	""
decreased cardiac output	gastrointestinal	activation_acute	EFO_0009872	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0005409	""
decreased/increased blood pressure	pancreas	activation_acute	HP_0030972	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0001264	""
increased/decreased memory	cardiovascular	activation_acute	EFO_0004874	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0004535	""
decreased/increased body temperature	cardiovascular	activation_acute	HP_0004370	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0004535	""
decreased anxiety	pancreas	activation_acute	EFO_0009874	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0001264	""
decreased gastrointestinal transit	gastrointestinal	activation_acute	HP_0030897	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0005409	""
sedation	gastrointestinal	activation_acute	EFO_0009868	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0005409	""
decreased gastric emptying	respiratory	activation_acute	GO_0120061	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0001004	""
decreased pain	gastrointestinal	activation_acute	GO_1904057	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0005409	""
drug abuse/dependence	cardiovascular	activation_acute	EFO_0003890	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0004535	""
decreased heart rate	renal	activation_acute	HP_0001662	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0001008	""
decreased gastric emptying	gastrointestinal	activation_acute	GO_0120061	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0005409	""
drug abuse/dependence	gastrointestinal	activation_acute	EFO_0003890	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0005409	""
decreased anxiety	gastrointestinal	activation_acute	EFO_0009874	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0005409	""
decreased anxiety	nervous system	activation_acute	EFO_0009874	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0001016	""
drug abuse/dependence	pancreas	activation_acute	EFO_0003890	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0001264	""
scratching	cardiovascular	activation_acute	""	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0004535	""
increased urinary sodium excretion	nervous system	activation_acute	GO_0035815	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0001016	""
increased urine excretion	gastrointestinal	activation_acute	HP_0000103	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0005409	""
decreased gastrointestinal transit	nervous system	activation_acute	HP_0030897	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0001016	""
decreased respiratory rate	gastrointestinal	activation_acute	EFO_0009839	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0005409	""
increased/decreased memory	pancreas	activation_acute	EFO_0004874	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0001264	""
sedation	respiratory	activation_acute	EFO_0009868	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0001004	""
decreased gastrointestinal transit	pancreas	activation_acute	HP_0030897	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0001264	""
decreased/increased pupil diameter	nervous system	activation_acute	HP_0007686	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0001016	""
decreased/increased body temperature	renal	activation_acute	HP_0004370	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0001008	""
decreased respiratory rate	renal	activation_acute	EFO_0009839	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0001008	""
sedation	pancreas	activation_acute	EFO_0009868	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0001264	""
decreased/increased blood pressure	gastrointestinal	activation_acute	HP_0030972	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0005409	""
increased urine excretion	cardiovascular	activation_acute	HP_0000103	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0004535	""
scratching	nervous system	activation_acute	""	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0001016	""
increased blood glucose	renal	activation_acute	HP_0003074	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0001008	""
sedation	cardiovascular	activation_acute	EFO_0009868	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0004535	""
increased blood glucose	nervous system	activation_acute	HP_0003074	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0001016	""
decreased pain	cardiovascular	activation_acute	GO_1904057	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0004535	""
increased/decreased memory	respiratory	activation_acute	EFO_0004874	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0001004	""
increased urinary sodium excretion	cardiovascular	activation_acute	GO_0035815	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0004535	""
increased urine excretion	pancreas	activation_acute	HP_0000103	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0001264	""
decreased/increased convulsions	respiratory	activation_acute	EFO_0009853	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0001004	""
decreased heart rate	cardiovascular	activation_acute	HP_0001662	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0004535	""
decreased gastric emptying	renal	activation_acute	GO_0120061	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0001008	""
increased blood insulin	cardiovascular	activation_acute	HP_0000842	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0004535	""
decreased gastric acid secretion	nervous system	activation_acute	GO_0060455	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0001016	""
drug abuse/dependence	respiratory	activation_acute	EFO_0003890	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0001004	""
increased urinary sodium excretion	pancreas	activation_acute	GO_0035815	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0001264	""
decreased gastrointestinal transit	renal	activation_acute	HP_0030897	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0001008	""
increased blood glucose	gastrointestinal	activation_acute	HP_0003074	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0005409	""
decreased/increased convulsions	gastrointestinal	activation_acute	EFO_0009853	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0005409	""
increased urinary sodium excretion	respiratory	activation_acute	GO_0035815	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0001004	""
decreased cardiac output	nervous system	activation_acute	EFO_0009872	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0001016	""
decreased anxiety	renal	activation_acute	EFO_0009874	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0001008	""
increased urinary sodium excretion	gastrointestinal	activation_acute	GO_0035815	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0005409	""
decreased/increased convulsions	cardiovascular	activation_acute	EFO_0009853	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0004535	""
increased urine excretion	nervous system	activation_acute	HP_0000103	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0001016	""
increased/decreased memory	renal	activation_acute	EFO_0004874	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0001008	""
increased/decreased memory	nervous system	activation_acute	EFO_0004874	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0001016	""
increased blood insulin	nervous system	activation_acute	HP_0000842	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0001016	""
decreased gastric acid secretion	cardiovascular	activation_acute	GO_0060455	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0004535	""
scratching	pancreas	activation_acute	""	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0001264	""
decreased gastric emptying	nervous system	activation_acute	GO_0120061	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0001016	""
increased blood insulin	gastrointestinal	activation_acute	HP_0000842	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0005409	""
scratching	respiratory	activation_acute	""	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0001004	""
decreased/increased pupil diameter	cardiovascular	activation_acute	HP_0007686	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0004535	""
increased blood insulin	respiratory	activation_acute	HP_0000842	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0001004	""
decreased/increased convulsions	nervous system	activation_acute	EFO_0009853	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0001016	""
decreased cardiac output	cardiovascular	activation_acute	EFO_0009872	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0004535	""
decreased respiratory rate	pancreas	activation_acute	EFO_0009839	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0001264	""
decreased/increased convulsions	renal	activation_acute	EFO_0009853	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0001008	""
decreased cardiac output	respiratory	activation_acute	EFO_0009872	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0001004	""
decreased/increased body temperature	pancreas	activation_acute	HP_0004370	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0001264	""
decreased/increased pupil diameter	gastrointestinal	activation_acute	HP_0007686	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0005409	""
increased blood glucose	pancreas	activation_acute	HP_0003074	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0001264	""
sedation	nervous system	activation_acute	EFO_0009868	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0001016	""
drug abuse/dependence	renal	activation_acute	EFO_0003890	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0001008	""
decreased/increased body temperature	gastrointestinal	activation_acute	HP_0004370	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0005409	""
increased blood insulin	pancreas	activation_acute	HP_0000842	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0001264	""
increased blood glucose	cardiovascular	activation_acute	HP_0003074	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0004535	""
sedation	renal	activation_acute	EFO_0009868	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0001008	""
decreased pain	pancreas	activation_acute	GO_1904057	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0001264	""
decreased anxiety	respiratory	activation_acute	EFO_0009874	ENSG00000112038	28216264	Lynch et al. (2017)	OPRM1	UBERON_0001004	""
decreased uterine motility	urogenital	activation_acute	HP_0000130	ENSG00000125384	28216264	Lynch et al. (2017)	PTGER2	UBERON_0004122	""
decreased/increased inflammation	urogenital	inhibition_acute	GO_0050727	ENSG00000125384	28216264	Lynch et al. (2017)	PTGER2	UBERON_0004122	""
increased/decreased inflammation	immune	activation_acute	GO_0050727	ENSG00000125384	28216264	Lynch et al. (2017)	PTGER2	UBERON_0002405	""
decreased/increased inflammation	immune	inhibition_acute	GO_0050727	ENSG00000125384	28216264	Lynch et al. (2017)	PTGER2	UBERON_0002405	""
decreased uterine motility	immune	activation_acute	HP_0000130	ENSG00000125384	28216264	Lynch et al. (2017)	PTGER2	UBERON_0002405	""
increased/decreased inflammation	urogenital	activation_acute	GO_0050727	ENSG00000125384	28216264	Lynch et al. (2017)	PTGER2	UBERON_0004122	""
cardiac arrhythmia	renal	activation_acute	EFO_0004269	ENSG00000163485	28216264	Lynch et al. (2017)	ADORA1	UBERON_0001008	""
convulsions	renal	inhibition_acute	EFO_0009853	ENSG00000163485	28216264	Lynch et al. (2017)	ADORA1	UBERON_0001008	""
increased urine excretion	renal	inhibition_acute	HP_0000103	ENSG00000163485	28216264	Lynch et al. (2017)	ADORA1	UBERON_0001008	""
increased urinary sodium excretion	renal	inhibition_acute	GO_0035815	ENSG00000163485	28216264	Lynch et al. (2017)	ADORA1	UBERON_0001008	""
cardiac arrhythmia	nervous system	activation_acute	EFO_0004269	ENSG00000163485	28216264	Lynch et al. (2017)	ADORA1	UBERON_0001016	""
convulsions	nervous system	inhibition_acute	EFO_0009853	ENSG00000163485	28216264	Lynch et al. (2017)	ADORA1	UBERON_0001016	""
increased urine excretion	nervous system	inhibition_acute	HP_0000103	ENSG00000163485	28216264	Lynch et al. (2017)	ADORA1	UBERON_0001016	""
increased urinary sodium excretion	nervous system	inhibition_acute	GO_0035815	ENSG00000163485	28216264	Lynch et al. (2017)	ADORA1	UBERON_0001016	""
atrioventricular block	renal	activation_acute	MONDO_0000465	ENSG00000163485	28216264	Lynch et al. (2017)	ADORA1	UBERON_0001008	""
atrioventricular block	nervous system	activation_acute	MONDO_0000465	ENSG00000163485	28216264	Lynch et al. (2017)	ADORA1	UBERON_0001016	""
heart failure	renal	activation_acute	EFO_0003144	ENSG00000163485	28216264	Lynch et al. (2017)	ADORA1	UBERON_0001008	""
decreased blood pressure	renal	activation_acute	EFO_0005251	ENSG00000163485	28216264	Lynch et al. (2017)	ADORA1	UBERON_0001008	""
death	renal	activation_acute	EFO_0000480	ENSG00000163485	28216264	Lynch et al. (2017)	ADORA1	UBERON_0001008	""
decreased blood pressure	cardiovascular	activation_acute	EFO_0005251	ENSG00000163485	28216264	Lynch et al. (2017)	ADORA1	UBERON_0004535	""
convulsions	cardiovascular	inhibition_acute	EFO_0009853	ENSG00000163485	28216264	Lynch et al. (2017)	ADORA1	UBERON_0004535	""
increased urine excretion	cardiovascular	inhibition_acute	HP_0000103	ENSG00000163485	28216264	Lynch et al. (2017)	ADORA1	UBERON_0004535	""
increased urinary sodium excretion	cardiovascular	inhibition_acute	GO_0035815	ENSG00000163485	28216264	Lynch et al. (2017)	ADORA1	UBERON_0004535	""
heart failure	cardiovascular	activation_acute	EFO_0003144	ENSG00000163485	28216264	Lynch et al. (2017)	ADORA1	UBERON_0004535	""
decreased pain	nervous system	activation_acute	GO_1904057	ENSG00000163485	28216264	Lynch et al. (2017)	ADORA1	UBERON_0001016	""
death	nervous system	activation_acute	EFO_0000480	ENSG00000163485	28216264	Lynch et al. (2017)	ADORA1	UBERON_0001016	""
death	cardiovascular	activation_acute	EFO_0000480	ENSG00000163485	28216264	Lynch et al. (2017)	ADORA1	UBERON_0004535	""
decreased heart rate	nervous system	activation_acute	HP_0001662	ENSG00000163485	28216264	Lynch et al. (2017)	ADORA1	UBERON_0001016	""
cardiac arrhythmia	cardiovascular	activation_acute	EFO_0004269	ENSG00000163485	28216264	Lynch et al. (2017)	ADORA1	UBERON_0004535	""
decreased pain	renal	activation_acute	GO_1904057	ENSG00000163485	28216264	Lynch et al. (2017)	ADORA1	UBERON_0001008	""
decreased blood pressure	nervous system	activation_acute	EFO_0005251	ENSG00000163485	28216264	Lynch et al. (2017)	ADORA1	UBERON_0001016	""
heart failure	nervous system	activation_acute	EFO_0003144	ENSG00000163485	28216264	Lynch et al. (2017)	ADORA1	UBERON_0001016	""
atrioventricular block	cardiovascular	activation_acute	MONDO_0000465	ENSG00000163485	28216264	Lynch et al. (2017)	ADORA1	UBERON_0004535	""
decreased heart rate	cardiovascular	activation_acute	HP_0001662	ENSG00000163485	28216264	Lynch et al. (2017)	ADORA1	UBERON_0004535	""
decreased pain	cardiovascular	activation_acute	GO_1904057	ENSG00000163485	28216264	Lynch et al. (2017)	ADORA1	UBERON_0004535	""
decreased heart rate	renal	activation_acute	HP_0001662	ENSG00000163485	28216264	Lynch et al. (2017)	ADORA1	UBERON_0001008	""
decreased anxiety	central nervous system	activation_acute	EFO_0009874	ENSG00000169083	28216264	Lynch et al. (2017)	AR	UBERON_0001017	""
increased body weight	central nervous system	inhibition_acute	EFO_0004566	ENSG00000169083	28216264	Lynch et al. (2017)	AR	UBERON_0001017	""
insulin resistance	central nervous system	inhibition_acute	EFO_0002614	ENSG00000169083	28216264	Lynch et al. (2017)	AR	UBERON_0001017	""
increased triglycerides	central nervous system	inhibition_acute	EFO_0004211	ENSG00000169083	28216264	Lynch et al. (2017)	AR	UBERON_0001017	""
hot flashes	central nervous system	inhibition_acute	HP_0031217	ENSG00000169083	28216264	Lynch et al. (2017)	AR	UBERON_0001017	""
sexual dysfunction	central nervous system	inhibition_acute	EFO_0004714	ENSG00000169083	28216264	Lynch et al. (2017)	AR	UBERON_0001017	""
bone pain	central nervous system	inhibition_acute	HP_0002653	ENSG00000169083	28216264	Lynch et al. (2017)	AR	UBERON_0001017	""
osteoporosis	central nervous system	inhibition_acute	EFO_0003882	ENSG00000169083	28216264	Lynch et al. (2017)	AR	UBERON_0001017	""
bone metastasis	central nervous system	inhibition_acute	EFO_0009870	ENSG00000169083	28216264	Lynch et al. (2017)	AR	UBERON_0001017	""
anemia	central nervous system	inhibition_acute	EFO_0004272	ENSG00000169083	28216264	Lynch et al. (2017)	AR	UBERON_0001017	""
decreased memory	central nervous system	inhibition_acute	EFO_0001072	ENSG00000169083	28216264	Lynch et al. (2017)	AR	UBERON_0001017	""
decreased attention	central nervous system	inhibition_acute	NCIT_C117245	ENSG00000169083	28216264	Lynch et al. (2017)	AR	UBERON_0001017	""
depression	central nervous system	inhibition_acute	MONDO_0002050	ENSG00000169083	28216264	Lynch et al. (2017)	AR	UBERON_0001017	""
heart attack	central nervous system	inhibition_acute	EFO_0000612	ENSG00000169083	28216264	Lynch et al. (2017)	AR	UBERON_0001017	""
death	central nervous system	inhibition_acute	EFO_0000480	ENSG00000169083	28216264	Lynch et al. (2017)	AR	UBERON_0001017	""
drug abuse/dependence	central nervous system	activation_acute	EFO_0003890	ENSG00000169083	28216264	Lynch et al. (2017)	AR	UBERON_0001017	""
drug abuse/dependence	endocrine	activation_acute	EFO_0003890	ENSG00000169083	28216264	Lynch et al. (2017)	AR	UBERON_0000949	""
increased body weight	endocrine	inhibition_acute	EFO_0004566	ENSG00000169083	28216264	Lynch et al. (2017)	AR	UBERON_0000949	""
insulin resistance	endocrine	inhibition_acute	EFO_0002614	ENSG00000169083	28216264	Lynch et al. (2017)	AR	UBERON_0000949	""
increased triglycerides	endocrine	inhibition_acute	EFO_0004211	ENSG00000169083	28216264	Lynch et al. (2017)	AR	UBERON_0000949	""
hot flashes	endocrine	inhibition_acute	HP_0031217	ENSG00000169083	28216264	Lynch et al. (2017)	AR	UBERON_0000949	""
sexual dysfunction	endocrine	inhibition_acute	EFO_0004714	ENSG00000169083	28216264	Lynch et al. (2017)	AR	UBERON_0000949	""
bone pain	endocrine	inhibition_acute	HP_0002653	ENSG00000169083	28216264	Lynch et al. (2017)	AR	UBERON_0000949	""
osteoporosis	endocrine	inhibition_acute	EFO_0003882	ENSG00000169083	28216264	Lynch et al. (2017)	AR	UBERON_0000949	""
bone metastasis	endocrine	inhibition_acute	EFO_0009870	ENSG00000169083	28216264	Lynch et al. (2017)	AR	UBERON_0000949	""
anemia	endocrine	inhibition_acute	EFO_0004272	ENSG00000169083	28216264	Lynch et al. (2017)	AR	UBERON_0000949	""
decreased memory	endocrine	inhibition_acute	EFO_0001072	ENSG00000169083	28216264	Lynch et al. (2017)	AR	UBERON_0000949	""
decreased attention	endocrine	inhibition_acute	NCIT_C117245	ENSG00000169083	28216264	Lynch et al. (2017)	AR	UBERON_0000949	""
depression	endocrine	inhibition_acute	MONDO_0002050	ENSG00000169083	28216264	Lynch et al. (2017)	AR	UBERON_0000949	""
heart attack	endocrine	inhibition_acute	EFO_0000612	ENSG00000169083	28216264	Lynch et al. (2017)	AR	UBERON_0000949	""
death	endocrine	inhibition_acute	EFO_0000480	ENSG00000169083	28216264	Lynch et al. (2017)	AR	UBERON_0000949	""
decreased anxiety	endocrine	activation_acute	EFO_0009874	ENSG00000169083	28216264	Lynch et al. (2017)	AR	UBERON_0000949	""
increased blood pressure	cardiovascular system	activation_general	HP_0032263	ENSG00000151617	23197038	Bowes et al. (2012)	EDNRA	UBERON_0004535	""
teratogenicity	cardiovascular system	inhibition_developmental toxicity	EFO_0009880	ENSG00000151617	23197038	Bowes et al. (2012)	EDNRA	UBERON_0004535	""
aldosterone secretion	cardiovascular system	activation_general	GO_0035932	ENSG00000151617	23197038	Bowes et al. (2012)	EDNRA	UBERON_0004535	""
osteoblast proliferation	cardiovascular system	activation_general	GO_0033687	ENSG00000151617	23197038	Bowes et al. (2012)	EDNRA	UBERON_0004535	""
increased blood pressure	development	activation_general	HP_0032263	ENSG00000151617	23197038	Bowes et al. (2012)	EDNRA	""	""
teratogenicity	development	inhibition_developmental toxicity	EFO_0009880	ENSG00000151617	23197038	Bowes et al. (2012)	EDNRA	""	""
aldosterone secretion	development	activation_general	GO_0035932	ENSG00000151617	23197038	Bowes et al. (2012)	EDNRA	""	""
osteoblast proliferation	development	activation_general	GO_0033687	ENSG00000151617	23197038	Bowes et al. (2012)	EDNRA	""	""
smooth muscle contraction	cardiovascular system	activation_general	GO_0006939	ENSG00000102468	23197038	Bowes et al. (2012)	HTR2A	UBERON_0004535	""
platelet aggregation	cardiovascular system	activation_general	GO_0070527	ENSG00000102468	23197038	Bowes et al. (2012)	HTR2A	UBERON_0004535	""
potential memory impairments	cardiovascular system	activation_general	EFO_0001072	ENSG00000102468	23197038	Bowes et al. (2012)	HTR2A	UBERON_0004535	""
hallucinations	cardiovascular system	activation_general	HP_0000738	ENSG00000102468	23197038	Bowes et al. (2012)	HTR2A	UBERON_0004535	""
schizophrenia	cardiovascular system	activation_general	EFO_0000692	ENSG00000102468	23197038	Bowes et al. (2012)	HTR2A	UBERON_0004535	""
serotonin syndrome	cardiovascular system	activation_general	EFO_1001842	ENSG00000102468	23197038	Bowes et al. (2012)	HTR2A	UBERON_0004535	""
smooth muscle contraction	central nervous system	activation_general	GO_0006939	ENSG00000102468	23197038	Bowes et al. (2012)	HTR2A	UBERON_0001017	""
platelet aggregation	central nervous system	activation_general	GO_0070527	ENSG00000102468	23197038	Bowes et al. (2012)	HTR2A	UBERON_0001017	""
potential memory impairments	central nervous system	activation_general	EFO_0001072	ENSG00000102468	23197038	Bowes et al. (2012)	HTR2A	UBERON_0001017	""
hallucinations	central nervous system	activation_general	HP_0000738	ENSG00000102468	23197038	Bowes et al. (2012)	HTR2A	UBERON_0001017	""
schizophrenia	central nervous system	activation_general	EFO_0000692	ENSG00000102468	23197038	Bowes et al. (2012)	HTR2A	UBERON_0001017	""
serotonin syndrome	central nervous system	activation_general	EFO_1001842	ENSG00000102468	23197038	Bowes et al. (2012)	HTR2A	UBERON_0001017	""
sedation	cardiovascular system	activation_general	EFO_0009868	ENSG00000112038	23197038	Bowes et al. (2012)	OPRM1	UBERON_0004535	""
increased gastrointestinal motility	cardiovascular system	inhibition_general	HP_0030895	ENSG00000112038	23197038	Bowes et al. (2012)	OPRM1	UBERON_0004535	""
dyspepsia	cardiovascular system	inhibition_general	EFO_0008533	ENSG00000112038	23197038	Bowes et al. (2012)	OPRM1	UBERON_0004535	""
flatulence	cardiovascular system	inhibition_general	EFO_0009669	ENSG00000112038	23197038	Bowes et al. (2012)	OPRM1	UBERON_0004535	""
decreased gastrointestinal motility	cardiovascular system	activation_general	HP_0002579	ENSG00000112038	23197038	Bowes et al. (2012)	OPRM1	UBERON_0004535	""
pupil constriction	cardiovascular system	activation_general	HP_0000616	ENSG00000112038	23197038	Bowes et al. (2012)	OPRM1	UBERON_0004535	""
abuse liability	cardiovascular system	activation_general	EFO_0003890	ENSG00000112038	23197038	Bowes et al. (2012)	OPRM1	UBERON_0004535	""
respiratory depression	cardiovascular system	activation_general	EFO_0009842	ENSG00000112038	23197038	Bowes et al. (2012)	OPRM1	UBERON_0004535	""
miosis	cardiovascular system	activation_general	HP_0000616	ENSG00000112038	23197038	Bowes et al. (2012)	OPRM1	UBERON_0004535	""
hypothermia	cardiovascular system	activation_general	HP_0002045	ENSG00000112038	23197038	Bowes et al. (2012)	OPRM1	UBERON_0004535	""
sedation	gastrointestinal	activation_general	EFO_0009868	ENSG00000112038	23197038	Bowes et al. (2012)	OPRM1	UBERON_0005409	""
increased gastrointestinal motility	gastrointestinal	inhibition_general	HP_0030895	ENSG00000112038	23197038	Bowes et al. (2012)	OPRM1	UBERON_0005409	""
dyspepsia	gastrointestinal	inhibition_general	EFO_0008533	ENSG00000112038	23197038	Bowes et al. (2012)	OPRM1	UBERON_0005409	""
flatulence	gastrointestinal	inhibition_general	EFO_0009669	ENSG00000112038	23197038	Bowes et al. (2012)	OPRM1	UBERON_0005409	""
decreased gastrointestinal motility	gastrointestinal	activation_general	HP_0002579	ENSG00000112038	23197038	Bowes et al. (2012)	OPRM1	UBERON_0005409	""
pupil constriction	gastrointestinal	activation_general	HP_0000616	ENSG00000112038	23197038	Bowes et al. (2012)	OPRM1	UBERON_0005409	""
abuse liability	gastrointestinal	activation_general	EFO_0003890	ENSG00000112038	23197038	Bowes et al. (2012)	OPRM1	UBERON_0005409	""
respiratory depression	gastrointestinal	activation_general	EFO_0009842	ENSG00000112038	23197038	Bowes et al. (2012)	OPRM1	UBERON_0005409	""
miosis	gastrointestinal	activation_general	HP_0000616	ENSG00000112038	23197038	Bowes et al. (2012)	OPRM1	UBERON_0005409	""
hypothermia	gastrointestinal	activation_general	HP_0002045	ENSG00000112038	23197038	Bowes et al. (2012)	OPRM1	UBERON_0005409	""
sedation	central nervous system	activation_general	EFO_0009868	ENSG00000112038	23197038	Bowes et al. (2012)	OPRM1	UBERON_0001017	""
increased gastrointestinal motility	central nervous system	inhibition_general	HP_0030895	ENSG00000112038	23197038	Bowes et al. (2012)	OPRM1	UBERON_0001017	""
dyspepsia	central nervous system	inhibition_general	EFO_0008533	ENSG00000112038	23197038	Bowes et al. (2012)	OPRM1	UBERON_0001017	""
flatulence	central nervous system	inhibition_general	EFO_0009669	ENSG00000112038	23197038	Bowes et al. (2012)	OPRM1	UBERON_0001017	""
decreased gastrointestinal motility	central nervous system	activation_general	HP_0002579	ENSG00000112038	23197038	Bowes et al. (2012)	OPRM1	UBERON_0001017	""
pupil constriction	central nervous system	activation_general	HP_0000616	ENSG00000112038	23197038	Bowes et al. (2012)	OPRM1	UBERON_0001017	""
abuse liability	central nervous system	activation_general	EFO_0003890	ENSG00000112038	23197038	Bowes et al. (2012)	OPRM1	UBERON_0001017	""
respiratory depression	central nervous system	activation_general	EFO_0009842	ENSG00000112038	23197038	Bowes et al. (2012)	OPRM1	UBERON_0001017	""
miosis	central nervous system	activation_general	HP_0000616	ENSG00000112038	23197038	Bowes et al. (2012)	OPRM1	UBERON_0001017	""
hypothermia	central nervous system	activation_general	HP_0002045	ENSG00000112038	23197038	Bowes et al. (2012)	OPRM1	UBERON_0001017	""
increased cardiac contractility	renal	inhibition_acute	GO_0045823	ENSG00000143153	28216264	Lynch et al. (2017)	ATP1B1	UBERON_0001008	""
decreased heart rate	renal	inhibition_acute	HP_0001662	ENSG00000143153	28216264	Lynch et al. (2017)	ATP1B1	UBERON_0001008	""
atrioventricular block	renal	inhibition_acute	MONDO_0000465	ENSG00000143153	28216264	Lynch et al. (2017)	ATP1B1	UBERON_0001008	""
cardiac arrhythmia	renal	inhibition_acute	EFO_0004269	ENSG00000143153	28216264	Lynch et al. (2017)	ATP1B1	UBERON_0001008	""
ventricular fibrillation	renal	inhibition_acute	EFO_0004287	ENSG00000143153	28216264	Lynch et al. (2017)	ATP1B1	UBERON_0001008	""
increased urine excretion	renal	inhibition_acute	HP_0000103	ENSG00000143153	28216264	Lynch et al. (2017)	ATP1B1	UBERON_0001008	""
increased urinary sodium excretion	renal	inhibition_acute	GO_0035815	ENSG00000143153	28216264	Lynch et al. (2017)	ATP1B1	UBERON_0001008	""
vomiting	renal	inhibition_acute	HP_0002017	ENSG00000143153	28216264	Lynch et al. (2017)	ATP1B1	UBERON_0001008	""
increased cardiac contractility	cardiovascular	inhibition_acute	GO_0045823	ENSG00000143153	28216264	Lynch et al. (2017)	ATP1B1	UBERON_0004535	""
decreased heart rate	cardiovascular	inhibition_acute	HP_0001662	ENSG00000143153	28216264	Lynch et al. (2017)	ATP1B1	UBERON_0004535	""
atrioventricular block	cardiovascular	inhibition_acute	MONDO_0000465	ENSG00000143153	28216264	Lynch et al. (2017)	ATP1B1	UBERON_0004535	""
cardiac arrhythmia	cardiovascular	inhibition_acute	EFO_0004269	ENSG00000143153	28216264	Lynch et al. (2017)	ATP1B1	UBERON_0004535	""
ventricular fibrillation	cardiovascular	inhibition_acute	EFO_0004287	ENSG00000143153	28216264	Lynch et al. (2017)	ATP1B1	UBERON_0004535	""
increased urine excretion	cardiovascular	inhibition_acute	HP_0000103	ENSG00000143153	28216264	Lynch et al. (2017)	ATP1B1	UBERON_0004535	""
increased urinary sodium excretion	cardiovascular	inhibition_acute	GO_0035815	ENSG00000143153	28216264	Lynch et al. (2017)	ATP1B1	UBERON_0004535	""
vomiting	cardiovascular	inhibition_acute	HP_0002017	ENSG00000143153	28216264	Lynch et al. (2017)	ATP1B1	UBERON_0004535	""
increased eating	central nervous system	activation_acute	HP_0100738	ENSG00000113327	28216264	Lynch et al. (2017)	GABRG2	UBERON_0001017	""
convulsions	central nervous system	inhibition_acute	EFO_0009853	ENSG00000113327	28216264	Lynch et al. (2017)	GABRG2	UBERON_0001017	""
decreased sleep	central nervous system	inhibition_acute	EFO_0008568	ENSG00000113327	28216264	Lynch et al. (2017)	GABRG2	UBERON_0001017	""
muscle relaxation	cardiovascular	activation_acute	""	ENSG00000113327	28216264	Lynch et al. (2017)	GABRG2	UBERON_0004535	""
convulsions	cardiovascular	inhibition_acute	EFO_0009853	ENSG00000113327	28216264	Lynch et al. (2017)	GABRG2	UBERON_0004535	""
decreased sleep	cardiovascular	inhibition_acute	EFO_0008568	ENSG00000113327	28216264	Lynch et al. (2017)	GABRG2	UBERON_0004535	""
increased eating	cardiovascular	activation_acute	HP_0100738	ENSG00000113327	28216264	Lynch et al. (2017)	GABRG2	UBERON_0004535	""
decreased anxiety	central nervous system	activation_acute	EFO_0009874	ENSG00000113327	28216264	Lynch et al. (2017)	GABRG2	UBERON_0001017	""
increased respiratory rate	central nervous system	activation_acute	EFO_0009840	ENSG00000113327	28216264	Lynch et al. (2017)	GABRG2	UBERON_0001017	""
ataxia	central nervous system	activation_acute	MONDO_0000437	ENSG00000113327	28216264	Lynch et al. (2017)	GABRG2	UBERON_0001017	""
muscle relaxation	central nervous system	activation_acute	""	ENSG00000113327	28216264	Lynch et al. (2017)	GABRG2	UBERON_0001017	""
increased cardiac output	cardiovascular	activation_acute	EFO_0009872	ENSG00000113327	28216264	Lynch et al. (2017)	GABRG2	UBERON_0004535	""
decreased memory	central nervous system	activation_acute	EFO_0001072	ENSG00000113327	28216264	Lynch et al. (2017)	GABRG2	UBERON_0001017	""
decreased cardiac contractility	cardiovascular	activation_acute	GO_0045822	ENSG00000113327	28216264	Lynch et al. (2017)	GABRG2	UBERON_0004535	""
increased cardiac output	central nervous system	activation_acute	EFO_0009872	ENSG00000113327	28216264	Lynch et al. (2017)	GABRG2	UBERON_0001017	""
decreased pain	cardiovascular	activation_acute	GO_1904057	ENSG00000113327	28216264	Lynch et al. (2017)	GABRG2	UBERON_0004535	""
increased sleep	central nervous system	activation_acute	EFO_0008568	ENSG00000113327	28216264	Lynch et al. (2017)	GABRG2	UBERON_0001017	""
drug abuse/dependence	central nervous system	activation_acute	EFO_0003890	ENSG00000113327	28216264	Lynch et al. (2017)	GABRG2	UBERON_0001017	""
decreased blood pressure	central nervous system	activation_acute	EFO_0005251	ENSG00000113327	28216264	Lynch et al. (2017)	GABRG2	UBERON_0001017	""
decreased body temperature	central nervous system	activation_acute	HP_0002045	ENSG00000113327	28216264	Lynch et al. (2017)	GABRG2	UBERON_0001017	""
decreased convulsions	cardiovascular	activation_acute	EFO_0009853	ENSG00000113327	28216264	Lynch et al. (2017)	GABRG2	UBERON_0004535	""
decreased pain	central nervous system	activation_acute	GO_1904057	ENSG00000113327	28216264	Lynch et al. (2017)	GABRG2	UBERON_0001017	""
increased respiratory rate	cardiovascular	activation_acute	EFO_0009840	ENSG00000113327	28216264	Lynch et al. (2017)	GABRG2	UBERON_0004535	""
increased sleep	cardiovascular	activation_acute	EFO_0008568	ENSG00000113327	28216264	Lynch et al. (2017)	GABRG2	UBERON_0004535	""
decreased blood pressure	cardiovascular	activation_acute	EFO_0005251	ENSG00000113327	28216264	Lynch et al. (2017)	GABRG2	UBERON_0004535	""
decreased locomotor activity	cardiovascular	activation_acute	GO_0040013	ENSG00000113327	28216264	Lynch et al. (2017)	GABRG2	UBERON_0004535	""
ataxia	cardiovascular	activation_acute	MONDO_0000437	ENSG00000113327	28216264	Lynch et al. (2017)	GABRG2	UBERON_0004535	""
decreased cardiac contractility	central nervous system	activation_acute	GO_0045822	ENSG00000113327	28216264	Lynch et al. (2017)	GABRG2	UBERON_0001017	""
decreased body temperature	cardiovascular	activation_acute	HP_0002045	ENSG00000113327	28216264	Lynch et al. (2017)	GABRG2	UBERON_0004535	""
decreased anxiety	cardiovascular	activation_acute	EFO_0009874	ENSG00000113327	28216264	Lynch et al. (2017)	GABRG2	UBERON_0004535	""
decreased locomotor activity	central nervous system	activation_acute	GO_0040013	ENSG00000113327	28216264	Lynch et al. (2017)	GABRG2	UBERON_0001017	""
drug abuse/dependence	cardiovascular	activation_acute	EFO_0003890	ENSG00000113327	28216264	Lynch et al. (2017)	GABRG2	UBERON_0004535	""
decreased memory	cardiovascular	activation_acute	EFO_0001072	ENSG00000113327	28216264	Lynch et al. (2017)	GABRG2	UBERON_0004535	""
decreased convulsions	central nervous system	activation_acute	EFO_0009853	ENSG00000113327	28216264	Lynch et al. (2017)	GABRG2	UBERON_0001017	""
cardiac lesions	cardiovascular	activation_acute	""	ENSG00000121361	28216264	Lynch et al. (2017)	KCNJ8	UBERON_0004535	""
decreased heart rate	cardiovascular	inhibition_acute	HP_0001662	ENSG00000121361	28216264	Lynch et al. (2017)	KCNJ8	UBERON_0004535	""
atrioventricular block	cardiovascular	inhibition_acute	MONDO_0000465	ENSG00000121361	28216264	Lynch et al. (2017)	KCNJ8	UBERON_0004535	""
increased blood insulin	cardiovascular	inhibition_acute	HP_0000842	ENSG00000121361	28216264	Lynch et al. (2017)	KCNJ8	UBERON_0004535	""
decreased blood glucose	cardiovascular	inhibition_acute	HP_0001943	ENSG00000121361	28216264	Lynch et al. (2017)	KCNJ8	UBERON_0004535	""
increased urine excretion	cardiovascular	inhibition_acute	HP_0000103	ENSG00000121361	28216264	Lynch et al. (2017)	KCNJ8	UBERON_0004535	""
increased urinary sodium excretion	cardiovascular	inhibition_acute	GO_0035815	ENSG00000121361	28216264	Lynch et al. (2017)	KCNJ8	UBERON_0004535	""
decreased blood insulin	pancreas	activation_acute	HP_0040216	ENSG00000121361	28216264	Lynch et al. (2017)	KCNJ8	UBERON_0001264	""
decreased heart rate	pancreas	inhibition_acute	HP_0001662	ENSG00000121361	28216264	Lynch et al. (2017)	KCNJ8	UBERON_0001264	""
atrioventricular block	pancreas	inhibition_acute	MONDO_0000465	ENSG00000121361	28216264	Lynch et al. (2017)	KCNJ8	UBERON_0001264	""
increased blood insulin	pancreas	inhibition_acute	HP_0000842	ENSG00000121361	28216264	Lynch et al. (2017)	KCNJ8	UBERON_0001264	""
decreased blood glucose	pancreas	inhibition_acute	HP_0001943	ENSG00000121361	28216264	Lynch et al. (2017)	KCNJ8	UBERON_0001264	""
increased urine excretion	pancreas	inhibition_acute	HP_0000103	ENSG00000121361	28216264	Lynch et al. (2017)	KCNJ8	UBERON_0001264	""
increased urinary sodium excretion	pancreas	inhibition_acute	GO_0035815	ENSG00000121361	28216264	Lynch et al. (2017)	KCNJ8	UBERON_0001264	""
decreased blood pressure	cardiovascular	activation_acute	EFO_0005251	ENSG00000121361	28216264	Lynch et al. (2017)	KCNJ8	UBERON_0004535	""
abnormal pulse	pancreas	activation_acute	HP_0031860	ENSG00000121361	28216264	Lynch et al. (2017)	KCNJ8	UBERON_0001264	""
decreased blood insulin	renal	activation_acute	HP_0040216	ENSG00000121361	28216264	Lynch et al. (2017)	KCNJ8	UBERON_0001008	""
decreased heart rate	renal	inhibition_acute	HP_0001662	ENSG00000121361	28216264	Lynch et al. (2017)	KCNJ8	UBERON_0001008	""
atrioventricular block	renal	inhibition_acute	MONDO_0000465	ENSG00000121361	28216264	Lynch et al. (2017)	KCNJ8	UBERON_0001008	""
increased blood insulin	renal	inhibition_acute	HP_0000842	ENSG00000121361	28216264	Lynch et al. (2017)	KCNJ8	UBERON_0001008	""
decreased blood glucose	renal	inhibition_acute	HP_0001943	ENSG00000121361	28216264	Lynch et al. (2017)	KCNJ8	UBERON_0001008	""
increased urine excretion	renal	inhibition_acute	HP_0000103	ENSG00000121361	28216264	Lynch et al. (2017)	KCNJ8	UBERON_0001008	""
increased urinary sodium excretion	renal	inhibition_acute	GO_0035815	ENSG00000121361	28216264	Lynch et al. (2017)	KCNJ8	UBERON_0001008	""
cardiac arrhythmia	renal	activation_acute	EFO_0004269	ENSG00000121361	28216264	Lynch et al. (2017)	KCNJ8	UBERON_0001008	""
cardiac lesions	renal	activation_acute	""	ENSG00000121361	28216264	Lynch et al. (2017)	KCNJ8	UBERON_0001008	""
decreased blood pressure	renal	activation_acute	EFO_0005251	ENSG00000121361	28216264	Lynch et al. (2017)	KCNJ8	UBERON_0001008	""
increased/decreased blood glucose	renal	activation_acute	HP_0011015	ENSG00000121361	28216264	Lynch et al. (2017)	KCNJ8	UBERON_0001008	""
decreased blood insulin	cardiovascular	activation_acute	HP_0040216	ENSG00000121361	28216264	Lynch et al. (2017)	KCNJ8	UBERON_0004535	""
abnormal pulse	cardiovascular	activation_acute	HP_0031860	ENSG00000121361	28216264	Lynch et al. (2017)	KCNJ8	UBERON_0004535	""
increased heart rate	cardiovascular	activation_acute	HP_0001649	ENSG00000121361	28216264	Lynch et al. (2017)	KCNJ8	UBERON_0004535	""
decreased blood pressure	pancreas	activation_acute	EFO_0005251	ENSG00000121361	28216264	Lynch et al. (2017)	KCNJ8	UBERON_0001264	""
abnormal pulse	renal	activation_acute	HP_0031860	ENSG00000121361	28216264	Lynch et al. (2017)	KCNJ8	UBERON_0001008	""
cardiac arrhythmia	cardiovascular	activation_acute	EFO_0004269	ENSG00000121361	28216264	Lynch et al. (2017)	KCNJ8	UBERON_0004535	""
cardiac arrhythmia	pancreas	activation_acute	EFO_0004269	ENSG00000121361	28216264	Lynch et al. (2017)	KCNJ8	UBERON_0001264	""
increased heart rate	pancreas	activation_acute	HP_0001649	ENSG00000121361	28216264	Lynch et al. (2017)	KCNJ8	UBERON_0001264	""
decreased convulsions	cardiovascular	activation_acute	EFO_0009853	ENSG00000121361	28216264	Lynch et al. (2017)	KCNJ8	UBERON_0004535	""
increased/decreased blood glucose	pancreas	activation_acute	HP_0011015	ENSG00000121361	28216264	Lynch et al. (2017)	KCNJ8	UBERON_0001264	""
increased/decreased blood glucose	cardiovascular	activation_acute	HP_0011015	ENSG00000121361	28216264	Lynch et al. (2017)	KCNJ8	UBERON_0004535	""
cardiac lesions	pancreas	activation_acute	""	ENSG00000121361	28216264	Lynch et al. (2017)	KCNJ8	UBERON_0001264	""
decreased convulsions	renal	activation_acute	EFO_0009853	ENSG00000121361	28216264	Lynch et al. (2017)	KCNJ8	UBERON_0001008	""
increased heart rate	renal	activation_acute	HP_0001649	ENSG00000121361	28216264	Lynch et al. (2017)	KCNJ8	UBERON_0001008	""
decreased convulsions	pancreas	activation_acute	EFO_0009853	ENSG00000121361	28216264	Lynch et al. (2017)	KCNJ8	UBERON_0001264	""
decreased convulsions	central nervous system	activation_acute	EFO_0009853	ENSG00000105642	28216264	Lynch et al. (2017)	KCNN1	UBERON_0001017	""
increased atrial refractory period	central nervous system	inhibition_acute	""	ENSG00000105642	28216264	Lynch et al. (2017)	KCNN1	UBERON_0001017	""
convulsions	central nervous system	inhibition_acute	EFO_0009853	ENSG00000105642	28216264	Lynch et al. (2017)	KCNN1	UBERON_0001017	""
neurotoxicity	central nervous system	inhibition_acute	EFO_0005595	ENSG00000105642	28216264	Lynch et al. (2017)	KCNN1	UBERON_0001017	""
decreased convulsions	cardiovascular	activation_acute	EFO_0009853	ENSG00000105642	28216264	Lynch et al. (2017)	KCNN1	UBERON_0004535	""
increased atrial refractory period	cardiovascular	inhibition_acute	""	ENSG00000105642	28216264	Lynch et al. (2017)	KCNN1	UBERON_0004535	""
convulsions	cardiovascular	inhibition_acute	EFO_0009853	ENSG00000105642	28216264	Lynch et al. (2017)	KCNN1	UBERON_0004535	""
neurotoxicity	cardiovascular	inhibition_acute	EFO_0005595	ENSG00000105642	28216264	Lynch et al. (2017)	KCNN1	UBERON_0004535	""
ataxia	cardiovascular	activation_acute	MONDO_0000437	ENSG00000105642	28216264	Lynch et al. (2017)	KCNN1	UBERON_0004535	""
decreased locomotor activity	central nervous system	activation_acute	GO_0040013	ENSG00000105642	28216264	Lynch et al. (2017)	KCNN1	UBERON_0001017	""
ataxia	central nervous system	activation_acute	MONDO_0000437	ENSG00000105642	28216264	Lynch et al. (2017)	KCNN1	UBERON_0001017	""
decreased locomotor activity	cardiovascular	activation_acute	GO_0040013	ENSG00000105642	28216264	Lynch et al. (2017)	KCNN1	UBERON_0004535	""
cardiac arrhythmia	cardiovascular	activation_acute	EFO_0004269	ENSG00000105711	28216264	Lynch et al. (2017)	SCN1B	UBERON_0004535	""
decreased pain	cardiovascular	inhibition_acute	GO_1904057	ENSG00000105711	28216264	Lynch et al. (2017)	SCN1B	UBERON_0004535	""
agitation	cardiovascular	inhibition_acute	NCIT_C74532	ENSG00000105711	28216264	Lynch et al. (2017)	SCN1B	UBERON_0004535	""
decreased sweating	cardiovascular	inhibition_acute	EFO_1000712	ENSG00000105711	28216264	Lynch et al. (2017)	SCN1B	UBERON_0004535	""
increased pupil diameter	cardiovascular	inhibition_acute	HP_0011499	ENSG00000105711	28216264	Lynch et al. (2017)	SCN1B	UBERON_0004535	""
decreased/increased convulsions	cardiovascular	inhibition_acute	EFO_0009853	ENSG00000105711	28216264	Lynch et al. (2017)	SCN1B	UBERON_0004535	""
decreased/increased heart rate	cardiovascular	inhibition_acute	HP_0031860	ENSG00000105711	28216264	Lynch et al. (2017)	SCN1B	UBERON_0004535	""
decreased blood pressure	cardiovascular	inhibition_acute	EFO_0005251	ENSG00000105711	28216264	Lynch et al. (2017)	SCN1B	UBERON_0004535	""
decreased cardiac contractility	cardiovascular	inhibition_acute	GO_0045822	ENSG00000105711	28216264	Lynch et al. (2017)	SCN1B	UBERON_0004535	""
decreased cardiac conduction	cardiovascular	inhibition_acute	EFO_1001497	ENSG00000105711	28216264	Lynch et al. (2017)	SCN1B	UBERON_0004535	""
increased QRS complex	cardiovascular	inhibition_acute	HP_0006677	ENSG00000105711	28216264	Lynch et al. (2017)	SCN1B	UBERON_0004535	""
cardiac arrhythmia	cardiovascular	inhibition_acute	EFO_0004269	ENSG00000105711	28216264	Lynch et al. (2017)	SCN1B	UBERON_0004535	""
decreased respiratory rate	cardiovascular	inhibition_acute	EFO_0009839	ENSG00000105711	28216264	Lynch et al. (2017)	SCN1B	UBERON_0004535	""
decreased gastrointestinal transit	cardiovascular	inhibition_acute	HP_0030897	ENSG00000105711	28216264	Lynch et al. (2017)	SCN1B	UBERON_0004535	""
decreased urine excretion	cardiovascular	inhibition_acute	HP_0011037	ENSG00000105711	28216264	Lynch et al. (2017)	SCN1B	UBERON_0004535	""
coma	cardiovascular	inhibition_acute	HP_0001259	ENSG00000105711	28216264	Lynch et al. (2017)	SCN1B	UBERON_0004535	""
dyspnea	respiratory	activation_acute	HP_0002094	ENSG00000105711	28216264	Lynch et al. (2017)	SCN1B	UBERON_0001004	""
decreased pain	respiratory	inhibition_acute	GO_1904057	ENSG00000105711	28216264	Lynch et al. (2017)	SCN1B	UBERON_0001004	""
agitation	respiratory	inhibition_acute	NCIT_C74532	ENSG00000105711	28216264	Lynch et al. (2017)	SCN1B	UBERON_0001004	""
decreased sweating	respiratory	inhibition_acute	EFO_1000712	ENSG00000105711	28216264	Lynch et al. (2017)	SCN1B	UBERON_0001004	""
increased pupil diameter	respiratory	inhibition_acute	HP_0011499	ENSG00000105711	28216264	Lynch et al. (2017)	SCN1B	UBERON_0001004	""
decreased/increased convulsions	respiratory	inhibition_acute	EFO_0009853	ENSG00000105711	28216264	Lynch et al. (2017)	SCN1B	UBERON_0001004	""
decreased/increased heart rate	respiratory	inhibition_acute	HP_0031860	ENSG00000105711	28216264	Lynch et al. (2017)	SCN1B	UBERON_0001004	""
decreased blood pressure	respiratory	inhibition_acute	EFO_0005251	ENSG00000105711	28216264	Lynch et al. (2017)	SCN1B	UBERON_0001004	""
decreased cardiac contractility	respiratory	inhibition_acute	GO_0045822	ENSG00000105711	28216264	Lynch et al. (2017)	SCN1B	UBERON_0001004	""
decreased cardiac conduction	respiratory	inhibition_acute	EFO_1001497	ENSG00000105711	28216264	Lynch et al. (2017)	SCN1B	UBERON_0001004	""
increased QRS complex	respiratory	inhibition_acute	HP_0006677	ENSG00000105711	28216264	Lynch et al. (2017)	SCN1B	UBERON_0001004	""
cardiac arrhythmia	respiratory	inhibition_acute	EFO_0004269	ENSG00000105711	28216264	Lynch et al. (2017)	SCN1B	UBERON_0001004	""
decreased respiratory rate	respiratory	inhibition_acute	EFO_0009839	ENSG00000105711	28216264	Lynch et al. (2017)	SCN1B	UBERON_0001004	""
decreased gastrointestinal transit	respiratory	inhibition_acute	HP_0030897	ENSG00000105711	28216264	Lynch et al. (2017)	SCN1B	UBERON_0001004	""
decreased urine excretion	respiratory	inhibition_acute	HP_0011037	ENSG00000105711	28216264	Lynch et al. (2017)	SCN1B	UBERON_0001004	""
coma	respiratory	inhibition_acute	HP_0001259	ENSG00000105711	28216264	Lynch et al. (2017)	SCN1B	UBERON_0001004	""
decreased locomotor activity	respiratory	activation_acute	GO_0040013	ENSG00000105711	28216264	Lynch et al. (2017)	SCN1B	UBERON_0001004	""
increased heart rate	cardiovascular	activation_acute	HP_0001649	ENSG00000105711	28216264	Lynch et al. (2017)	SCN1B	UBERON_0004535	""
increased heart rate	respiratory	activation_acute	HP_0001649	ENSG00000105711	28216264	Lynch et al. (2017)	SCN1B	UBERON_0001004	""
dyspnea	cardiovascular	activation_acute	HP_0002094	ENSG00000105711	28216264	Lynch et al. (2017)	SCN1B	UBERON_0004535	""
cardiac arrhythmia	respiratory	activation_acute	EFO_0004269	ENSG00000105711	28216264	Lynch et al. (2017)	SCN1B	UBERON_0001004	""
convulsions	respiratory	activation_acute	EFO_0009853	ENSG00000105711	28216264	Lynch et al. (2017)	SCN1B	UBERON_0001004	""
decreased locomotor activity	cardiovascular	activation_acute	GO_0040013	ENSG00000105711	28216264	Lynch et al. (2017)	SCN1B	UBERON_0004535	""
convulsions	nervous system	activation_acute	EFO_0009853	ENSG00000105711	28216264	Lynch et al. (2017)	SCN1B	UBERON_0001016	""
decreased pain	nervous system	inhibition_acute	GO_1904057	ENSG00000105711	28216264	Lynch et al. (2017)	SCN1B	UBERON_0001016	""
agitation	nervous system	inhibition_acute	NCIT_C74532	ENSG00000105711	28216264	Lynch et al. (2017)	SCN1B	UBERON_0001016	""
decreased sweating	nervous system	inhibition_acute	EFO_1000712	ENSG00000105711	28216264	Lynch et al. (2017)	SCN1B	UBERON_0001016	""
increased pupil diameter	nervous system	inhibition_acute	HP_0011499	ENSG00000105711	28216264	Lynch et al. (2017)	SCN1B	UBERON_0001016	""
decreased/increased convulsions	nervous system	inhibition_acute	EFO_0009853	ENSG00000105711	28216264	Lynch et al. (2017)	SCN1B	UBERON_0001016	""
decreased/increased heart rate	nervous system	inhibition_acute	HP_0031860	ENSG00000105711	28216264	Lynch et al. (2017)	SCN1B	UBERON_0001016	""
decreased blood pressure	nervous system	inhibition_acute	EFO_0005251	ENSG00000105711	28216264	Lynch et al. (2017)	SCN1B	UBERON_0001016	""
decreased cardiac contractility	nervous system	inhibition_acute	GO_0045822	ENSG00000105711	28216264	Lynch et al. (2017)	SCN1B	UBERON_0001016	""
decreased cardiac conduction	nervous system	inhibition_acute	EFO_1001497	ENSG00000105711	28216264	Lynch et al. (2017)	SCN1B	UBERON_0001016	""
increased QRS complex	nervous system	inhibition_acute	HP_0006677	ENSG00000105711	28216264	Lynch et al. (2017)	SCN1B	UBERON_0001016	""
cardiac arrhythmia	nervous system	inhibition_acute	EFO_0004269	ENSG00000105711	28216264	Lynch et al. (2017)	SCN1B	UBERON_0001016	""
decreased respiratory rate	nervous system	inhibition_acute	EFO_0009839	ENSG00000105711	28216264	Lynch et al. (2017)	SCN1B	UBERON_0001016	""
decreased gastrointestinal transit	nervous system	inhibition_acute	HP_0030897	ENSG00000105711	28216264	Lynch et al. (2017)	SCN1B	UBERON_0001016	""
decreased urine excretion	nervous system	inhibition_acute	HP_0011037	ENSG00000105711	28216264	Lynch et al. (2017)	SCN1B	UBERON_0001016	""
coma	nervous system	inhibition_acute	HP_0001259	ENSG00000105711	28216264	Lynch et al. (2017)	SCN1B	UBERON_0001016	""
decreased locomotor activity	nervous system	activation_acute	GO_0040013	ENSG00000105711	28216264	Lynch et al. (2017)	SCN1B	UBERON_0001016	""
increased heart rate	nervous system	activation_acute	HP_0001649	ENSG00000105711	28216264	Lynch et al. (2017)	SCN1B	UBERON_0001016	""
convulsions	cardiovascular	activation_acute	EFO_0009853	ENSG00000105711	28216264	Lynch et al. (2017)	SCN1B	UBERON_0004535	""
dyspnea	nervous system	activation_acute	HP_0002094	ENSG00000105711	28216264	Lynch et al. (2017)	SCN1B	UBERON_0001016	""
cardiac arrhythmia	nervous system	activation_acute	EFO_0004269	ENSG00000105711	28216264	Lynch et al. (2017)	SCN1B	UBERON_0001016	""
decreased blood pressure	immune	activation_general	EFO_0005251	ENSG00000196639	23197038	Bowes et al. (2012)	HRH1	UBERON_0002405	""
sedation	immune	inhibition_general	EFO_0009868	ENSG00000196639	23197038	Bowes et al. (2012)	HRH1	UBERON_0002405	""
decreased allergic responses	immune	inhibition_general	""	ENSG00000196639	23197038	Bowes et al. (2012)	HRH1	UBERON_0002405	""
increased body weight	immune	inhibition_general	EFO_0004566	ENSG00000196639	23197038	Bowes et al. (2012)	HRH1	UBERON_0002405	""
allergic responses of flare, flush and wheal	immune	activation_general	EFO_1000669	ENSG00000196639	23197038	Bowes et al. (2012)	HRH1	UBERON_0002405	""
bronchoconstriction	immune	activation_general	EFO_0009836	ENSG00000196639	23197038	Bowes et al. (2012)	HRH1	UBERON_0002405	""
decreased blood pressure	cardiovascular system	activation_general	EFO_0005251	ENSG00000196639	23197038	Bowes et al. (2012)	HRH1	UBERON_0004535	""
sedation	cardiovascular system	inhibition_general	EFO_0009868	ENSG00000196639	23197038	Bowes et al. (2012)	HRH1	UBERON_0004535	""
decreased allergic responses	cardiovascular system	inhibition_general	""	ENSG00000196639	23197038	Bowes et al. (2012)	HRH1	UBERON_0004535	""
increased body weight	cardiovascular system	inhibition_general	EFO_0004566	ENSG00000196639	23197038	Bowes et al. (2012)	HRH1	UBERON_0004535	""
allergic responses of flare, flush and wheal	cardiovascular system	activation_general	EFO_1000669	ENSG00000196639	23197038	Bowes et al. (2012)	HRH1	UBERON_0004535	""
bronchoconstriction	cardiovascular system	activation_general	EFO_0009836	ENSG00000196639	23197038	Bowes et al. (2012)	HRH1	UBERON_0004535	""
increased blood pressure when combined with amines such as tyramine	cardiovascular system	inhibition_general	HP_0032263	ENSG00000189221	23197038	Bowes et al. (2012)	MAOA	UBERON_0004535	""
drug-drug interaction potential	cardiovascular system	inhibition_general	EFO_0009878	ENSG00000189221	23197038	Bowes et al. (2012)	MAOA	UBERON_0004535	""
dizziness	cardiovascular system	inhibition_general	EFO_0009847	ENSG00000189221	23197038	Bowes et al. (2012)	MAOA	UBERON_0004535	""
sleep disturbances	cardiovascular system	inhibition_general	EFO_0008568	ENSG00000189221	23197038	Bowes et al. (2012)	MAOA	UBERON_0004535	""
nausea	cardiovascular system	inhibition_general	HP_0002018	ENSG00000189221	23197038	Bowes et al. (2012)	MAOA	UBERON_0004535	""
increased blood pressure when combined with amines such as tyramine	central nervous system	inhibition_general	HP_0032263	ENSG00000189221	23197038	Bowes et al. (2012)	MAOA	UBERON_0001017	""
drug-drug interaction potential	central nervous system	inhibition_general	EFO_0009878	ENSG00000189221	23197038	Bowes et al. (2012)	MAOA	UBERON_0001017	""
dizziness	central nervous system	inhibition_general	EFO_0009847	ENSG00000189221	23197038	Bowes et al. (2012)	MAOA	UBERON_0001017	""
sleep disturbances	central nervous system	inhibition_general	EFO_0008568	ENSG00000189221	23197038	Bowes et al. (2012)	MAOA	UBERON_0001017	""
nausea	central nervous system	inhibition_general	HP_0002018	ENSG00000189221	23197038	Bowes et al. (2012)	MAOA	UBERON_0001017	""
ventricular fibrillation	cardiovascular	activation_acute	EFO_0004287	ENSG00000043591	28216264	Lynch et al. (2017)	ADRB1	UBERON_0004535	""
cardiac hypertrophy	cardiovascular	activation_chronic	EFO_0002503	ENSG00000043591	28216264	Lynch et al. (2017)	ADRB1	UBERON_0004535	""
decreased blood pressure	cardiovascular	inhibition_acute	EFO_0005251	ENSG00000043591	28216264	Lynch et al. (2017)	ADRB1	UBERON_0004535	""
decreased heart rate	cardiovascular	inhibition_acute	HP_0001662	ENSG00000043591	28216264	Lynch et al. (2017)	ADRB1	UBERON_0004535	""
myocardial fibrosis	cardiovascular	activation_chronic	HP_0001685	ENSG00000043591	28216264	Lynch et al. (2017)	ADRB1	UBERON_0004535	""
heart failure	cardiovascular	activation_chronic	EFO_0003144	ENSG00000043591	28216264	Lynch et al. (2017)	ADRB1	UBERON_0004535	""
bronchospasm	cardiovascular	activation_acute	HP_0025428	ENSG00000043591	28216264	Lynch et al. (2017)	ADRB1	UBERON_0004535	""
increased heart rate	cardiovascular	activation_acute	HP_0001649	ENSG00000043591	28216264	Lynch et al. (2017)	ADRB1	UBERON_0004535	""
increased cardiac contractility	cardiovascular	activation_acute	GO_0045823	ENSG00000043591	28216264	Lynch et al. (2017)	ADRB1	UBERON_0004535	""
glomerular and tubulointerstitial structural injury	renal	activation_acute	EFO_0009833	ENSG00000151617	28216264	Lynch et al. (2017)	EDNRA	UBERON_0001008	""
increased heart rate	renal	inhibition_acute	HP_0001649	ENSG00000151617	28216264	Lynch et al. (2017)	EDNRA	UBERON_0001008	""
cardiac anomaly	renal	inhibition_developmental toxicity	Orphanet_271853	ENSG00000151617	28216264	Lynch et al. (2017)	EDNRA	UBERON_0001008	""
abnormal face	renal	inhibition_developmental toxicity	HP_0000271	ENSG00000151617	28216264	Lynch et al. (2017)	EDNRA	UBERON_0001008	""
cleft palate	renal	inhibition_developmental toxicity	HP_0000175	ENSG00000151617	28216264	Lynch et al. (2017)	EDNRA	UBERON_0001008	""
thymic hypoplasia	renal	inhibition_developmental toxicity	HP_0010515	ENSG00000151617	28216264	Lynch et al. (2017)	EDNRA	UBERON_0001008	""
chromosome 22 deletions	renal	inhibition_developmental toxicity	Orphanet_68335	ENSG00000151617	28216264	Lynch et al. (2017)	EDNRA	UBERON_0001008	""
decreased blood pressure	renal	inhibition_acute	EFO_0005251	ENSG00000151617	28216264	Lynch et al. (2017)	EDNRA	UBERON_0001008	""
decreased urine excretion	renal	inhibition_acute	HP_0011037	ENSG00000151617	28216264	Lynch et al. (2017)	EDNRA	UBERON_0001008	""
decreased pain	renal	inhibition_acute	GO_1904057	ENSG00000151617	28216264	Lynch et al. (2017)	EDNRA	UBERON_0001008	""
decreased gastric emptying	renal	inhibition_acute	GO_0120061	ENSG00000151617	28216264	Lynch et al. (2017)	EDNRA	UBERON_0001008	""
decreased intestinal transit	renal	inhibition_acute	HP_0030897	ENSG00000151617	28216264	Lynch et al. (2017)	EDNRA	UBERON_0001008	""
increased blood pressure	gastrointestinal	activation_acute	HP_0032263	ENSG00000151617	28216264	Lynch et al. (2017)	EDNRA	UBERON_0005409	""
increased heart rate	gastrointestinal	inhibition_acute	HP_0001649	ENSG00000151617	28216264	Lynch et al. (2017)	EDNRA	UBERON_0005409	""
cardiac anomaly	gastrointestinal	inhibition_developmental toxicity	Orphanet_271853	ENSG00000151617	28216264	Lynch et al. (2017)	EDNRA	UBERON_0005409	""
abnormal face	gastrointestinal	inhibition_developmental toxicity	HP_0000271	ENSG00000151617	28216264	Lynch et al. (2017)	EDNRA	UBERON_0005409	""
cleft palate	gastrointestinal	inhibition_developmental toxicity	HP_0000175	ENSG00000151617	28216264	Lynch et al. (2017)	EDNRA	UBERON_0005409	""
thymic hypoplasia	gastrointestinal	inhibition_developmental toxicity	HP_0010515	ENSG00000151617	28216264	Lynch et al. (2017)	EDNRA	UBERON_0005409	""
chromosome 22 deletions	gastrointestinal	inhibition_developmental toxicity	Orphanet_68335	ENSG00000151617	28216264	Lynch et al. (2017)	EDNRA	UBERON_0005409	""
decreased blood pressure	gastrointestinal	inhibition_acute	EFO_0005251	ENSG00000151617	28216264	Lynch et al. (2017)	EDNRA	UBERON_0005409	""
decreased urine excretion	gastrointestinal	inhibition_acute	HP_0011037	ENSG00000151617	28216264	Lynch et al. (2017)	EDNRA	UBERON_0005409	""
decreased pain	gastrointestinal	inhibition_acute	GO_1904057	ENSG00000151617	28216264	Lynch et al. (2017)	EDNRA	UBERON_0005409	""
decreased gastric emptying	gastrointestinal	inhibition_acute	GO_0120061	ENSG00000151617	28216264	Lynch et al. (2017)	EDNRA	UBERON_0005409	""
decreased intestinal transit	gastrointestinal	inhibition_acute	HP_0030897	ENSG00000151617	28216264	Lynch et al. (2017)	EDNRA	UBERON_0005409	""
increased cell proliferation	renal	activation_acute	GO_0008283	ENSG00000151617	28216264	Lynch et al. (2017)	EDNRA	UBERON_0001008	""
increased cell proliferation	cardiovascular	activation_acute	GO_0008283	ENSG00000151617	28216264	Lynch et al. (2017)	EDNRA	UBERON_0004535	""
increased heart rate	cardiovascular	inhibition_acute	HP_0001649	ENSG00000151617	28216264	Lynch et al. (2017)	EDNRA	UBERON_0004535	""
cardiac anomaly	cardiovascular	inhibition_developmental toxicity	Orphanet_271853	ENSG00000151617	28216264	Lynch et al. (2017)	EDNRA	UBERON_0004535	""
abnormal face	cardiovascular	inhibition_developmental toxicity	HP_0000271	ENSG00000151617	28216264	Lynch et al. (2017)	EDNRA	UBERON_0004535	""
cleft palate	cardiovascular	inhibition_developmental toxicity	HP_0000175	ENSG00000151617	28216264	Lynch et al. (2017)	EDNRA	UBERON_0004535	""
thymic hypoplasia	cardiovascular	inhibition_developmental toxicity	HP_0010515	ENSG00000151617	28216264	Lynch et al. (2017)	EDNRA	UBERON_0004535	""
chromosome 22 deletions	cardiovascular	inhibition_developmental toxicity	Orphanet_68335	ENSG00000151617	28216264	Lynch et al. (2017)	EDNRA	UBERON_0004535	""
decreased blood pressure	cardiovascular	inhibition_acute	EFO_0005251	ENSG00000151617	28216264	Lynch et al. (2017)	EDNRA	UBERON_0004535	""
decreased urine excretion	cardiovascular	inhibition_acute	HP_0011037	ENSG00000151617	28216264	Lynch et al. (2017)	EDNRA	UBERON_0004535	""
decreased pain	cardiovascular	inhibition_acute	GO_1904057	ENSG00000151617	28216264	Lynch et al. (2017)	EDNRA	UBERON_0004535	""
decreased gastric emptying	cardiovascular	inhibition_acute	GO_0120061	ENSG00000151617	28216264	Lynch et al. (2017)	EDNRA	UBERON_0004535	""
decreased intestinal transit	cardiovascular	inhibition_acute	HP_0030897	ENSG00000151617	28216264	Lynch et al. (2017)	EDNRA	UBERON_0004535	""
glomerular and tubulointerstitial structural injury	nervous system	activation_acute	EFO_0009833	ENSG00000151617	28216264	Lynch et al. (2017)	EDNRA	UBERON_0001016	""
increased heart rate	nervous system	inhibition_acute	HP_0001649	ENSG00000151617	28216264	Lynch et al. (2017)	EDNRA	UBERON_0001016	""
cardiac anomaly	nervous system	inhibition_developmental toxicity	Orphanet_271853	ENSG00000151617	28216264	Lynch et al. (2017)	EDNRA	UBERON_0001016	""
abnormal face	nervous system	inhibition_developmental toxicity	HP_0000271	ENSG00000151617	28216264	Lynch et al. (2017)	EDNRA	UBERON_0001016	""
cleft palate	nervous system	inhibition_developmental toxicity	HP_0000175	ENSG00000151617	28216264	Lynch et al. (2017)	EDNRA	UBERON_0001016	""
thymic hypoplasia	nervous system	inhibition_developmental toxicity	HP_0010515	ENSG00000151617	28216264	Lynch et al. (2017)	EDNRA	UBERON_0001016	""
chromosome 22 deletions	nervous system	inhibition_developmental toxicity	Orphanet_68335	ENSG00000151617	28216264	Lynch et al. (2017)	EDNRA	UBERON_0001016	""
decreased blood pressure	nervous system	inhibition_acute	EFO_0005251	ENSG00000151617	28216264	Lynch et al. (2017)	EDNRA	UBERON_0001016	""
decreased urine excretion	nervous system	inhibition_acute	HP_0011037	ENSG00000151617	28216264	Lynch et al. (2017)	EDNRA	UBERON_0001016	""
decreased pain	nervous system	inhibition_acute	GO_1904057	ENSG00000151617	28216264	Lynch et al. (2017)	EDNRA	UBERON_0001016	""
decreased gastric emptying	nervous system	inhibition_acute	GO_0120061	ENSG00000151617	28216264	Lynch et al. (2017)	EDNRA	UBERON_0001016	""
decreased intestinal transit	nervous system	inhibition_acute	HP_0030897	ENSG00000151617	28216264	Lynch et al. (2017)	EDNRA	UBERON_0001016	""
pulmonary left ventricular hypertrophy	cardiovascular	activation_acute	EFO_0003896	ENSG00000151617	28216264	Lynch et al. (2017)	EDNRA	UBERON_0004535	""
bronchoconstriction	nervous system	activation_acute	EFO_0009836	ENSG00000151617	28216264	Lynch et al. (2017)	EDNRA	UBERON_0001016	""
pulmonary left ventricular hypertrophy	renal	activation_acute	EFO_0003896	ENSG00000151617	28216264	Lynch et al. (2017)	EDNRA	UBERON_0001008	""
decreased heart rate	nervous system	activation_acute	HP_0001662	ENSG00000151617	28216264	Lynch et al. (2017)	EDNRA	UBERON_0001016	""
increased cardiac contractility	gastrointestinal	activation_acute	GO_0045823	ENSG00000151617	28216264	Lynch et al. (2017)	EDNRA	UBERON_0005409	""
pulmonary left ventricular hypertrophy	nervous system	activation_acute	EFO_0003896	ENSG00000151617	28216264	Lynch et al. (2017)	EDNRA	UBERON_0001016	""
increased cell proliferation	gastrointestinal	activation_acute	GO_0008283	ENSG00000151617	28216264	Lynch et al. (2017)	EDNRA	UBERON_0005409	""
glomerular and tubulointerstitial structural injury	cardiovascular	activation_acute	EFO_0009833	ENSG00000151617	28216264	Lynch et al. (2017)	EDNRA	UBERON_0004535	""
increased cardiac contractility	renal	activation_acute	GO_0045823	ENSG00000151617	28216264	Lynch et al. (2017)	EDNRA	UBERON_0001008	""
increased pain	nervous system	activation_acute	GO_1904058	ENSG00000151617	28216264	Lynch et al. (2017)	EDNRA	UBERON_0001016	""
increased pain	gastrointestinal	activation_acute	GO_1904058	ENSG00000151617	28216264	Lynch et al. (2017)	EDNRA	UBERON_0005409	""
bronchoconstriction	cardiovascular	activation_acute	EFO_0009836	ENSG00000151617	28216264	Lynch et al. (2017)	EDNRA	UBERON_0004535	""
increased pain	cardiovascular	activation_acute	GO_1904058	ENSG00000151617	28216264	Lynch et al. (2017)	EDNRA	UBERON_0004535	""
increased aldosterone secretion	renal	activation_acute	EFO_0009452	ENSG00000151617	28216264	Lynch et al. (2017)	EDNRA	UBERON_0001008	""
decreased heart rate	renal	activation_acute	HP_0001662	ENSG00000151617	28216264	Lynch et al. (2017)	EDNRA	UBERON_0001008	""
increased blood pressure	renal	activation_acute	HP_0032263	ENSG00000151617	28216264	Lynch et al. (2017)	EDNRA	UBERON_0001008	""
increased blood pressure	cardiovascular	activation_acute	HP_0032263	ENSG00000151617	28216264	Lynch et al. (2017)	EDNRA	UBERON_0004535	""
increased cardiac contractility	nervous system	activation_acute	GO_0045823	ENSG00000151617	28216264	Lynch et al. (2017)	EDNRA	UBERON_0001016	""
glomerular and tubulointerstitial structural injury	gastrointestinal	activation_acute	EFO_0009833	ENSG00000151617	28216264	Lynch et al. (2017)	EDNRA	UBERON_0005409	""
increased blood pressure	nervous system	activation_acute	HP_0032263	ENSG00000151617	28216264	Lynch et al. (2017)	EDNRA	UBERON_0001016	""
increased cell proliferation	nervous system	activation_acute	GO_0008283	ENSG00000151617	28216264	Lynch et al. (2017)	EDNRA	UBERON_0001016	""
increased aldosterone secretion	nervous system	activation_acute	EFO_0009452	ENSG00000151617	28216264	Lynch et al. (2017)	EDNRA	UBERON_0001016	""
pulmonary left ventricular hypertrophy	gastrointestinal	activation_acute	EFO_0003896	ENSG00000151617	28216264	Lynch et al. (2017)	EDNRA	UBERON_0005409	""
increased aldosterone secretion	gastrointestinal	activation_acute	EFO_0009452	ENSG00000151617	28216264	Lynch et al. (2017)	EDNRA	UBERON_0005409	""
decreased heart rate	cardiovascular	activation_acute	HP_0001662	ENSG00000151617	28216264	Lynch et al. (2017)	EDNRA	UBERON_0004535	""
increased aldosterone secretion	cardiovascular	activation_acute	EFO_0009452	ENSG00000151617	28216264	Lynch et al. (2017)	EDNRA	UBERON_0004535	""
bronchoconstriction	renal	activation_acute	EFO_0009836	ENSG00000151617	28216264	Lynch et al. (2017)	EDNRA	UBERON_0001008	""
increased cardiac contractility	cardiovascular	activation_acute	GO_0045823	ENSG00000151617	28216264	Lynch et al. (2017)	EDNRA	UBERON_0004535	""
decreased heart rate	gastrointestinal	activation_acute	HP_0001662	ENSG00000151617	28216264	Lynch et al. (2017)	EDNRA	UBERON_0005409	""
bronchoconstriction	gastrointestinal	activation_acute	EFO_0009836	ENSG00000151617	28216264	Lynch et al. (2017)	EDNRA	UBERON_0005409	""
increased pain	renal	activation_acute	GO_1904058	ENSG00000151617	28216264	Lynch et al. (2017)	EDNRA	UBERON_0001008	""
decreased locomotor activity	nervous system	activation_acute	GO_0040013	ENSG00000282608	28216264	Lynch et al. (2017)	ADORA3	UBERON_0001016	""
increased convulsions	nervous system	inhibition_acute	EFO_0009853	ENSG00000282608	28216264	Lynch et al. (2017)	ADORA3	UBERON_0001016	""
decreased pain	respiratory	activation_acute	GO_1904057	ENSG00000282608	28216264	Lynch et al. (2017)	ADORA3	UBERON_0001004	""
increased convulsions	respiratory	inhibition_acute	EFO_0009853	ENSG00000282608	28216264	Lynch et al. (2017)	ADORA3	UBERON_0001004	""
decreased pain	nervous system	activation_acute	GO_1904057	ENSG00000282608	28216264	Lynch et al. (2017)	ADORA3	UBERON_0001016	""
increased bronchoconstriction	respiratory	activation_acute	EFO_0009836	ENSG00000282608	28216264	Lynch et al. (2017)	ADORA3	UBERON_0001004	""
decreased convulsions	nervous system	activation_acute	EFO_0009853	ENSG00000282608	28216264	Lynch et al. (2017)	ADORA3	UBERON_0001016	""
increased bronchoconstriction	nervous system	activation_acute	EFO_0009836	ENSG00000282608	28216264	Lynch et al. (2017)	ADORA3	UBERON_0001016	""
decreased convulsions	respiratory	activation_acute	EFO_0009853	ENSG00000282608	28216264	Lynch et al. (2017)	ADORA3	UBERON_0001004	""
decreased locomotor activity	respiratory	activation_acute	GO_0040013	ENSG00000282608	28216264	Lynch et al. (2017)	ADORA3	UBERON_0001004	""
scratching	gastrointestinal	activation_acute	""	ENSG00000196639	28216264	Lynch et al. (2017)	HRH1	UBERON_0005409	""
decreased inflammation	gastrointestinal	inhibition_acute	GO_0050728	ENSG00000196639	28216264	Lynch et al. (2017)	HRH1	UBERON_0005409	""
decreased pain	gastrointestinal	inhibition_acute	GO_1904057	ENSG00000196639	28216264	Lynch et al. (2017)	HRH1	UBERON_0005409	""
increased sleep	gastrointestinal	inhibition_acute	EFO_0008568	ENSG00000196639	28216264	Lynch et al. (2017)	HRH1	UBERON_0005409	""
sedation	gastrointestinal	inhibition_acute	EFO_0009868	ENSG00000196639	28216264	Lynch et al. (2017)	HRH1	UBERON_0005409	""
increased locomotor activity	gastrointestinal	inhibition_acute	GO_0040017	ENSG00000196639	28216264	Lynch et al. (2017)	HRH1	UBERON_0005409	""
increased convulsions	gastrointestinal	inhibition_acute	EFO_0009853	ENSG00000196639	28216264	Lynch et al. (2017)	HRH1	UBERON_0005409	""
decreased/increased blood pressure	gastrointestinal	inhibition_acute	HP_0030972	ENSG00000196639	28216264	Lynch et al. (2017)	HRH1	UBERON_0005409	""
increased heart rate	gastrointestinal	inhibition_acute	HP_0001649	ENSG00000196639	28216264	Lynch et al. (2017)	HRH1	UBERON_0005409	""
increased QTc interval	gastrointestinal	inhibition_acute	HP_0005184	ENSG00000196639	28216264	Lynch et al. (2017)	HRH1	UBERON_0005409	""
cardiac arrhythmia	gastrointestinal	inhibition_acute	EFO_0004269	ENSG00000196639	28216264	Lynch et al. (2017)	HRH1	UBERON_0005409	""
decreased gastrointestinal transit	gastrointestinal	inhibition_acute	HP_0030897	ENSG00000196639	28216264	Lynch et al. (2017)	HRH1	UBERON_0005409	""
increased body weight	gastrointestinal	inhibition_acute	EFO_0004566	ENSG00000196639	28216264	Lynch et al. (2017)	HRH1	UBERON_0005409	""
scratching	immune	activation_acute	""	ENSG00000196639	28216264	Lynch et al. (2017)	HRH1	UBERON_0002405	""
decreased inflammation	immune	inhibition_acute	GO_0050728	ENSG00000196639	28216264	Lynch et al. (2017)	HRH1	UBERON_0002405	""
decreased pain	immune	inhibition_acute	GO_1904057	ENSG00000196639	28216264	Lynch et al. (2017)	HRH1	UBERON_0002405	""
increased sleep	immune	inhibition_acute	EFO_0008568	ENSG00000196639	28216264	Lynch et al. (2017)	HRH1	UBERON_0002405	""
sedation	immune	inhibition_acute	EFO_0009868	ENSG00000196639	28216264	Lynch et al. (2017)	HRH1	UBERON_0002405	""
increased locomotor activity	immune	inhibition_acute	GO_0040017	ENSG00000196639	28216264	Lynch et al. (2017)	HRH1	UBERON_0002405	""
increased convulsions	immune	inhibition_acute	EFO_0009853	ENSG00000196639	28216264	Lynch et al. (2017)	HRH1	UBERON_0002405	""
decreased/increased blood pressure	immune	inhibition_acute	HP_0030972	ENSG00000196639	28216264	Lynch et al. (2017)	HRH1	UBERON_0002405	""
increased heart rate	immune	inhibition_acute	HP_0001649	ENSG00000196639	28216264	Lynch et al. (2017)	HRH1	UBERON_0002405	""
increased QTc interval	immune	inhibition_acute	HP_0005184	ENSG00000196639	28216264	Lynch et al. (2017)	HRH1	UBERON_0002405	""
cardiac arrhythmia	immune	inhibition_acute	EFO_0004269	ENSG00000196639	28216264	Lynch et al. (2017)	HRH1	UBERON_0002405	""
decreased gastrointestinal transit	immune	inhibition_acute	HP_0030897	ENSG00000196639	28216264	Lynch et al. (2017)	HRH1	UBERON_0002405	""
increased body weight	immune	inhibition_acute	EFO_0004566	ENSG00000196639	28216264	Lynch et al. (2017)	HRH1	UBERON_0002405	""
increased pain	nervous system	activation_acute	GO_1904058	ENSG00000196639	28216264	Lynch et al. (2017)	HRH1	UBERON_0001016	""
decreased inflammation	nervous system	inhibition_acute	GO_0050728	ENSG00000196639	28216264	Lynch et al. (2017)	HRH1	UBERON_0001016	""
decreased pain	nervous system	inhibition_acute	GO_1904057	ENSG00000196639	28216264	Lynch et al. (2017)	HRH1	UBERON_0001016	""
increased sleep	nervous system	inhibition_acute	EFO_0008568	ENSG00000196639	28216264	Lynch et al. (2017)	HRH1	UBERON_0001016	""
sedation	nervous system	inhibition_acute	EFO_0009868	ENSG00000196639	28216264	Lynch et al. (2017)	HRH1	UBERON_0001016	""
increased locomotor activity	nervous system	inhibition_acute	GO_0040017	ENSG00000196639	28216264	Lynch et al. (2017)	HRH1	UBERON_0001016	""
increased convulsions	nervous system	inhibition_acute	EFO_0009853	ENSG00000196639	28216264	Lynch et al. (2017)	HRH1	UBERON_0001016	""
decreased/increased blood pressure	nervous system	inhibition_acute	HP_0030972	ENSG00000196639	28216264	Lynch et al. (2017)	HRH1	UBERON_0001016	""
increased heart rate	nervous system	inhibition_acute	HP_0001649	ENSG00000196639	28216264	Lynch et al. (2017)	HRH1	UBERON_0001016	""
increased QTc interval	nervous system	inhibition_acute	HP_0005184	ENSG00000196639	28216264	Lynch et al. (2017)	HRH1	UBERON_0001016	""
cardiac arrhythmia	nervous system	inhibition_acute	EFO_0004269	ENSG00000196639	28216264	Lynch et al. (2017)	HRH1	UBERON_0001016	""
decreased gastrointestinal transit	nervous system	inhibition_acute	HP_0030897	ENSG00000196639	28216264	Lynch et al. (2017)	HRH1	UBERON_0001016	""
increased body weight	nervous system	inhibition_acute	EFO_0004566	ENSG00000196639	28216264	Lynch et al. (2017)	HRH1	UBERON_0001016	""
tongue swelling	cardiovascular	activation_acute	EFO_1000951	ENSG00000196639	28216264	Lynch et al. (2017)	HRH1	UBERON_0004535	""
decreased inflammation	cardiovascular	inhibition_acute	GO_0050728	ENSG00000196639	28216264	Lynch et al. (2017)	HRH1	UBERON_0004535	""
decreased pain	cardiovascular	inhibition_acute	GO_1904057	ENSG00000196639	28216264	Lynch et al. (2017)	HRH1	UBERON_0004535	""
increased sleep	cardiovascular	inhibition_acute	EFO_0008568	ENSG00000196639	28216264	Lynch et al. (2017)	HRH1	UBERON_0004535	""
sedation	cardiovascular	inhibition_acute	EFO_0009868	ENSG00000196639	28216264	Lynch et al. (2017)	HRH1	UBERON_0004535	""
increased locomotor activity	cardiovascular	inhibition_acute	GO_0040017	ENSG00000196639	28216264	Lynch et al. (2017)	HRH1	UBERON_0004535	""
increased convulsions	cardiovascular	inhibition_acute	EFO_0009853	ENSG00000196639	28216264	Lynch et al. (2017)	HRH1	UBERON_0004535	""
decreased/increased blood pressure	cardiovascular	inhibition_acute	HP_0030972	ENSG00000196639	28216264	Lynch et al. (2017)	HRH1	UBERON_0004535	""
increased heart rate	cardiovascular	inhibition_acute	HP_0001649	ENSG00000196639	28216264	Lynch et al. (2017)	HRH1	UBERON_0004535	""
increased QTc interval	cardiovascular	inhibition_acute	HP_0005184	ENSG00000196639	28216264	Lynch et al. (2017)	HRH1	UBERON_0004535	""
cardiac arrhythmia	cardiovascular	inhibition_acute	EFO_0004269	ENSG00000196639	28216264	Lynch et al. (2017)	HRH1	UBERON_0004535	""
decreased gastrointestinal transit	cardiovascular	inhibition_acute	HP_0030897	ENSG00000196639	28216264	Lynch et al. (2017)	HRH1	UBERON_0004535	""
increased body weight	cardiovascular	inhibition_acute	EFO_0004566	ENSG00000196639	28216264	Lynch et al. (2017)	HRH1	UBERON_0004535	""
sweating	immune	activation_acute	HP_0000975	ENSG00000196639	28216264	Lynch et al. (2017)	HRH1	UBERON_0002405	""
bronchoconstriction	gastrointestinal	activation_acute	EFO_0009836	ENSG00000196639	28216264	Lynch et al. (2017)	HRH1	UBERON_0005409	""
facial swelling	immune	activation_acute	HP_0000282	ENSG00000196639	28216264	Lynch et al. (2017)	HRH1	UBERON_0002405	""
increased pain	immune	activation_acute	GO_1904058	ENSG00000196639	28216264	Lynch et al. (2017)	HRH1	UBERON_0002405	""
decreased blood pressure	immune	activation_acute	EFO_0005251	ENSG00000196639	28216264	Lynch et al. (2017)	HRH1	UBERON_0002405	""
abdominal cramps	nervous system	activation_acute	HP_0032155	ENSG00000196639	28216264	Lynch et al. (2017)	HRH1	UBERON_0001016	""
increased drinking	cardiovascular	activation_acute	HP_0001959	ENSG00000196639	28216264	Lynch et al. (2017)	HRH1	UBERON_0004535	""
inflammation	immune	activation_acute	GO_0006954	ENSG00000196639	28216264	Lynch et al. (2017)	HRH1	UBERON_0002405	""
abdominal cramps	gastrointestinal	activation_acute	HP_0032155	ENSG00000196639	28216264	Lynch et al. (2017)	HRH1	UBERON_0005409	""
decreased blood pressure	nervous system	activation_acute	EFO_0005251	ENSG00000196639	28216264	Lynch et al. (2017)	HRH1	UBERON_0001016	""
facial swelling	cardiovascular	activation_acute	HP_0000282	ENSG00000196639	28216264	Lynch et al. (2017)	HRH1	UBERON_0004535	""
tongue swelling	immune	activation_acute	EFO_1000951	ENSG00000196639	28216264	Lynch et al. (2017)	HRH1	UBERON_0002405	""
diarrhea	immune	activation_acute	HP_0002014	ENSG00000196639	28216264	Lynch et al. (2017)	HRH1	UBERON_0002405	""
flushing	cardiovascular	activation_acute	HP_0031284	ENSG00000196639	28216264	Lynch et al. (2017)	HRH1	UBERON_0004535	""
inflammation	cardiovascular	activation_acute	GO_0006954	ENSG00000196639	28216264	Lynch et al. (2017)	HRH1	UBERON_0004535	""
flushing	gastrointestinal	activation_acute	HP_0031284	ENSG00000196639	28216264	Lynch et al. (2017)	HRH1	UBERON_0005409	""
skin rash	cardiovascular	activation_acute	EFO_1000697	ENSG00000196639	28216264	Lynch et al. (2017)	HRH1	UBERON_0004535	""
facial swelling	nervous system	activation_acute	HP_0000282	ENSG00000196639	28216264	Lynch et al. (2017)	HRH1	UBERON_0001016	""
sweating	cardiovascular	activation_acute	HP_0000975	ENSG00000196639	28216264	Lynch et al. (2017)	HRH1	UBERON_0004535	""
increased drinking	gastrointestinal	activation_acute	HP_0001959	ENSG00000196639	28216264	Lynch et al. (2017)	HRH1	UBERON_0005409	""
decreased blood pressure	cardiovascular	activation_acute	EFO_0005251	ENSG00000196639	28216264	Lynch et al. (2017)	HRH1	UBERON_0004535	""
increased pain	gastrointestinal	activation_acute	GO_1904058	ENSG00000196639	28216264	Lynch et al. (2017)	HRH1	UBERON_0005409	""
diarrhea	nervous system	activation_acute	HP_0002014	ENSG00000196639	28216264	Lynch et al. (2017)	HRH1	UBERON_0001016	""
increased drinking	nervous system	activation_acute	HP_0001959	ENSG00000196639	28216264	Lynch et al. (2017)	HRH1	UBERON_0001016	""
sweating	gastrointestinal	activation_acute	HP_0000975	ENSG00000196639	28216264	Lynch et al. (2017)	HRH1	UBERON_0005409	""
diarrhea	gastrointestinal	activation_acute	HP_0002014	ENSG00000196639	28216264	Lynch et al. (2017)	HRH1	UBERON_0005409	""
flushing	immune	activation_acute	HP_0031284	ENSG00000196639	28216264	Lynch et al. (2017)	HRH1	UBERON_0002405	""
skin rash	immune	activation_acute	EFO_1000697	ENSG00000196639	28216264	Lynch et al. (2017)	HRH1	UBERON_0002405	""
abdominal cramps	cardiovascular	activation_acute	HP_0032155	ENSG00000196639	28216264	Lynch et al. (2017)	HRH1	UBERON_0004535	""
increased drinking	immune	activation_acute	HP_0001959	ENSG00000196639	28216264	Lynch et al. (2017)	HRH1	UBERON_0002405	""
inflammation	gastrointestinal	activation_acute	GO_0006954	ENSG00000196639	28216264	Lynch et al. (2017)	HRH1	UBERON_0005409	""
skin rash	gastrointestinal	activation_acute	EFO_1000697	ENSG00000196639	28216264	Lynch et al. (2017)	HRH1	UBERON_0005409	""
diarrhea	cardiovascular	activation_acute	HP_0002014	ENSG00000196639	28216264	Lynch et al. (2017)	HRH1	UBERON_0004535	""
tongue swelling	gastrointestinal	activation_acute	EFO_1000951	ENSG00000196639	28216264	Lynch et al. (2017)	HRH1	UBERON_0005409	""
increased pain	cardiovascular	activation_acute	GO_1904058	ENSG00000196639	28216264	Lynch et al. (2017)	HRH1	UBERON_0004535	""
inflammation	nervous system	activation_acute	GO_0006954	ENSG00000196639	28216264	Lynch et al. (2017)	HRH1	UBERON_0001016	""
scratching	nervous system	activation_acute	""	ENSG00000196639	28216264	Lynch et al. (2017)	HRH1	UBERON_0001016	""
flushing	nervous system	activation_acute	HP_0031284	ENSG00000196639	28216264	Lynch et al. (2017)	HRH1	UBERON_0001016	""
abdominal cramps	immune	activation_acute	HP_0032155	ENSG00000196639	28216264	Lynch et al. (2017)	HRH1	UBERON_0002405	""
bronchoconstriction	cardiovascular	activation_acute	EFO_0009836	ENSG00000196639	28216264	Lynch et al. (2017)	HRH1	UBERON_0004535	""
tongue swelling	nervous system	activation_acute	EFO_1000951	ENSG00000196639	28216264	Lynch et al. (2017)	HRH1	UBERON_0001016	""
bronchoconstriction	nervous system	activation_acute	EFO_0009836	ENSG00000196639	28216264	Lynch et al. (2017)	HRH1	UBERON_0001016	""
decreased convulsions	nervous system	activation_acute	EFO_0009853	ENSG00000196639	28216264	Lynch et al. (2017)	HRH1	UBERON_0001016	""
scratching	cardiovascular	activation_acute	""	ENSG00000196639	28216264	Lynch et al. (2017)	HRH1	UBERON_0004535	""
facial swelling	gastrointestinal	activation_acute	HP_0000282	ENSG00000196639	28216264	Lynch et al. (2017)	HRH1	UBERON_0005409	""
skin rash	nervous system	activation_acute	EFO_1000697	ENSG00000196639	28216264	Lynch et al. (2017)	HRH1	UBERON_0001016	""
decreased convulsions	cardiovascular	activation_acute	EFO_0009853	ENSG00000196639	28216264	Lynch et al. (2017)	HRH1	UBERON_0004535	""
sweating	nervous system	activation_acute	HP_0000975	ENSG00000196639	28216264	Lynch et al. (2017)	HRH1	UBERON_0001016	""
bronchoconstriction	immune	activation_acute	EFO_0009836	ENSG00000196639	28216264	Lynch et al. (2017)	HRH1	UBERON_0002405	""
decreased blood pressure	gastrointestinal	activation_acute	EFO_0005251	ENSG00000196639	28216264	Lynch et al. (2017)	HRH1	UBERON_0005409	""
decreased convulsions	gastrointestinal	activation_acute	EFO_0009853	ENSG00000196639	28216264	Lynch et al. (2017)	HRH1	UBERON_0005409	""
decreased convulsions	immune	activation_acute	EFO_0009853	ENSG00000196639	28216264	Lynch et al. (2017)	HRH1	UBERON_0002405	""
decreased body temperature	renal	activation_acute	HP_0002045	ENSG00000149295	28216264	Lynch et al. (2017)	DRD2	UBERON_0001008	""
fibrotic valvular heart disease	renal	activation_chronic	EFO_0009551	ENSG00000149295	28216264	Lynch et al. (2017)	DRD2	UBERON_0001008	""
decreased locomotor activity	renal	inhibition_acute	GO_0040013	ENSG00000149295	28216264	Lynch et al. (2017)	DRD2	UBERON_0001008	""
catalepsy	renal	inhibition_acute	EFO_0009845	ENSG00000149295	28216264	Lynch et al. (2017)	DRD2	UBERON_0001008	""
increased convulsions	renal	inhibition_acute	EFO_0009853	ENSG00000149295	28216264	Lynch et al. (2017)	DRD2	UBERON_0001008	""
increased gastrointestinal transit	renal	inhibition_acute	HP_0410204	ENSG00000149295	28216264	Lynch et al. (2017)	DRD2	UBERON_0001008	""
increased blood pressure	renal	inhibition_acute	HP_0032263	ENSG00000149295	28216264	Lynch et al. (2017)	DRD2	UBERON_0001008	""
orthostatic hypotension	renal	inhibition_acute	EFO_0005252	ENSG00000149295	28216264	Lynch et al. (2017)	DRD2	UBERON_0001008	""
drowsiness	renal	inhibition_acute	NCIT_C95746	ENSG00000149295	28216264	Lynch et al. (2017)	DRD2	UBERON_0001008	""
increased urine excretion	renal	inhibition_acute	HP_0000103	ENSG00000149295	28216264	Lynch et al. (2017)	DRD2	UBERON_0001008	""
increased urinary sodium excretion	renal	inhibition_acute	GO_0035815	ENSG00000149295	28216264	Lynch et al. (2017)	DRD2	UBERON_0001008	""
heart failure	renal	activation_chronic	EFO_0003144	ENSG00000149295	28216264	Lynch et al. (2017)	DRD2	UBERON_0001008	""
stereotypy	gastrointestinal	activation_acute	HP_0000733	ENSG00000149295	28216264	Lynch et al. (2017)	DRD2	UBERON_0005409	""
fibrotic valvular heart disease	gastrointestinal	activation_chronic	EFO_0009551	ENSG00000149295	28216264	Lynch et al. (2017)	DRD2	UBERON_0005409	""
decreased locomotor activity	gastrointestinal	inhibition_acute	GO_0040013	ENSG00000149295	28216264	Lynch et al. (2017)	DRD2	UBERON_0005409	""
catalepsy	gastrointestinal	inhibition_acute	EFO_0009845	ENSG00000149295	28216264	Lynch et al. (2017)	DRD2	UBERON_0005409	""
increased convulsions	gastrointestinal	inhibition_acute	EFO_0009853	ENSG00000149295	28216264	Lynch et al. (2017)	DRD2	UBERON_0005409	""
increased gastrointestinal transit	gastrointestinal	inhibition_acute	HP_0410204	ENSG00000149295	28216264	Lynch et al. (2017)	DRD2	UBERON_0005409	""
increased blood pressure	gastrointestinal	inhibition_acute	HP_0032263	ENSG00000149295	28216264	Lynch et al. (2017)	DRD2	UBERON_0005409	""
orthostatic hypotension	gastrointestinal	inhibition_acute	EFO_0005252	ENSG00000149295	28216264	Lynch et al. (2017)	DRD2	UBERON_0005409	""
drowsiness	gastrointestinal	inhibition_acute	NCIT_C95746	ENSG00000149295	28216264	Lynch et al. (2017)	DRD2	UBERON_0005409	""
increased urine excretion	gastrointestinal	inhibition_acute	HP_0000103	ENSG00000149295	28216264	Lynch et al. (2017)	DRD2	UBERON_0005409	""
increased urinary sodium excretion	gastrointestinal	inhibition_acute	GO_0035815	ENSG00000149295	28216264	Lynch et al. (2017)	DRD2	UBERON_0005409	""
heart failure	gastrointestinal	activation_chronic	EFO_0003144	ENSG00000149295	28216264	Lynch et al. (2017)	DRD2	UBERON_0005409	""
decreased blood pressure	central nervous system	activation_acute	EFO_0005251	ENSG00000149295	28216264	Lynch et al. (2017)	DRD2	UBERON_0001017	""
fibrotic valvular heart disease	central nervous system	activation_chronic	EFO_0009551	ENSG00000149295	28216264	Lynch et al. (2017)	DRD2	UBERON_0001017	""
decreased locomotor activity	central nervous system	inhibition_acute	GO_0040013	ENSG00000149295	28216264	Lynch et al. (2017)	DRD2	UBERON_0001017	""
catalepsy	central nervous system	inhibition_acute	EFO_0009845	ENSG00000149295	28216264	Lynch et al. (2017)	DRD2	UBERON_0001017	""
increased convulsions	central nervous system	inhibition_acute	EFO_0009853	ENSG00000149295	28216264	Lynch et al. (2017)	DRD2	UBERON_0001017	""
increased gastrointestinal transit	central nervous system	inhibition_acute	HP_0410204	ENSG00000149295	28216264	Lynch et al. (2017)	DRD2	UBERON_0001017	""
increased blood pressure	central nervous system	inhibition_acute	HP_0032263	ENSG00000149295	28216264	Lynch et al. (2017)	DRD2	UBERON_0001017	""
orthostatic hypotension	central nervous system	inhibition_acute	EFO_0005252	ENSG00000149295	28216264	Lynch et al. (2017)	DRD2	UBERON_0001017	""
drowsiness	central nervous system	inhibition_acute	NCIT_C95746	ENSG00000149295	28216264	Lynch et al. (2017)	DRD2	UBERON_0001017	""
increased urine excretion	central nervous system	inhibition_acute	HP_0000103	ENSG00000149295	28216264	Lynch et al. (2017)	DRD2	UBERON_0001017	""
increased urinary sodium excretion	central nervous system	inhibition_acute	GO_0035815	ENSG00000149295	28216264	Lynch et al. (2017)	DRD2	UBERON_0001017	""
heart failure	central nervous system	activation_chronic	EFO_0003144	ENSG00000149295	28216264	Lynch et al. (2017)	DRD2	UBERON_0001017	""
stereotypy	cardiovascular	activation_acute	HP_0000733	ENSG00000149295	28216264	Lynch et al. (2017)	DRD2	UBERON_0004535	""
fibrotic valvular heart disease	cardiovascular	activation_chronic	EFO_0009551	ENSG00000149295	28216264	Lynch et al. (2017)	DRD2	UBERON_0004535	""
decreased locomotor activity	cardiovascular	inhibition_acute	GO_0040013	ENSG00000149295	28216264	Lynch et al. (2017)	DRD2	UBERON_0004535	""
catalepsy	cardiovascular	inhibition_acute	EFO_0009845	ENSG00000149295	28216264	Lynch et al. (2017)	DRD2	UBERON_0004535	""
increased convulsions	cardiovascular	inhibition_acute	EFO_0009853	ENSG00000149295	28216264	Lynch et al. (2017)	DRD2	UBERON_0004535	""
increased gastrointestinal transit	cardiovascular	inhibition_acute	HP_0410204	ENSG00000149295	28216264	Lynch et al. (2017)	DRD2	UBERON_0004535	""
increased blood pressure	cardiovascular	inhibition_acute	HP_0032263	ENSG00000149295	28216264	Lynch et al. (2017)	DRD2	UBERON_0004535	""
orthostatic hypotension	cardiovascular	inhibition_acute	EFO_0005252	ENSG00000149295	28216264	Lynch et al. (2017)	DRD2	UBERON_0004535	""
drowsiness	cardiovascular	inhibition_acute	NCIT_C95746	ENSG00000149295	28216264	Lynch et al. (2017)	DRD2	UBERON_0004535	""
increased urine excretion	cardiovascular	inhibition_acute	HP_0000103	ENSG00000149295	28216264	Lynch et al. (2017)	DRD2	UBERON_0004535	""
increased urinary sodium excretion	cardiovascular	inhibition_acute	GO_0035815	ENSG00000149295	28216264	Lynch et al. (2017)	DRD2	UBERON_0004535	""
heart failure	cardiovascular	activation_chronic	EFO_0003144	ENSG00000149295	28216264	Lynch et al. (2017)	DRD2	UBERON_0004535	""
increased urinary sodium excretion	cardiovascular	activation_acute	GO_0035815	ENSG00000149295	28216264	Lynch et al. (2017)	DRD2	UBERON_0004535	""
decreased heart rate	central nervous system	activation_acute	HP_0001662	ENSG00000149295	28216264	Lynch et al. (2017)	DRD2	UBERON_0001017	""
drug abuse/dependence	gastrointestinal	activation_acute	EFO_0003890	ENSG00000149295	28216264	Lynch et al. (2017)	DRD2	UBERON_0005409	""
decreased convulsions	central nervous system	activation_acute	EFO_0009853	ENSG00000149295	28216264	Lynch et al. (2017)	DRD2	UBERON_0001017	""
decreased heart rate	cardiovascular	activation_acute	HP_0001662	ENSG00000149295	28216264	Lynch et al. (2017)	DRD2	UBERON_0004535	""
confusion	cardiovascular	activation_acute	HP_0004372	ENSG00000149295	28216264	Lynch et al. (2017)	DRD2	UBERON_0004535	""
decreased pain	renal	activation_acute	GO_1904057	ENSG00000149295	28216264	Lynch et al. (2017)	DRD2	UBERON_0001008	""
vomiting	central nervous system	activation_acute	HP_0002017	ENSG00000149295	28216264	Lynch et al. (2017)	DRD2	UBERON_0001017	""
drug abuse/dependence	cardiovascular	activation_acute	EFO_0003890	ENSG00000149295	28216264	Lynch et al. (2017)	DRD2	UBERON_0004535	""
decreased convulsions	gastrointestinal	activation_acute	EFO_0009853	ENSG00000149295	28216264	Lynch et al. (2017)	DRD2	UBERON_0005409	""
decreased heart rate	gastrointestinal	activation_acute	HP_0001662	ENSG00000149295	28216264	Lynch et al. (2017)	DRD2	UBERON_0005409	""
confusion	renal	activation_acute	HP_0004372	ENSG00000149295	28216264	Lynch et al. (2017)	DRD2	UBERON_0001008	""
fainting	gastrointestinal	activation_acute	HP_0001279	ENSG00000149295	28216264	Lynch et al. (2017)	DRD2	UBERON_0005409	""
confusion	gastrointestinal	activation_acute	HP_0004372	ENSG00000149295	28216264	Lynch et al. (2017)	DRD2	UBERON_0005409	""
decreased pituitary hormone secretion	cardiovascular	activation_acute	EFO_0001380	ENSG00000149295	28216264	Lynch et al. (2017)	DRD2	UBERON_0004535	""
hallucinations	renal	activation_acute	HP_0000738	ENSG00000149295	28216264	Lynch et al. (2017)	DRD2	UBERON_0001008	""
decreased pituitary hormone secretion	renal	activation_acute	EFO_0001380	ENSG00000149295	28216264	Lynch et al. (2017)	DRD2	UBERON_0001008	""
decreased pain	cardiovascular	activation_acute	GO_1904057	ENSG00000149295	28216264	Lynch et al. (2017)	DRD2	UBERON_0004535	""
decreased convulsions	renal	activation_acute	EFO_0009853	ENSG00000149295	28216264	Lynch et al. (2017)	DRD2	UBERON_0001008	""
drug abuse/dependence	renal	activation_acute	EFO_0003890	ENSG00000149295	28216264	Lynch et al. (2017)	DRD2	UBERON_0001008	""
hallucinations	cardiovascular	activation_acute	HP_0000738	ENSG00000149295	28216264	Lynch et al. (2017)	DRD2	UBERON_0004535	""
fainting	central nervous system	activation_acute	HP_0001279	ENSG00000149295	28216264	Lynch et al. (2017)	DRD2	UBERON_0001017	""
decreased body temperature	cardiovascular	activation_acute	HP_0002045	ENSG00000149295	28216264	Lynch et al. (2017)	DRD2	UBERON_0004535	""
increased urinary sodium excretion	central nervous system	activation_acute	GO_0035815	ENSG00000149295	28216264	Lynch et al. (2017)	DRD2	UBERON_0001017	""
fainting	renal	activation_acute	HP_0001279	ENSG00000149295	28216264	Lynch et al. (2017)	DRD2	UBERON_0001008	""
decreased blood pressure	renal	activation_acute	EFO_0005251	ENSG00000149295	28216264	Lynch et al. (2017)	DRD2	UBERON_0001008	""
decreased gastrointestinal transit	central nervous system	activation_acute	HP_0030897	ENSG00000149295	28216264	Lynch et al. (2017)	DRD2	UBERON_0001017	""
confusion	central nervous system	activation_acute	HP_0004372	ENSG00000149295	28216264	Lynch et al. (2017)	DRD2	UBERON_0001017	""
vomiting	renal	activation_acute	HP_0002017	ENSG00000149295	28216264	Lynch et al. (2017)	DRD2	UBERON_0001008	""
decreased pituitary hormone secretion	gastrointestinal	activation_acute	EFO_0001380	ENSG00000149295	28216264	Lynch et al. (2017)	DRD2	UBERON_0005409	""
vomiting	cardiovascular	activation_acute	HP_0002017	ENSG00000149295	28216264	Lynch et al. (2017)	DRD2	UBERON_0004535	""
increased urinary sodium excretion	renal	activation_acute	GO_0035815	ENSG00000149295	28216264	Lynch et al. (2017)	DRD2	UBERON_0001008	""
decreased blood pressure	cardiovascular	activation_acute	EFO_0005251	ENSG00000149295	28216264	Lynch et al. (2017)	DRD2	UBERON_0004535	""
decreased gastrointestinal transit	cardiovascular	activation_acute	HP_0030897	ENSG00000149295	28216264	Lynch et al. (2017)	DRD2	UBERON_0004535	""
increased urinary sodium excretion	gastrointestinal	activation_acute	GO_0035815	ENSG00000149295	28216264	Lynch et al. (2017)	DRD2	UBERON_0005409	""
decreased gastrointestinal transit	renal	activation_acute	HP_0030897	ENSG00000149295	28216264	Lynch et al. (2017)	DRD2	UBERON_0001008	""
drowsiness	renal	activation_acute	NCIT_C95746	ENSG00000149295	28216264	Lynch et al. (2017)	DRD2	UBERON_0001008	""
decreased body temperature	central nervous system	activation_acute	HP_0002045	ENSG00000149295	28216264	Lynch et al. (2017)	DRD2	UBERON_0001017	""
drowsiness	gastrointestinal	activation_acute	NCIT_C95746	ENSG00000149295	28216264	Lynch et al. (2017)	DRD2	UBERON_0005409	""
fainting	cardiovascular	activation_acute	HP_0001279	ENSG00000149295	28216264	Lynch et al. (2017)	DRD2	UBERON_0004535	""
decreased heart rate	renal	activation_acute	HP_0001662	ENSG00000149295	28216264	Lynch et al. (2017)	DRD2	UBERON_0001008	""
decreased pain	gastrointestinal	activation_acute	GO_1904057	ENSG00000149295	28216264	Lynch et al. (2017)	DRD2	UBERON_0005409	""
decreased gastrointestinal transit	gastrointestinal	activation_acute	HP_0030897	ENSG00000149295	28216264	Lynch et al. (2017)	DRD2	UBERON_0005409	""
decreased/increased Locomotor activity	renal	activation_acute	""	ENSG00000149295	28216264	Lynch et al. (2017)	DRD2	UBERON_0001008	""
drug abuse/dependence	central nervous system	activation_acute	EFO_0003890	ENSG00000149295	28216264	Lynch et al. (2017)	DRD2	UBERON_0001017	""
stereotypy	renal	activation_acute	HP_0000733	ENSG00000149295	28216264	Lynch et al. (2017)	DRD2	UBERON_0001008	""
hallucinations	gastrointestinal	activation_acute	HP_0000738	ENSG00000149295	28216264	Lynch et al. (2017)	DRD2	UBERON_0005409	""
decreased pituitary hormone secretion	central nervous system	activation_acute	EFO_0001380	ENSG00000149295	28216264	Lynch et al. (2017)	DRD2	UBERON_0001017	""
decreased/increased Locomotor activity	cardiovascular	activation_acute	""	ENSG00000149295	28216264	Lynch et al. (2017)	DRD2	UBERON_0004535	""
drowsiness	central nervous system	activation_acute	NCIT_C95746	ENSG00000149295	28216264	Lynch et al. (2017)	DRD2	UBERON_0001017	""
drowsiness	cardiovascular	activation_acute	NCIT_C95746	ENSG00000149295	28216264	Lynch et al. (2017)	DRD2	UBERON_0004535	""
decreased blood pressure	gastrointestinal	activation_acute	EFO_0005251	ENSG00000149295	28216264	Lynch et al. (2017)	DRD2	UBERON_0005409	""
vomiting	gastrointestinal	activation_acute	HP_0002017	ENSG00000149295	28216264	Lynch et al. (2017)	DRD2	UBERON_0005409	""
decreased/increased Locomotor activity	gastrointestinal	activation_acute	""	ENSG00000149295	28216264	Lynch et al. (2017)	DRD2	UBERON_0005409	""
stereotypy	central nervous system	activation_acute	HP_0000733	ENSG00000149295	28216264	Lynch et al. (2017)	DRD2	UBERON_0001017	""
decreased body temperature	gastrointestinal	activation_acute	HP_0002045	ENSG00000149295	28216264	Lynch et al. (2017)	DRD2	UBERON_0005409	""
decreased convulsions	cardiovascular	activation_acute	EFO_0009853	ENSG00000149295	28216264	Lynch et al. (2017)	DRD2	UBERON_0004535	""
decreased/increased Locomotor activity	central nervous system	activation_acute	""	ENSG00000149295	28216264	Lynch et al. (2017)	DRD2	UBERON_0001017	""
decreased pain	central nervous system	activation_acute	GO_1904057	ENSG00000149295	28216264	Lynch et al. (2017)	DRD2	UBERON_0001017	""
hallucinations	central nervous system	activation_acute	HP_0000738	ENSG00000149295	28216264	Lynch et al. (2017)	DRD2	UBERON_0001017	""
increased/decreased locomotor activity	renal	activation_acute	GO_0040012	ENSG00000184845	28216264	Lynch et al. (2017)	DRD1	UBERON_0001008	""
fibrotic valvular heart disease	renal	activation_chronic	EFO_0009551	ENSG00000184845	28216264	Lynch et al. (2017)	DRD1	UBERON_0001008	""
decreased locomotor activity	renal	inhibition_acute	GO_0040013	ENSG00000184845	28216264	Lynch et al. (2017)	DRD1	UBERON_0001008	""
dyskinesia	renal	inhibition_acute	EFO_1000904	ENSG00000184845	28216264	Lynch et al. (2017)	DRD1	UBERON_0001008	""
parkinsonism	renal	inhibition_acute	HP_0001300	ENSG00000184845	28216264	Lynch et al. (2017)	DRD1	UBERON_0001008	""
depression	renal	inhibition_acute	MONDO_0002050	ENSG00000184845	28216264	Lynch et al. (2017)	DRD1	UBERON_0001008	""
anxiety	renal	inhibition_acute	EFO_0005230	ENSG00000184845	28216264	Lynch et al. (2017)	DRD1	UBERON_0001008	""
suicidal intent	renal	inhibition_acute	EFO_0004320	ENSG00000184845	28216264	Lynch et al. (2017)	DRD1	UBERON_0001008	""
catalepsy	renal	inhibition_acute	EFO_0009845	ENSG00000184845	28216264	Lynch et al. (2017)	DRD1	UBERON_0001008	""
decreased convulsions	renal	inhibition_acute	EFO_0009853	ENSG00000184845	28216264	Lynch et al. (2017)	DRD1	UBERON_0001008	""
increased blood pressure	renal	inhibition_acute	HP_0032263	ENSG00000184845	28216264	Lynch et al. (2017)	DRD1	UBERON_0001008	""
heart failure	renal	activation_chronic	EFO_0003144	ENSG00000184845	28216264	Lynch et al. (2017)	DRD1	UBERON_0001008	""
dyskinesia	central nervous system	activation_acute	EFO_1000904	ENSG00000184845	28216264	Lynch et al. (2017)	DRD1	UBERON_0001017	""
fibrotic valvular heart disease	central nervous system	activation_chronic	EFO_0009551	ENSG00000184845	28216264	Lynch et al. (2017)	DRD1	UBERON_0001017	""
decreased locomotor activity	central nervous system	inhibition_acute	GO_0040013	ENSG00000184845	28216264	Lynch et al. (2017)	DRD1	UBERON_0001017	""
dyskinesia	central nervous system	inhibition_acute	EFO_1000904	ENSG00000184845	28216264	Lynch et al. (2017)	DRD1	UBERON_0001017	""
parkinsonism	central nervous system	inhibition_acute	HP_0001300	ENSG00000184845	28216264	Lynch et al. (2017)	DRD1	UBERON_0001017	""
depression	central nervous system	inhibition_acute	MONDO_0002050	ENSG00000184845	28216264	Lynch et al. (2017)	DRD1	UBERON_0001017	""
anxiety	central nervous system	inhibition_acute	EFO_0005230	ENSG00000184845	28216264	Lynch et al. (2017)	DRD1	UBERON_0001017	""
suicidal intent	central nervous system	inhibition_acute	EFO_0004320	ENSG00000184845	28216264	Lynch et al. (2017)	DRD1	UBERON_0001017	""
catalepsy	central nervous system	inhibition_acute	EFO_0009845	ENSG00000184845	28216264	Lynch et al. (2017)	DRD1	UBERON_0001017	""
decreased convulsions	central nervous system	inhibition_acute	EFO_0009853	ENSG00000184845	28216264	Lynch et al. (2017)	DRD1	UBERON_0001017	""
increased blood pressure	central nervous system	inhibition_acute	HP_0032263	ENSG00000184845	28216264	Lynch et al. (2017)	DRD1	UBERON_0001017	""
heart failure	central nervous system	activation_chronic	EFO_0003144	ENSG00000184845	28216264	Lynch et al. (2017)	DRD1	UBERON_0001017	""
convulsions	central nervous system	activation_acute	EFO_0009853	ENSG00000184845	28216264	Lynch et al. (2017)	DRD1	UBERON_0001017	""
convulsions	renal	activation_acute	EFO_0009853	ENSG00000184845	28216264	Lynch et al. (2017)	DRD1	UBERON_0001008	""
decreased blood pressure	renal	activation_acute	EFO_0005251	ENSG00000184845	28216264	Lynch et al. (2017)	DRD1	UBERON_0001008	""
headache	cardiovascular	activation_acute	HP_0002315	ENSG00000184845	28216264	Lynch et al. (2017)	DRD1	UBERON_0004535	""
fibrotic valvular heart disease	cardiovascular	activation_chronic	EFO_0009551	ENSG00000184845	28216264	Lynch et al. (2017)	DRD1	UBERON_0004535	""
decreased locomotor activity	cardiovascular	inhibition_acute	GO_0040013	ENSG00000184845	28216264	Lynch et al. (2017)	DRD1	UBERON_0004535	""
dyskinesia	cardiovascular	inhibition_acute	EFO_1000904	ENSG00000184845	28216264	Lynch et al. (2017)	DRD1	UBERON_0004535	""
parkinsonism	cardiovascular	inhibition_acute	HP_0001300	ENSG00000184845	28216264	Lynch et al. (2017)	DRD1	UBERON_0004535	""
depression	cardiovascular	inhibition_acute	MONDO_0002050	ENSG00000184845	28216264	Lynch et al. (2017)	DRD1	UBERON_0004535	""
anxiety	cardiovascular	inhibition_acute	EFO_0005230	ENSG00000184845	28216264	Lynch et al. (2017)	DRD1	UBERON_0004535	""
suicidal intent	cardiovascular	inhibition_acute	EFO_0004320	ENSG00000184845	28216264	Lynch et al. (2017)	DRD1	UBERON_0004535	""
catalepsy	cardiovascular	inhibition_acute	EFO_0009845	ENSG00000184845	28216264	Lynch et al. (2017)	DRD1	UBERON_0004535	""
decreased convulsions	cardiovascular	inhibition_acute	EFO_0009853	ENSG00000184845	28216264	Lynch et al. (2017)	DRD1	UBERON_0004535	""
increased blood pressure	cardiovascular	inhibition_acute	HP_0032263	ENSG00000184845	28216264	Lynch et al. (2017)	DRD1	UBERON_0004535	""
heart failure	cardiovascular	activation_chronic	EFO_0003144	ENSG00000184845	28216264	Lynch et al. (2017)	DRD1	UBERON_0004535	""
increased urinary sodium excretion	cardiovascular	activation_acute	GO_0035815	ENSG00000184845	28216264	Lynch et al. (2017)	DRD1	UBERON_0004535	""
increased arousal	renal	activation_acute	EFO_0009849	ENSG00000184845	28216264	Lynch et al. (2017)	DRD1	UBERON_0001008	""
neurodegeneration	cardiovascular	activation_acute	HP_0002180	ENSG00000184845	28216264	Lynch et al. (2017)	DRD1	UBERON_0004535	""
drug abuse/dependence	cardiovascular	activation_acute	EFO_0003890	ENSG00000184845	28216264	Lynch et al. (2017)	DRD1	UBERON_0004535	""
decreased blood pressure	central nervous system	activation_acute	EFO_0005251	ENSG00000184845	28216264	Lynch et al. (2017)	DRD1	UBERON_0001017	""
nausea	renal	activation_acute	HP_0002018	ENSG00000184845	28216264	Lynch et al. (2017)	DRD1	UBERON_0001008	""
nausea	central nervous system	activation_acute	HP_0002018	ENSG00000184845	28216264	Lynch et al. (2017)	DRD1	UBERON_0001017	""
neurodegeneration	central nervous system	activation_acute	HP_0002180	ENSG00000184845	28216264	Lynch et al. (2017)	DRD1	UBERON_0001017	""
neurodegeneration	renal	activation_acute	HP_0002180	ENSG00000184845	28216264	Lynch et al. (2017)	DRD1	UBERON_0001008	""
psychosis	renal	activation_acute	EFO_0005407	ENSG00000184845	28216264	Lynch et al. (2017)	DRD1	UBERON_0001008	""
headache	central nervous system	activation_acute	HP_0002315	ENSG00000184845	28216264	Lynch et al. (2017)	DRD1	UBERON_0001017	""
increased arousal	cardiovascular	activation_acute	EFO_0009849	ENSG00000184845	28216264	Lynch et al. (2017)	DRD1	UBERON_0004535	""
dizziness	central nervous system	activation_acute	EFO_0009847	ENSG00000184845	28216264	Lynch et al. (2017)	DRD1	UBERON_0001017	""
dizziness	renal	activation_acute	EFO_0009847	ENSG00000184845	28216264	Lynch et al. (2017)	DRD1	UBERON_0001008	""
psychosis	cardiovascular	activation_acute	EFO_0005407	ENSG00000184845	28216264	Lynch et al. (2017)	DRD1	UBERON_0004535	""
dyskinesia	cardiovascular	activation_acute	EFO_1000904	ENSG00000184845	28216264	Lynch et al. (2017)	DRD1	UBERON_0004535	""
nausea	cardiovascular	activation_acute	HP_0002018	ENSG00000184845	28216264	Lynch et al. (2017)	DRD1	UBERON_0004535	""
drug abuse/dependence	central nervous system	activation_acute	EFO_0003890	ENSG00000184845	28216264	Lynch et al. (2017)	DRD1	UBERON_0001017	""
increased/decreased locomotor activity	cardiovascular	activation_acute	GO_0040012	ENSG00000184845	28216264	Lynch et al. (2017)	DRD1	UBERON_0004535	""
increased arousal	central nervous system	activation_acute	EFO_0009849	ENSG00000184845	28216264	Lynch et al. (2017)	DRD1	UBERON_0001017	""
increased/decreased locomotor activity	central nervous system	activation_acute	GO_0040012	ENSG00000184845	28216264	Lynch et al. (2017)	DRD1	UBERON_0001017	""
decreased blood pressure	cardiovascular	activation_acute	EFO_0005251	ENSG00000184845	28216264	Lynch et al. (2017)	DRD1	UBERON_0004535	""
convulsions	cardiovascular	activation_acute	EFO_0009853	ENSG00000184845	28216264	Lynch et al. (2017)	DRD1	UBERON_0004535	""
increased urinary sodium excretion	central nervous system	activation_acute	GO_0035815	ENSG00000184845	28216264	Lynch et al. (2017)	DRD1	UBERON_0001017	""
increased urine excretion	cardiovascular	activation_acute	HP_0000103	ENSG00000184845	28216264	Lynch et al. (2017)	DRD1	UBERON_0004535	""
increased urine excretion	renal	activation_acute	HP_0000103	ENSG00000184845	28216264	Lynch et al. (2017)	DRD1	UBERON_0001008	""
psychosis	central nervous system	activation_acute	EFO_0005407	ENSG00000184845	28216264	Lynch et al. (2017)	DRD1	UBERON_0001017	""
headache	renal	activation_acute	HP_0002315	ENSG00000184845	28216264	Lynch et al. (2017)	DRD1	UBERON_0001008	""
increased urinary sodium excretion	renal	activation_acute	GO_0035815	ENSG00000184845	28216264	Lynch et al. (2017)	DRD1	UBERON_0001008	""
dizziness	cardiovascular	activation_acute	EFO_0009847	ENSG00000184845	28216264	Lynch et al. (2017)	DRD1	UBERON_0004535	""
increased urine excretion	central nervous system	activation_acute	HP_0000103	ENSG00000184845	28216264	Lynch et al. (2017)	DRD1	UBERON_0001017	""
drug abuse/dependence	renal	activation_acute	EFO_0003890	ENSG00000184845	28216264	Lynch et al. (2017)	DRD1	UBERON_0001008	""
dyskinesia	renal	activation_acute	EFO_1000904	ENSG00000184845	28216264	Lynch et al. (2017)	DRD1	UBERON_0001008	""
increased urine excretion	immune	activation_acute	HP_0000103	ENSG00000135124	28216264	Lynch et al. (2017)	P2RX4	UBERON_0002405	""
neurodegeneration	immune	activation_chronic	HP_0002180	ENSG00000135124	28216264	Lynch et al. (2017)	P2RX4	UBERON_0002405	""
decreased pain	immune	inhibition_acute	GO_1904057	ENSG00000135124	28216264	Lynch et al. (2017)	P2RX4	UBERON_0002405	""
decreased inflammation	immune	inhibition_acute	GO_0050728	ENSG00000135124	28216264	Lynch et al. (2017)	P2RX4	UBERON_0002405	""
decreased convulsions	immune	inhibition_acute	EFO_0009853	ENSG00000135124	28216264	Lynch et al. (2017)	P2RX4	UBERON_0002405	""
hemolysis	immune	activation_acute	EFO_0009473	ENSG00000135124	28216264	Lynch et al. (2017)	P2RX4	UBERON_0002405	""
increased urine excretion	nervous system	activation_acute	HP_0000103	ENSG00000135124	28216264	Lynch et al. (2017)	P2RX4	UBERON_0001016	""
neurodegeneration	nervous system	activation_chronic	HP_0002180	ENSG00000135124	28216264	Lynch et al. (2017)	P2RX4	UBERON_0001016	""
decreased pain	nervous system	inhibition_acute	GO_1904057	ENSG00000135124	28216264	Lynch et al. (2017)	P2RX4	UBERON_0001016	""
decreased inflammation	nervous system	inhibition_acute	GO_0050728	ENSG00000135124	28216264	Lynch et al. (2017)	P2RX4	UBERON_0001016	""
decreased convulsions	nervous system	inhibition_acute	EFO_0009853	ENSG00000135124	28216264	Lynch et al. (2017)	P2RX4	UBERON_0001016	""
increased urine excretion	renal	activation_acute	HP_0000103	ENSG00000135124	28216264	Lynch et al. (2017)	P2RX4	UBERON_0001008	""
neurodegeneration	renal	activation_chronic	HP_0002180	ENSG00000135124	28216264	Lynch et al. (2017)	P2RX4	UBERON_0001008	""
decreased pain	renal	inhibition_acute	GO_1904057	ENSG00000135124	28216264	Lynch et al. (2017)	P2RX4	UBERON_0001008	""
decreased inflammation	renal	inhibition_acute	GO_0050728	ENSG00000135124	28216264	Lynch et al. (2017)	P2RX4	UBERON_0001008	""
decreased convulsions	renal	inhibition_acute	EFO_0009853	ENSG00000135124	28216264	Lynch et al. (2017)	P2RX4	UBERON_0001008	""
increased urinary sodium excretion	immune	activation_acute	GO_0035815	ENSG00000135124	28216264	Lynch et al. (2017)	P2RX4	UBERON_0002405	""
hemolysis	nervous system	activation_acute	EFO_0009473	ENSG00000135124	28216264	Lynch et al. (2017)	P2RX4	UBERON_0001016	""
increased urinary sodium excretion	renal	activation_acute	GO_0035815	ENSG00000135124	28216264	Lynch et al. (2017)	P2RX4	UBERON_0001008	""
increased pain	nervous system	activation_acute	GO_1904058	ENSG00000135124	28216264	Lynch et al. (2017)	P2RX4	UBERON_0001016	""
increased pain	renal	activation_acute	GO_1904058	ENSG00000135124	28216264	Lynch et al. (2017)	P2RX4	UBERON_0001008	""
increased urinary sodium excretion	nervous system	activation_acute	GO_0035815	ENSG00000135124	28216264	Lynch et al. (2017)	P2RX4	UBERON_0001016	""
hemolysis	renal	activation_acute	EFO_0009473	ENSG00000135124	28216264	Lynch et al. (2017)	P2RX4	UBERON_0001008	""
increased pain	immune	activation_acute	GO_1904058	ENSG00000135124	28216264	Lynch et al. (2017)	P2RX4	UBERON_0002405	""
decreased blood pressure	renal	inhibition_acute	EFO_0005251	ENSG00000159640	28216264	Lynch et al. (2017)	ACE	UBERON_0001008	""
increased risk spontaneous abortion	renal	inhibition_developmental toxicity	EFO_1001255	ENSG00000159640	28216264	Lynch et al. (2017)	ACE	UBERON_0001008	""
increased urine excretion	renal	inhibition_acute	HP_0000103	ENSG00000159640	28216264	Lynch et al. (2017)	ACE	UBERON_0001008	""
increased urinary sodium excretion	renal	inhibition_acute	GO_0035815	ENSG00000159640	28216264	Lynch et al. (2017)	ACE	UBERON_0001008	""
proximal tubular degeneration	renal	inhibition_acute	Orphanet_47159	ENSG00000159640	28216264	Lynch et al. (2017)	ACE	UBERON_0001008	""
juxtaglomerular cell hyperplasia	renal	inhibition_acute	HP_0000111	ENSG00000159640	28216264	Lynch et al. (2017)	ACE	UBERON_0001008	""
interstitial cell infiltration	renal	inhibition_acute	EFO_0009832	ENSG00000159640	28216264	Lynch et al. (2017)	ACE	UBERON_0001008	""
gastrointestinal hemorrhagic erosion/ulcer	renal	inhibition_acute	HP_0004398	ENSG00000159640	28216264	Lynch et al. (2017)	ACE	UBERON_0001008	""
decreased bone marrow erythropoiesis	renal	inhibition_acute	HP_0010972	ENSG00000159640	28216264	Lynch et al. (2017)	ACE	UBERON_0001008	""
hepatocytic vacuolar degeneration	renal	inhibition_acute	""	ENSG00000159640	28216264	Lynch et al. (2017)	ACE	UBERON_0001008	""
decreased blood pressure	cardiovascular	inhibition_acute	EFO_0005251	ENSG00000159640	28216264	Lynch et al. (2017)	ACE	UBERON_0004535	""
increased risk spontaneous abortion	cardiovascular	inhibition_developmental toxicity	EFO_1001255	ENSG00000159640	28216264	Lynch et al. (2017)	ACE	UBERON_0004535	""
increased urine excretion	cardiovascular	inhibition_acute	HP_0000103	ENSG00000159640	28216264	Lynch et al. (2017)	ACE	UBERON_0004535	""
increased urinary sodium excretion	cardiovascular	inhibition_acute	GO_0035815	ENSG00000159640	28216264	Lynch et al. (2017)	ACE	UBERON_0004535	""
proximal tubular degeneration	cardiovascular	inhibition_acute	Orphanet_47159	ENSG00000159640	28216264	Lynch et al. (2017)	ACE	UBERON_0004535	""
juxtaglomerular cell hyperplasia	cardiovascular	inhibition_acute	HP_0000111	ENSG00000159640	28216264	Lynch et al. (2017)	ACE	UBERON_0004535	""
interstitial cell infiltration	cardiovascular	inhibition_acute	EFO_0009832	ENSG00000159640	28216264	Lynch et al. (2017)	ACE	UBERON_0004535	""
gastrointestinal hemorrhagic erosion/ulcer	cardiovascular	inhibition_acute	HP_0004398	ENSG00000159640	28216264	Lynch et al. (2017)	ACE	UBERON_0004535	""
decreased bone marrow erythropoiesis	cardiovascular	inhibition_acute	HP_0010972	ENSG00000159640	28216264	Lynch et al. (2017)	ACE	UBERON_0004535	""
hepatocytic vacuolar degeneration	cardiovascular	inhibition_acute	""	ENSG00000159640	28216264	Lynch et al. (2017)	ACE	UBERON_0004535	""
muscle relaxation	cardiovascular	activation_acute	""	ENSG00000151834	28216264	Lynch et al. (2017)	GABRA2	UBERON_0004535	""
convulsions	cardiovascular	inhibition_acute	EFO_0009853	ENSG00000151834	28216264	Lynch et al. (2017)	GABRA2	UBERON_0004535	""
decreased sleep	cardiovascular	inhibition_acute	EFO_0008568	ENSG00000151834	28216264	Lynch et al. (2017)	GABRA2	UBERON_0004535	""
increased sleep	central nervous system	activation_acute	EFO_0008568	ENSG00000151834	28216264	Lynch et al. (2017)	GABRA2	UBERON_0001017	""
convulsions	central nervous system	inhibition_acute	EFO_0009853	ENSG00000151834	28216264	Lynch et al. (2017)	GABRA2	UBERON_0001017	""
decreased sleep	central nervous system	inhibition_acute	EFO_0008568	ENSG00000151834	28216264	Lynch et al. (2017)	GABRA2	UBERON_0001017	""
decreased cardiac contractility	central nervous system	activation_acute	GO_0045822	ENSG00000151834	28216264	Lynch et al. (2017)	GABRA2	UBERON_0001017	""
decreased convulsions	central nervous system	activation_acute	EFO_0009853	ENSG00000151834	28216264	Lynch et al. (2017)	GABRA2	UBERON_0001017	""
decreased body temperature	cardiovascular	activation_acute	HP_0002045	ENSG00000151834	28216264	Lynch et al. (2017)	GABRA2	UBERON_0004535	""
drug abuse/dependence	cardiovascular	activation_acute	EFO_0003890	ENSG00000151834	28216264	Lynch et al. (2017)	GABRA2	UBERON_0004535	""
decreased pain	cardiovascular	activation_acute	GO_1904057	ENSG00000151834	28216264	Lynch et al. (2017)	GABRA2	UBERON_0004535	""
decreased convulsions	cardiovascular	activation_acute	EFO_0009853	ENSG00000151834	28216264	Lynch et al. (2017)	GABRA2	UBERON_0004535	""
decreased anxiety	central nervous system	activation_acute	EFO_0009874	ENSG00000151834	28216264	Lynch et al. (2017)	GABRA2	UBERON_0001017	""
ataxia	central nervous system	activation_acute	MONDO_0000437	ENSG00000151834	28216264	Lynch et al. (2017)	GABRA2	UBERON_0001017	""
decreased locomotor activity	central nervous system	activation_acute	GO_0040013	ENSG00000151834	28216264	Lynch et al. (2017)	GABRA2	UBERON_0001017	""
decreased blood pressure	cardiovascular	activation_acute	EFO_0005251	ENSG00000151834	28216264	Lynch et al. (2017)	GABRA2	UBERON_0004535	""
drug abuse/dependence	central nervous system	activation_acute	EFO_0003890	ENSG00000151834	28216264	Lynch et al. (2017)	GABRA2	UBERON_0001017	""
increased respiratory rate	central nervous system	activation_acute	EFO_0009840	ENSG00000151834	28216264	Lynch et al. (2017)	GABRA2	UBERON_0001017	""
decreased memory	central nervous system	activation_acute	EFO_0001072	ENSG00000151834	28216264	Lynch et al. (2017)	GABRA2	UBERON_0001017	""
decreased locomotor activity	cardiovascular	activation_acute	GO_0040013	ENSG00000151834	28216264	Lynch et al. (2017)	GABRA2	UBERON_0004535	""
increased respiratory rate	cardiovascular	activation_acute	EFO_0009840	ENSG00000151834	28216264	Lynch et al. (2017)	GABRA2	UBERON_0004535	""
increased cardiac output	central nervous system	activation_acute	EFO_0009872	ENSG00000151834	28216264	Lynch et al. (2017)	GABRA2	UBERON_0001017	""
decreased memory	cardiovascular	activation_acute	EFO_0001072	ENSG00000151834	28216264	Lynch et al. (2017)	GABRA2	UBERON_0004535	""
increased sleep	cardiovascular	activation_acute	EFO_0008568	ENSG00000151834	28216264	Lynch et al. (2017)	GABRA2	UBERON_0004535	""
increased cardiac output	cardiovascular	activation_acute	EFO_0009872	ENSG00000151834	28216264	Lynch et al. (2017)	GABRA2	UBERON_0004535	""
ataxia	cardiovascular	activation_acute	MONDO_0000437	ENSG00000151834	28216264	Lynch et al. (2017)	GABRA2	UBERON_0004535	""
increased eating	cardiovascular	activation_acute	HP_0100738	ENSG00000151834	28216264	Lynch et al. (2017)	GABRA2	UBERON_0004535	""
decreased cardiac contractility	cardiovascular	activation_acute	GO_0045822	ENSG00000151834	28216264	Lynch et al. (2017)	GABRA2	UBERON_0004535	""
decreased blood pressure	central nervous system	activation_acute	EFO_0005251	ENSG00000151834	28216264	Lynch et al. (2017)	GABRA2	UBERON_0001017	""
decreased body temperature	central nervous system	activation_acute	HP_0002045	ENSG00000151834	28216264	Lynch et al. (2017)	GABRA2	UBERON_0001017	""
muscle relaxation	central nervous system	activation_acute	""	ENSG00000151834	28216264	Lynch et al. (2017)	GABRA2	UBERON_0001017	""
decreased pain	central nervous system	activation_acute	GO_1904057	ENSG00000151834	28216264	Lynch et al. (2017)	GABRA2	UBERON_0001017	""
increased eating	central nervous system	activation_acute	HP_0100738	ENSG00000151834	28216264	Lynch et al. (2017)	GABRA2	UBERON_0001017	""
decreased anxiety	cardiovascular	activation_acute	EFO_0009874	ENSG00000151834	28216264	Lynch et al. (2017)	GABRA2	UBERON_0004535	""
paralysis	gastrointestinal	activation_general	HP_0003470	ENSG00000101204	23197038	Bowes et al. (2012)	CHRNA4	UBERON_0005409	""
muscle relaxation	gastrointestinal	inhibition_general	""	ENSG00000101204	23197038	Bowes et al. (2012)	CHRNA4	UBERON_0005409	""
constipation	gastrointestinal	inhibition_general	HP_0002019	ENSG00000101204	23197038	Bowes et al. (2012)	CHRNA4	UBERON_0005409	""
apnoea	gastrointestinal	inhibition_general	HP_0002104	ENSG00000101204	23197038	Bowes et al. (2012)	CHRNA4	UBERON_0005409	""
decreased blood pressure	gastrointestinal	inhibition_general	EFO_0005251	ENSG00000101204	23197038	Bowes et al. (2012)	CHRNA4	UBERON_0005409	""
decreased heart rate	gastrointestinal	inhibition_general	HP_0001662	ENSG00000101204	23197038	Bowes et al. (2012)	CHRNA4	UBERON_0005409	""
analgesia	gastrointestinal	activation_general	EFO_1001484	ENSG00000101204	23197038	Bowes et al. (2012)	CHRNA4	UBERON_0005409	""
increased heart rate	gastrointestinal	activation_general	HP_0001649	ENSG00000101204	23197038	Bowes et al. (2012)	CHRNA4	UBERON_0005409	""
palpitations	gastrointestinal	activation_general	HP_0001962	ENSG00000101204	23197038	Bowes et al. (2012)	CHRNA4	UBERON_0005409	""
nausea	gastrointestinal	activation_general	HP_0002018	ENSG00000101204	23197038	Bowes et al. (2012)	CHRNA4	UBERON_0005409	""
abuse potential	gastrointestinal	activation_general	EFO_0003890	ENSG00000101204	23197038	Bowes et al. (2012)	CHRNA4	UBERON_0005409	""
paralysis	cardiovascular system	activation_general	HP_0003470	ENSG00000101204	23197038	Bowes et al. (2012)	CHRNA4	UBERON_0004535	""
muscle relaxation	cardiovascular system	inhibition_general	""	ENSG00000101204	23197038	Bowes et al. (2012)	CHRNA4	UBERON_0004535	""
constipation	cardiovascular system	inhibition_general	HP_0002019	ENSG00000101204	23197038	Bowes et al. (2012)	CHRNA4	UBERON_0004535	""
apnoea	cardiovascular system	inhibition_general	HP_0002104	ENSG00000101204	23197038	Bowes et al. (2012)	CHRNA4	UBERON_0004535	""
decreased blood pressure	cardiovascular system	inhibition_general	EFO_0005251	ENSG00000101204	23197038	Bowes et al. (2012)	CHRNA4	UBERON_0004535	""
decreased heart rate	cardiovascular system	inhibition_general	HP_0001662	ENSG00000101204	23197038	Bowes et al. (2012)	CHRNA4	UBERON_0004535	""
analgesia	cardiovascular system	activation_general	EFO_1001484	ENSG00000101204	23197038	Bowes et al. (2012)	CHRNA4	UBERON_0004535	""
increased heart rate	cardiovascular system	activation_general	HP_0001649	ENSG00000101204	23197038	Bowes et al. (2012)	CHRNA4	UBERON_0004535	""
palpitations	cardiovascular system	activation_general	HP_0001962	ENSG00000101204	23197038	Bowes et al. (2012)	CHRNA4	UBERON_0004535	""
nausea	cardiovascular system	activation_general	HP_0002018	ENSG00000101204	23197038	Bowes et al. (2012)	CHRNA4	UBERON_0004535	""
abuse potential	cardiovascular system	activation_general	EFO_0003890	ENSG00000101204	23197038	Bowes et al. (2012)	CHRNA4	UBERON_0004535	""
paralysis	central nervous system	activation_general	HP_0003470	ENSG00000101204	23197038	Bowes et al. (2012)	CHRNA4	UBERON_0001017	""
muscle relaxation	central nervous system	inhibition_general	""	ENSG00000101204	23197038	Bowes et al. (2012)	CHRNA4	UBERON_0001017	""
constipation	central nervous system	inhibition_general	HP_0002019	ENSG00000101204	23197038	Bowes et al. (2012)	CHRNA4	UBERON_0001017	""
apnoea	central nervous system	inhibition_general	HP_0002104	ENSG00000101204	23197038	Bowes et al. (2012)	CHRNA4	UBERON_0001017	""
decreased blood pressure	central nervous system	inhibition_general	EFO_0005251	ENSG00000101204	23197038	Bowes et al. (2012)	CHRNA4	UBERON_0001017	""
decreased heart rate	central nervous system	inhibition_general	HP_0001662	ENSG00000101204	23197038	Bowes et al. (2012)	CHRNA4	UBERON_0001017	""
analgesia	central nervous system	activation_general	EFO_1001484	ENSG00000101204	23197038	Bowes et al. (2012)	CHRNA4	UBERON_0001017	""
increased heart rate	central nervous system	activation_general	HP_0001649	ENSG00000101204	23197038	Bowes et al. (2012)	CHRNA4	UBERON_0001017	""
palpitations	central nervous system	activation_general	HP_0001962	ENSG00000101204	23197038	Bowes et al. (2012)	CHRNA4	UBERON_0001017	""
nausea	central nervous system	activation_general	HP_0002018	ENSG00000101204	23197038	Bowes et al. (2012)	CHRNA4	UBERON_0001017	""
abuse potential	central nervous system	activation_general	EFO_0003890	ENSG00000101204	23197038	Bowes et al. (2012)	CHRNA4	UBERON_0001017	""
paralysis	pulmonary	activation_general	HP_0003470	ENSG00000101204	23197038	Bowes et al. (2012)	CHRNA4	UBERON_0002048	""
muscle relaxation	pulmonary	inhibition_general	""	ENSG00000101204	23197038	Bowes et al. (2012)	CHRNA4	UBERON_0002048	""
constipation	pulmonary	inhibition_general	HP_0002019	ENSG00000101204	23197038	Bowes et al. (2012)	CHRNA4	UBERON_0002048	""
apnoea	pulmonary	inhibition_general	HP_0002104	ENSG00000101204	23197038	Bowes et al. (2012)	CHRNA4	UBERON_0002048	""
decreased blood pressure	pulmonary	inhibition_general	EFO_0005251	ENSG00000101204	23197038	Bowes et al. (2012)	CHRNA4	UBERON_0002048	""
decreased heart rate	pulmonary	inhibition_general	HP_0001662	ENSG00000101204	23197038	Bowes et al. (2012)	CHRNA4	UBERON_0002048	""
analgesia	pulmonary	activation_general	EFO_1001484	ENSG00000101204	23197038	Bowes et al. (2012)	CHRNA4	UBERON_0002048	""
increased heart rate	pulmonary	activation_general	HP_0001649	ENSG00000101204	23197038	Bowes et al. (2012)	CHRNA4	UBERON_0002048	""
palpitations	pulmonary	activation_general	HP_0001962	ENSG00000101204	23197038	Bowes et al. (2012)	CHRNA4	UBERON_0002048	""
nausea	pulmonary	activation_general	HP_0002018	ENSG00000101204	23197038	Bowes et al. (2012)	CHRNA4	UBERON_0002048	""
abuse potential	pulmonary	activation_general	EFO_0003890	ENSG00000101204	23197038	Bowes et al. (2012)	CHRNA4	UBERON_0002048	""
bronchoconstriction	gonad	activation_acute	EFO_0009836	ENSG00000075073	28216264	Lynch et al. (2017)	TACR2	UBERON_0000991	""
decreased intestinal transit	gonad	inhibition_acute	HP_0030897	ENSG00000075073	28216264	Lynch et al. (2017)	TACR2	UBERON_0000991	""
decreased pain	gonad	inhibition_acute	GO_1904057	ENSG00000075073	28216264	Lynch et al. (2017)	TACR2	UBERON_0000991	""
decreased inflammation	gonad	inhibition_acute	GO_0050728	ENSG00000075073	28216264	Lynch et al. (2017)	TACR2	UBERON_0000991	""
decreased anxiety	gonad	inhibition_acute	EFO_0009874	ENSG00000075073	28216264	Lynch et al. (2017)	TACR2	UBERON_0000991	""
testicular degeneration	gonad	inhibition_acute	HP_0000029	ENSG00000075073	28216264	Lynch et al. (2017)	TACR2	UBERON_0000991	""
delayed/absent sexual maturity	gonad	inhibition_acute	HP_0000823	ENSG00000075073	28216264	Lynch et al. (2017)	TACR2	UBERON_0000991	""
bronchoconstriction	gastrointestinal	activation_acute	EFO_0009836	ENSG00000075073	28216264	Lynch et al. (2017)	TACR2	UBERON_0005409	""
decreased intestinal transit	gastrointestinal	inhibition_acute	HP_0030897	ENSG00000075073	28216264	Lynch et al. (2017)	TACR2	UBERON_0005409	""
decreased pain	gastrointestinal	inhibition_acute	GO_1904057	ENSG00000075073	28216264	Lynch et al. (2017)	TACR2	UBERON_0005409	""
decreased inflammation	gastrointestinal	inhibition_acute	GO_0050728	ENSG00000075073	28216264	Lynch et al. (2017)	TACR2	UBERON_0005409	""
decreased anxiety	gastrointestinal	inhibition_acute	EFO_0009874	ENSG00000075073	28216264	Lynch et al. (2017)	TACR2	UBERON_0005409	""
testicular degeneration	gastrointestinal	inhibition_acute	HP_0000029	ENSG00000075073	28216264	Lynch et al. (2017)	TACR2	UBERON_0005409	""
delayed/absent sexual maturity	gastrointestinal	inhibition_acute	HP_0000823	ENSG00000075073	28216264	Lynch et al. (2017)	TACR2	UBERON_0005409	""
increased intestinal transit	gastrointestinal	activation_acute	HP_0410204	ENSG00000075073	28216264	Lynch et al. (2017)	TACR2	UBERON_0005409	""
increased urinary bladder contractions	immune	activation_acute	EFO_1000781	ENSG00000075073	28216264	Lynch et al. (2017)	TACR2	UBERON_0002405	""
decreased intestinal transit	immune	inhibition_acute	HP_0030897	ENSG00000075073	28216264	Lynch et al. (2017)	TACR2	UBERON_0002405	""
decreased pain	immune	inhibition_acute	GO_1904057	ENSG00000075073	28216264	Lynch et al. (2017)	TACR2	UBERON_0002405	""
decreased inflammation	immune	inhibition_acute	GO_0050728	ENSG00000075073	28216264	Lynch et al. (2017)	TACR2	UBERON_0002405	""
decreased anxiety	immune	inhibition_acute	EFO_0009874	ENSG00000075073	28216264	Lynch et al. (2017)	TACR2	UBERON_0002405	""
testicular degeneration	immune	inhibition_acute	HP_0000029	ENSG00000075073	28216264	Lynch et al. (2017)	TACR2	UBERON_0002405	""
delayed/absent sexual maturity	immune	inhibition_acute	HP_0000823	ENSG00000075073	28216264	Lynch et al. (2017)	TACR2	UBERON_0002405	""
increased intestinal transit	immune	activation_acute	HP_0410204	ENSG00000075073	28216264	Lynch et al. (2017)	TACR2	UBERON_0002405	""
increased intestinal transit	gonad	activation_acute	HP_0410204	ENSG00000075073	28216264	Lynch et al. (2017)	TACR2	UBERON_0000991	""
bronchoconstriction	immune	activation_acute	EFO_0009836	ENSG00000075073	28216264	Lynch et al. (2017)	TACR2	UBERON_0002405	""
increased urinary bladder contractions	gonad	activation_acute	EFO_1000781	ENSG00000075073	28216264	Lynch et al. (2017)	TACR2	UBERON_0000991	""
increased urinary bladder contractions	gastrointestinal	activation_acute	EFO_1000781	ENSG00000075073	28216264	Lynch et al. (2017)	TACR2	UBERON_0005409	""
increased cardiac contractility	renal	inhibition_acute	GO_0045823	ENSG00000132681	28216264	Lynch et al. (2017)	ATP1A4	UBERON_0001008	""
decreased heart rate	renal	inhibition_acute	HP_0001662	ENSG00000132681	28216264	Lynch et al. (2017)	ATP1A4	UBERON_0001008	""
atrioventricular block	renal	inhibition_acute	MONDO_0000465	ENSG00000132681	28216264	Lynch et al. (2017)	ATP1A4	UBERON_0001008	""
cardiac arrhythmia	renal	inhibition_acute	EFO_0004269	ENSG00000132681	28216264	Lynch et al. (2017)	ATP1A4	UBERON_0001008	""
ventricular fibrillation	renal	inhibition_acute	EFO_0004287	ENSG00000132681	28216264	Lynch et al. (2017)	ATP1A4	UBERON_0001008	""
increased urine excretion	renal	inhibition_acute	HP_0000103	ENSG00000132681	28216264	Lynch et al. (2017)	ATP1A4	UBERON_0001008	""
increased urinary sodium excretion	renal	inhibition_acute	GO_0035815	ENSG00000132681	28216264	Lynch et al. (2017)	ATP1A4	UBERON_0001008	""
vomiting	renal	inhibition_acute	HP_0002017	ENSG00000132681	28216264	Lynch et al. (2017)	ATP1A4	UBERON_0001008	""
increased cardiac contractility	cardiovascular	inhibition_acute	GO_0045823	ENSG00000132681	28216264	Lynch et al. (2017)	ATP1A4	UBERON_0004535	""
decreased heart rate	cardiovascular	inhibition_acute	HP_0001662	ENSG00000132681	28216264	Lynch et al. (2017)	ATP1A4	UBERON_0004535	""
atrioventricular block	cardiovascular	inhibition_acute	MONDO_0000465	ENSG00000132681	28216264	Lynch et al. (2017)	ATP1A4	UBERON_0004535	""
cardiac arrhythmia	cardiovascular	inhibition_acute	EFO_0004269	ENSG00000132681	28216264	Lynch et al. (2017)	ATP1A4	UBERON_0004535	""
ventricular fibrillation	cardiovascular	inhibition_acute	EFO_0004287	ENSG00000132681	28216264	Lynch et al. (2017)	ATP1A4	UBERON_0004535	""
increased urine excretion	cardiovascular	inhibition_acute	HP_0000103	ENSG00000132681	28216264	Lynch et al. (2017)	ATP1A4	UBERON_0004535	""
increased urinary sodium excretion	cardiovascular	inhibition_acute	GO_0035815	ENSG00000132681	28216264	Lynch et al. (2017)	ATP1A4	UBERON_0004535	""
vomiting	cardiovascular	inhibition_acute	HP_0002017	ENSG00000132681	28216264	Lynch et al. (2017)	ATP1A4	UBERON_0004535	""
increased cardiac contractility	cardiovascular system	inhibition_general	GO_0045823	ENSG00000172572	23197038	Bowes et al. (2012)	PDE3A	UBERON_0004535	""
increased heart rate	cardiovascular system	inhibition_general	HP_0001649	ENSG00000172572	23197038	Bowes et al. (2012)	PDE3A	UBERON_0004535	""
decreased blood pressure	cardiovascular system	inhibition_general	EFO_0005251	ENSG00000172572	23197038	Bowes et al. (2012)	PDE3A	UBERON_0004535	""
thrombocytopaenia	cardiovascular system	inhibition_general	HP_0001873	ENSG00000172572	23197038	Bowes et al. (2012)	PDE3A	UBERON_0004535	""
ventricular arrhythmia	cardiovascular system	inhibition_general	HP_0004308	ENSG00000172572	23197038	Bowes et al. (2012)	PDE3A	UBERON_0004535	""
decreased gastrointestinal motility	pulmonary	inhibition_acute	HP_0002579	ENSG00000087085	23197038	Bowes et al. (2012)	ACHE	UBERON_0002048	""
decreased blood pressure	pulmonary	inhibition_general	EFO_0005251	ENSG00000087085	23197038	Bowes et al. (2012)	ACHE	UBERON_0002048	""
decreased heart rate	pulmonary	inhibition_general	HP_0001662	ENSG00000087085	23197038	Bowes et al. (2012)	ACHE	UBERON_0002048	""
increased gastrointestinal motility	pulmonary	inhibition_general	HP_0030895	ENSG00000087085	23197038	Bowes et al. (2012)	ACHE	UBERON_0002048	""
bronchoconstriction	pulmonary	inhibition_general	EFO_0009836	ENSG00000087085	23197038	Bowes et al. (2012)	ACHE	UBERON_0002048	""
increased respiratory secretions	pulmonary	inhibition_general	EFO_0009835	ENSG00000087085	23197038	Bowes et al. (2012)	ACHE	UBERON_0002048	""
decreased gastrointestinal motility	gastrointestinal	inhibition_acute	HP_0002579	ENSG00000087085	23197038	Bowes et al. (2012)	ACHE	UBERON_0005409	""
decreased blood pressure	gastrointestinal	inhibition_general	EFO_0005251	ENSG00000087085	23197038	Bowes et al. (2012)	ACHE	UBERON_0005409	""
decreased heart rate	gastrointestinal	inhibition_general	HP_0001662	ENSG00000087085	23197038	Bowes et al. (2012)	ACHE	UBERON_0005409	""
increased gastrointestinal motility	gastrointestinal	inhibition_general	HP_0030895	ENSG00000087085	23197038	Bowes et al. (2012)	ACHE	UBERON_0005409	""
bronchoconstriction	gastrointestinal	inhibition_general	EFO_0009836	ENSG00000087085	23197038	Bowes et al. (2012)	ACHE	UBERON_0005409	""
increased respiratory secretions	gastrointestinal	inhibition_general	EFO_0009835	ENSG00000087085	23197038	Bowes et al. (2012)	ACHE	UBERON_0005409	""
decreased gastrointestinal motility	cardiovascular system	inhibition_acute	HP_0002579	ENSG00000087085	23197038	Bowes et al. (2012)	ACHE	UBERON_0004535	""
decreased blood pressure	cardiovascular system	inhibition_general	EFO_0005251	ENSG00000087085	23197038	Bowes et al. (2012)	ACHE	UBERON_0004535	""
decreased heart rate	cardiovascular system	inhibition_general	HP_0001662	ENSG00000087085	23197038	Bowes et al. (2012)	ACHE	UBERON_0004535	""
increased gastrointestinal motility	cardiovascular system	inhibition_general	HP_0030895	ENSG00000087085	23197038	Bowes et al. (2012)	ACHE	UBERON_0004535	""
bronchoconstriction	cardiovascular system	inhibition_general	EFO_0009836	ENSG00000087085	23197038	Bowes et al. (2012)	ACHE	UBERON_0004535	""
increased respiratory secretions	cardiovascular system	inhibition_general	EFO_0009835	ENSG00000087085	23197038	Bowes et al. (2012)	ACHE	UBERON_0004535	""
decreased blood phosphate	cardiovascular	activation_acute	HP_0002148	ENSG00000064989	28216264	Lynch et al. (2017)	CALCRL	UBERON_0004535	""
decreased pain	cardiovascular	inhibition_acute	GO_1904057	ENSG00000064989	28216264	Lynch et al. (2017)	CALCRL	UBERON_0004535	""
increased blood pressure	cardiovascular	inhibition_acute	HP_0032263	ENSG00000064989	28216264	Lynch et al. (2017)	CALCRL	UBERON_0004535	""
increased blood glucose	nervous system	activation_acute	HP_0003074	ENSG00000064989	28216264	Lynch et al. (2017)	CALCRL	UBERON_0001016	""
decreased pain	nervous system	inhibition_acute	GO_1904057	ENSG00000064989	28216264	Lynch et al. (2017)	CALCRL	UBERON_0001016	""
increased blood pressure	nervous system	inhibition_acute	HP_0032263	ENSG00000064989	28216264	Lynch et al. (2017)	CALCRL	UBERON_0001016	""
increased pain	gastrointestinal	activation_acute	GO_1904058	ENSG00000064989	28216264	Lynch et al. (2017)	CALCRL	UBERON_0005409	""
decreased pain	gastrointestinal	inhibition_acute	GO_1904057	ENSG00000064989	28216264	Lynch et al. (2017)	CALCRL	UBERON_0005409	""
increased blood pressure	gastrointestinal	inhibition_acute	HP_0032263	ENSG00000064989	28216264	Lynch et al. (2017)	CALCRL	UBERON_0005409	""
facial flushing	gastrointestinal	activation_acute	HP_0031284	ENSG00000064989	28216264	Lynch et al. (2017)	CALCRL	UBERON_0005409	""
increased heart rate	cardiovascular	activation_acute	HP_0001649	ENSG00000064989	28216264	Lynch et al. (2017)	CALCRL	UBERON_0004535	""
decreased blood calcium	nervous system	activation_acute	HP_0002901	ENSG00000064989	28216264	Lynch et al. (2017)	CALCRL	UBERON_0001016	""
increased heart rate	gastrointestinal	activation_acute	HP_0001649	ENSG00000064989	28216264	Lynch et al. (2017)	CALCRL	UBERON_0005409	""
facial flushing	blood	activation_acute	HP_0031284	ENSG00000064989	28216264	Lynch et al. (2017)	CALCRL	UBERON_0000178	""
decreased pain	blood	inhibition_acute	GO_1904057	ENSG00000064989	28216264	Lynch et al. (2017)	CALCRL	UBERON_0000178	""
increased blood pressure	blood	inhibition_acute	HP_0032263	ENSG00000064989	28216264	Lynch et al. (2017)	CALCRL	UBERON_0000178	""
decreased gastric emptying	nervous system	activation_acute	GO_0120061	ENSG00000064989	28216264	Lynch et al. (2017)	CALCRL	UBERON_0001016	""
increased blood glucose	cardiovascular	activation_acute	HP_0003074	ENSG00000064989	28216264	Lynch et al. (2017)	CALCRL	UBERON_0004535	""
decreased blood phosphate	blood	activation_acute	HP_0002148	ENSG00000064989	28216264	Lynch et al. (2017)	CALCRL	UBERON_0000178	""
decreased blood pressure	blood	activation_acute	EFO_0005251	ENSG00000064989	28216264	Lynch et al. (2017)	CALCRL	UBERON_0000178	""
facial flushing	cardiovascular	activation_acute	HP_0031284	ENSG00000064989	28216264	Lynch et al. (2017)	CALCRL	UBERON_0004535	""
increased pain	blood	activation_acute	GO_1904058	ENSG00000064989	28216264	Lynch et al. (2017)	CALCRL	UBERON_0000178	""
decreased blood calcium	blood	activation_acute	HP_0002901	ENSG00000064989	28216264	Lynch et al. (2017)	CALCRL	UBERON_0000178	""
increased cardiac contractility	cardiovascular	activation_acute	GO_0045823	ENSG00000064989	28216264	Lynch et al. (2017)	CALCRL	UBERON_0004535	""
decreased gastric emptying	blood	activation_acute	GO_0120061	ENSG00000064989	28216264	Lynch et al. (2017)	CALCRL	UBERON_0000178	""
increased cardiac contractility	nervous system	activation_acute	GO_0045823	ENSG00000064989	28216264	Lynch et al. (2017)	CALCRL	UBERON_0001016	""
decreased gastric emptying	gastrointestinal	activation_acute	GO_0120061	ENSG00000064989	28216264	Lynch et al. (2017)	CALCRL	UBERON_0005409	""
decreased gastric emptying	cardiovascular	activation_acute	GO_0120061	ENSG00000064989	28216264	Lynch et al. (2017)	CALCRL	UBERON_0004535	""
increased blood glucose	blood	activation_acute	HP_0003074	ENSG00000064989	28216264	Lynch et al. (2017)	CALCRL	UBERON_0000178	""
decreased blood pressure	cardiovascular	activation_acute	EFO_0005251	ENSG00000064989	28216264	Lynch et al. (2017)	CALCRL	UBERON_0004535	""
increased heart rate	blood	activation_acute	HP_0001649	ENSG00000064989	28216264	Lynch et al. (2017)	CALCRL	UBERON_0000178	""
decreased blood calcium	gastrointestinal	activation_acute	HP_0002901	ENSG00000064989	28216264	Lynch et al. (2017)	CALCRL	UBERON_0005409	""
facial flushing	nervous system	activation_acute	HP_0031284	ENSG00000064989	28216264	Lynch et al. (2017)	CALCRL	UBERON_0001016	""
increased cardiac contractility	blood	activation_acute	GO_0045823	ENSG00000064989	28216264	Lynch et al. (2017)	CALCRL	UBERON_0000178	""
increased heart rate	nervous system	activation_acute	HP_0001649	ENSG00000064989	28216264	Lynch et al. (2017)	CALCRL	UBERON_0001016	""
decreased blood pressure	gastrointestinal	activation_acute	EFO_0005251	ENSG00000064989	28216264	Lynch et al. (2017)	CALCRL	UBERON_0005409	""
increased pain	cardiovascular	activation_acute	GO_1904058	ENSG00000064989	28216264	Lynch et al. (2017)	CALCRL	UBERON_0004535	""
increased cardiac contractility	gastrointestinal	activation_acute	GO_0045823	ENSG00000064989	28216264	Lynch et al. (2017)	CALCRL	UBERON_0005409	""
decreased blood phosphate	nervous system	activation_acute	HP_0002148	ENSG00000064989	28216264	Lynch et al. (2017)	CALCRL	UBERON_0001016	""
decreased blood pressure	nervous system	activation_acute	EFO_0005251	ENSG00000064989	28216264	Lynch et al. (2017)	CALCRL	UBERON_0001016	""
decreased blood phosphate	gastrointestinal	activation_acute	HP_0002148	ENSG00000064989	28216264	Lynch et al. (2017)	CALCRL	UBERON_0005409	""
increased blood glucose	gastrointestinal	activation_acute	HP_0003074	ENSG00000064989	28216264	Lynch et al. (2017)	CALCRL	UBERON_0005409	""
increased pain	nervous system	activation_acute	GO_1904058	ENSG00000064989	28216264	Lynch et al. (2017)	CALCRL	UBERON_0001016	""
decreased blood calcium	cardiovascular	activation_acute	HP_0002901	ENSG00000064989	28216264	Lynch et al. (2017)	CALCRL	UBERON_0004535	""
increased urinary sodium excretion	immune	activation_acute	GO_0035815	ENSG00000099957	28216264	Lynch et al. (2017)	P2RX6	UBERON_0002405	""
neurodegeneration	immune	activation_chronic	HP_0002180	ENSG00000099957	28216264	Lynch et al. (2017)	P2RX6	UBERON_0002405	""
decreased pain	immune	inhibition_acute	GO_1904057	ENSG00000099957	28216264	Lynch et al. (2017)	P2RX6	UBERON_0002405	""
decreased inflammation	immune	inhibition_acute	GO_0050728	ENSG00000099957	28216264	Lynch et al. (2017)	P2RX6	UBERON_0002405	""
decreased convulsions	immune	inhibition_acute	EFO_0009853	ENSG00000099957	28216264	Lynch et al. (2017)	P2RX6	UBERON_0002405	""
increased urinary sodium excretion	renal	activation_acute	GO_0035815	ENSG00000099957	28216264	Lynch et al. (2017)	P2RX6	UBERON_0001008	""
neurodegeneration	renal	activation_chronic	HP_0002180	ENSG00000099957	28216264	Lynch et al. (2017)	P2RX6	UBERON_0001008	""
decreased pain	renal	inhibition_acute	GO_1904057	ENSG00000099957	28216264	Lynch et al. (2017)	P2RX6	UBERON_0001008	""
decreased inflammation	renal	inhibition_acute	GO_0050728	ENSG00000099957	28216264	Lynch et al. (2017)	P2RX6	UBERON_0001008	""
decreased convulsions	renal	inhibition_acute	EFO_0009853	ENSG00000099957	28216264	Lynch et al. (2017)	P2RX6	UBERON_0001008	""
increased urine excretion	renal	activation_acute	HP_0000103	ENSG00000099957	28216264	Lynch et al. (2017)	P2RX6	UBERON_0001008	""
increased urinary sodium excretion	nervous system	activation_acute	GO_0035815	ENSG00000099957	28216264	Lynch et al. (2017)	P2RX6	UBERON_0001016	""
neurodegeneration	nervous system	activation_chronic	HP_0002180	ENSG00000099957	28216264	Lynch et al. (2017)	P2RX6	UBERON_0001016	""
decreased pain	nervous system	inhibition_acute	GO_1904057	ENSG00000099957	28216264	Lynch et al. (2017)	P2RX6	UBERON_0001016	""
decreased inflammation	nervous system	inhibition_acute	GO_0050728	ENSG00000099957	28216264	Lynch et al. (2017)	P2RX6	UBERON_0001016	""
decreased convulsions	nervous system	inhibition_acute	EFO_0009853	ENSG00000099957	28216264	Lynch et al. (2017)	P2RX6	UBERON_0001016	""
hemolysis	nervous system	activation_acute	EFO_0009473	ENSG00000099957	28216264	Lynch et al. (2017)	P2RX6	UBERON_0001016	""
increased urine excretion	immune	activation_acute	HP_0000103	ENSG00000099957	28216264	Lynch et al. (2017)	P2RX6	UBERON_0002405	""
increased pain	renal	activation_acute	GO_1904058	ENSG00000099957	28216264	Lynch et al. (2017)	P2RX6	UBERON_0001008	""
increased urine excretion	nervous system	activation_acute	HP_0000103	ENSG00000099957	28216264	Lynch et al. (2017)	P2RX6	UBERON_0001016	""
increased pain	nervous system	activation_acute	GO_1904058	ENSG00000099957	28216264	Lynch et al. (2017)	P2RX6	UBERON_0001016	""
hemolysis	renal	activation_acute	EFO_0009473	ENSG00000099957	28216264	Lynch et al. (2017)	P2RX6	UBERON_0001008	""
increased pain	immune	activation_acute	GO_1904058	ENSG00000099957	28216264	Lynch et al. (2017)	P2RX6	UBERON_0002405	""
hemolysis	immune	activation_acute	EFO_0009473	ENSG00000099957	28216264	Lynch et al. (2017)	P2RX6	UBERON_0002405	""
decreased blood pressure	gastrointestinal	activation_acute	EFO_0005251	ENSG00000082556	28216264	Lynch et al. (2017)	OPRK1	UBERON_0005409	""
increased pain	gastrointestinal	inhibition_acute	GO_1904058	ENSG00000082556	28216264	Lynch et al. (2017)	OPRK1	UBERON_0005409	""
increased convulsions	gastrointestinal	inhibition_acute	EFO_0009853	ENSG00000082556	28216264	Lynch et al. (2017)	OPRK1	UBERON_0005409	""
decreased anxiety	gastrointestinal	inhibition_acute	EFO_0009874	ENSG00000082556	28216264	Lynch et al. (2017)	OPRK1	UBERON_0005409	""
decreased drinking	gastrointestinal	inhibition_acute	HP_0025382	ENSG00000082556	28216264	Lynch et al. (2017)	OPRK1	UBERON_0005409	""
decreased eating	gastrointestinal	inhibition_acute	HP_0100738	ENSG00000082556	28216264	Lynch et al. (2017)	OPRK1	UBERON_0005409	""
increased anxiety	nervous system	activation_acute	EFO_0005230	ENSG00000082556	28216264	Lynch et al. (2017)	OPRK1	UBERON_0001016	""
increased pain	nervous system	inhibition_acute	GO_1904058	ENSG00000082556	28216264	Lynch et al. (2017)	OPRK1	UBERON_0001016	""
increased convulsions	nervous system	inhibition_acute	EFO_0009853	ENSG00000082556	28216264	Lynch et al. (2017)	OPRK1	UBERON_0001016	""
decreased anxiety	nervous system	inhibition_acute	EFO_0009874	ENSG00000082556	28216264	Lynch et al. (2017)	OPRK1	UBERON_0001016	""
decreased drinking	nervous system	inhibition_acute	HP_0025382	ENSG00000082556	28216264	Lynch et al. (2017)	OPRK1	UBERON_0001016	""
decreased eating	nervous system	inhibition_acute	HP_0100738	ENSG00000082556	28216264	Lynch et al. (2017)	OPRK1	UBERON_0001016	""
hallucinations	gastrointestinal	activation_acute	HP_0000738	ENSG00000082556	28216264	Lynch et al. (2017)	OPRK1	UBERON_0005409	""
decreased then increased drinking	nervous system	activation_acute	HP_0030082	ENSG00000082556	28216264	Lynch et al. (2017)	OPRK1	UBERON_0001016	""
decreased blood pressure	nervous system	activation_acute	EFO_0005251	ENSG00000082556	28216264	Lynch et al. (2017)	OPRK1	UBERON_0001016	""
decreased then increased drinking	cardiovascular	activation_acute	HP_0030082	ENSG00000082556	28216264	Lynch et al. (2017)	OPRK1	UBERON_0004535	""
increased pain	cardiovascular	inhibition_acute	GO_1904058	ENSG00000082556	28216264	Lynch et al. (2017)	OPRK1	UBERON_0004535	""
increased convulsions	cardiovascular	inhibition_acute	EFO_0009853	ENSG00000082556	28216264	Lynch et al. (2017)	OPRK1	UBERON_0004535	""
decreased anxiety	cardiovascular	inhibition_acute	EFO_0009874	ENSG00000082556	28216264	Lynch et al. (2017)	OPRK1	UBERON_0004535	""
decreased drinking	cardiovascular	inhibition_acute	HP_0025382	ENSG00000082556	28216264	Lynch et al. (2017)	OPRK1	UBERON_0004535	""
decreased eating	cardiovascular	inhibition_acute	HP_0100738	ENSG00000082556	28216264	Lynch et al. (2017)	OPRK1	UBERON_0004535	""
drug abuse/dependence	gastrointestinal	activation_acute	EFO_0003890	ENSG00000082556	28216264	Lynch et al. (2017)	OPRK1	UBERON_0005409	""
decreased/increased heart rate	gastrointestinal	activation_acute	HP_0031860	ENSG00000082556	28216264	Lynch et al. (2017)	OPRK1	UBERON_0005409	""
hallucinations	nervous system	activation_acute	HP_0000738	ENSG00000082556	28216264	Lynch et al. (2017)	OPRK1	UBERON_0001016	""
decreased body temperature	nervous system	activation_acute	HP_0002045	ENSG00000082556	28216264	Lynch et al. (2017)	OPRK1	UBERON_0001016	""
increased urine excretion	cardiovascular	activation_acute	HP_0000103	ENSG00000082556	28216264	Lynch et al. (2017)	OPRK1	UBERON_0004535	""
dysphoria	cardiovascular	activation_acute	EFO_0009867	ENSG00000082556	28216264	Lynch et al. (2017)	OPRK1	UBERON_0004535	""
decreased body temperature	cardiovascular	activation_acute	HP_0002045	ENSG00000082556	28216264	Lynch et al. (2017)	OPRK1	UBERON_0004535	""
dizziness	cardiovascular	activation_acute	EFO_0009847	ENSG00000082556	28216264	Lynch et al. (2017)	OPRK1	UBERON_0004535	""
decreased convulsions	nervous system	activation_acute	EFO_0009853	ENSG00000082556	28216264	Lynch et al. (2017)	OPRK1	UBERON_0001016	""
decreased convulsions	gastrointestinal	activation_acute	EFO_0009853	ENSG00000082556	28216264	Lynch et al. (2017)	OPRK1	UBERON_0005409	""
decreased locomotor activity	cardiovascular	activation_acute	GO_0040013	ENSG00000082556	28216264	Lynch et al. (2017)	OPRK1	UBERON_0004535	""
decreased locomotor activity	gastrointestinal	activation_acute	GO_0040013	ENSG00000082556	28216264	Lynch et al. (2017)	OPRK1	UBERON_0005409	""
decreased then increased drinking	gastrointestinal	activation_acute	HP_0030082	ENSG00000082556	28216264	Lynch et al. (2017)	OPRK1	UBERON_0005409	""
decreased cardiac contractility	gastrointestinal	activation_acute	GO_0045822	ENSG00000082556	28216264	Lynch et al. (2017)	OPRK1	UBERON_0005409	""
decreased/increased heart rate	nervous system	activation_acute	HP_0031860	ENSG00000082556	28216264	Lynch et al. (2017)	OPRK1	UBERON_0001016	""
decreased inflammation	cardiovascular	activation_acute	GO_0050728	ENSG00000082556	28216264	Lynch et al. (2017)	OPRK1	UBERON_0004535	""
drug abuse/dependence	cardiovascular	activation_acute	EFO_0003890	ENSG00000082556	28216264	Lynch et al. (2017)	OPRK1	UBERON_0004535	""
decreased locomotor activity	nervous system	activation_acute	GO_0040013	ENSG00000082556	28216264	Lynch et al. (2017)	OPRK1	UBERON_0001016	""
decreased cardiac contractility	nervous system	activation_acute	GO_0045822	ENSG00000082556	28216264	Lynch et al. (2017)	OPRK1	UBERON_0001016	""
decreased gastrointestinal transit	cardiovascular	activation_acute	HP_0030897	ENSG00000082556	28216264	Lynch et al. (2017)	OPRK1	UBERON_0004535	""
increased urine excretion	nervous system	activation_acute	HP_0000103	ENSG00000082556	28216264	Lynch et al. (2017)	OPRK1	UBERON_0001016	""
drug abuse/dependence	nervous system	activation_acute	EFO_0003890	ENSG00000082556	28216264	Lynch et al. (2017)	OPRK1	UBERON_0001016	""
decreased cardiac contractility	cardiovascular	activation_acute	GO_0045822	ENSG00000082556	28216264	Lynch et al. (2017)	OPRK1	UBERON_0004535	""
decreased pain	nervous system	activation_acute	GO_1904057	ENSG00000082556	28216264	Lynch et al. (2017)	OPRK1	UBERON_0001016	""
decreased body temperature	gastrointestinal	activation_acute	HP_0002045	ENSG00000082556	28216264	Lynch et al. (2017)	OPRK1	UBERON_0005409	""
decreased blood pressure	cardiovascular	activation_acute	EFO_0005251	ENSG00000082556	28216264	Lynch et al. (2017)	OPRK1	UBERON_0004535	""
hallucinations	cardiovascular	activation_acute	HP_0000738	ENSG00000082556	28216264	Lynch et al. (2017)	OPRK1	UBERON_0004535	""
decreased inflammation	gastrointestinal	activation_acute	GO_0050728	ENSG00000082556	28216264	Lynch et al. (2017)	OPRK1	UBERON_0005409	""
decreased/increased heart rate	cardiovascular	activation_acute	HP_0031860	ENSG00000082556	28216264	Lynch et al. (2017)	OPRK1	UBERON_0004535	""
decreased pain	gastrointestinal	activation_acute	GO_1904057	ENSG00000082556	28216264	Lynch et al. (2017)	OPRK1	UBERON_0005409	""
increased/decreased eating	cardiovascular	activation_acute	HP_0100738	ENSG00000082556	28216264	Lynch et al. (2017)	OPRK1	UBERON_0004535	""
decreased pain	cardiovascular	activation_acute	GO_1904057	ENSG00000082556	28216264	Lynch et al. (2017)	OPRK1	UBERON_0004535	""
dizziness	gastrointestinal	activation_acute	EFO_0009847	ENSG00000082556	28216264	Lynch et al. (2017)	OPRK1	UBERON_0005409	""
increased anxiety	gastrointestinal	activation_acute	EFO_0005230	ENSG00000082556	28216264	Lynch et al. (2017)	OPRK1	UBERON_0005409	""
dysphoria	gastrointestinal	activation_acute	EFO_0009867	ENSG00000082556	28216264	Lynch et al. (2017)	OPRK1	UBERON_0005409	""
increased anxiety	cardiovascular	activation_acute	EFO_0005230	ENSG00000082556	28216264	Lynch et al. (2017)	OPRK1	UBERON_0004535	""
decreased gastrointestinal transit	gastrointestinal	activation_acute	HP_0030897	ENSG00000082556	28216264	Lynch et al. (2017)	OPRK1	UBERON_0005409	""
confusion	cardiovascular	activation_acute	HP_0004372	ENSG00000082556	28216264	Lynch et al. (2017)	OPRK1	UBERON_0004535	""
confusion	nervous system	activation_acute	HP_0004372	ENSG00000082556	28216264	Lynch et al. (2017)	OPRK1	UBERON_0001016	""
decreased gastrointestinal transit	nervous system	activation_acute	HP_0030897	ENSG00000082556	28216264	Lynch et al. (2017)	OPRK1	UBERON_0001016	""
increased/decreased eating	nervous system	activation_acute	HP_0100738	ENSG00000082556	28216264	Lynch et al. (2017)	OPRK1	UBERON_0001016	""
dysphoria	nervous system	activation_acute	EFO_0009867	ENSG00000082556	28216264	Lynch et al. (2017)	OPRK1	UBERON_0001016	""
confusion	gastrointestinal	activation_acute	HP_0004372	ENSG00000082556	28216264	Lynch et al. (2017)	OPRK1	UBERON_0005409	""
decreased convulsions	cardiovascular	activation_acute	EFO_0009853	ENSG00000082556	28216264	Lynch et al. (2017)	OPRK1	UBERON_0004535	""
dizziness	nervous system	activation_acute	EFO_0009847	ENSG00000082556	28216264	Lynch et al. (2017)	OPRK1	UBERON_0001016	""
decreased inflammation	nervous system	activation_acute	GO_0050728	ENSG00000082556	28216264	Lynch et al. (2017)	OPRK1	UBERON_0001016	""
increased/decreased eating	gastrointestinal	activation_acute	HP_0100738	ENSG00000082556	28216264	Lynch et al. (2017)	OPRK1	UBERON_0005409	""
increased urine excretion	gastrointestinal	activation_acute	HP_0000103	ENSG00000082556	28216264	Lynch et al. (2017)	OPRK1	UBERON_0005409	""
decreased convulsions	central nervous system	activation_acute	EFO_0009853	ENSG00000022355	28216264	Lynch et al. (2017)	GABRA1	UBERON_0001017	""
convulsions	central nervous system	inhibition_acute	EFO_0009853	ENSG00000022355	28216264	Lynch et al. (2017)	GABRA1	UBERON_0001017	""
decreased sleep	central nervous system	inhibition_acute	EFO_0008568	ENSG00000022355	28216264	Lynch et al. (2017)	GABRA1	UBERON_0001017	""
drug abuse/dependence	cardiovascular	activation_acute	EFO_0003890	ENSG00000022355	28216264	Lynch et al. (2017)	GABRA1	UBERON_0004535	""
convulsions	cardiovascular	inhibition_acute	EFO_0009853	ENSG00000022355	28216264	Lynch et al. (2017)	GABRA1	UBERON_0004535	""
decreased sleep	cardiovascular	inhibition_acute	EFO_0008568	ENSG00000022355	28216264	Lynch et al. (2017)	GABRA1	UBERON_0004535	""
increased eating	cardiovascular	activation_acute	HP_0100738	ENSG00000022355	28216264	Lynch et al. (2017)	GABRA1	UBERON_0004535	""
muscle relaxation	cardiovascular	activation_acute	""	ENSG00000022355	28216264	Lynch et al. (2017)	GABRA1	UBERON_0004535	""
increased sleep	cardiovascular	activation_acute	EFO_0008568	ENSG00000022355	28216264	Lynch et al. (2017)	GABRA1	UBERON_0004535	""
decreased blood pressure	central nervous system	activation_acute	EFO_0005251	ENSG00000022355	28216264	Lynch et al. (2017)	GABRA1	UBERON_0001017	""
decreased locomotor activity	central nervous system	activation_acute	GO_0040013	ENSG00000022355	28216264	Lynch et al. (2017)	GABRA1	UBERON_0001017	""
decreased memory	cardiovascular	activation_acute	EFO_0001072	ENSG00000022355	28216264	Lynch et al. (2017)	GABRA1	UBERON_0004535	""
increased eating	central nervous system	activation_acute	HP_0100738	ENSG00000022355	28216264	Lynch et al. (2017)	GABRA1	UBERON_0001017	""
decreased anxiety	central nervous system	activation_acute	EFO_0009874	ENSG00000022355	28216264	Lynch et al. (2017)	GABRA1	UBERON_0001017	""
muscle relaxation	central nervous system	activation_acute	""	ENSG00000022355	28216264	Lynch et al. (2017)	GABRA1	UBERON_0001017	""
decreased anxiety	cardiovascular	activation_acute	EFO_0009874	ENSG00000022355	28216264	Lynch et al. (2017)	GABRA1	UBERON_0004535	""
decreased convulsions	cardiovascular	activation_acute	EFO_0009853	ENSG00000022355	28216264	Lynch et al. (2017)	GABRA1	UBERON_0004535	""
decreased pain	central nervous system	activation_acute	GO_1904057	ENSG00000022355	28216264	Lynch et al. (2017)	GABRA1	UBERON_0001017	""
ataxia	central nervous system	activation_acute	MONDO_0000437	ENSG00000022355	28216264	Lynch et al. (2017)	GABRA1	UBERON_0001017	""
ataxia	cardiovascular	activation_acute	MONDO_0000437	ENSG00000022355	28216264	Lynch et al. (2017)	GABRA1	UBERON_0004535	""
increased sleep	central nervous system	activation_acute	EFO_0008568	ENSG00000022355	28216264	Lynch et al. (2017)	GABRA1	UBERON_0001017	""
decreased body temperature	central nervous system	activation_acute	HP_0002045	ENSG00000022355	28216264	Lynch et al. (2017)	GABRA1	UBERON_0001017	""
increased respiratory rate	central nervous system	activation_acute	EFO_0009840	ENSG00000022355	28216264	Lynch et al. (2017)	GABRA1	UBERON_0001017	""
drug abuse/dependence	central nervous system	activation_acute	EFO_0003890	ENSG00000022355	28216264	Lynch et al. (2017)	GABRA1	UBERON_0001017	""
decreased cardiac contractility	central nervous system	activation_acute	GO_0045822	ENSG00000022355	28216264	Lynch et al. (2017)	GABRA1	UBERON_0001017	""
decreased pain	cardiovascular	activation_acute	GO_1904057	ENSG00000022355	28216264	Lynch et al. (2017)	GABRA1	UBERON_0004535	""
decreased memory	central nervous system	activation_acute	EFO_0001072	ENSG00000022355	28216264	Lynch et al. (2017)	GABRA1	UBERON_0001017	""
increased respiratory rate	cardiovascular	activation_acute	EFO_0009840	ENSG00000022355	28216264	Lynch et al. (2017)	GABRA1	UBERON_0004535	""
decreased cardiac contractility	cardiovascular	activation_acute	GO_0045822	ENSG00000022355	28216264	Lynch et al. (2017)	GABRA1	UBERON_0004535	""
increased cardiac output	cardiovascular	activation_acute	EFO_0009872	ENSG00000022355	28216264	Lynch et al. (2017)	GABRA1	UBERON_0004535	""
increased cardiac output	central nervous system	activation_acute	EFO_0009872	ENSG00000022355	28216264	Lynch et al. (2017)	GABRA1	UBERON_0001017	""
decreased locomotor activity	cardiovascular	activation_acute	GO_0040013	ENSG00000022355	28216264	Lynch et al. (2017)	GABRA1	UBERON_0004535	""
decreased body temperature	cardiovascular	activation_acute	HP_0002045	ENSG00000022355	28216264	Lynch et al. (2017)	GABRA1	UBERON_0004535	""
decreased blood pressure	cardiovascular	activation_acute	EFO_0005251	ENSG00000022355	28216264	Lynch et al. (2017)	GABRA1	UBERON_0004535	""
convulsions	cardiovascular	activation_acute	EFO_0009853	ENSG00000183454	28216264	Lynch et al. (2017)	GRIN2A	UBERON_0004535	""
decreased pain	cardiovascular	inhibition_acute	GO_1904057	ENSG00000183454	28216264	Lynch et al. (2017)	GRIN2A	UBERON_0004535	""
impaired social interactions	cardiovascular	inhibition_chronic	HP_0000735	ENSG00000183454	28216264	Lynch et al. (2017)	GRIN2A	UBERON_0004535	""
stereotypy	cardiovascular	inhibition_chronic	HP_0000733	ENSG00000183454	28216264	Lynch et al. (2017)	GRIN2A	UBERON_0004535	""
psychosis	cardiovascular	inhibition_chronic	EFO_0005407	ENSG00000183454	28216264	Lynch et al. (2017)	GRIN2A	UBERON_0004535	""
neurodegeneration	cardiovascular	inhibition_chronic	HP_0002180	ENSG00000183454	28216264	Lynch et al. (2017)	GRIN2A	UBERON_0004535	""
increased locomotor activity	cardiovascular	inhibition_acute	GO_0040017	ENSG00000183454	28216264	Lynch et al. (2017)	GRIN2A	UBERON_0004535	""
ataxia	cardiovascular	inhibition_acute	MONDO_0000437	ENSG00000183454	28216264	Lynch et al. (2017)	GRIN2A	UBERON_0004535	""
dizziness	cardiovascular	inhibition_acute	EFO_0009847	ENSG00000183454	28216264	Lynch et al. (2017)	GRIN2A	UBERON_0004535	""
decreased memory	cardiovascular	inhibition_acute	EFO_0001072	ENSG00000183454	28216264	Lynch et al. (2017)	GRIN2A	UBERON_0004535	""
psychosis	cardiovascular	inhibition_acute	EFO_0005407	ENSG00000183454	28216264	Lynch et al. (2017)	GRIN2A	UBERON_0004535	""
decreased convulsions	cardiovascular	inhibition_acute	EFO_0009853	ENSG00000183454	28216264	Lynch et al. (2017)	GRIN2A	UBERON_0004535	""
drug abuse/dependence	cardiovascular	inhibition_acute	EFO_0003890	ENSG00000183454	28216264	Lynch et al. (2017)	GRIN2A	UBERON_0004535	""
neurotoxicity	cardiovascular	inhibition_acute	EFO_0005595	ENSG00000183454	28216264	Lynch et al. (2017)	GRIN2A	UBERON_0004535	""
increased blood pressure	cardiovascular	inhibition_acute	HP_0032263	ENSG00000183454	28216264	Lynch et al. (2017)	GRIN2A	UBERON_0004535	""
increased heart rate	cardiovascular	inhibition_acute	HP_0001649	ENSG00000183454	28216264	Lynch et al. (2017)	GRIN2A	UBERON_0004535	""
pain	central nervous system	activation_acute	EFO_0003843	ENSG00000183454	28216264	Lynch et al. (2017)	GRIN2A	UBERON_0001017	""
decreased pain	central nervous system	inhibition_acute	GO_1904057	ENSG00000183454	28216264	Lynch et al. (2017)	GRIN2A	UBERON_0001017	""
impaired social interactions	central nervous system	inhibition_chronic	HP_0000735	ENSG00000183454	28216264	Lynch et al. (2017)	GRIN2A	UBERON_0001017	""
stereotypy	central nervous system	inhibition_chronic	HP_0000733	ENSG00000183454	28216264	Lynch et al. (2017)	GRIN2A	UBERON_0001017	""
psychosis	central nervous system	inhibition_chronic	EFO_0005407	ENSG00000183454	28216264	Lynch et al. (2017)	GRIN2A	UBERON_0001017	""
neurodegeneration	central nervous system	inhibition_chronic	HP_0002180	ENSG00000183454	28216264	Lynch et al. (2017)	GRIN2A	UBERON_0001017	""
increased locomotor activity	central nervous system	inhibition_acute	GO_0040017	ENSG00000183454	28216264	Lynch et al. (2017)	GRIN2A	UBERON_0001017	""
ataxia	central nervous system	inhibition_acute	MONDO_0000437	ENSG00000183454	28216264	Lynch et al. (2017)	GRIN2A	UBERON_0001017	""
dizziness	central nervous system	inhibition_acute	EFO_0009847	ENSG00000183454	28216264	Lynch et al. (2017)	GRIN2A	UBERON_0001017	""
decreased memory	central nervous system	inhibition_acute	EFO_0001072	ENSG00000183454	28216264	Lynch et al. (2017)	GRIN2A	UBERON_0001017	""
psychosis	central nervous system	inhibition_acute	EFO_0005407	ENSG00000183454	28216264	Lynch et al. (2017)	GRIN2A	UBERON_0001017	""
decreased convulsions	central nervous system	inhibition_acute	EFO_0009853	ENSG00000183454	28216264	Lynch et al. (2017)	GRIN2A	UBERON_0001017	""
drug abuse/dependence	central nervous system	inhibition_acute	EFO_0003890	ENSG00000183454	28216264	Lynch et al. (2017)	GRIN2A	UBERON_0001017	""
neurotoxicity	central nervous system	inhibition_acute	EFO_0005595	ENSG00000183454	28216264	Lynch et al. (2017)	GRIN2A	UBERON_0001017	""
increased blood pressure	central nervous system	inhibition_acute	HP_0032263	ENSG00000183454	28216264	Lynch et al. (2017)	GRIN2A	UBERON_0001017	""
increased heart rate	central nervous system	inhibition_acute	HP_0001649	ENSG00000183454	28216264	Lynch et al. (2017)	GRIN2A	UBERON_0001017	""
increased blood pressure	cardiovascular	activation_acute	HP_0032263	ENSG00000183454	28216264	Lynch et al. (2017)	GRIN2A	UBERON_0004535	""
increased then decreased heart rate	cardiovascular	activation_acute	HP_0031860	ENSG00000183454	28216264	Lynch et al. (2017)	GRIN2A	UBERON_0004535	""
increased then decreased heart rate	central nervous system	activation_acute	HP_0031860	ENSG00000183454	28216264	Lynch et al. (2017)	GRIN2A	UBERON_0001017	""
increased blood pressure	central nervous system	activation_acute	HP_0032263	ENSG00000183454	28216264	Lynch et al. (2017)	GRIN2A	UBERON_0001017	""
pain	cardiovascular	activation_acute	EFO_0003843	ENSG00000183454	28216264	Lynch et al. (2017)	GRIN2A	UBERON_0004535	""
convulsions	central nervous system	activation_acute	EFO_0009853	ENSG00000183454	28216264	Lynch et al. (2017)	GRIN2A	UBERON_0001017	""
decreased anxiety	immune	activation_acute	EFO_0009874	ENSG00000100300	28216264	Lynch et al. (2017)	TSPO	UBERON_0002405	""
decreased convulsions	immune	inhibition_acute	EFO_0009853	ENSG00000100300	28216264	Lynch et al. (2017)	TSPO	UBERON_0002405	""
decreased inflammation	immune	inhibition_acute	GO_0050728	ENSG00000100300	28216264	Lynch et al. (2017)	TSPO	UBERON_0002405	""
decreased inflammation	immune	activation_acute	GO_0050728	ENSG00000100300	28216264	Lynch et al. (2017)	TSPO	UBERON_0002405	""
decreased inflammation	central nervous system	activation_acute	GO_0050728	ENSG00000100300	28216264	Lynch et al. (2017)	TSPO	UBERON_0001017	""
decreased convulsions	central nervous system	inhibition_acute	EFO_0009853	ENSG00000100300	28216264	Lynch et al. (2017)	TSPO	UBERON_0001017	""
decreased inflammation	central nervous system	inhibition_acute	GO_0050728	ENSG00000100300	28216264	Lynch et al. (2017)	TSPO	UBERON_0001017	""
convulsions	immune	activation_acute	EFO_0009853	ENSG00000100300	28216264	Lynch et al. (2017)	TSPO	UBERON_0002405	""
decreased anxiety	central nervous system	activation_acute	EFO_0009874	ENSG00000100300	28216264	Lynch et al. (2017)	TSPO	UBERON_0001017	""
convulsions	central nervous system	activation_acute	EFO_0009853	ENSG00000100300	28216264	Lynch et al. (2017)	TSPO	UBERON_0001017	""
pulmonary hypertension	blood	activation_acute	EFO_0001361	ENSG00000108576	28216264	Lynch et al. (2017)	SLC6A4	UBERON_0000178	""
decreased/increased anxiety	blood	inhibition_acute	EFO_0005230	ENSG00000108576	28216264	Lynch et al. (2017)	SLC6A4	UBERON_0000178	""
decreased/increased locomotor activity	blood	inhibition_acute	GO_0040012	ENSG00000108576	28216264	Lynch et al. (2017)	SLC6A4	UBERON_0000178	""
decreased platelet aggregation	blood	inhibition_acute	GO_0090331	ENSG00000108576	28216264	Lynch et al. (2017)	SLC6A4	UBERON_0000178	""
nausea	blood	inhibition_acute	HP_0002018	ENSG00000108576	28216264	Lynch et al. (2017)	SLC6A4	UBERON_0000178	""
decreased appetite	blood	inhibition_acute	""	ENSG00000108576	28216264	Lynch et al. (2017)	SLC6A4	UBERON_0000178	""
decreased eating	blood	inhibition_acute	HP_0100738	ENSG00000108576	28216264	Lynch et al. (2017)	SLC6A4	UBERON_0000178	""
decreased body weight	blood	inhibition_acute	EFO_0005245	ENSG00000108576	28216264	Lynch et al. (2017)	SLC6A4	UBERON_0000178	""
diarrhea	blood	inhibition_acute	HP_0002014	ENSG00000108576	28216264	Lynch et al. (2017)	SLC6A4	UBERON_0000178	""
constipation	blood	inhibition_acute	HP_0002019	ENSG00000108576	28216264	Lynch et al. (2017)	SLC6A4	UBERON_0000178	""
dry mouth	blood	inhibition_acute	EFO_0009869	ENSG00000108576	28216264	Lynch et al. (2017)	SLC6A4	UBERON_0000178	""
headache	blood	inhibition_acute	HP_0002315	ENSG00000108576	28216264	Lynch et al. (2017)	SLC6A4	UBERON_0000178	""
dizziness	blood	inhibition_acute	EFO_0009847	ENSG00000108576	28216264	Lynch et al. (2017)	SLC6A4	UBERON_0000178	""
decreased sleep	blood	inhibition_acute	EFO_0008568	ENSG00000108576	28216264	Lynch et al. (2017)	SLC6A4	UBERON_0000178	""
agitation	blood	inhibition_acute	NCIT_C74532	ENSG00000108576	28216264	Lynch et al. (2017)	SLC6A4	UBERON_0000178	""
tremor	blood	inhibition_acute	HP_0001337	ENSG00000108576	28216264	Lynch et al. (2017)	SLC6A4	UBERON_0000178	""
pulmonary hypertension	gastrointestinal	activation_acute	EFO_0001361	ENSG00000108576	28216264	Lynch et al. (2017)	SLC6A4	UBERON_0005409	""
decreased/increased anxiety	gastrointestinal	inhibition_acute	EFO_0005230	ENSG00000108576	28216264	Lynch et al. (2017)	SLC6A4	UBERON_0005409	""
decreased/increased locomotor activity	gastrointestinal	inhibition_acute	GO_0040012	ENSG00000108576	28216264	Lynch et al. (2017)	SLC6A4	UBERON_0005409	""
decreased platelet aggregation	gastrointestinal	inhibition_acute	GO_0090331	ENSG00000108576	28216264	Lynch et al. (2017)	SLC6A4	UBERON_0005409	""
nausea	gastrointestinal	inhibition_acute	HP_0002018	ENSG00000108576	28216264	Lynch et al. (2017)	SLC6A4	UBERON_0005409	""
decreased appetite	gastrointestinal	inhibition_acute	""	ENSG00000108576	28216264	Lynch et al. (2017)	SLC6A4	UBERON_0005409	""
decreased eating	gastrointestinal	inhibition_acute	HP_0100738	ENSG00000108576	28216264	Lynch et al. (2017)	SLC6A4	UBERON_0005409	""
decreased body weight	gastrointestinal	inhibition_acute	EFO_0005245	ENSG00000108576	28216264	Lynch et al. (2017)	SLC6A4	UBERON_0005409	""
diarrhea	gastrointestinal	inhibition_acute	HP_0002014	ENSG00000108576	28216264	Lynch et al. (2017)	SLC6A4	UBERON_0005409	""
constipation	gastrointestinal	inhibition_acute	HP_0002019	ENSG00000108576	28216264	Lynch et al. (2017)	SLC6A4	UBERON_0005409	""
dry mouth	gastrointestinal	inhibition_acute	EFO_0009869	ENSG00000108576	28216264	Lynch et al. (2017)	SLC6A4	UBERON_0005409	""
headache	gastrointestinal	inhibition_acute	HP_0002315	ENSG00000108576	28216264	Lynch et al. (2017)	SLC6A4	UBERON_0005409	""
dizziness	gastrointestinal	inhibition_acute	EFO_0009847	ENSG00000108576	28216264	Lynch et al. (2017)	SLC6A4	UBERON_0005409	""
decreased sleep	gastrointestinal	inhibition_acute	EFO_0008568	ENSG00000108576	28216264	Lynch et al. (2017)	SLC6A4	UBERON_0005409	""
agitation	gastrointestinal	inhibition_acute	NCIT_C74532	ENSG00000108576	28216264	Lynch et al. (2017)	SLC6A4	UBERON_0005409	""
tremor	gastrointestinal	inhibition_acute	HP_0001337	ENSG00000108576	28216264	Lynch et al. (2017)	SLC6A4	UBERON_0005409	""
pulmonary hypertension	central nervous system	activation_acute	EFO_0001361	ENSG00000108576	28216264	Lynch et al. (2017)	SLC6A4	UBERON_0001017	""
decreased/increased anxiety	central nervous system	inhibition_acute	EFO_0005230	ENSG00000108576	28216264	Lynch et al. (2017)	SLC6A4	UBERON_0001017	""
decreased/increased locomotor activity	central nervous system	inhibition_acute	GO_0040012	ENSG00000108576	28216264	Lynch et al. (2017)	SLC6A4	UBERON_0001017	""
decreased platelet aggregation	central nervous system	inhibition_acute	GO_0090331	ENSG00000108576	28216264	Lynch et al. (2017)	SLC6A4	UBERON_0001017	""
nausea	central nervous system	inhibition_acute	HP_0002018	ENSG00000108576	28216264	Lynch et al. (2017)	SLC6A4	UBERON_0001017	""
decreased appetite	central nervous system	inhibition_acute	""	ENSG00000108576	28216264	Lynch et al. (2017)	SLC6A4	UBERON_0001017	""
decreased eating	central nervous system	inhibition_acute	HP_0100738	ENSG00000108576	28216264	Lynch et al. (2017)	SLC6A4	UBERON_0001017	""
decreased body weight	central nervous system	inhibition_acute	EFO_0005245	ENSG00000108576	28216264	Lynch et al. (2017)	SLC6A4	UBERON_0001017	""
diarrhea	central nervous system	inhibition_acute	HP_0002014	ENSG00000108576	28216264	Lynch et al. (2017)	SLC6A4	UBERON_0001017	""
constipation	central nervous system	inhibition_acute	HP_0002019	ENSG00000108576	28216264	Lynch et al. (2017)	SLC6A4	UBERON_0001017	""
dry mouth	central nervous system	inhibition_acute	EFO_0009869	ENSG00000108576	28216264	Lynch et al. (2017)	SLC6A4	UBERON_0001017	""
headache	central nervous system	inhibition_acute	HP_0002315	ENSG00000108576	28216264	Lynch et al. (2017)	SLC6A4	UBERON_0001017	""
dizziness	central nervous system	inhibition_acute	EFO_0009847	ENSG00000108576	28216264	Lynch et al. (2017)	SLC6A4	UBERON_0001017	""
decreased sleep	central nervous system	inhibition_acute	EFO_0008568	ENSG00000108576	28216264	Lynch et al. (2017)	SLC6A4	UBERON_0001017	""
agitation	central nervous system	inhibition_acute	NCIT_C74532	ENSG00000108576	28216264	Lynch et al. (2017)	SLC6A4	UBERON_0001017	""
tremor	central nervous system	inhibition_acute	HP_0001337	ENSG00000108576	28216264	Lynch et al. (2017)	SLC6A4	UBERON_0001017	""
pulmonary hypertension	cardiovascular	activation_acute	EFO_0001361	ENSG00000108576	28216264	Lynch et al. (2017)	SLC6A4	UBERON_0004535	""
decreased/increased anxiety	cardiovascular	inhibition_acute	EFO_0005230	ENSG00000108576	28216264	Lynch et al. (2017)	SLC6A4	UBERON_0004535	""
decreased/increased locomotor activity	cardiovascular	inhibition_acute	GO_0040012	ENSG00000108576	28216264	Lynch et al. (2017)	SLC6A4	UBERON_0004535	""
decreased platelet aggregation	cardiovascular	inhibition_acute	GO_0090331	ENSG00000108576	28216264	Lynch et al. (2017)	SLC6A4	UBERON_0004535	""
nausea	cardiovascular	inhibition_acute	HP_0002018	ENSG00000108576	28216264	Lynch et al. (2017)	SLC6A4	UBERON_0004535	""
decreased appetite	cardiovascular	inhibition_acute	""	ENSG00000108576	28216264	Lynch et al. (2017)	SLC6A4	UBERON_0004535	""
decreased eating	cardiovascular	inhibition_acute	HP_0100738	ENSG00000108576	28216264	Lynch et al. (2017)	SLC6A4	UBERON_0004535	""
decreased body weight	cardiovascular	inhibition_acute	EFO_0005245	ENSG00000108576	28216264	Lynch et al. (2017)	SLC6A4	UBERON_0004535	""
diarrhea	cardiovascular	inhibition_acute	HP_0002014	ENSG00000108576	28216264	Lynch et al. (2017)	SLC6A4	UBERON_0004535	""
constipation	cardiovascular	inhibition_acute	HP_0002019	ENSG00000108576	28216264	Lynch et al. (2017)	SLC6A4	UBERON_0004535	""
dry mouth	cardiovascular	inhibition_acute	EFO_0009869	ENSG00000108576	28216264	Lynch et al. (2017)	SLC6A4	UBERON_0004535	""
headache	cardiovascular	inhibition_acute	HP_0002315	ENSG00000108576	28216264	Lynch et al. (2017)	SLC6A4	UBERON_0004535	""
dizziness	cardiovascular	inhibition_acute	EFO_0009847	ENSG00000108576	28216264	Lynch et al. (2017)	SLC6A4	UBERON_0004535	""
decreased sleep	cardiovascular	inhibition_acute	EFO_0008568	ENSG00000108576	28216264	Lynch et al. (2017)	SLC6A4	UBERON_0004535	""
agitation	cardiovascular	inhibition_acute	NCIT_C74532	ENSG00000108576	28216264	Lynch et al. (2017)	SLC6A4	UBERON_0004535	""
tremor	cardiovascular	inhibition_acute	HP_0001337	ENSG00000108576	28216264	Lynch et al. (2017)	SLC6A4	UBERON_0004535	""
decreased urinary sodium excretion	cardiovascular	activation_acute	GO_0035814	ENSG00000181408	28216264	Lynch et al. (2017)	UTS2R	UBERON_0004535	""
increased urine excretion	cardiovascular	inhibition_acute	HP_0000103	ENSG00000181408	28216264	Lynch et al. (2017)	UTS2R	UBERON_0004535	""
increased urinary sodium excretion	cardiovascular	inhibition_acute	GO_0035815	ENSG00000181408	28216264	Lynch et al. (2017)	UTS2R	UBERON_0004535	""
decreased blood glucose	cardiovascular	inhibition_acute	HP_0001943	ENSG00000181408	28216264	Lynch et al. (2017)	UTS2R	UBERON_0004535	""
decreased inflammation	cardiovascular	inhibition_acute	GO_0050728	ENSG00000181408	28216264	Lynch et al. (2017)	UTS2R	UBERON_0004535	""
decreased blood pressure	cardiovascular	inhibition_acute	EFO_0005251	ENSG00000181408	28216264	Lynch et al. (2017)	UTS2R	UBERON_0004535	""
decreased blood pressure	renal	activation_acute	EFO_0005251	ENSG00000181408	28216264	Lynch et al. (2017)	UTS2R	UBERON_0001008	""
increased urine excretion	renal	inhibition_acute	HP_0000103	ENSG00000181408	28216264	Lynch et al. (2017)	UTS2R	UBERON_0001008	""
increased urinary sodium excretion	renal	inhibition_acute	GO_0035815	ENSG00000181408	28216264	Lynch et al. (2017)	UTS2R	UBERON_0001008	""
decreased blood glucose	renal	inhibition_acute	HP_0001943	ENSG00000181408	28216264	Lynch et al. (2017)	UTS2R	UBERON_0001008	""
decreased inflammation	renal	inhibition_acute	GO_0050728	ENSG00000181408	28216264	Lynch et al. (2017)	UTS2R	UBERON_0001008	""
decreased blood pressure	renal	inhibition_acute	EFO_0005251	ENSG00000181408	28216264	Lynch et al. (2017)	UTS2R	UBERON_0001008	""
decreased cardiac contractility	cardiovascular	activation_acute	GO_0045822	ENSG00000181408	28216264	Lynch et al. (2017)	UTS2R	UBERON_0004535	""
decreased urinary sodium excretion	renal	activation_acute	GO_0035814	ENSG00000181408	28216264	Lynch et al. (2017)	UTS2R	UBERON_0001008	""
decreased urinary potassium excretion	renal	activation_acute	HP_0012364	ENSG00000181408	28216264	Lynch et al. (2017)	UTS2R	UBERON_0001008	""
decreased blood pressure	cardiovascular	activation_acute	EFO_0005251	ENSG00000181408	28216264	Lynch et al. (2017)	UTS2R	UBERON_0004535	""
decreased urine excretion	renal	activation_acute	HP_0011037	ENSG00000181408	28216264	Lynch et al. (2017)	UTS2R	UBERON_0001008	""
decreased urine excretion	cardiovascular	activation_acute	HP_0011037	ENSG00000181408	28216264	Lynch et al. (2017)	UTS2R	UBERON_0004535	""
decreased urinary potassium excretion	cardiovascular	activation_acute	HP_0012364	ENSG00000181408	28216264	Lynch et al. (2017)	UTS2R	UBERON_0004535	""
decreased cardiac contractility	renal	activation_acute	GO_0045822	ENSG00000181408	28216264	Lynch et al. (2017)	UTS2R	UBERON_0001008	""
stereotypy	cardiovascular	activation_acute	HP_0000733	ENSG00000178394	28216264	Lynch et al. (2017)	HTR1A	UBERON_0004535	""
increased locomotor activity	cardiovascular	inhibition_acute	GO_0040017	ENSG00000178394	28216264	Lynch et al. (2017)	HTR1A	UBERON_0004535	""
decreased anxiety	cardiovascular	inhibition_acute	EFO_0009874	ENSG00000178394	28216264	Lynch et al. (2017)	HTR1A	UBERON_0004535	""
increased memory	cardiovascular	inhibition_acute	EFO_0004874	ENSG00000178394	28216264	Lynch et al. (2017)	HTR1A	UBERON_0004535	""
decreased sleep	cardiovascular	inhibition_acute	EFO_0008568	ENSG00000178394	28216264	Lynch et al. (2017)	HTR1A	UBERON_0004535	""
paresthesia	cardiovascular	inhibition_acute	HP_0003401	ENSG00000178394	28216264	Lynch et al. (2017)	HTR1A	UBERON_0004535	""
dizziness	cardiovascular	inhibition_acute	EFO_0009847	ENSG00000178394	28216264	Lynch et al. (2017)	HTR1A	UBERON_0004535	""
visual disturbances	cardiovascular	inhibition_acute	MONDO_0021084	ENSG00000178394	28216264	Lynch et al. (2017)	HTR1A	UBERON_0004535	""
decreased body temperature	endocrine	activation_acute	HP_0002045	ENSG00000178394	28216264	Lynch et al. (2017)	HTR1A	UBERON_0000949	""
increased locomotor activity	endocrine	inhibition_acute	GO_0040017	ENSG00000178394	28216264	Lynch et al. (2017)	HTR1A	UBERON_0000949	""
decreased anxiety	endocrine	inhibition_acute	EFO_0009874	ENSG00000178394	28216264	Lynch et al. (2017)	HTR1A	UBERON_0000949	""
increased memory	endocrine	inhibition_acute	EFO_0004874	ENSG00000178394	28216264	Lynch et al. (2017)	HTR1A	UBERON_0000949	""
decreased sleep	endocrine	inhibition_acute	EFO_0008568	ENSG00000178394	28216264	Lynch et al. (2017)	HTR1A	UBERON_0000949	""
paresthesia	endocrine	inhibition_acute	HP_0003401	ENSG00000178394	28216264	Lynch et al. (2017)	HTR1A	UBERON_0000949	""
dizziness	endocrine	inhibition_acute	EFO_0009847	ENSG00000178394	28216264	Lynch et al. (2017)	HTR1A	UBERON_0000949	""
visual disturbances	endocrine	inhibition_acute	MONDO_0021084	ENSG00000178394	28216264	Lynch et al. (2017)	HTR1A	UBERON_0000949	""
increased/decreased sleep	cardiovascular	activation_acute	EFO_0008568	ENSG00000178394	28216264	Lynch et al. (2017)	HTR1A	UBERON_0004535	""
decreased blood pressure	endocrine	activation_acute	EFO_0005251	ENSG00000178394	28216264	Lynch et al. (2017)	HTR1A	UBERON_0000949	""
increased heart rate	nervous system	activation_acute	HP_0001649	ENSG00000178394	28216264	Lynch et al. (2017)	HTR1A	UBERON_0001016	""
increased locomotor activity	nervous system	inhibition_acute	GO_0040017	ENSG00000178394	28216264	Lynch et al. (2017)	HTR1A	UBERON_0001016	""
decreased anxiety	nervous system	inhibition_acute	EFO_0009874	ENSG00000178394	28216264	Lynch et al. (2017)	HTR1A	UBERON_0001016	""
increased memory	nervous system	inhibition_acute	EFO_0004874	ENSG00000178394	28216264	Lynch et al. (2017)	HTR1A	UBERON_0001016	""
decreased sleep	nervous system	inhibition_acute	EFO_0008568	ENSG00000178394	28216264	Lynch et al. (2017)	HTR1A	UBERON_0001016	""
paresthesia	nervous system	inhibition_acute	HP_0003401	ENSG00000178394	28216264	Lynch et al. (2017)	HTR1A	UBERON_0001016	""
dizziness	nervous system	inhibition_acute	EFO_0009847	ENSG00000178394	28216264	Lynch et al. (2017)	HTR1A	UBERON_0001016	""
visual disturbances	nervous system	inhibition_acute	MONDO_0021084	ENSG00000178394	28216264	Lynch et al. (2017)	HTR1A	UBERON_0001016	""
increased heart rate	endocrine	activation_acute	HP_0001649	ENSG00000178394	28216264	Lynch et al. (2017)	HTR1A	UBERON_0000949	""
growth hormone secretion	cardiovascular	activation_acute	GO_0030252	ENSG00000178394	28216264	Lynch et al. (2017)	HTR1A	UBERON_0004535	""
growth hormone secretion	endocrine	activation_acute	GO_0030252	ENSG00000178394	28216264	Lynch et al. (2017)	HTR1A	UBERON_0000949	""
stereotypy	endocrine	activation_acute	HP_0000733	ENSG00000178394	28216264	Lynch et al. (2017)	HTR1A	UBERON_0000949	""
increased/decreased sleep	endocrine	activation_acute	EFO_0008568	ENSG00000178394	28216264	Lynch et al. (2017)	HTR1A	UBERON_0000949	""
stereotypy	nervous system	activation_acute	HP_0000733	ENSG00000178394	28216264	Lynch et al. (2017)	HTR1A	UBERON_0001016	""
decreased aggression	endocrine	activation_acute	EFO_0003015	ENSG00000178394	28216264	Lynch et al. (2017)	HTR1A	UBERON_0000949	""
decreased/increased locomotor activity	cardiovascular	activation_acute	GO_0040012	ENSG00000178394	28216264	Lynch et al. (2017)	HTR1A	UBERON_0004535	""
decreased body temperature	cardiovascular	activation_acute	HP_0002045	ENSG00000178394	28216264	Lynch et al. (2017)	HTR1A	UBERON_0004535	""
cortisol secretion	nervous system	activation_acute	GO_0043400	ENSG00000178394	28216264	Lynch et al. (2017)	HTR1A	UBERON_0001016	""
increased/decreased pupil diameter	cardiovascular	activation_acute	HP_0007686	ENSG00000178394	28216264	Lynch et al. (2017)	HTR1A	UBERON_0004535	""
decreased memory	cardiovascular	activation_acute	EFO_0001072	ENSG00000178394	28216264	Lynch et al. (2017)	HTR1A	UBERON_0004535	""
growth hormone secretion	nervous system	activation_acute	GO_0030252	ENSG00000178394	28216264	Lynch et al. (2017)	HTR1A	UBERON_0001016	""
decreased body temperature	nervous system	activation_acute	HP_0002045	ENSG00000178394	28216264	Lynch et al. (2017)	HTR1A	UBERON_0001016	""
cortisol secretion	cardiovascular	activation_acute	GO_0043400	ENSG00000178394	28216264	Lynch et al. (2017)	HTR1A	UBERON_0004535	""
increased heart rate	cardiovascular	activation_acute	HP_0001649	ENSG00000178394	28216264	Lynch et al. (2017)	HTR1A	UBERON_0004535	""
decreased anxiety	endocrine	activation_acute	EFO_0009874	ENSG00000178394	28216264	Lynch et al. (2017)	HTR1A	UBERON_0000949	""
decreased pain	endocrine	activation_acute	GO_1904057	ENSG00000178394	28216264	Lynch et al. (2017)	HTR1A	UBERON_0000949	""
decreased/increased locomotor activity	endocrine	activation_acute	GO_0040012	ENSG00000178394	28216264	Lynch et al. (2017)	HTR1A	UBERON_0000949	""
increased/decreased sleep	nervous system	activation_acute	EFO_0008568	ENSG00000178394	28216264	Lynch et al. (2017)	HTR1A	UBERON_0001016	""
decreased anxiety	cardiovascular	activation_acute	EFO_0009874	ENSG00000178394	28216264	Lynch et al. (2017)	HTR1A	UBERON_0004535	""
decreased blood pressure	cardiovascular	activation_acute	EFO_0005251	ENSG00000178394	28216264	Lynch et al. (2017)	HTR1A	UBERON_0004535	""
decreased pain	cardiovascular	activation_acute	GO_1904057	ENSG00000178394	28216264	Lynch et al. (2017)	HTR1A	UBERON_0004535	""
decreased memory	nervous system	activation_acute	EFO_0001072	ENSG00000178394	28216264	Lynch et al. (2017)	HTR1A	UBERON_0001016	""
increased adrenocorticotropic hormone	endocrine	activation_acute	HP_0003154	ENSG00000178394	28216264	Lynch et al. (2017)	HTR1A	UBERON_0000949	""
increased/decreased pupil diameter	endocrine	activation_acute	HP_0007686	ENSG00000178394	28216264	Lynch et al. (2017)	HTR1A	UBERON_0000949	""
decreased/increased locomotor activity	nervous system	activation_acute	GO_0040012	ENSG00000178394	28216264	Lynch et al. (2017)	HTR1A	UBERON_0001016	""
increased adrenocorticotropic hormone	cardiovascular	activation_acute	HP_0003154	ENSG00000178394	28216264	Lynch et al. (2017)	HTR1A	UBERON_0004535	""
decreased pain	nervous system	activation_acute	GO_1904057	ENSG00000178394	28216264	Lynch et al. (2017)	HTR1A	UBERON_0001016	""
cortisol secretion	endocrine	activation_acute	GO_0043400	ENSG00000178394	28216264	Lynch et al. (2017)	HTR1A	UBERON_0000949	""
decreased aggression	cardiovascular	activation_acute	EFO_0003015	ENSG00000178394	28216264	Lynch et al. (2017)	HTR1A	UBERON_0004535	""
decreased memory	endocrine	activation_acute	EFO_0001072	ENSG00000178394	28216264	Lynch et al. (2017)	HTR1A	UBERON_0000949	""
decreased aggression	nervous system	activation_acute	EFO_0003015	ENSG00000178394	28216264	Lynch et al. (2017)	HTR1A	UBERON_0001016	""
increased/decreased pupil diameter	nervous system	activation_acute	HP_0007686	ENSG00000178394	28216264	Lynch et al. (2017)	HTR1A	UBERON_0001016	""
increased adrenocorticotropic hormone	nervous system	activation_acute	HP_0003154	ENSG00000178394	28216264	Lynch et al. (2017)	HTR1A	UBERON_0001016	""
decreased anxiety	nervous system	activation_acute	EFO_0009874	ENSG00000178394	28216264	Lynch et al. (2017)	HTR1A	UBERON_0001016	""
decreased blood pressure	nervous system	activation_acute	EFO_0005251	ENSG00000178394	28216264	Lynch et al. (2017)	HTR1A	UBERON_0001016	""
decreased gastrointestinal transit	gastrointestinal	activation_acute	HP_0030897	ENSG00000163394	28216264	Lynch et al. (2017)	CCKAR	UBERON_0005409	""
increased blood pressure	gastrointestinal	activation_chronic	HP_0032263	ENSG00000163394	28216264	Lynch et al. (2017)	CCKAR	UBERON_0005409	""
increased eating	gastrointestinal	inhibition_acute	HP_0100738	ENSG00000163394	28216264	Lynch et al. (2017)	CCKAR	UBERON_0005409	""
increased gastric emptying	gastrointestinal	inhibition_acute	GO_0120062	ENSG00000163394	28216264	Lynch et al. (2017)	CCKAR	UBERON_0005409	""
increased intestinal transit	gastrointestinal	inhibition_acute	HP_0410204	ENSG00000163394	28216264	Lynch et al. (2017)	CCKAR	UBERON_0005409	""
cholestasis	gastrointestinal	inhibition_acute	MONDO_0001751	ENSG00000163394	28216264	Lynch et al. (2017)	CCKAR	UBERON_0005409	""
cholelethiasis	gastrointestinal	inhibition_acute	EFO_0004799	ENSG00000163394	28216264	Lynch et al. (2017)	CCKAR	UBERON_0005409	""
increased heart rate	gastrointestinal	activation_chronic	HP_0001649	ENSG00000163394	28216264	Lynch et al. (2017)	CCKAR	UBERON_0005409	""
anxiety	gastrointestinal	activation_chronic	EFO_0005230	ENSG00000163394	28216264	Lynch et al. (2017)	CCKAR	UBERON_0005409	""
fatigue	gastrointestinal	activation_chronic	HP_0012378	ENSG00000163394	28216264	Lynch et al. (2017)	CCKAR	UBERON_0005409	""
decreased sleep	gastrointestinal	activation_chronic	EFO_0008568	ENSG00000163394	28216264	Lynch et al. (2017)	CCKAR	UBERON_0005409	""
nausea	gastrointestinal	activation_acute	HP_0002018	ENSG00000163394	28216264	Lynch et al. (2017)	CCKAR	UBERON_0005409	""
gas	nervous system	activation_acute	EFO_0009669	ENSG00000163394	28216264	Lynch et al. (2017)	CCKAR	UBERON_0001016	""
increased blood pressure	nervous system	activation_chronic	HP_0032263	ENSG00000163394	28216264	Lynch et al. (2017)	CCKAR	UBERON_0001016	""
increased eating	nervous system	inhibition_acute	HP_0100738	ENSG00000163394	28216264	Lynch et al. (2017)	CCKAR	UBERON_0001016	""
increased gastric emptying	nervous system	inhibition_acute	GO_0120062	ENSG00000163394	28216264	Lynch et al. (2017)	CCKAR	UBERON_0001016	""
increased intestinal transit	nervous system	inhibition_acute	HP_0410204	ENSG00000163394	28216264	Lynch et al. (2017)	CCKAR	UBERON_0001016	""
cholestasis	nervous system	inhibition_acute	MONDO_0001751	ENSG00000163394	28216264	Lynch et al. (2017)	CCKAR	UBERON_0001016	""
cholelethiasis	nervous system	inhibition_acute	EFO_0004799	ENSG00000163394	28216264	Lynch et al. (2017)	CCKAR	UBERON_0001016	""
increased heart rate	nervous system	activation_chronic	HP_0001649	ENSG00000163394	28216264	Lynch et al. (2017)	CCKAR	UBERON_0001016	""
anxiety	nervous system	activation_chronic	EFO_0005230	ENSG00000163394	28216264	Lynch et al. (2017)	CCKAR	UBERON_0001016	""
fatigue	nervous system	activation_chronic	HP_0012378	ENSG00000163394	28216264	Lynch et al. (2017)	CCKAR	UBERON_0001016	""
decreased sleep	nervous system	activation_chronic	EFO_0008568	ENSG00000163394	28216264	Lynch et al. (2017)	CCKAR	UBERON_0001016	""
decreased gastric emptying	gastrointestinal	activation_acute	GO_0120061	ENSG00000163394	28216264	Lynch et al. (2017)	CCKAR	UBERON_0005409	""
decreased eating	nervous system	activation_acute	HP_0100738	ENSG00000163394	28216264	Lynch et al. (2017)	CCKAR	UBERON_0001016	""
decreased body temperature	gastrointestinal	activation_acute	HP_0002045	ENSG00000163394	28216264	Lynch et al. (2017)	CCKAR	UBERON_0005409	""
decreased eating	gallbladder	activation_acute	HP_0100738	ENSG00000163394	28216264	Lynch et al. (2017)	CCKAR	UBERON_0002110	""
increased blood pressure	gallbladder	activation_chronic	HP_0032263	ENSG00000163394	28216264	Lynch et al. (2017)	CCKAR	UBERON_0002110	""
increased eating	gallbladder	inhibition_acute	HP_0100738	ENSG00000163394	28216264	Lynch et al. (2017)	CCKAR	UBERON_0002110	""
increased gastric emptying	gallbladder	inhibition_acute	GO_0120062	ENSG00000163394	28216264	Lynch et al. (2017)	CCKAR	UBERON_0002110	""
increased intestinal transit	gallbladder	inhibition_acute	HP_0410204	ENSG00000163394	28216264	Lynch et al. (2017)	CCKAR	UBERON_0002110	""
cholestasis	gallbladder	inhibition_acute	MONDO_0001751	ENSG00000163394	28216264	Lynch et al. (2017)	CCKAR	UBERON_0002110	""
cholelethiasis	gallbladder	inhibition_acute	EFO_0004799	ENSG00000163394	28216264	Lynch et al. (2017)	CCKAR	UBERON_0002110	""
increased heart rate	gallbladder	activation_chronic	HP_0001649	ENSG00000163394	28216264	Lynch et al. (2017)	CCKAR	UBERON_0002110	""
anxiety	gallbladder	activation_chronic	EFO_0005230	ENSG00000163394	28216264	Lynch et al. (2017)	CCKAR	UBERON_0002110	""
fatigue	gallbladder	activation_chronic	HP_0012378	ENSG00000163394	28216264	Lynch et al. (2017)	CCKAR	UBERON_0002110	""
decreased sleep	gallbladder	activation_chronic	EFO_0008568	ENSG00000163394	28216264	Lynch et al. (2017)	CCKAR	UBERON_0002110	""
decreased locomotor activity	gastrointestinal	activation_acute	GO_0040013	ENSG00000163394	28216264	Lynch et al. (2017)	CCKAR	UBERON_0005409	""
decreased body temperature	nervous system	activation_acute	HP_0002045	ENSG00000163394	28216264	Lynch et al. (2017)	CCKAR	UBERON_0001016	""
decreased gastrointestinal transit	nervous system	activation_acute	HP_0030897	ENSG00000163394	28216264	Lynch et al. (2017)	CCKAR	UBERON_0001016	""
abdominal pain hypersenstivity	gastrointestinal	activation_acute	HP_0002027	ENSG00000163394	28216264	Lynch et al. (2017)	CCKAR	UBERON_0005409	""
decreased gastric emptying	gallbladder	activation_acute	GO_0120061	ENSG00000163394	28216264	Lynch et al. (2017)	CCKAR	UBERON_0002110	""
nausea	nervous system	activation_acute	HP_0002018	ENSG00000163394	28216264	Lynch et al. (2017)	CCKAR	UBERON_0001016	""
decreased locomotor activity	gallbladder	activation_acute	GO_0040013	ENSG00000163394	28216264	Lynch et al. (2017)	CCKAR	UBERON_0002110	""
gallbladder contraction	gastrointestinal	activation_acute	HP_0005609	ENSG00000163394	28216264	Lynch et al. (2017)	CCKAR	UBERON_0005409	""
bloating	gallbladder	activation_acute	HP_0003270	ENSG00000163394	28216264	Lynch et al. (2017)	CCKAR	UBERON_0002110	""
abdominal pain hypersenstivity	nervous system	activation_acute	HP_0002027	ENSG00000163394	28216264	Lynch et al. (2017)	CCKAR	UBERON_0001016	""
decreased body temperature	gallbladder	activation_acute	HP_0002045	ENSG00000163394	28216264	Lynch et al. (2017)	CCKAR	UBERON_0002110	""
bloating	gastrointestinal	activation_acute	HP_0003270	ENSG00000163394	28216264	Lynch et al. (2017)	CCKAR	UBERON_0005409	""
nausea	gallbladder	activation_acute	HP_0002018	ENSG00000163394	28216264	Lynch et al. (2017)	CCKAR	UBERON_0002110	""
decreased gastric emptying	nervous system	activation_acute	GO_0120061	ENSG00000163394	28216264	Lynch et al. (2017)	CCKAR	UBERON_0001016	""
decreased eating	gastrointestinal	activation_acute	HP_0100738	ENSG00000163394	28216264	Lynch et al. (2017)	CCKAR	UBERON_0005409	""
abdominal pain hypersenstivity	gallbladder	activation_acute	HP_0002027	ENSG00000163394	28216264	Lynch et al. (2017)	CCKAR	UBERON_0002110	""
gas	gallbladder	activation_acute	EFO_0009669	ENSG00000163394	28216264	Lynch et al. (2017)	CCKAR	UBERON_0002110	""
gallbladder contraction	nervous system	activation_acute	HP_0005609	ENSG00000163394	28216264	Lynch et al. (2017)	CCKAR	UBERON_0001016	""
decreased gastrointestinal transit	gallbladder	activation_acute	HP_0030897	ENSG00000163394	28216264	Lynch et al. (2017)	CCKAR	UBERON_0002110	""
bloating	nervous system	activation_acute	HP_0003270	ENSG00000163394	28216264	Lynch et al. (2017)	CCKAR	UBERON_0001016	""
gas	gastrointestinal	activation_acute	EFO_0009669	ENSG00000163394	28216264	Lynch et al. (2017)	CCKAR	UBERON_0005409	""
decreased locomotor activity	nervous system	activation_acute	GO_0040013	ENSG00000163394	28216264	Lynch et al. (2017)	CCKAR	UBERON_0001016	""
gallbladder contraction	gallbladder	activation_acute	HP_0005609	ENSG00000163394	28216264	Lynch et al. (2017)	CCKAR	UBERON_0002110	""
decreased gastrointestinal transit	immune	activation_acute	HP_0030897	ENSG00000114812	28216264	Lynch et al. (2017)	VIPR1	UBERON_0002405	""
inflammation	immune	inhibition_acute	GO_0006954	ENSG00000114812	28216264	Lynch et al. (2017)	VIPR1	UBERON_0002405	""
increased gastrointestinal transit	immune	inhibition_acute	HP_0410204	ENSG00000114812	28216264	Lynch et al. (2017)	VIPR1	UBERON_0002405	""
immunosuppression	immune	activation_acute	GO_0050777	ENSG00000114812	28216264	Lynch et al. (2017)	VIPR1	UBERON_0002405	""
decreased gastrointestinal transit	gastrointestinal	activation_acute	HP_0030897	ENSG00000114812	28216264	Lynch et al. (2017)	VIPR1	UBERON_0005409	""
inflammation	gastrointestinal	inhibition_acute	GO_0006954	ENSG00000114812	28216264	Lynch et al. (2017)	VIPR1	UBERON_0005409	""
increased gastrointestinal transit	gastrointestinal	inhibition_acute	HP_0410204	ENSG00000114812	28216264	Lynch et al. (2017)	VIPR1	UBERON_0005409	""
decreased inflammation	gastrointestinal	activation_acute	GO_0050728	ENSG00000114812	28216264	Lynch et al. (2017)	VIPR1	UBERON_0005409	""
decreased inflammation	immune	activation_acute	GO_0050728	ENSG00000114812	28216264	Lynch et al. (2017)	VIPR1	UBERON_0002405	""
immunosuppression	gastrointestinal	activation_acute	GO_0050777	ENSG00000114812	28216264	Lynch et al. (2017)	VIPR1	UBERON_0005409	""
increased blood pressure	renal	activation_acute	HP_0032263	ENSG00000144891	28216264	Lynch et al. (2017)	AGTR1	UBERON_0001008	""
decreased blood pressure	renal	inhibition_acute	EFO_0005251	ENSG00000144891	28216264	Lynch et al. (2017)	AGTR1	UBERON_0001008	""
death	renal	inhibition_developmental toxicity	EFO_0000480	ENSG00000144891	28216264	Lynch et al. (2017)	AGTR1	UBERON_0001008	""
oligoamnios	renal	inhibition_developmental toxicity	EFO_0007401	ENSG00000144891	28216264	Lynch et al. (2017)	AGTR1	UBERON_0001008	""
renal failure	renal	inhibition_developmental toxicity	EFO_1002048	ENSG00000144891	28216264	Lynch et al. (2017)	AGTR1	UBERON_0001008	""
decreased blood pressure	renal	inhibition_developmental toxicity	EFO_0005251	ENSG00000144891	28216264	Lynch et al. (2017)	AGTR1	UBERON_0001008	""
pulmonary hypoplasia	renal	inhibition_developmental toxicity	HP_0002089	ENSG00000144891	28216264	Lynch et al. (2017)	AGTR1	UBERON_0001008	""
respiratory distress syndrome	renal	inhibition_developmental toxicity	EFO_1000644	ENSG00000144891	28216264	Lynch et al. (2017)	AGTR1	UBERON_0001008	""
persistent patent ductus arteriosus	renal	inhibition_developmental toxicity	HP_0001643	ENSG00000144891	28216264	Lynch et al. (2017)	AGTR1	UBERON_0001008	""
hypocalvaria	renal	inhibition_developmental toxicity	HP_0010539	ENSG00000144891	28216264	Lynch et al. (2017)	AGTR1	UBERON_0001008	""
limb defects	renal	inhibition_developmental toxicity	MONDO_0019054	ENSG00000144891	28216264	Lynch et al. (2017)	AGTR1	UBERON_0001008	""
intrauterine growth retardation	renal	inhibition_developmental toxicity	EFO_0000495	ENSG00000144891	28216264	Lynch et al. (2017)	AGTR1	UBERON_0001008	""
cerebral complications	renal	inhibition_developmental toxicity	MONDO_0016054	ENSG00000144891	28216264	Lynch et al. (2017)	AGTR1	UBERON_0001008	""
decreased pain	renal	inhibition_acute	GO_1904057	ENSG00000144891	28216264	Lynch et al. (2017)	AGTR1	UBERON_0001008	""
increased/decreased urine excretion	renal	inhibition_acute	HP_0012590	ENSG00000144891	28216264	Lynch et al. (2017)	AGTR1	UBERON_0001008	""
increased/decreased urinary sodium excretion	renal	inhibition_acute	GO_0035813	ENSG00000144891	28216264	Lynch et al. (2017)	AGTR1	UBERON_0001008	""
increased pain	cardiovascular	activation_acute	GO_1904058	ENSG00000144891	28216264	Lynch et al. (2017)	AGTR1	UBERON_0004535	""
decreased blood pressure	cardiovascular	inhibition_acute	EFO_0005251	ENSG00000144891	28216264	Lynch et al. (2017)	AGTR1	UBERON_0004535	""
death	cardiovascular	inhibition_developmental toxicity	EFO_0000480	ENSG00000144891	28216264	Lynch et al. (2017)	AGTR1	UBERON_0004535	""
oligoamnios	cardiovascular	inhibition_developmental toxicity	EFO_0007401	ENSG00000144891	28216264	Lynch et al. (2017)	AGTR1	UBERON_0004535	""
renal failure	cardiovascular	inhibition_developmental toxicity	EFO_1002048	ENSG00000144891	28216264	Lynch et al. (2017)	AGTR1	UBERON_0004535	""
decreased blood pressure	cardiovascular	inhibition_developmental toxicity	EFO_0005251	ENSG00000144891	28216264	Lynch et al. (2017)	AGTR1	UBERON_0004535	""
pulmonary hypoplasia	cardiovascular	inhibition_developmental toxicity	HP_0002089	ENSG00000144891	28216264	Lynch et al. (2017)	AGTR1	UBERON_0004535	""
respiratory distress syndrome	cardiovascular	inhibition_developmental toxicity	EFO_1000644	ENSG00000144891	28216264	Lynch et al. (2017)	AGTR1	UBERON_0004535	""
persistent patent ductus arteriosus	cardiovascular	inhibition_developmental toxicity	HP_0001643	ENSG00000144891	28216264	Lynch et al. (2017)	AGTR1	UBERON_0004535	""
hypocalvaria	cardiovascular	inhibition_developmental toxicity	HP_0010539	ENSG00000144891	28216264	Lynch et al. (2017)	AGTR1	UBERON_0004535	""
limb defects	cardiovascular	inhibition_developmental toxicity	MONDO_0019054	ENSG00000144891	28216264	Lynch et al. (2017)	AGTR1	UBERON_0004535	""
intrauterine growth retardation	cardiovascular	inhibition_developmental toxicity	EFO_0000495	ENSG00000144891	28216264	Lynch et al. (2017)	AGTR1	UBERON_0004535	""
cerebral complications	cardiovascular	inhibition_developmental toxicity	MONDO_0016054	ENSG00000144891	28216264	Lynch et al. (2017)	AGTR1	UBERON_0004535	""
decreased pain	cardiovascular	inhibition_acute	GO_1904057	ENSG00000144891	28216264	Lynch et al. (2017)	AGTR1	UBERON_0004535	""
increased/decreased urine excretion	cardiovascular	inhibition_acute	HP_0012590	ENSG00000144891	28216264	Lynch et al. (2017)	AGTR1	UBERON_0004535	""
increased/decreased urinary sodium excretion	cardiovascular	inhibition_acute	GO_0035813	ENSG00000144891	28216264	Lynch et al. (2017)	AGTR1	UBERON_0004535	""
increased pain	renal	activation_acute	GO_1904058	ENSG00000144891	28216264	Lynch et al. (2017)	AGTR1	UBERON_0001008	""
decreased urinary sodium excretion	cardiovascular	activation_acute	GO_0035814	ENSG00000144891	28216264	Lynch et al. (2017)	AGTR1	UBERON_0004535	""
decreased urinary sodium excretion	renal	activation_acute	GO_0035814	ENSG00000144891	28216264	Lynch et al. (2017)	AGTR1	UBERON_0001008	""
increased blood pressure	cardiovascular	activation_acute	HP_0032263	ENSG00000144891	28216264	Lynch et al. (2017)	AGTR1	UBERON_0004535	""
decreased pain	cardiovascular	activation_acute	GO_1904057	ENSG00000135312	28216264	Lynch et al. (2017)	HTR1B	UBERON_0004535	""
increased aggression	cardiovascular	inhibition_acute	EFO_0003015	ENSG00000135312	28216264	Lynch et al. (2017)	HTR1B	UBERON_0004535	""
decreased anxiety	cardiovascular	inhibition_acute	EFO_0009874	ENSG00000135312	28216264	Lynch et al. (2017)	HTR1B	UBERON_0004535	""
increased memory	cardiovascular	inhibition_acute	EFO_0004874	ENSG00000135312	28216264	Lynch et al. (2017)	HTR1B	UBERON_0004535	""
decreased memory	nervous system	activation_acute	EFO_0001072	ENSG00000135312	28216264	Lynch et al. (2017)	HTR1B	UBERON_0001016	""
increased aggression	nervous system	inhibition_acute	EFO_0003015	ENSG00000135312	28216264	Lynch et al. (2017)	HTR1B	UBERON_0001016	""
decreased anxiety	nervous system	inhibition_acute	EFO_0009874	ENSG00000135312	28216264	Lynch et al. (2017)	HTR1B	UBERON_0001016	""
increased memory	nervous system	inhibition_acute	EFO_0004874	ENSG00000135312	28216264	Lynch et al. (2017)	HTR1B	UBERON_0001016	""
decreased aggression	cardiovascular	activation_acute	EFO_0003015	ENSG00000135312	28216264	Lynch et al. (2017)	HTR1B	UBERON_0004535	""
increased blood pressure	cardiovascular	activation_acute	HP_0032263	ENSG00000135312	28216264	Lynch et al. (2017)	HTR1B	UBERON_0004535	""
decreased eating	nervous system	activation_acute	HP_0100738	ENSG00000135312	28216264	Lynch et al. (2017)	HTR1B	UBERON_0001016	""
decreased anxiety	nervous system	activation_acute	EFO_0009874	ENSG00000135312	28216264	Lynch et al. (2017)	HTR1B	UBERON_0001016	""
increased blood pressure	nervous system	activation_acute	HP_0032263	ENSG00000135312	28216264	Lynch et al. (2017)	HTR1B	UBERON_0001016	""
decreased memory	cardiovascular	activation_acute	EFO_0001072	ENSG00000135312	28216264	Lynch et al. (2017)	HTR1B	UBERON_0004535	""
decreased eating	cardiovascular	activation_acute	HP_0100738	ENSG00000135312	28216264	Lynch et al. (2017)	HTR1B	UBERON_0004535	""
decreased body temperature	cardiovascular	activation_acute	HP_0002045	ENSG00000135312	28216264	Lynch et al. (2017)	HTR1B	UBERON_0004535	""
decreased pain	nervous system	activation_acute	GO_1904057	ENSG00000135312	28216264	Lynch et al. (2017)	HTR1B	UBERON_0001016	""
decreased body temperature	nervous system	activation_acute	HP_0002045	ENSG00000135312	28216264	Lynch et al. (2017)	HTR1B	UBERON_0001016	""
decreased anxiety	cardiovascular	activation_acute	EFO_0009874	ENSG00000135312	28216264	Lynch et al. (2017)	HTR1B	UBERON_0004535	""
decreased aggression	nervous system	activation_acute	EFO_0003015	ENSG00000135312	28216264	Lynch et al. (2017)	HTR1B	UBERON_0001016	""
immunosuppression	immune	activation_general	GO_0050777	ENSG00000113580	23197038	Bowes et al. (2012)	NR3C1	UBERON_0002405	""
hypoglycaemia	immune	inhibition_general	HP_0001943	ENSG00000113580	23197038	Bowes et al. (2012)	NR3C1	UBERON_0002405	""
hyperglycaemia	immune	activation_general	HP_0003074	ENSG00000113580	23197038	Bowes et al. (2012)	NR3C1	UBERON_0002405	""
insulin resistance	immune	activation_general	EFO_0002614	ENSG00000113580	23197038	Bowes et al. (2012)	NR3C1	UBERON_0002405	""
muscle wasting	immune	activation_general	EFO_0009851	ENSG00000113580	23197038	Bowes et al. (2012)	NR3C1	UBERON_0002405	""
increased body weight	immune	activation_general	EFO_0004566	ENSG00000113580	23197038	Bowes et al. (2012)	NR3C1	UBERON_0002405	""
osteoporosis	immune	activation_general	EFO_0003882	ENSG00000113580	23197038	Bowes et al. (2012)	NR3C1	UBERON_0002405	""
glaucoma	immune	activation_general	EFO_0000516	ENSG00000113580	23197038	Bowes et al. (2012)	NR3C1	UBERON_0002405	""
increased blood pressure	immune	activation_general	HP_0032263	ENSG00000113580	23197038	Bowes et al. (2012)	NR3C1	UBERON_0002405	""
decreased plasma potassium	immune	activation_general	HP_0002900	ENSG00000113580	23197038	Bowes et al. (2012)	NR3C1	UBERON_0002405	""
cardiac arrhythmia	immune	activation_general	EFO_0004269	ENSG00000113580	23197038	Bowes et al. (2012)	NR3C1	UBERON_0002405	""
immunosuppression	endocrine	activation_general	GO_0050777	ENSG00000113580	23197038	Bowes et al. (2012)	NR3C1	UBERON_0000949	""
hypoglycaemia	endocrine	inhibition_general	HP_0001943	ENSG00000113580	23197038	Bowes et al. (2012)	NR3C1	UBERON_0000949	""
hyperglycaemia	endocrine	activation_general	HP_0003074	ENSG00000113580	23197038	Bowes et al. (2012)	NR3C1	UBERON_0000949	""
insulin resistance	endocrine	activation_general	EFO_0002614	ENSG00000113580	23197038	Bowes et al. (2012)	NR3C1	UBERON_0000949	""
muscle wasting	endocrine	activation_general	EFO_0009851	ENSG00000113580	23197038	Bowes et al. (2012)	NR3C1	UBERON_0000949	""
increased body weight	endocrine	activation_general	EFO_0004566	ENSG00000113580	23197038	Bowes et al. (2012)	NR3C1	UBERON_0000949	""
osteoporosis	endocrine	activation_general	EFO_0003882	ENSG00000113580	23197038	Bowes et al. (2012)	NR3C1	UBERON_0000949	""
glaucoma	endocrine	activation_general	EFO_0000516	ENSG00000113580	23197038	Bowes et al. (2012)	NR3C1	UBERON_0000949	""
increased blood pressure	endocrine	activation_general	HP_0032263	ENSG00000113580	23197038	Bowes et al. (2012)	NR3C1	UBERON_0000949	""
decreased plasma potassium	endocrine	activation_general	HP_0002900	ENSG00000113580	23197038	Bowes et al. (2012)	NR3C1	UBERON_0000949	""
cardiac arrhythmia	endocrine	activation_general	EFO_0004269	ENSG00000113580	23197038	Bowes et al. (2012)	NR3C1	UBERON_0000949	""
addictive psychostimulation	central nervous system	inhibition_general	EFO_0003890	ENSG00000142319	23197038	Bowes et al. (2012)	SLC6A3	UBERON_0001017	""
depression	central nervous system	inhibition_general	MONDO_0002050	ENSG00000142319	23197038	Bowes et al. (2012)	SLC6A3	UBERON_0001017	""
parkinsonism	central nervous system	inhibition_general	HP_0001300	ENSG00000142319	23197038	Bowes et al. (2012)	SLC6A3	UBERON_0001017	""
seizures	central nervous system	inhibition_general	HP_0001250	ENSG00000142319	23197038	Bowes et al. (2012)	SLC6A3	UBERON_0001017	""
dystonia	central nervous system	inhibition_general	HP_0001332	ENSG00000142319	23197038	Bowes et al. (2012)	SLC6A3	UBERON_0001017	""
dyskinesia	central nervous system	inhibition_general	EFO_1000904	ENSG00000142319	23197038	Bowes et al. (2012)	SLC6A3	UBERON_0001017	""
acne	central nervous system	inhibition_general	EFO_0003894	ENSG00000142319	23197038	Bowes et al. (2012)	SLC6A3	UBERON_0001017	""
increased cardiac contractility	cardiovascular	inhibition_acute	GO_0045823	ENSG00000163399	28216264	Lynch et al. (2017)	ATP1A1	UBERON_0004535	""
decreased heart rate	cardiovascular	inhibition_acute	HP_0001662	ENSG00000163399	28216264	Lynch et al. (2017)	ATP1A1	UBERON_0004535	""
atrioventricular block	cardiovascular	inhibition_acute	MONDO_0000465	ENSG00000163399	28216264	Lynch et al. (2017)	ATP1A1	UBERON_0004535	""
cardiac arrhythmia	cardiovascular	inhibition_acute	EFO_0004269	ENSG00000163399	28216264	Lynch et al. (2017)	ATP1A1	UBERON_0004535	""
ventricular fibrillation	cardiovascular	inhibition_acute	EFO_0004287	ENSG00000163399	28216264	Lynch et al. (2017)	ATP1A1	UBERON_0004535	""
increased urine excretion	cardiovascular	inhibition_acute	HP_0000103	ENSG00000163399	28216264	Lynch et al. (2017)	ATP1A1	UBERON_0004535	""
increased urinary sodium excretion	cardiovascular	inhibition_acute	GO_0035815	ENSG00000163399	28216264	Lynch et al. (2017)	ATP1A1	UBERON_0004535	""
vomiting	cardiovascular	inhibition_acute	HP_0002017	ENSG00000163399	28216264	Lynch et al. (2017)	ATP1A1	UBERON_0004535	""
increased cardiac contractility	renal	inhibition_acute	GO_0045823	ENSG00000163399	28216264	Lynch et al. (2017)	ATP1A1	UBERON_0001008	""
decreased heart rate	renal	inhibition_acute	HP_0001662	ENSG00000163399	28216264	Lynch et al. (2017)	ATP1A1	UBERON_0001008	""
atrioventricular block	renal	inhibition_acute	MONDO_0000465	ENSG00000163399	28216264	Lynch et al. (2017)	ATP1A1	UBERON_0001008	""
cardiac arrhythmia	renal	inhibition_acute	EFO_0004269	ENSG00000163399	28216264	Lynch et al. (2017)	ATP1A1	UBERON_0001008	""
ventricular fibrillation	renal	inhibition_acute	EFO_0004287	ENSG00000163399	28216264	Lynch et al. (2017)	ATP1A1	UBERON_0001008	""
increased urine excretion	renal	inhibition_acute	HP_0000103	ENSG00000163399	28216264	Lynch et al. (2017)	ATP1A1	UBERON_0001008	""
increased urinary sodium excretion	renal	inhibition_acute	GO_0035815	ENSG00000163399	28216264	Lynch et al. (2017)	ATP1A1	UBERON_0001008	""
vomiting	renal	inhibition_acute	HP_0002017	ENSG00000163399	28216264	Lynch et al. (2017)	ATP1A1	UBERON_0001008	""
convulsions	cardiovascular	activation_acute	EFO_0009853	ENSG00000105464	28216264	Lynch et al. (2017)	GRIN2D	UBERON_0004535	""
decreased pain	cardiovascular	inhibition_acute	GO_1904057	ENSG00000105464	28216264	Lynch et al. (2017)	GRIN2D	UBERON_0004535	""
impaired social interactions	cardiovascular	inhibition_chronic	HP_0000735	ENSG00000105464	28216264	Lynch et al. (2017)	GRIN2D	UBERON_0004535	""
stereotypy	cardiovascular	inhibition_chronic	HP_0000733	ENSG00000105464	28216264	Lynch et al. (2017)	GRIN2D	UBERON_0004535	""
psychosis	cardiovascular	inhibition_chronic	EFO_0005407	ENSG00000105464	28216264	Lynch et al. (2017)	GRIN2D	UBERON_0004535	""
neurodegeneration	cardiovascular	inhibition_chronic	HP_0002180	ENSG00000105464	28216264	Lynch et al. (2017)	GRIN2D	UBERON_0004535	""
increased locomotor activity	cardiovascular	inhibition_acute	GO_0040017	ENSG00000105464	28216264	Lynch et al. (2017)	GRIN2D	UBERON_0004535	""
ataxia	cardiovascular	inhibition_acute	MONDO_0000437	ENSG00000105464	28216264	Lynch et al. (2017)	GRIN2D	UBERON_0004535	""
dizziness	cardiovascular	inhibition_acute	EFO_0009847	ENSG00000105464	28216264	Lynch et al. (2017)	GRIN2D	UBERON_0004535	""
decreased memory	cardiovascular	inhibition_acute	EFO_0001072	ENSG00000105464	28216264	Lynch et al. (2017)	GRIN2D	UBERON_0004535	""
psychosis	cardiovascular	inhibition_acute	EFO_0005407	ENSG00000105464	28216264	Lynch et al. (2017)	GRIN2D	UBERON_0004535	""
decreased convulsions	cardiovascular	inhibition_acute	EFO_0009853	ENSG00000105464	28216264	Lynch et al. (2017)	GRIN2D	UBERON_0004535	""
drug abuse/dependence	cardiovascular	inhibition_acute	EFO_0003890	ENSG00000105464	28216264	Lynch et al. (2017)	GRIN2D	UBERON_0004535	""
neurotoxicity	cardiovascular	inhibition_acute	EFO_0005595	ENSG00000105464	28216264	Lynch et al. (2017)	GRIN2D	UBERON_0004535	""
increased blood pressure	cardiovascular	inhibition_acute	HP_0032263	ENSG00000105464	28216264	Lynch et al. (2017)	GRIN2D	UBERON_0004535	""
increased heart rate	cardiovascular	inhibition_acute	HP_0001649	ENSG00000105464	28216264	Lynch et al. (2017)	GRIN2D	UBERON_0004535	""
pain	cardiovascular	activation_acute	EFO_0003843	ENSG00000105464	28216264	Lynch et al. (2017)	GRIN2D	UBERON_0004535	""
convulsions	central nervous system	activation_acute	EFO_0009853	ENSG00000105464	28216264	Lynch et al. (2017)	GRIN2D	UBERON_0001017	""
decreased pain	central nervous system	inhibition_acute	GO_1904057	ENSG00000105464	28216264	Lynch et al. (2017)	GRIN2D	UBERON_0001017	""
impaired social interactions	central nervous system	inhibition_chronic	HP_0000735	ENSG00000105464	28216264	Lynch et al. (2017)	GRIN2D	UBERON_0001017	""
stereotypy	central nervous system	inhibition_chronic	HP_0000733	ENSG00000105464	28216264	Lynch et al. (2017)	GRIN2D	UBERON_0001017	""
psychosis	central nervous system	inhibition_chronic	EFO_0005407	ENSG00000105464	28216264	Lynch et al. (2017)	GRIN2D	UBERON_0001017	""
neurodegeneration	central nervous system	inhibition_chronic	HP_0002180	ENSG00000105464	28216264	Lynch et al. (2017)	GRIN2D	UBERON_0001017	""
increased locomotor activity	central nervous system	inhibition_acute	GO_0040017	ENSG00000105464	28216264	Lynch et al. (2017)	GRIN2D	UBERON_0001017	""
ataxia	central nervous system	inhibition_acute	MONDO_0000437	ENSG00000105464	28216264	Lynch et al. (2017)	GRIN2D	UBERON_0001017	""
dizziness	central nervous system	inhibition_acute	EFO_0009847	ENSG00000105464	28216264	Lynch et al. (2017)	GRIN2D	UBERON_0001017	""
decreased memory	central nervous system	inhibition_acute	EFO_0001072	ENSG00000105464	28216264	Lynch et al. (2017)	GRIN2D	UBERON_0001017	""
psychosis	central nervous system	inhibition_acute	EFO_0005407	ENSG00000105464	28216264	Lynch et al. (2017)	GRIN2D	UBERON_0001017	""
decreased convulsions	central nervous system	inhibition_acute	EFO_0009853	ENSG00000105464	28216264	Lynch et al. (2017)	GRIN2D	UBERON_0001017	""
drug abuse/dependence	central nervous system	inhibition_acute	EFO_0003890	ENSG00000105464	28216264	Lynch et al. (2017)	GRIN2D	UBERON_0001017	""
neurotoxicity	central nervous system	inhibition_acute	EFO_0005595	ENSG00000105464	28216264	Lynch et al. (2017)	GRIN2D	UBERON_0001017	""
increased blood pressure	central nervous system	inhibition_acute	HP_0032263	ENSG00000105464	28216264	Lynch et al. (2017)	GRIN2D	UBERON_0001017	""
increased heart rate	central nervous system	inhibition_acute	HP_0001649	ENSG00000105464	28216264	Lynch et al. (2017)	GRIN2D	UBERON_0001017	""
increased then decreased heart rate	cardiovascular	activation_acute	HP_0031860	ENSG00000105464	28216264	Lynch et al. (2017)	GRIN2D	UBERON_0004535	""
pain	central nervous system	activation_acute	EFO_0003843	ENSG00000105464	28216264	Lynch et al. (2017)	GRIN2D	UBERON_0001017	""
increased then decreased heart rate	central nervous system	activation_acute	HP_0031860	ENSG00000105464	28216264	Lynch et al. (2017)	GRIN2D	UBERON_0001017	""
increased blood pressure	central nervous system	activation_acute	HP_0032263	ENSG00000105464	28216264	Lynch et al. (2017)	GRIN2D	UBERON_0001017	""
increased blood pressure	cardiovascular	activation_acute	HP_0032263	ENSG00000105464	28216264	Lynch et al. (2017)	GRIN2D	UBERON_0004535	""
dyspnea	cardiovascular	activation_acute	HP_0002094	ENSG00000149575	28216264	Lynch et al. (2017)	SCN2B	UBERON_0004535	""
decreased pain	cardiovascular	inhibition_acute	GO_1904057	ENSG00000149575	28216264	Lynch et al. (2017)	SCN2B	UBERON_0004535	""
agitation	cardiovascular	inhibition_acute	NCIT_C74532	ENSG00000149575	28216264	Lynch et al. (2017)	SCN2B	UBERON_0004535	""
decreased sweating	cardiovascular	inhibition_acute	EFO_1000712	ENSG00000149575	28216264	Lynch et al. (2017)	SCN2B	UBERON_0004535	""
increased pupil diameter	cardiovascular	inhibition_acute	HP_0011499	ENSG00000149575	28216264	Lynch et al. (2017)	SCN2B	UBERON_0004535	""
decreased/increased convulsions	cardiovascular	inhibition_acute	EFO_0009853	ENSG00000149575	28216264	Lynch et al. (2017)	SCN2B	UBERON_0004535	""
decreased/increased heart rate	cardiovascular	inhibition_acute	HP_0031860	ENSG00000149575	28216264	Lynch et al. (2017)	SCN2B	UBERON_0004535	""
decreased blood pressure	cardiovascular	inhibition_acute	EFO_0005251	ENSG00000149575	28216264	Lynch et al. (2017)	SCN2B	UBERON_0004535	""
decreased cardiac contractility	cardiovascular	inhibition_acute	GO_0045822	ENSG00000149575	28216264	Lynch et al. (2017)	SCN2B	UBERON_0004535	""
decreased cardiac conduction	cardiovascular	inhibition_acute	EFO_1001497	ENSG00000149575	28216264	Lynch et al. (2017)	SCN2B	UBERON_0004535	""
increased QRS complex	cardiovascular	inhibition_acute	HP_0006677	ENSG00000149575	28216264	Lynch et al. (2017)	SCN2B	UBERON_0004535	""
cardiac arrhythmia	cardiovascular	inhibition_acute	EFO_0004269	ENSG00000149575	28216264	Lynch et al. (2017)	SCN2B	UBERON_0004535	""
decreased respiratory rate	cardiovascular	inhibition_acute	EFO_0009839	ENSG00000149575	28216264	Lynch et al. (2017)	SCN2B	UBERON_0004535	""
decreased gastrointestinal transit	cardiovascular	inhibition_acute	HP_0030897	ENSG00000149575	28216264	Lynch et al. (2017)	SCN2B	UBERON_0004535	""
decreased urine excretion	cardiovascular	inhibition_acute	HP_0011037	ENSG00000149575	28216264	Lynch et al. (2017)	SCN2B	UBERON_0004535	""
coma	cardiovascular	inhibition_acute	HP_0001259	ENSG00000149575	28216264	Lynch et al. (2017)	SCN2B	UBERON_0004535	""
convulsions	cardiovascular	activation_acute	EFO_0009853	ENSG00000149575	28216264	Lynch et al. (2017)	SCN2B	UBERON_0004535	""
cardiac arrhythmia	respiratory	activation_acute	EFO_0004269	ENSG00000149575	28216264	Lynch et al. (2017)	SCN2B	UBERON_0001004	""
decreased pain	respiratory	inhibition_acute	GO_1904057	ENSG00000149575	28216264	Lynch et al. (2017)	SCN2B	UBERON_0001004	""
agitation	respiratory	inhibition_acute	NCIT_C74532	ENSG00000149575	28216264	Lynch et al. (2017)	SCN2B	UBERON_0001004	""
decreased sweating	respiratory	inhibition_acute	EFO_1000712	ENSG00000149575	28216264	Lynch et al. (2017)	SCN2B	UBERON_0001004	""
increased pupil diameter	respiratory	inhibition_acute	HP_0011499	ENSG00000149575	28216264	Lynch et al. (2017)	SCN2B	UBERON_0001004	""
decreased/increased convulsions	respiratory	inhibition_acute	EFO_0009853	ENSG00000149575	28216264	Lynch et al. (2017)	SCN2B	UBERON_0001004	""
decreased/increased heart rate	respiratory	inhibition_acute	HP_0031860	ENSG00000149575	28216264	Lynch et al. (2017)	SCN2B	UBERON_0001004	""
decreased blood pressure	respiratory	inhibition_acute	EFO_0005251	ENSG00000149575	28216264	Lynch et al. (2017)	SCN2B	UBERON_0001004	""
decreased cardiac contractility	respiratory	inhibition_acute	GO_0045822	ENSG00000149575	28216264	Lynch et al. (2017)	SCN2B	UBERON_0001004	""
decreased cardiac conduction	respiratory	inhibition_acute	EFO_1001497	ENSG00000149575	28216264	Lynch et al. (2017)	SCN2B	UBERON_0001004	""
increased QRS complex	respiratory	inhibition_acute	HP_0006677	ENSG00000149575	28216264	Lynch et al. (2017)	SCN2B	UBERON_0001004	""
cardiac arrhythmia	respiratory	inhibition_acute	EFO_0004269	ENSG00000149575	28216264	Lynch et al. (2017)	SCN2B	UBERON_0001004	""
decreased respiratory rate	respiratory	inhibition_acute	EFO_0009839	ENSG00000149575	28216264	Lynch et al. (2017)	SCN2B	UBERON_0001004	""
decreased gastrointestinal transit	respiratory	inhibition_acute	HP_0030897	ENSG00000149575	28216264	Lynch et al. (2017)	SCN2B	UBERON_0001004	""
decreased urine excretion	respiratory	inhibition_acute	HP_0011037	ENSG00000149575	28216264	Lynch et al. (2017)	SCN2B	UBERON_0001004	""
coma	respiratory	inhibition_acute	HP_0001259	ENSG00000149575	28216264	Lynch et al. (2017)	SCN2B	UBERON_0001004	""
increased heart rate	respiratory	activation_acute	HP_0001649	ENSG00000149575	28216264	Lynch et al. (2017)	SCN2B	UBERON_0001004	""
dyspnea	nervous system	activation_acute	HP_0002094	ENSG00000149575	28216264	Lynch et al. (2017)	SCN2B	UBERON_0001016	""
decreased pain	nervous system	inhibition_acute	GO_1904057	ENSG00000149575	28216264	Lynch et al. (2017)	SCN2B	UBERON_0001016	""
agitation	nervous system	inhibition_acute	NCIT_C74532	ENSG00000149575	28216264	Lynch et al. (2017)	SCN2B	UBERON_0001016	""
decreased sweating	nervous system	inhibition_acute	EFO_1000712	ENSG00000149575	28216264	Lynch et al. (2017)	SCN2B	UBERON_0001016	""
increased pupil diameter	nervous system	inhibition_acute	HP_0011499	ENSG00000149575	28216264	Lynch et al. (2017)	SCN2B	UBERON_0001016	""
decreased/increased convulsions	nervous system	inhibition_acute	EFO_0009853	ENSG00000149575	28216264	Lynch et al. (2017)	SCN2B	UBERON_0001016	""
decreased/increased heart rate	nervous system	inhibition_acute	HP_0031860	ENSG00000149575	28216264	Lynch et al. (2017)	SCN2B	UBERON_0001016	""
decreased blood pressure	nervous system	inhibition_acute	EFO_0005251	ENSG00000149575	28216264	Lynch et al. (2017)	SCN2B	UBERON_0001016	""
decreased cardiac contractility	nervous system	inhibition_acute	GO_0045822	ENSG00000149575	28216264	Lynch et al. (2017)	SCN2B	UBERON_0001016	""
decreased cardiac conduction	nervous system	inhibition_acute	EFO_1001497	ENSG00000149575	28216264	Lynch et al. (2017)	SCN2B	UBERON_0001016	""
increased QRS complex	nervous system	inhibition_acute	HP_0006677	ENSG00000149575	28216264	Lynch et al. (2017)	SCN2B	UBERON_0001016	""
cardiac arrhythmia	nervous system	inhibition_acute	EFO_0004269	ENSG00000149575	28216264	Lynch et al. (2017)	SCN2B	UBERON_0001016	""
decreased respiratory rate	nervous system	inhibition_acute	EFO_0009839	ENSG00000149575	28216264	Lynch et al. (2017)	SCN2B	UBERON_0001016	""
decreased gastrointestinal transit	nervous system	inhibition_acute	HP_0030897	ENSG00000149575	28216264	Lynch et al. (2017)	SCN2B	UBERON_0001016	""
decreased urine excretion	nervous system	inhibition_acute	HP_0011037	ENSG00000149575	28216264	Lynch et al. (2017)	SCN2B	UBERON_0001016	""
coma	nervous system	inhibition_acute	HP_0001259	ENSG00000149575	28216264	Lynch et al. (2017)	SCN2B	UBERON_0001016	""
dyspnea	respiratory	activation_acute	HP_0002094	ENSG00000149575	28216264	Lynch et al. (2017)	SCN2B	UBERON_0001004	""
cardiac arrhythmia	cardiovascular	activation_acute	EFO_0004269	ENSG00000149575	28216264	Lynch et al. (2017)	SCN2B	UBERON_0004535	""
decreased locomotor activity	nervous system	activation_acute	GO_0040013	ENSG00000149575	28216264	Lynch et al. (2017)	SCN2B	UBERON_0001016	""
increased heart rate	cardiovascular	activation_acute	HP_0001649	ENSG00000149575	28216264	Lynch et al. (2017)	SCN2B	UBERON_0004535	""
decreased locomotor activity	cardiovascular	activation_acute	GO_0040013	ENSG00000149575	28216264	Lynch et al. (2017)	SCN2B	UBERON_0004535	""
increased heart rate	nervous system	activation_acute	HP_0001649	ENSG00000149575	28216264	Lynch et al. (2017)	SCN2B	UBERON_0001016	""
cardiac arrhythmia	nervous system	activation_acute	EFO_0004269	ENSG00000149575	28216264	Lynch et al. (2017)	SCN2B	UBERON_0001016	""
convulsions	respiratory	activation_acute	EFO_0009853	ENSG00000149575	28216264	Lynch et al. (2017)	SCN2B	UBERON_0001004	""
convulsions	nervous system	activation_acute	EFO_0009853	ENSG00000149575	28216264	Lynch et al. (2017)	SCN2B	UBERON_0001016	""
decreased locomotor activity	respiratory	activation_acute	GO_0040013	ENSG00000149575	28216264	Lynch et al. (2017)	SCN2B	UBERON_0001004	""
increased gastrointestinal transit	gastrointestinal	activation_acute	HP_0410204	ENSG00000166736	28216264	Lynch et al. (2017)	HTR3A	UBERON_0005409	""
decreased gastrointestinal transit	gastrointestinal	inhibition_acute	HP_0030897	ENSG00000166736	28216264	Lynch et al. (2017)	HTR3A	UBERON_0005409	""
constipation	gastrointestinal	inhibition_acute	HP_0002019	ENSG00000166736	28216264	Lynch et al. (2017)	HTR3A	UBERON_0005409	""
hard stool	gastrointestinal	inhibition_acute	HP_0031685	ENSG00000166736	28216264	Lynch et al. (2017)	HTR3A	UBERON_0005409	""
abdominal distension	gastrointestinal	inhibition_acute	HP_0003270	ENSG00000166736	28216264	Lynch et al. (2017)	HTR3A	UBERON_0005409	""
ischemic colitis	gastrointestinal	inhibition_acute	MONDO_0000701	ENSG00000166736	28216264	Lynch et al. (2017)	HTR3A	UBERON_0005409	""
decreased pain	gastrointestinal	inhibition_acute	GO_1904057	ENSG00000166736	28216264	Lynch et al. (2017)	HTR3A	UBERON_0005409	""
decreased inflammation	gastrointestinal	inhibition_acute	GO_0050728	ENSG00000166736	28216264	Lynch et al. (2017)	HTR3A	UBERON_0005409	""
increased memory	gastrointestinal	inhibition_acute	EFO_0004874	ENSG00000166736	28216264	Lynch et al. (2017)	HTR3A	UBERON_0005409	""
decreased anxiety	gastrointestinal	inhibition_acute	EFO_0009874	ENSG00000166736	28216264	Lynch et al. (2017)	HTR3A	UBERON_0005409	""
dizziness	gastrointestinal	inhibition_acute	EFO_0009847	ENSG00000166736	28216264	Lynch et al. (2017)	HTR3A	UBERON_0005409	""
increased heart rate	cardiovascular	activation_acute	HP_0001649	ENSG00000166736	28216264	Lynch et al. (2017)	HTR3A	UBERON_0004535	""
decreased gastrointestinal transit	cardiovascular	inhibition_acute	HP_0030897	ENSG00000166736	28216264	Lynch et al. (2017)	HTR3A	UBERON_0004535	""
constipation	cardiovascular	inhibition_acute	HP_0002019	ENSG00000166736	28216264	Lynch et al. (2017)	HTR3A	UBERON_0004535	""
hard stool	cardiovascular	inhibition_acute	HP_0031685	ENSG00000166736	28216264	Lynch et al. (2017)	HTR3A	UBERON_0004535	""
abdominal distension	cardiovascular	inhibition_acute	HP_0003270	ENSG00000166736	28216264	Lynch et al. (2017)	HTR3A	UBERON_0004535	""
ischemic colitis	cardiovascular	inhibition_acute	MONDO_0000701	ENSG00000166736	28216264	Lynch et al. (2017)	HTR3A	UBERON_0004535	""
decreased pain	cardiovascular	inhibition_acute	GO_1904057	ENSG00000166736	28216264	Lynch et al. (2017)	HTR3A	UBERON_0004535	""
decreased inflammation	cardiovascular	inhibition_acute	GO_0050728	ENSG00000166736	28216264	Lynch et al. (2017)	HTR3A	UBERON_0004535	""
increased memory	cardiovascular	inhibition_acute	EFO_0004874	ENSG00000166736	28216264	Lynch et al. (2017)	HTR3A	UBERON_0004535	""
decreased anxiety	cardiovascular	inhibition_acute	EFO_0009874	ENSG00000166736	28216264	Lynch et al. (2017)	HTR3A	UBERON_0004535	""
dizziness	cardiovascular	inhibition_acute	EFO_0009847	ENSG00000166736	28216264	Lynch et al. (2017)	HTR3A	UBERON_0004535	""
increased gastrointestinal transit	central nervous system	activation_acute	HP_0410204	ENSG00000166736	28216264	Lynch et al. (2017)	HTR3A	UBERON_0001017	""
decreased gastrointestinal transit	central nervous system	inhibition_acute	HP_0030897	ENSG00000166736	28216264	Lynch et al. (2017)	HTR3A	UBERON_0001017	""
constipation	central nervous system	inhibition_acute	HP_0002019	ENSG00000166736	28216264	Lynch et al. (2017)	HTR3A	UBERON_0001017	""
hard stool	central nervous system	inhibition_acute	HP_0031685	ENSG00000166736	28216264	Lynch et al. (2017)	HTR3A	UBERON_0001017	""
abdominal distension	central nervous system	inhibition_acute	HP_0003270	ENSG00000166736	28216264	Lynch et al. (2017)	HTR3A	UBERON_0001017	""
ischemic colitis	central nervous system	inhibition_acute	MONDO_0000701	ENSG00000166736	28216264	Lynch et al. (2017)	HTR3A	UBERON_0001017	""
decreased pain	central nervous system	inhibition_acute	GO_1904057	ENSG00000166736	28216264	Lynch et al. (2017)	HTR3A	UBERON_0001017	""
decreased inflammation	central nervous system	inhibition_acute	GO_0050728	ENSG00000166736	28216264	Lynch et al. (2017)	HTR3A	UBERON_0001017	""
increased memory	central nervous system	inhibition_acute	EFO_0004874	ENSG00000166736	28216264	Lynch et al. (2017)	HTR3A	UBERON_0001017	""
decreased anxiety	central nervous system	inhibition_acute	EFO_0009874	ENSG00000166736	28216264	Lynch et al. (2017)	HTR3A	UBERON_0001017	""
dizziness	central nervous system	inhibition_acute	EFO_0009847	ENSG00000166736	28216264	Lynch et al. (2017)	HTR3A	UBERON_0001017	""
increased blood pressure	cardiovascular	activation_acute	HP_0032263	ENSG00000166736	28216264	Lynch et al. (2017)	HTR3A	UBERON_0004535	""
drug abuse/dependence	cardiovascular	activation_acute	EFO_0003890	ENSG00000166736	28216264	Lynch et al. (2017)	HTR3A	UBERON_0004535	""
increased gastric emptying	cardiovascular	activation_acute	GO_0120062	ENSG00000166736	28216264	Lynch et al. (2017)	HTR3A	UBERON_0004535	""
increased gastric emptying	gastrointestinal	activation_acute	GO_0120062	ENSG00000166736	28216264	Lynch et al. (2017)	HTR3A	UBERON_0005409	""
vomiting	gastrointestinal	activation_acute	HP_0002017	ENSG00000166736	28216264	Lynch et al. (2017)	HTR3A	UBERON_0005409	""
apnea	gastrointestinal	activation_acute	HP_0002104	ENSG00000166736	28216264	Lynch et al. (2017)	HTR3A	UBERON_0005409	""
increased blood pressure	central nervous system	activation_acute	HP_0032263	ENSG00000166736	28216264	Lynch et al. (2017)	HTR3A	UBERON_0001017	""
vomiting	central nervous system	activation_acute	HP_0002017	ENSG00000166736	28216264	Lynch et al. (2017)	HTR3A	UBERON_0001017	""
decreased memory	gastrointestinal	activation_acute	EFO_0001072	ENSG00000166736	28216264	Lynch et al. (2017)	HTR3A	UBERON_0005409	""
apnea	central nervous system	activation_acute	HP_0002104	ENSG00000166736	28216264	Lynch et al. (2017)	HTR3A	UBERON_0001017	""
apnea	cardiovascular	activation_acute	HP_0002104	ENSG00000166736	28216264	Lynch et al. (2017)	HTR3A	UBERON_0004535	""
increased gastric emptying	central nervous system	activation_acute	GO_0120062	ENSG00000166736	28216264	Lynch et al. (2017)	HTR3A	UBERON_0001017	""
increased gastrointestinal transit	cardiovascular	activation_acute	HP_0410204	ENSG00000166736	28216264	Lynch et al. (2017)	HTR3A	UBERON_0004535	""
drug abuse/dependence	gastrointestinal	activation_acute	EFO_0003890	ENSG00000166736	28216264	Lynch et al. (2017)	HTR3A	UBERON_0005409	""
increased heart rate	central nervous system	activation_acute	HP_0001649	ENSG00000166736	28216264	Lynch et al. (2017)	HTR3A	UBERON_0001017	""
increased heart rate	gastrointestinal	activation_acute	HP_0001649	ENSG00000166736	28216264	Lynch et al. (2017)	HTR3A	UBERON_0005409	""
decreased memory	central nervous system	activation_acute	EFO_0001072	ENSG00000166736	28216264	Lynch et al. (2017)	HTR3A	UBERON_0001017	""
decreased memory	cardiovascular	activation_acute	EFO_0001072	ENSG00000166736	28216264	Lynch et al. (2017)	HTR3A	UBERON_0004535	""
increased blood pressure	gastrointestinal	activation_acute	HP_0032263	ENSG00000166736	28216264	Lynch et al. (2017)	HTR3A	UBERON_0005409	""
drug abuse/dependence	central nervous system	activation_acute	EFO_0003890	ENSG00000166736	28216264	Lynch et al. (2017)	HTR3A	UBERON_0001017	""
vomiting	cardiovascular	activation_acute	HP_0002017	ENSG00000166736	28216264	Lynch et al. (2017)	HTR3A	UBERON_0004535	""
decreased pain	endocrine	activation_acute	GO_1904057	ENSG00000113580	28216264	Lynch et al. (2017)	NR3C1	UBERON_0000949	""
increased inflammation	endocrine	inhibition_acute	GO_0050729	ENSG00000113580	28216264	Lynch et al. (2017)	NR3C1	UBERON_0000949	""
increased/decreased pain	endocrine	inhibition_acute	GO_0051930	ENSG00000113580	28216264	Lynch et al. (2017)	NR3C1	UBERON_0000949	""
decreased memory	endocrine	inhibition_acute	EFO_0001072	ENSG00000113580	28216264	Lynch et al. (2017)	NR3C1	UBERON_0000949	""
fatigue	endocrine	inhibition_acute	HP_0012378	ENSG00000113580	28216264	Lynch et al. (2017)	NR3C1	UBERON_0000949	""
decreased blood potassium	endocrine	inhibition_acute	HP_0002900	ENSG00000113580	28216264	Lynch et al. (2017)	NR3C1	UBERON_0000949	""
edema	endocrine	inhibition_acute	EFO_0009373	ENSG00000113580	28216264	Lynch et al. (2017)	NR3C1	UBERON_0000949	""
endometrial thickening	endocrine	inhibition_acute	MONDO_0041161	ENSG00000113580	28216264	Lynch et al. (2017)	NR3C1	UBERON_0000949	""
increased blood glucose	immune	activation_acute	HP_0003074	ENSG00000113580	28216264	Lynch et al. (2017)	NR3C1	UBERON_0002405	""
increased inflammation	immune	inhibition_acute	GO_0050729	ENSG00000113580	28216264	Lynch et al. (2017)	NR3C1	UBERON_0002405	""
increased/decreased pain	immune	inhibition_acute	GO_0051930	ENSG00000113580	28216264	Lynch et al. (2017)	NR3C1	UBERON_0002405	""
decreased memory	immune	inhibition_acute	EFO_0001072	ENSG00000113580	28216264	Lynch et al. (2017)	NR3C1	UBERON_0002405	""
fatigue	immune	inhibition_acute	HP_0012378	ENSG00000113580	28216264	Lynch et al. (2017)	NR3C1	UBERON_0002405	""
decreased blood potassium	immune	inhibition_acute	HP_0002900	ENSG00000113580	28216264	Lynch et al. (2017)	NR3C1	UBERON_0002405	""
edema	immune	inhibition_acute	EFO_0009373	ENSG00000113580	28216264	Lynch et al. (2017)	NR3C1	UBERON_0002405	""
endometrial thickening	immune	inhibition_acute	MONDO_0041161	ENSG00000113580	28216264	Lynch et al. (2017)	NR3C1	UBERON_0002405	""
decreased wound repair	nervous system	activation_acute	GO_0061045	ENSG00000113580	28216264	Lynch et al. (2017)	NR3C1	UBERON_0001016	""
increased inflammation	nervous system	inhibition_acute	GO_0050729	ENSG00000113580	28216264	Lynch et al. (2017)	NR3C1	UBERON_0001016	""
increased/decreased pain	nervous system	inhibition_acute	GO_0051930	ENSG00000113580	28216264	Lynch et al. (2017)	NR3C1	UBERON_0001016	""
decreased memory	nervous system	inhibition_acute	EFO_0001072	ENSG00000113580	28216264	Lynch et al. (2017)	NR3C1	UBERON_0001016	""
fatigue	nervous system	inhibition_acute	HP_0012378	ENSG00000113580	28216264	Lynch et al. (2017)	NR3C1	UBERON_0001016	""
decreased blood potassium	nervous system	inhibition_acute	HP_0002900	ENSG00000113580	28216264	Lynch et al. (2017)	NR3C1	UBERON_0001016	""
edema	nervous system	inhibition_acute	EFO_0009373	ENSG00000113580	28216264	Lynch et al. (2017)	NR3C1	UBERON_0001016	""
endometrial thickening	nervous system	inhibition_acute	MONDO_0041161	ENSG00000113580	28216264	Lynch et al. (2017)	NR3C1	UBERON_0001016	""
insulin resistance	nervous system	activation_acute	EFO_0002614	ENSG00000113580	28216264	Lynch et al. (2017)	NR3C1	UBERON_0001016	""
osteoporosis	immune	activation_acute	EFO_0003882	ENSG00000113580	28216264	Lynch et al. (2017)	NR3C1	UBERON_0002405	""
lipid redistribution	immune	activation_acute	GO_0010876	ENSG00000113580	28216264	Lynch et al. (2017)	NR3C1	UBERON_0002405	""
decreased inflammation	immune	activation_acute	GO_0050728	ENSG00000113580	28216264	Lynch et al. (2017)	NR3C1	UBERON_0002405	""
increased blood glucose	nervous system	activation_acute	HP_0003074	ENSG00000113580	28216264	Lynch et al. (2017)	NR3C1	UBERON_0001016	""
decreased muscle mass	nervous system	activation_acute	HP_0003199	ENSG00000113580	28216264	Lynch et al. (2017)	NR3C1	UBERON_0001016	""
lipid redistribution	nervous system	activation_acute	GO_0010876	ENSG00000113580	28216264	Lynch et al. (2017)	NR3C1	UBERON_0001016	""
increased blood glucose	endocrine	activation_acute	HP_0003074	ENSG00000113580	28216264	Lynch et al. (2017)	NR3C1	UBERON_0000949	""
decreased wound repair	endocrine	activation_acute	GO_0061045	ENSG00000113580	28216264	Lynch et al. (2017)	NR3C1	UBERON_0000949	""
osteoporosis	nervous system	activation_acute	EFO_0003882	ENSG00000113580	28216264	Lynch et al. (2017)	NR3C1	UBERON_0001016	""
insulin resistance	endocrine	activation_acute	EFO_0002614	ENSG00000113580	28216264	Lynch et al. (2017)	NR3C1	UBERON_0000949	""
insulin resistance	immune	activation_acute	EFO_0002614	ENSG00000113580	28216264	Lynch et al. (2017)	NR3C1	UBERON_0002405	""
increased blood pressure	immune	activation_acute	HP_0032263	ENSG00000113580	28216264	Lynch et al. (2017)	NR3C1	UBERON_0002405	""
increased urinary sodium excretion	endocrine	activation_acute	GO_0035815	ENSG00000113580	28216264	Lynch et al. (2017)	NR3C1	UBERON_0000949	""
decreased wound repair	immune	activation_acute	GO_0061045	ENSG00000113580	28216264	Lynch et al. (2017)	NR3C1	UBERON_0002405	""
decreased inflammation	nervous system	activation_acute	GO_0050728	ENSG00000113580	28216264	Lynch et al. (2017)	NR3C1	UBERON_0001016	""
lipid redistribution	endocrine	activation_acute	GO_0010876	ENSG00000113580	28216264	Lynch et al. (2017)	NR3C1	UBERON_0000949	""
decreased pain	nervous system	activation_acute	GO_1904057	ENSG00000113580	28216264	Lynch et al. (2017)	NR3C1	UBERON_0001016	""
increased urinary sodium excretion	immune	activation_acute	GO_0035815	ENSG00000113580	28216264	Lynch et al. (2017)	NR3C1	UBERON_0002405	""
increased memory	immune	activation_acute	EFO_0004874	ENSG00000113580	28216264	Lynch et al. (2017)	NR3C1	UBERON_0002405	""
osteoporosis	endocrine	activation_acute	EFO_0003882	ENSG00000113580	28216264	Lynch et al. (2017)	NR3C1	UBERON_0000949	""
increased blood pressure	endocrine	activation_acute	HP_0032263	ENSG00000113580	28216264	Lynch et al. (2017)	NR3C1	UBERON_0000949	""
decreased muscle mass	immune	activation_acute	HP_0003199	ENSG00000113580	28216264	Lynch et al. (2017)	NR3C1	UBERON_0002405	""
increased memory	nervous system	activation_acute	EFO_0004874	ENSG00000113580	28216264	Lynch et al. (2017)	NR3C1	UBERON_0001016	""
increased blood pressure	nervous system	activation_acute	HP_0032263	ENSG00000113580	28216264	Lynch et al. (2017)	NR3C1	UBERON_0001016	""
decreased inflammation	endocrine	activation_acute	GO_0050728	ENSG00000113580	28216264	Lynch et al. (2017)	NR3C1	UBERON_0000949	""
decreased pain	immune	activation_acute	GO_1904057	ENSG00000113580	28216264	Lynch et al. (2017)	NR3C1	UBERON_0002405	""
decreased muscle mass	endocrine	activation_acute	HP_0003199	ENSG00000113580	28216264	Lynch et al. (2017)	NR3C1	UBERON_0000949	""
increased urinary sodium excretion	nervous system	activation_acute	GO_0035815	ENSG00000113580	28216264	Lynch et al. (2017)	NR3C1	UBERON_0001016	""
increased memory	endocrine	activation_acute	EFO_0004874	ENSG00000113580	28216264	Lynch et al. (2017)	NR3C1	UBERON_0000949	""
cardiac arrhythmia	renal	activation_acute	EFO_0004269	ENSG00000006071	28216264	Lynch et al. (2017)	ABCC8	UBERON_0001008	""
decreased heart rate	renal	inhibition_acute	HP_0001662	ENSG00000006071	28216264	Lynch et al. (2017)	ABCC8	UBERON_0001008	""
atrioventricular block	renal	inhibition_acute	MONDO_0000465	ENSG00000006071	28216264	Lynch et al. (2017)	ABCC8	UBERON_0001008	""
increased blood insulin	renal	inhibition_acute	HP_0000842	ENSG00000006071	28216264	Lynch et al. (2017)	ABCC8	UBERON_0001008	""
decreased blood glucose	renal	inhibition_acute	HP_0001943	ENSG00000006071	28216264	Lynch et al. (2017)	ABCC8	UBERON_0001008	""
increased urine excretion	renal	inhibition_acute	HP_0000103	ENSG00000006071	28216264	Lynch et al. (2017)	ABCC8	UBERON_0001008	""
increased urinary sodium excretion	renal	inhibition_acute	GO_0035815	ENSG00000006071	28216264	Lynch et al. (2017)	ABCC8	UBERON_0001008	""
cardiac arrhythmia	pancreas	activation_acute	EFO_0004269	ENSG00000006071	28216264	Lynch et al. (2017)	ABCC8	UBERON_0001264	""
decreased heart rate	pancreas	inhibition_acute	HP_0001662	ENSG00000006071	28216264	Lynch et al. (2017)	ABCC8	UBERON_0001264	""
atrioventricular block	pancreas	inhibition_acute	MONDO_0000465	ENSG00000006071	28216264	Lynch et al. (2017)	ABCC8	UBERON_0001264	""
increased blood insulin	pancreas	inhibition_acute	HP_0000842	ENSG00000006071	28216264	Lynch et al. (2017)	ABCC8	UBERON_0001264	""
decreased blood glucose	pancreas	inhibition_acute	HP_0001943	ENSG00000006071	28216264	Lynch et al. (2017)	ABCC8	UBERON_0001264	""
increased urine excretion	pancreas	inhibition_acute	HP_0000103	ENSG00000006071	28216264	Lynch et al. (2017)	ABCC8	UBERON_0001264	""
increased urinary sodium excretion	pancreas	inhibition_acute	GO_0035815	ENSG00000006071	28216264	Lynch et al. (2017)	ABCC8	UBERON_0001264	""
decreased convulsions	pancreas	activation_acute	EFO_0009853	ENSG00000006071	28216264	Lynch et al. (2017)	ABCC8	UBERON_0001264	""
decreased blood pressure	renal	activation_acute	EFO_0005251	ENSG00000006071	28216264	Lynch et al. (2017)	ABCC8	UBERON_0001008	""
increased/decreased blood glucose	pancreas	activation_acute	HP_0011015	ENSG00000006071	28216264	Lynch et al. (2017)	ABCC8	UBERON_0001264	""
cardiac lesions	cardiovascular	activation_acute	""	ENSG00000006071	28216264	Lynch et al. (2017)	ABCC8	UBERON_0004535	""
decreased heart rate	cardiovascular	inhibition_acute	HP_0001662	ENSG00000006071	28216264	Lynch et al. (2017)	ABCC8	UBERON_0004535	""
atrioventricular block	cardiovascular	inhibition_acute	MONDO_0000465	ENSG00000006071	28216264	Lynch et al. (2017)	ABCC8	UBERON_0004535	""
increased blood insulin	cardiovascular	inhibition_acute	HP_0000842	ENSG00000006071	28216264	Lynch et al. (2017)	ABCC8	UBERON_0004535	""
decreased blood glucose	cardiovascular	inhibition_acute	HP_0001943	ENSG00000006071	28216264	Lynch et al. (2017)	ABCC8	UBERON_0004535	""
increased urine excretion	cardiovascular	inhibition_acute	HP_0000103	ENSG00000006071	28216264	Lynch et al. (2017)	ABCC8	UBERON_0004535	""
increased urinary sodium excretion	cardiovascular	inhibition_acute	GO_0035815	ENSG00000006071	28216264	Lynch et al. (2017)	ABCC8	UBERON_0004535	""
increased heart rate	cardiovascular	activation_acute	HP_0001649	ENSG00000006071	28216264	Lynch et al. (2017)	ABCC8	UBERON_0004535	""
increased heart rate	pancreas	activation_acute	HP_0001649	ENSG00000006071	28216264	Lynch et al. (2017)	ABCC8	UBERON_0001264	""
abnormal pulse	renal	activation_acute	HP_0031860	ENSG00000006071	28216264	Lynch et al. (2017)	ABCC8	UBERON_0001008	""
increased heart rate	renal	activation_acute	HP_0001649	ENSG00000006071	28216264	Lynch et al. (2017)	ABCC8	UBERON_0001008	""
increased/decreased blood glucose	renal	activation_acute	HP_0011015	ENSG00000006071	28216264	Lynch et al. (2017)	ABCC8	UBERON_0001008	""
decreased blood insulin	cardiovascular	activation_acute	HP_0040216	ENSG00000006071	28216264	Lynch et al. (2017)	ABCC8	UBERON_0004535	""
decreased blood insulin	pancreas	activation_acute	HP_0040216	ENSG00000006071	28216264	Lynch et al. (2017)	ABCC8	UBERON_0001264	""
decreased convulsions	cardiovascular	activation_acute	EFO_0009853	ENSG00000006071	28216264	Lynch et al. (2017)	ABCC8	UBERON_0004535	""
cardiac lesions	renal	activation_acute	""	ENSG00000006071	28216264	Lynch et al. (2017)	ABCC8	UBERON_0001008	""
decreased blood pressure	pancreas	activation_acute	EFO_0005251	ENSG00000006071	28216264	Lynch et al. (2017)	ABCC8	UBERON_0001264	""
abnormal pulse	cardiovascular	activation_acute	HP_0031860	ENSG00000006071	28216264	Lynch et al. (2017)	ABCC8	UBERON_0004535	""
decreased blood insulin	renal	activation_acute	HP_0040216	ENSG00000006071	28216264	Lynch et al. (2017)	ABCC8	UBERON_0001008	""
cardiac lesions	pancreas	activation_acute	""	ENSG00000006071	28216264	Lynch et al. (2017)	ABCC8	UBERON_0001264	""
increased/decreased blood glucose	cardiovascular	activation_acute	HP_0011015	ENSG00000006071	28216264	Lynch et al. (2017)	ABCC8	UBERON_0004535	""
decreased blood pressure	cardiovascular	activation_acute	EFO_0005251	ENSG00000006071	28216264	Lynch et al. (2017)	ABCC8	UBERON_0004535	""
abnormal pulse	pancreas	activation_acute	HP_0031860	ENSG00000006071	28216264	Lynch et al. (2017)	ABCC8	UBERON_0001264	""
decreased convulsions	renal	activation_acute	EFO_0009853	ENSG00000006071	28216264	Lynch et al. (2017)	ABCC8	UBERON_0001008	""
cardiac arrhythmia	cardiovascular	activation_acute	EFO_0004269	ENSG00000006071	28216264	Lynch et al. (2017)	ABCC8	UBERON_0004535	""
decreased/increased inflammation	immune	activation_acute	GO_0050727	ENSG00000164128	28216264	Lynch et al. (2017)	NPY1R	UBERON_0002405	""
decreased eating	immune	inhibition_acute	HP_0100738	ENSG00000164128	28216264	Lynch et al. (2017)	NPY1R	UBERON_0002405	""
decreased pain	immune	activation_acute	GO_1904057	ENSG00000164128	28216264	Lynch et al. (2017)	NPY1R	UBERON_0002405	""
decreased pain	nervous system	activation_acute	GO_1904057	ENSG00000164128	28216264	Lynch et al. (2017)	NPY1R	UBERON_0001016	""
decreased eating	nervous system	inhibition_acute	HP_0100738	ENSG00000164128	28216264	Lynch et al. (2017)	NPY1R	UBERON_0001016	""
decreased/increased inflammation	nervous system	activation_acute	GO_0050727	ENSG00000164128	28216264	Lynch et al. (2017)	NPY1R	UBERON_0001016	""
decreased/increased inflammation	gastrointestinal	activation_acute	GO_0050727	ENSG00000164128	28216264	Lynch et al. (2017)	NPY1R	UBERON_0005409	""
decreased eating	gastrointestinal	inhibition_acute	HP_0100738	ENSG00000164128	28216264	Lynch et al. (2017)	NPY1R	UBERON_0005409	""
decreased pain	gastrointestinal	activation_acute	GO_1904057	ENSG00000164128	28216264	Lynch et al. (2017)	NPY1R	UBERON_0005409	""
smooth muscle contraction	central nervous system	activation_general	GO_0006939	ENSG00000120907	23197038	Bowes et al. (2012)	ADRA1A	UBERON_0001017	""
decreased smooth muscle tone	central nervous system	inhibition_general	HP_0001252	ENSG00000120907	23197038	Bowes et al. (2012)	ADRA1A	UBERON_0001017	""
orthostatic hypotension	central nervous system	inhibition_general	EFO_0005252	ENSG00000120907	23197038	Bowes et al. (2012)	ADRA1A	UBERON_0001017	""
increased heart rate	central nervous system	inhibition_general	HP_0001649	ENSG00000120907	23197038	Bowes et al. (2012)	ADRA1A	UBERON_0001017	""
dizziness	central nervous system	inhibition_general	EFO_0009847	ENSG00000120907	23197038	Bowes et al. (2012)	ADRA1A	UBERON_0001017	""
impact on various aspects of sexual function	central nervous system	inhibition_general	EFO_0004714	ENSG00000120907	23197038	Bowes et al. (2012)	ADRA1A	UBERON_0001017	""
increased blood pressure	central nervous system	activation_general	HP_0032263	ENSG00000120907	23197038	Bowes et al. (2012)	ADRA1A	UBERON_0001017	""
cardiac positive ionotropy	central nervous system	activation_general	GO_0045823	ENSG00000120907	23197038	Bowes et al. (2012)	ADRA1A	UBERON_0001017	""
potential for arrhythmia	central nervous system	activation_general	EFO_0004269	ENSG00000120907	23197038	Bowes et al. (2012)	ADRA1A	UBERON_0001017	""
mydriasis	central nervous system	activation_general	HP_0011499	ENSG00000120907	23197038	Bowes et al. (2012)	ADRA1A	UBERON_0001017	""
decreased insulin release	central nervous system	activation_general	HP_0040216	ENSG00000120907	23197038	Bowes et al. (2012)	ADRA1A	UBERON_0001017	""
smooth muscle contraction	cardiovascular system	activation_general	GO_0006939	ENSG00000120907	23197038	Bowes et al. (2012)	ADRA1A	UBERON_0004535	""
decreased smooth muscle tone	cardiovascular system	inhibition_general	HP_0001252	ENSG00000120907	23197038	Bowes et al. (2012)	ADRA1A	UBERON_0004535	""
orthostatic hypotension	cardiovascular system	inhibition_general	EFO_0005252	ENSG00000120907	23197038	Bowes et al. (2012)	ADRA1A	UBERON_0004535	""
increased heart rate	cardiovascular system	inhibition_general	HP_0001649	ENSG00000120907	23197038	Bowes et al. (2012)	ADRA1A	UBERON_0004535	""
dizziness	cardiovascular system	inhibition_general	EFO_0009847	ENSG00000120907	23197038	Bowes et al. (2012)	ADRA1A	UBERON_0004535	""
impact on various aspects of sexual function	cardiovascular system	inhibition_general	EFO_0004714	ENSG00000120907	23197038	Bowes et al. (2012)	ADRA1A	UBERON_0004535	""
increased blood pressure	cardiovascular system	activation_general	HP_0032263	ENSG00000120907	23197038	Bowes et al. (2012)	ADRA1A	UBERON_0004535	""
cardiac positive ionotropy	cardiovascular system	activation_general	GO_0045823	ENSG00000120907	23197038	Bowes et al. (2012)	ADRA1A	UBERON_0004535	""
potential for arrhythmia	cardiovascular system	activation_general	EFO_0004269	ENSG00000120907	23197038	Bowes et al. (2012)	ADRA1A	UBERON_0004535	""
mydriasis	cardiovascular system	activation_general	HP_0011499	ENSG00000120907	23197038	Bowes et al. (2012)	ADRA1A	UBERON_0004535	""
decreased insulin release	cardiovascular system	activation_general	HP_0040216	ENSG00000120907	23197038	Bowes et al. (2012)	ADRA1A	UBERON_0004535	""
smooth muscle contraction	gastrointestinal	activation_general	GO_0006939	ENSG00000120907	23197038	Bowes et al. (2012)	ADRA1A	UBERON_0005409	""
decreased smooth muscle tone	gastrointestinal	inhibition_general	HP_0001252	ENSG00000120907	23197038	Bowes et al. (2012)	ADRA1A	UBERON_0005409	""
orthostatic hypotension	gastrointestinal	inhibition_general	EFO_0005252	ENSG00000120907	23197038	Bowes et al. (2012)	ADRA1A	UBERON_0005409	""
increased heart rate	gastrointestinal	inhibition_general	HP_0001649	ENSG00000120907	23197038	Bowes et al. (2012)	ADRA1A	UBERON_0005409	""
dizziness	gastrointestinal	inhibition_general	EFO_0009847	ENSG00000120907	23197038	Bowes et al. (2012)	ADRA1A	UBERON_0005409	""
impact on various aspects of sexual function	gastrointestinal	inhibition_general	EFO_0004714	ENSG00000120907	23197038	Bowes et al. (2012)	ADRA1A	UBERON_0005409	""
increased blood pressure	gastrointestinal	activation_general	HP_0032263	ENSG00000120907	23197038	Bowes et al. (2012)	ADRA1A	UBERON_0005409	""
cardiac positive ionotropy	gastrointestinal	activation_general	GO_0045823	ENSG00000120907	23197038	Bowes et al. (2012)	ADRA1A	UBERON_0005409	""
potential for arrhythmia	gastrointestinal	activation_general	EFO_0004269	ENSG00000120907	23197038	Bowes et al. (2012)	ADRA1A	UBERON_0005409	""
mydriasis	gastrointestinal	activation_general	HP_0011499	ENSG00000120907	23197038	Bowes et al. (2012)	ADRA1A	UBERON_0005409	""
decreased insulin release	gastrointestinal	activation_general	HP_0040216	ENSG00000120907	23197038	Bowes et al. (2012)	ADRA1A	UBERON_0005409	""
decreased food intake	gastrointestinal	activation_general	HP_0100738	ENSG00000163394	23197038	Bowes et al. (2012)	CCKAR	UBERON_0005409	""
increased development of gallstones	gastrointestinal	inhibition_general	EFO_0004210	ENSG00000163394	23197038	Bowes et al. (2012)	CCKAR	UBERON_0005409	""
gallbladder contraction	gastrointestinal	activation_general	HP_0005609	ENSG00000163394	23197038	Bowes et al. (2012)	CCKAR	UBERON_0005409	""
pancreatic enzyme secretion	gastrointestinal	activation_general	GO_0030157	ENSG00000163394	23197038	Bowes et al. (2012)	CCKAR	UBERON_0005409	""
increased gastrointestinal motility	gastrointestinal	activation_general	HP_0030895	ENSG00000163394	23197038	Bowes et al. (2012)	CCKAR	UBERON_0005409	""
activation of dopamine-mediated behaviour	gastrointestinal	activation_general	""	ENSG00000163394	23197038	Bowes et al. (2012)	CCKAR	UBERON_0005409	""
cerebral and coronary artery vasoconstriction	central nervous system	activation_general	""	ENSG00000135312	23197038	Bowes et al. (2012)	HTR1B	UBERON_0001017	""
increased aggression	central nervous system	inhibition_general	EFO_0003015	ENSG00000135312	23197038	Bowes et al. (2012)	HTR1B	UBERON_0001017	""
increased blood pressure	central nervous system	activation_general	HP_0032263	ENSG00000135312	23197038	Bowes et al. (2012)	HTR1B	UBERON_0001017	""
cerebral and coronary artery vasoconstriction	cardiovascular system	activation_general	""	ENSG00000135312	23197038	Bowes et al. (2012)	HTR1B	UBERON_0004535	""
increased aggression	cardiovascular system	inhibition_general	EFO_0003015	ENSG00000135312	23197038	Bowes et al. (2012)	HTR1B	UBERON_0004535	""
increased blood pressure	cardiovascular system	activation_general	HP_0032263	ENSG00000135312	23197038	Bowes et al. (2012)	HTR1B	UBERON_0004535	""
inflammation	immune	activation_acute	GO_0006954	ENSG00000067182	28216264	Lynch et al. (2017)	TNFRSF1A	UBERON_0002405	""
decreased pain	immune	inhibition_acute	GO_1904057	ENSG00000067182	28216264	Lynch et al. (2017)	TNFRSF1A	UBERON_0002405	""
lupus-like syndrome	immune	inhibition_acute	MONDO_0016474	ENSG00000067182	28216264	Lynch et al. (2017)	TNFRSF1A	UBERON_0002405	""
sarcoidosis	immune	inhibition_acute	Orphanet_797	ENSG00000067182	28216264	Lynch et al. (2017)	TNFRSF1A	UBERON_0002405	""
decreased blood pressure	immune	activation_acute	EFO_0005251	ENSG00000067182	28216264	Lynch et al. (2017)	TNFRSF1A	UBERON_0002405	""
increased pain	immune	activation_acute	GO_1904058	ENSG00000067182	28216264	Lynch et al. (2017)	TNFRSF1A	UBERON_0002405	""
pain	cardiovascular	activation_acute	EFO_0003843	ENSG00000161509	28216264	Lynch et al. (2017)	GRIN2C	UBERON_0004535	""
decreased pain	cardiovascular	inhibition_acute	GO_1904057	ENSG00000161509	28216264	Lynch et al. (2017)	GRIN2C	UBERON_0004535	""
impaired social interactions	cardiovascular	inhibition_chronic	HP_0000735	ENSG00000161509	28216264	Lynch et al. (2017)	GRIN2C	UBERON_0004535	""
stereotypy	cardiovascular	inhibition_chronic	HP_0000733	ENSG00000161509	28216264	Lynch et al. (2017)	GRIN2C	UBERON_0004535	""
psychosis	cardiovascular	inhibition_chronic	EFO_0005407	ENSG00000161509	28216264	Lynch et al. (2017)	GRIN2C	UBERON_0004535	""
neurodegeneration	cardiovascular	inhibition_chronic	HP_0002180	ENSG00000161509	28216264	Lynch et al. (2017)	GRIN2C	UBERON_0004535	""
increased locomotor activity	cardiovascular	inhibition_acute	GO_0040017	ENSG00000161509	28216264	Lynch et al. (2017)	GRIN2C	UBERON_0004535	""
ataxia	cardiovascular	inhibition_acute	MONDO_0000437	ENSG00000161509	28216264	Lynch et al. (2017)	GRIN2C	UBERON_0004535	""
dizziness	cardiovascular	inhibition_acute	EFO_0009847	ENSG00000161509	28216264	Lynch et al. (2017)	GRIN2C	UBERON_0004535	""
decreased memory	cardiovascular	inhibition_acute	EFO_0001072	ENSG00000161509	28216264	Lynch et al. (2017)	GRIN2C	UBERON_0004535	""
psychosis	cardiovascular	inhibition_acute	EFO_0005407	ENSG00000161509	28216264	Lynch et al. (2017)	GRIN2C	UBERON_0004535	""
decreased convulsions	cardiovascular	inhibition_acute	EFO_0009853	ENSG00000161509	28216264	Lynch et al. (2017)	GRIN2C	UBERON_0004535	""
drug abuse/dependence	cardiovascular	inhibition_acute	EFO_0003890	ENSG00000161509	28216264	Lynch et al. (2017)	GRIN2C	UBERON_0004535	""
neurotoxicity	cardiovascular	inhibition_acute	EFO_0005595	ENSG00000161509	28216264	Lynch et al. (2017)	GRIN2C	UBERON_0004535	""
increased blood pressure	cardiovascular	inhibition_acute	HP_0032263	ENSG00000161509	28216264	Lynch et al. (2017)	GRIN2C	UBERON_0004535	""
increased heart rate	cardiovascular	inhibition_acute	HP_0001649	ENSG00000161509	28216264	Lynch et al. (2017)	GRIN2C	UBERON_0004535	""
convulsions	cardiovascular	activation_acute	EFO_0009853	ENSG00000161509	28216264	Lynch et al. (2017)	GRIN2C	UBERON_0004535	""
increased blood pressure	cardiovascular	activation_acute	HP_0032263	ENSG00000161509	28216264	Lynch et al. (2017)	GRIN2C	UBERON_0004535	""
convulsions	central nervous system	activation_acute	EFO_0009853	ENSG00000161509	28216264	Lynch et al. (2017)	GRIN2C	UBERON_0001017	""
decreased pain	central nervous system	inhibition_acute	GO_1904057	ENSG00000161509	28216264	Lynch et al. (2017)	GRIN2C	UBERON_0001017	""
impaired social interactions	central nervous system	inhibition_chronic	HP_0000735	ENSG00000161509	28216264	Lynch et al. (2017)	GRIN2C	UBERON_0001017	""
stereotypy	central nervous system	inhibition_chronic	HP_0000733	ENSG00000161509	28216264	Lynch et al. (2017)	GRIN2C	UBERON_0001017	""
psychosis	central nervous system	inhibition_chronic	EFO_0005407	ENSG00000161509	28216264	Lynch et al. (2017)	GRIN2C	UBERON_0001017	""
neurodegeneration	central nervous system	inhibition_chronic	HP_0002180	ENSG00000161509	28216264	Lynch et al. (2017)	GRIN2C	UBERON_0001017	""
increased locomotor activity	central nervous system	inhibition_acute	GO_0040017	ENSG00000161509	28216264	Lynch et al. (2017)	GRIN2C	UBERON_0001017	""
ataxia	central nervous system	inhibition_acute	MONDO_0000437	ENSG00000161509	28216264	Lynch et al. (2017)	GRIN2C	UBERON_0001017	""
dizziness	central nervous system	inhibition_acute	EFO_0009847	ENSG00000161509	28216264	Lynch et al. (2017)	GRIN2C	UBERON_0001017	""
decreased memory	central nervous system	inhibition_acute	EFO_0001072	ENSG00000161509	28216264	Lynch et al. (2017)	GRIN2C	UBERON_0001017	""
psychosis	central nervous system	inhibition_acute	EFO_0005407	ENSG00000161509	28216264	Lynch et al. (2017)	GRIN2C	UBERON_0001017	""
decreased convulsions	central nervous system	inhibition_acute	EFO_0009853	ENSG00000161509	28216264	Lynch et al. (2017)	GRIN2C	UBERON_0001017	""
drug abuse/dependence	central nervous system	inhibition_acute	EFO_0003890	ENSG00000161509	28216264	Lynch et al. (2017)	GRIN2C	UBERON_0001017	""
neurotoxicity	central nervous system	inhibition_acute	EFO_0005595	ENSG00000161509	28216264	Lynch et al. (2017)	GRIN2C	UBERON_0001017	""
increased blood pressure	central nervous system	inhibition_acute	HP_0032263	ENSG00000161509	28216264	Lynch et al. (2017)	GRIN2C	UBERON_0001017	""
increased heart rate	central nervous system	inhibition_acute	HP_0001649	ENSG00000161509	28216264	Lynch et al. (2017)	GRIN2C	UBERON_0001017	""
pain	central nervous system	activation_acute	EFO_0003843	ENSG00000161509	28216264	Lynch et al. (2017)	GRIN2C	UBERON_0001017	""
increased blood pressure	central nervous system	activation_acute	HP_0032263	ENSG00000161509	28216264	Lynch et al. (2017)	GRIN2C	UBERON_0001017	""
increased then decreased heart rate	central nervous system	activation_acute	HP_0031860	ENSG00000161509	28216264	Lynch et al. (2017)	GRIN2C	UBERON_0001017	""
increased then decreased heart rate	cardiovascular	activation_acute	HP_0031860	ENSG00000161509	28216264	Lynch et al. (2017)	GRIN2C	UBERON_0004535	""
pain	cardiovascular	activation_acute	EFO_0003843	ENSG00000198785	28216264	Lynch et al. (2017)	GRIN3A	UBERON_0004535	""
decreased pain	cardiovascular	inhibition_acute	GO_1904057	ENSG00000198785	28216264	Lynch et al. (2017)	GRIN3A	UBERON_0004535	""
impaired social interactions	cardiovascular	inhibition_chronic	HP_0000735	ENSG00000198785	28216264	Lynch et al. (2017)	GRIN3A	UBERON_0004535	""
stereotypy	cardiovascular	inhibition_chronic	HP_0000733	ENSG00000198785	28216264	Lynch et al. (2017)	GRIN3A	UBERON_0004535	""
psychosis	cardiovascular	inhibition_chronic	EFO_0005407	ENSG00000198785	28216264	Lynch et al. (2017)	GRIN3A	UBERON_0004535	""
neurodegeneration	cardiovascular	inhibition_chronic	HP_0002180	ENSG00000198785	28216264	Lynch et al. (2017)	GRIN3A	UBERON_0004535	""
increased locomotor activity	cardiovascular	inhibition_acute	GO_0040017	ENSG00000198785	28216264	Lynch et al. (2017)	GRIN3A	UBERON_0004535	""
ataxia	cardiovascular	inhibition_acute	MONDO_0000437	ENSG00000198785	28216264	Lynch et al. (2017)	GRIN3A	UBERON_0004535	""
dizziness	cardiovascular	inhibition_acute	EFO_0009847	ENSG00000198785	28216264	Lynch et al. (2017)	GRIN3A	UBERON_0004535	""
decreased memory	cardiovascular	inhibition_acute	EFO_0001072	ENSG00000198785	28216264	Lynch et al. (2017)	GRIN3A	UBERON_0004535	""
psychosis	cardiovascular	inhibition_acute	EFO_0005407	ENSG00000198785	28216264	Lynch et al. (2017)	GRIN3A	UBERON_0004535	""
decreased convulsions	cardiovascular	inhibition_acute	EFO_0009853	ENSG00000198785	28216264	Lynch et al. (2017)	GRIN3A	UBERON_0004535	""
drug abuse/dependence	cardiovascular	inhibition_acute	EFO_0003890	ENSG00000198785	28216264	Lynch et al. (2017)	GRIN3A	UBERON_0004535	""
neurotoxicity	cardiovascular	inhibition_acute	EFO_0005595	ENSG00000198785	28216264	Lynch et al. (2017)	GRIN3A	UBERON_0004535	""
increased blood pressure	cardiovascular	inhibition_acute	HP_0032263	ENSG00000198785	28216264	Lynch et al. (2017)	GRIN3A	UBERON_0004535	""
increased heart rate	cardiovascular	inhibition_acute	HP_0001649	ENSG00000198785	28216264	Lynch et al. (2017)	GRIN3A	UBERON_0004535	""
increased then decreased heart rate	cardiovascular	activation_acute	HP_0031860	ENSG00000198785	28216264	Lynch et al. (2017)	GRIN3A	UBERON_0004535	""
increased blood pressure	central nervous system	activation_acute	HP_0032263	ENSG00000198785	28216264	Lynch et al. (2017)	GRIN3A	UBERON_0001017	""
decreased pain	central nervous system	inhibition_acute	GO_1904057	ENSG00000198785	28216264	Lynch et al. (2017)	GRIN3A	UBERON_0001017	""
impaired social interactions	central nervous system	inhibition_chronic	HP_0000735	ENSG00000198785	28216264	Lynch et al. (2017)	GRIN3A	UBERON_0001017	""
stereotypy	central nervous system	inhibition_chronic	HP_0000733	ENSG00000198785	28216264	Lynch et al. (2017)	GRIN3A	UBERON_0001017	""
psychosis	central nervous system	inhibition_chronic	EFO_0005407	ENSG00000198785	28216264	Lynch et al. (2017)	GRIN3A	UBERON_0001017	""
neurodegeneration	central nervous system	inhibition_chronic	HP_0002180	ENSG00000198785	28216264	Lynch et al. (2017)	GRIN3A	UBERON_0001017	""
increased locomotor activity	central nervous system	inhibition_acute	GO_0040017	ENSG00000198785	28216264	Lynch et al. (2017)	GRIN3A	UBERON_0001017	""
ataxia	central nervous system	inhibition_acute	MONDO_0000437	ENSG00000198785	28216264	Lynch et al. (2017)	GRIN3A	UBERON_0001017	""
dizziness	central nervous system	inhibition_acute	EFO_0009847	ENSG00000198785	28216264	Lynch et al. (2017)	GRIN3A	UBERON_0001017	""
decreased memory	central nervous system	inhibition_acute	EFO_0001072	ENSG00000198785	28216264	Lynch et al. (2017)	GRIN3A	UBERON_0001017	""
psychosis	central nervous system	inhibition_acute	EFO_0005407	ENSG00000198785	28216264	Lynch et al. (2017)	GRIN3A	UBERON_0001017	""
decreased convulsions	central nervous system	inhibition_acute	EFO_0009853	ENSG00000198785	28216264	Lynch et al. (2017)	GRIN3A	UBERON_0001017	""
drug abuse/dependence	central nervous system	inhibition_acute	EFO_0003890	ENSG00000198785	28216264	Lynch et al. (2017)	GRIN3A	UBERON_0001017	""
neurotoxicity	central nervous system	inhibition_acute	EFO_0005595	ENSG00000198785	28216264	Lynch et al. (2017)	GRIN3A	UBERON_0001017	""
increased blood pressure	central nervous system	inhibition_acute	HP_0032263	ENSG00000198785	28216264	Lynch et al. (2017)	GRIN3A	UBERON_0001017	""
increased heart rate	central nervous system	inhibition_acute	HP_0001649	ENSG00000198785	28216264	Lynch et al. (2017)	GRIN3A	UBERON_0001017	""
increased then decreased heart rate	central nervous system	activation_acute	HP_0031860	ENSG00000198785	28216264	Lynch et al. (2017)	GRIN3A	UBERON_0001017	""
convulsions	central nervous system	activation_acute	EFO_0009853	ENSG00000198785	28216264	Lynch et al. (2017)	GRIN3A	UBERON_0001017	""
convulsions	cardiovascular	activation_acute	EFO_0009853	ENSG00000198785	28216264	Lynch et al. (2017)	GRIN3A	UBERON_0004535	""
pain	central nervous system	activation_acute	EFO_0003843	ENSG00000198785	28216264	Lynch et al. (2017)	GRIN3A	UBERON_0001017	""
increased blood pressure	cardiovascular	activation_acute	HP_0032263	ENSG00000198785	28216264	Lynch et al. (2017)	GRIN3A	UBERON_0004535	""
decreased heart rate	central nervous system	activation_general	HP_0001662	ENSG00000149295	23197038	Bowes et al. (2012)	DRD2	UBERON_0001017	""
orthostatic hypotension	central nervous system	inhibition_general	EFO_0005252	ENSG00000149295	23197038	Bowes et al. (2012)	DRD2	UBERON_0001017	""
drowsiness	central nervous system	inhibition_general	NCIT_C95746	ENSG00000149295	23197038	Bowes et al. (2012)	DRD2	UBERON_0001017	""
increased gastrointestinal motility	central nervous system	inhibition_general	HP_0030895	ENSG00000149295	23197038	Bowes et al. (2012)	DRD2	UBERON_0001017	""
syncope	central nervous system	activation_general	HP_0001279	ENSG00000149295	23197038	Bowes et al. (2012)	DRD2	UBERON_0001017	""
hallucinations	central nervous system	activation_general	HP_0000738	ENSG00000149295	23197038	Bowes et al. (2012)	DRD2	UBERON_0001017	""
confusion	central nervous system	activation_general	HP_0004372	ENSG00000149295	23197038	Bowes et al. (2012)	DRD2	UBERON_0001017	""
drowsiness	central nervous system	activation_general	NCIT_C95746	ENSG00000149295	23197038	Bowes et al. (2012)	DRD2	UBERON_0001017	""
increased sodium excretion	central nervous system	activation_general	GO_0035815	ENSG00000149295	23197038	Bowes et al. (2012)	DRD2	UBERON_0001017	""
emesis	central nervous system	activation_general	HP_0002017	ENSG00000149295	23197038	Bowes et al. (2012)	DRD2	UBERON_0001017	""
decreased pituitary hormone secretions	central nervous system	activation_general	EFO_0001380	ENSG00000149295	23197038	Bowes et al. (2012)	DRD2	UBERON_0001017	""
decreased heart rate	endocrine	activation_general	HP_0001662	ENSG00000149295	23197038	Bowes et al. (2012)	DRD2	UBERON_0000949	""
orthostatic hypotension	endocrine	inhibition_general	EFO_0005252	ENSG00000149295	23197038	Bowes et al. (2012)	DRD2	UBERON_0000949	""
drowsiness	endocrine	inhibition_general	NCIT_C95746	ENSG00000149295	23197038	Bowes et al. (2012)	DRD2	UBERON_0000949	""
increased gastrointestinal motility	endocrine	inhibition_general	HP_0030895	ENSG00000149295	23197038	Bowes et al. (2012)	DRD2	UBERON_0000949	""
syncope	endocrine	activation_general	HP_0001279	ENSG00000149295	23197038	Bowes et al. (2012)	DRD2	UBERON_0000949	""
hallucinations	endocrine	activation_general	HP_0000738	ENSG00000149295	23197038	Bowes et al. (2012)	DRD2	UBERON_0000949	""
confusion	endocrine	activation_general	HP_0004372	ENSG00000149295	23197038	Bowes et al. (2012)	DRD2	UBERON_0000949	""
drowsiness	endocrine	activation_general	NCIT_C95746	ENSG00000149295	23197038	Bowes et al. (2012)	DRD2	UBERON_0000949	""
increased sodium excretion	endocrine	activation_general	GO_0035815	ENSG00000149295	23197038	Bowes et al. (2012)	DRD2	UBERON_0000949	""
emesis	endocrine	activation_general	HP_0002017	ENSG00000149295	23197038	Bowes et al. (2012)	DRD2	UBERON_0000949	""
decreased pituitary hormone secretions	endocrine	activation_general	EFO_0001380	ENSG00000149295	23197038	Bowes et al. (2012)	DRD2	UBERON_0000949	""
decreased heart rate	cardiovascular system	activation_general	HP_0001662	ENSG00000149295	23197038	Bowes et al. (2012)	DRD2	UBERON_0004535	""
orthostatic hypotension	cardiovascular system	inhibition_general	EFO_0005252	ENSG00000149295	23197038	Bowes et al. (2012)	DRD2	UBERON_0004535	""
drowsiness	cardiovascular system	inhibition_general	NCIT_C95746	ENSG00000149295	23197038	Bowes et al. (2012)	DRD2	UBERON_0004535	""
increased gastrointestinal motility	cardiovascular system	inhibition_general	HP_0030895	ENSG00000149295	23197038	Bowes et al. (2012)	DRD2	UBERON_0004535	""
syncope	cardiovascular system	activation_general	HP_0001279	ENSG00000149295	23197038	Bowes et al. (2012)	DRD2	UBERON_0004535	""
hallucinations	cardiovascular system	activation_general	HP_0000738	ENSG00000149295	23197038	Bowes et al. (2012)	DRD2	UBERON_0004535	""
confusion	cardiovascular system	activation_general	HP_0004372	ENSG00000149295	23197038	Bowes et al. (2012)	DRD2	UBERON_0004535	""
drowsiness	cardiovascular system	activation_general	NCIT_C95746	ENSG00000149295	23197038	Bowes et al. (2012)	DRD2	UBERON_0004535	""
increased sodium excretion	cardiovascular system	activation_general	GO_0035815	ENSG00000149295	23197038	Bowes et al. (2012)	DRD2	UBERON_0004535	""
emesis	cardiovascular system	activation_general	HP_0002017	ENSG00000149295	23197038	Bowes et al. (2012)	DRD2	UBERON_0004535	""
decreased pituitary hormone secretions	cardiovascular system	activation_general	EFO_0001380	ENSG00000149295	23197038	Bowes et al. (2012)	DRD2	UBERON_0004535	""
increased memory	immune	activation_acute	EFO_0004874	ENSG00000148680	28216264	Lynch et al. (2017)	HTR7	UBERON_0002405	""
increased/decreased memory	immune	inhibition_acute	EFO_0004874	ENSG00000148680	28216264	Lynch et al. (2017)	HTR7	UBERON_0002405	""
decreased sleep	immune	inhibition_acute	EFO_0008568	ENSG00000148680	28216264	Lynch et al. (2017)	HTR7	UBERON_0002405	""
decreased pain	immune	inhibition_acute	GO_1904057	ENSG00000148680	28216264	Lynch et al. (2017)	HTR7	UBERON_0002405	""
decreased anxiety	immune	inhibition_acute	EFO_0009874	ENSG00000148680	28216264	Lynch et al. (2017)	HTR7	UBERON_0002405	""
decreased inflammation	immune	activation_acute	GO_0050728	ENSG00000148680	28216264	Lynch et al. (2017)	HTR7	UBERON_0002405	""
decreased/increased pain	nervous system	activation_acute	GO_0051930	ENSG00000148680	28216264	Lynch et al. (2017)	HTR7	UBERON_0001016	""
increased/decreased memory	nervous system	inhibition_acute	EFO_0004874	ENSG00000148680	28216264	Lynch et al. (2017)	HTR7	UBERON_0001016	""
decreased sleep	nervous system	inhibition_acute	EFO_0008568	ENSG00000148680	28216264	Lynch et al. (2017)	HTR7	UBERON_0001016	""
decreased pain	nervous system	inhibition_acute	GO_1904057	ENSG00000148680	28216264	Lynch et al. (2017)	HTR7	UBERON_0001016	""
decreased anxiety	nervous system	inhibition_acute	EFO_0009874	ENSG00000148680	28216264	Lynch et al. (2017)	HTR7	UBERON_0001016	""
increased memory	nervous system	activation_acute	EFO_0004874	ENSG00000148680	28216264	Lynch et al. (2017)	HTR7	UBERON_0001016	""
decreased sleep	immune	activation_acute	EFO_0008568	ENSG00000148680	28216264	Lynch et al. (2017)	HTR7	UBERON_0002405	""
decreased/increased pain	immune	activation_acute	GO_0051930	ENSG00000148680	28216264	Lynch et al. (2017)	HTR7	UBERON_0002405	""
decreased body temperature	nervous system	activation_acute	HP_0002045	ENSG00000148680	28216264	Lynch et al. (2017)	HTR7	UBERON_0001016	""
decreased sleep	nervous system	activation_acute	EFO_0008568	ENSG00000148680	28216264	Lynch et al. (2017)	HTR7	UBERON_0001016	""
decreased body temperature	immune	activation_acute	HP_0002045	ENSG00000148680	28216264	Lynch et al. (2017)	HTR7	UBERON_0002405	""
decreased inflammation	nervous system	activation_acute	GO_0050728	ENSG00000148680	28216264	Lynch et al. (2017)	HTR7	UBERON_0001016	""
increased then decreased heart rate	central nervous system	activation_acute	HP_0031860	ENSG00000176884	28216264	Lynch et al. (2017)	GRIN1	UBERON_0001017	""
decreased pain	central nervous system	inhibition_acute	GO_1904057	ENSG00000176884	28216264	Lynch et al. (2017)	GRIN1	UBERON_0001017	""
impaired social interactions	central nervous system	inhibition_chronic	HP_0000735	ENSG00000176884	28216264	Lynch et al. (2017)	GRIN1	UBERON_0001017	""
stereotypy	central nervous system	inhibition_chronic	HP_0000733	ENSG00000176884	28216264	Lynch et al. (2017)	GRIN1	UBERON_0001017	""
psychosis	central nervous system	inhibition_chronic	EFO_0005407	ENSG00000176884	28216264	Lynch et al. (2017)	GRIN1	UBERON_0001017	""
neurodegeneration	central nervous system	inhibition_chronic	HP_0002180	ENSG00000176884	28216264	Lynch et al. (2017)	GRIN1	UBERON_0001017	""
increased locomotor activity	central nervous system	inhibition_acute	GO_0040017	ENSG00000176884	28216264	Lynch et al. (2017)	GRIN1	UBERON_0001017	""
ataxia	central nervous system	inhibition_acute	MONDO_0000437	ENSG00000176884	28216264	Lynch et al. (2017)	GRIN1	UBERON_0001017	""
dizziness	central nervous system	inhibition_acute	EFO_0009847	ENSG00000176884	28216264	Lynch et al. (2017)	GRIN1	UBERON_0001017	""
decreased memory	central nervous system	inhibition_acute	EFO_0001072	ENSG00000176884	28216264	Lynch et al. (2017)	GRIN1	UBERON_0001017	""
psychosis	central nervous system	inhibition_acute	EFO_0005407	ENSG00000176884	28216264	Lynch et al. (2017)	GRIN1	UBERON_0001017	""
decreased convulsions	central nervous system	inhibition_acute	EFO_0009853	ENSG00000176884	28216264	Lynch et al. (2017)	GRIN1	UBERON_0001017	""
drug abuse/dependence	central nervous system	inhibition_acute	EFO_0003890	ENSG00000176884	28216264	Lynch et al. (2017)	GRIN1	UBERON_0001017	""
neurotoxicity	central nervous system	inhibition_acute	EFO_0005595	ENSG00000176884	28216264	Lynch et al. (2017)	GRIN1	UBERON_0001017	""
increased blood pressure	central nervous system	inhibition_acute	HP_0032263	ENSG00000176884	28216264	Lynch et al. (2017)	GRIN1	UBERON_0001017	""
increased heart rate	central nervous system	inhibition_acute	HP_0001649	ENSG00000176884	28216264	Lynch et al. (2017)	GRIN1	UBERON_0001017	""
convulsions	central nervous system	activation_acute	EFO_0009853	ENSG00000176884	28216264	Lynch et al. (2017)	GRIN1	UBERON_0001017	""
pain	central nervous system	activation_acute	EFO_0003843	ENSG00000176884	28216264	Lynch et al. (2017)	GRIN1	UBERON_0001017	""
pain	cardiovascular	activation_acute	EFO_0003843	ENSG00000176884	28216264	Lynch et al. (2017)	GRIN1	UBERON_0004535	""
decreased pain	cardiovascular	inhibition_acute	GO_1904057	ENSG00000176884	28216264	Lynch et al. (2017)	GRIN1	UBERON_0004535	""
impaired social interactions	cardiovascular	inhibition_chronic	HP_0000735	ENSG00000176884	28216264	Lynch et al. (2017)	GRIN1	UBERON_0004535	""
stereotypy	cardiovascular	inhibition_chronic	HP_0000733	ENSG00000176884	28216264	Lynch et al. (2017)	GRIN1	UBERON_0004535	""
psychosis	cardiovascular	inhibition_chronic	EFO_0005407	ENSG00000176884	28216264	Lynch et al. (2017)	GRIN1	UBERON_0004535	""
neurodegeneration	cardiovascular	inhibition_chronic	HP_0002180	ENSG00000176884	28216264	Lynch et al. (2017)	GRIN1	UBERON_0004535	""
increased locomotor activity	cardiovascular	inhibition_acute	GO_0040017	ENSG00000176884	28216264	Lynch et al. (2017)	GRIN1	UBERON_0004535	""
ataxia	cardiovascular	inhibition_acute	MONDO_0000437	ENSG00000176884	28216264	Lynch et al. (2017)	GRIN1	UBERON_0004535	""
dizziness	cardiovascular	inhibition_acute	EFO_0009847	ENSG00000176884	28216264	Lynch et al. (2017)	GRIN1	UBERON_0004535	""
decreased memory	cardiovascular	inhibition_acute	EFO_0001072	ENSG00000176884	28216264	Lynch et al. (2017)	GRIN1	UBERON_0004535	""
psychosis	cardiovascular	inhibition_acute	EFO_0005407	ENSG00000176884	28216264	Lynch et al. (2017)	GRIN1	UBERON_0004535	""
decreased convulsions	cardiovascular	inhibition_acute	EFO_0009853	ENSG00000176884	28216264	Lynch et al. (2017)	GRIN1	UBERON_0004535	""
drug abuse/dependence	cardiovascular	inhibition_acute	EFO_0003890	ENSG00000176884	28216264	Lynch et al. (2017)	GRIN1	UBERON_0004535	""
neurotoxicity	cardiovascular	inhibition_acute	EFO_0005595	ENSG00000176884	28216264	Lynch et al. (2017)	GRIN1	UBERON_0004535	""
increased blood pressure	cardiovascular	inhibition_acute	HP_0032263	ENSG00000176884	28216264	Lynch et al. (2017)	GRIN1	UBERON_0004535	""
increased heart rate	cardiovascular	inhibition_acute	HP_0001649	ENSG00000176884	28216264	Lynch et al. (2017)	GRIN1	UBERON_0004535	""
increased blood pressure	cardiovascular	activation_acute	HP_0032263	ENSG00000176884	28216264	Lynch et al. (2017)	GRIN1	UBERON_0004535	""
increased then decreased heart rate	cardiovascular	activation_acute	HP_0031860	ENSG00000176884	28216264	Lynch et al. (2017)	GRIN1	UBERON_0004535	""
convulsions	cardiovascular	activation_acute	EFO_0009853	ENSG00000176884	28216264	Lynch et al. (2017)	GRIN1	UBERON_0004535	""
increased blood pressure	central nervous system	activation_acute	HP_0032263	ENSG00000176884	28216264	Lynch et al. (2017)	GRIN1	UBERON_0001017	""
decreased anxiety	central nervous system	activation_acute	EFO_0009874	ENSG00000182256	28216264	Lynch et al. (2017)	GABRG3	UBERON_0001017	""
convulsions	central nervous system	inhibition_acute	EFO_0009853	ENSG00000182256	28216264	Lynch et al. (2017)	GABRG3	UBERON_0001017	""
decreased sleep	central nervous system	inhibition_acute	EFO_0008568	ENSG00000182256	28216264	Lynch et al. (2017)	GABRG3	UBERON_0001017	""
drug abuse/dependence	cardiovascular	activation_acute	EFO_0003890	ENSG00000182256	28216264	Lynch et al. (2017)	GABRG3	UBERON_0004535	""
convulsions	cardiovascular	inhibition_acute	EFO_0009853	ENSG00000182256	28216264	Lynch et al. (2017)	GABRG3	UBERON_0004535	""
decreased sleep	cardiovascular	inhibition_acute	EFO_0008568	ENSG00000182256	28216264	Lynch et al. (2017)	GABRG3	UBERON_0004535	""
decreased body temperature	cardiovascular	activation_acute	HP_0002045	ENSG00000182256	28216264	Lynch et al. (2017)	GABRG3	UBERON_0004535	""
muscle relaxation	cardiovascular	activation_acute	""	ENSG00000182256	28216264	Lynch et al. (2017)	GABRG3	UBERON_0004535	""
decreased convulsions	central nervous system	activation_acute	EFO_0009853	ENSG00000182256	28216264	Lynch et al. (2017)	GABRG3	UBERON_0001017	""
increased cardiac output	central nervous system	activation_acute	EFO_0009872	ENSG00000182256	28216264	Lynch et al. (2017)	GABRG3	UBERON_0001017	""
decreased cardiac contractility	central nervous system	activation_acute	GO_0045822	ENSG00000182256	28216264	Lynch et al. (2017)	GABRG3	UBERON_0001017	""
decreased pain	cardiovascular	activation_acute	GO_1904057	ENSG00000182256	28216264	Lynch et al. (2017)	GABRG3	UBERON_0004535	""
increased respiratory rate	central nervous system	activation_acute	EFO_0009840	ENSG00000182256	28216264	Lynch et al. (2017)	GABRG3	UBERON_0001017	""
increased cardiac output	cardiovascular	activation_acute	EFO_0009872	ENSG00000182256	28216264	Lynch et al. (2017)	GABRG3	UBERON_0004535	""
decreased convulsions	cardiovascular	activation_acute	EFO_0009853	ENSG00000182256	28216264	Lynch et al. (2017)	GABRG3	UBERON_0004535	""
decreased pain	central nervous system	activation_acute	GO_1904057	ENSG00000182256	28216264	Lynch et al. (2017)	GABRG3	UBERON_0001017	""
ataxia	central nervous system	activation_acute	MONDO_0000437	ENSG00000182256	28216264	Lynch et al. (2017)	GABRG3	UBERON_0001017	""
increased sleep	cardiovascular	activation_acute	EFO_0008568	ENSG00000182256	28216264	Lynch et al. (2017)	GABRG3	UBERON_0004535	""
decreased body temperature	central nervous system	activation_acute	HP_0002045	ENSG00000182256	28216264	Lynch et al. (2017)	GABRG3	UBERON_0001017	""
increased eating	cardiovascular	activation_acute	HP_0100738	ENSG00000182256	28216264	Lynch et al. (2017)	GABRG3	UBERON_0004535	""
decreased locomotor activity	cardiovascular	activation_acute	GO_0040013	ENSG00000182256	28216264	Lynch et al. (2017)	GABRG3	UBERON_0004535	""
decreased cardiac contractility	cardiovascular	activation_acute	GO_0045822	ENSG00000182256	28216264	Lynch et al. (2017)	GABRG3	UBERON_0004535	""
ataxia	cardiovascular	activation_acute	MONDO_0000437	ENSG00000182256	28216264	Lynch et al. (2017)	GABRG3	UBERON_0004535	""
decreased blood pressure	central nervous system	activation_acute	EFO_0005251	ENSG00000182256	28216264	Lynch et al. (2017)	GABRG3	UBERON_0001017	""
decreased memory	cardiovascular	activation_acute	EFO_0001072	ENSG00000182256	28216264	Lynch et al. (2017)	GABRG3	UBERON_0004535	""
decreased memory	central nervous system	activation_acute	EFO_0001072	ENSG00000182256	28216264	Lynch et al. (2017)	GABRG3	UBERON_0001017	""
decreased anxiety	cardiovascular	activation_acute	EFO_0009874	ENSG00000182256	28216264	Lynch et al. (2017)	GABRG3	UBERON_0004535	""
drug abuse/dependence	central nervous system	activation_acute	EFO_0003890	ENSG00000182256	28216264	Lynch et al. (2017)	GABRG3	UBERON_0001017	""
increased respiratory rate	cardiovascular	activation_acute	EFO_0009840	ENSG00000182256	28216264	Lynch et al. (2017)	GABRG3	UBERON_0004535	""
decreased locomotor activity	central nervous system	activation_acute	GO_0040013	ENSG00000182256	28216264	Lynch et al. (2017)	GABRG3	UBERON_0001017	""
increased eating	central nervous system	activation_acute	HP_0100738	ENSG00000182256	28216264	Lynch et al. (2017)	GABRG3	UBERON_0001017	""
muscle relaxation	central nervous system	activation_acute	""	ENSG00000182256	28216264	Lynch et al. (2017)	GABRG3	UBERON_0001017	""
decreased blood pressure	cardiovascular	activation_acute	EFO_0005251	ENSG00000182256	28216264	Lynch et al. (2017)	GABRG3	UBERON_0004535	""
increased sleep	central nervous system	activation_acute	EFO_0008568	ENSG00000182256	28216264	Lynch et al. (2017)	GABRG3	UBERON_0001017	""
increased cardiac output	central nervous system	activation_acute	EFO_0009872	ENSG00000109158	28216264	Lynch et al. (2017)	GABRA4	UBERON_0001017	""
convulsions	central nervous system	inhibition_acute	EFO_0009853	ENSG00000109158	28216264	Lynch et al. (2017)	GABRA4	UBERON_0001017	""
decreased sleep	central nervous system	inhibition_acute	EFO_0008568	ENSG00000109158	28216264	Lynch et al. (2017)	GABRA4	UBERON_0001017	""
decreased locomotor activity	central nervous system	activation_acute	GO_0040013	ENSG00000109158	28216264	Lynch et al. (2017)	GABRA4	UBERON_0001017	""
increased respiratory rate	central nervous system	activation_acute	EFO_0009840	ENSG00000109158	28216264	Lynch et al. (2017)	GABRA4	UBERON_0001017	""
decreased memory	cardiovascular	activation_acute	EFO_0001072	ENSG00000109158	28216264	Lynch et al. (2017)	GABRA4	UBERON_0004535	""
convulsions	cardiovascular	inhibition_acute	EFO_0009853	ENSG00000109158	28216264	Lynch et al. (2017)	GABRA4	UBERON_0004535	""
decreased sleep	cardiovascular	inhibition_acute	EFO_0008568	ENSG00000109158	28216264	Lynch et al. (2017)	GABRA4	UBERON_0004535	""
muscle relaxation	cardiovascular	activation_acute	""	ENSG00000109158	28216264	Lynch et al. (2017)	GABRA4	UBERON_0004535	""
drug abuse/dependence	central nervous system	activation_acute	EFO_0003890	ENSG00000109158	28216264	Lynch et al. (2017)	GABRA4	UBERON_0001017	""
decreased pain	central nervous system	activation_acute	GO_1904057	ENSG00000109158	28216264	Lynch et al. (2017)	GABRA4	UBERON_0001017	""
decreased body temperature	cardiovascular	activation_acute	HP_0002045	ENSG00000109158	28216264	Lynch et al. (2017)	GABRA4	UBERON_0004535	""
decreased locomotor activity	cardiovascular	activation_acute	GO_0040013	ENSG00000109158	28216264	Lynch et al. (2017)	GABRA4	UBERON_0004535	""
ataxia	central nervous system	activation_acute	MONDO_0000437	ENSG00000109158	28216264	Lynch et al. (2017)	GABRA4	UBERON_0001017	""
decreased convulsions	cardiovascular	activation_acute	EFO_0009853	ENSG00000109158	28216264	Lynch et al. (2017)	GABRA4	UBERON_0004535	""
decreased anxiety	cardiovascular	activation_acute	EFO_0009874	ENSG00000109158	28216264	Lynch et al. (2017)	GABRA4	UBERON_0004535	""
decreased blood pressure	cardiovascular	activation_acute	EFO_0005251	ENSG00000109158	28216264	Lynch et al. (2017)	GABRA4	UBERON_0004535	""
increased eating	central nervous system	activation_acute	HP_0100738	ENSG00000109158	28216264	Lynch et al. (2017)	GABRA4	UBERON_0001017	""
increased cardiac output	cardiovascular	activation_acute	EFO_0009872	ENSG00000109158	28216264	Lynch et al. (2017)	GABRA4	UBERON_0004535	""
increased sleep	central nervous system	activation_acute	EFO_0008568	ENSG00000109158	28216264	Lynch et al. (2017)	GABRA4	UBERON_0001017	""
decreased cardiac contractility	cardiovascular	activation_acute	GO_0045822	ENSG00000109158	28216264	Lynch et al. (2017)	GABRA4	UBERON_0004535	""
increased eating	cardiovascular	activation_acute	HP_0100738	ENSG00000109158	28216264	Lynch et al. (2017)	GABRA4	UBERON_0004535	""
decreased anxiety	central nervous system	activation_acute	EFO_0009874	ENSG00000109158	28216264	Lynch et al. (2017)	GABRA4	UBERON_0001017	""
decreased convulsions	central nervous system	activation_acute	EFO_0009853	ENSG00000109158	28216264	Lynch et al. (2017)	GABRA4	UBERON_0001017	""
increased sleep	cardiovascular	activation_acute	EFO_0008568	ENSG00000109158	28216264	Lynch et al. (2017)	GABRA4	UBERON_0004535	""
decreased memory	central nervous system	activation_acute	EFO_0001072	ENSG00000109158	28216264	Lynch et al. (2017)	GABRA4	UBERON_0001017	""
decreased blood pressure	central nervous system	activation_acute	EFO_0005251	ENSG00000109158	28216264	Lynch et al. (2017)	GABRA4	UBERON_0001017	""
muscle relaxation	central nervous system	activation_acute	""	ENSG00000109158	28216264	Lynch et al. (2017)	GABRA4	UBERON_0001017	""
increased respiratory rate	cardiovascular	activation_acute	EFO_0009840	ENSG00000109158	28216264	Lynch et al. (2017)	GABRA4	UBERON_0004535	""
decreased body temperature	central nervous system	activation_acute	HP_0002045	ENSG00000109158	28216264	Lynch et al. (2017)	GABRA4	UBERON_0001017	""
decreased cardiac contractility	central nervous system	activation_acute	GO_0045822	ENSG00000109158	28216264	Lynch et al. (2017)	GABRA4	UBERON_0001017	""
decreased pain	cardiovascular	activation_acute	GO_1904057	ENSG00000109158	28216264	Lynch et al. (2017)	GABRA4	UBERON_0004535	""
drug abuse/dependence	cardiovascular	activation_acute	EFO_0003890	ENSG00000109158	28216264	Lynch et al. (2017)	GABRA4	UBERON_0004535	""
ataxia	cardiovascular	activation_acute	MONDO_0000437	ENSG00000109158	28216264	Lynch et al. (2017)	GABRA4	UBERON_0004535	""
decreased body temperature	cardiovascular	activation_acute	HP_0002045	ENSG00000011677	28216264	Lynch et al. (2017)	GABRA3	UBERON_0004535	""
convulsions	cardiovascular	inhibition_acute	EFO_0009853	ENSG00000011677	28216264	Lynch et al. (2017)	GABRA3	UBERON_0004535	""
decreased sleep	cardiovascular	inhibition_acute	EFO_0008568	ENSG00000011677	28216264	Lynch et al. (2017)	GABRA3	UBERON_0004535	""
decreased anxiety	cardiovascular	activation_acute	EFO_0009874	ENSG00000011677	28216264	Lynch et al. (2017)	GABRA3	UBERON_0004535	""
ataxia	cardiovascular	activation_acute	MONDO_0000437	ENSG00000011677	28216264	Lynch et al. (2017)	GABRA3	UBERON_0004535	""
increased sleep	central nervous system	activation_acute	EFO_0008568	ENSG00000011677	28216264	Lynch et al. (2017)	GABRA3	UBERON_0001017	""
convulsions	central nervous system	inhibition_acute	EFO_0009853	ENSG00000011677	28216264	Lynch et al. (2017)	GABRA3	UBERON_0001017	""
decreased sleep	central nervous system	inhibition_acute	EFO_0008568	ENSG00000011677	28216264	Lynch et al. (2017)	GABRA3	UBERON_0001017	""
decreased cardiac contractility	cardiovascular	activation_acute	GO_0045822	ENSG00000011677	28216264	Lynch et al. (2017)	GABRA3	UBERON_0004535	""
decreased memory	central nervous system	activation_acute	EFO_0001072	ENSG00000011677	28216264	Lynch et al. (2017)	GABRA3	UBERON_0001017	""
decreased pain	cardiovascular	activation_acute	GO_1904057	ENSG00000011677	28216264	Lynch et al. (2017)	GABRA3	UBERON_0004535	""
decreased convulsions	central nervous system	activation_acute	EFO_0009853	ENSG00000011677	28216264	Lynch et al. (2017)	GABRA3	UBERON_0001017	""
drug abuse/dependence	central nervous system	activation_acute	EFO_0003890	ENSG00000011677	28216264	Lynch et al. (2017)	GABRA3	UBERON_0001017	""
increased eating	cardiovascular	activation_acute	HP_0100738	ENSG00000011677	28216264	Lynch et al. (2017)	GABRA3	UBERON_0004535	""
increased eating	central nervous system	activation_acute	HP_0100738	ENSG00000011677	28216264	Lynch et al. (2017)	GABRA3	UBERON_0001017	""
increased sleep	cardiovascular	activation_acute	EFO_0008568	ENSG00000011677	28216264	Lynch et al. (2017)	GABRA3	UBERON_0004535	""
decreased blood pressure	cardiovascular	activation_acute	EFO_0005251	ENSG00000011677	28216264	Lynch et al. (2017)	GABRA3	UBERON_0004535	""
decreased locomotor activity	cardiovascular	activation_acute	GO_0040013	ENSG00000011677	28216264	Lynch et al. (2017)	GABRA3	UBERON_0004535	""
muscle relaxation	central nervous system	activation_acute	""	ENSG00000011677	28216264	Lynch et al. (2017)	GABRA3	UBERON_0001017	""
ataxia	central nervous system	activation_acute	MONDO_0000437	ENSG00000011677	28216264	Lynch et al. (2017)	GABRA3	UBERON_0001017	""
increased cardiac output	central nervous system	activation_acute	EFO_0009872	ENSG00000011677	28216264	Lynch et al. (2017)	GABRA3	UBERON_0001017	""
drug abuse/dependence	cardiovascular	activation_acute	EFO_0003890	ENSG00000011677	28216264	Lynch et al. (2017)	GABRA3	UBERON_0004535	""
muscle relaxation	cardiovascular	activation_acute	""	ENSG00000011677	28216264	Lynch et al. (2017)	GABRA3	UBERON_0004535	""
decreased locomotor activity	central nervous system	activation_acute	GO_0040013	ENSG00000011677	28216264	Lynch et al. (2017)	GABRA3	UBERON_0001017	""
decreased memory	cardiovascular	activation_acute	EFO_0001072	ENSG00000011677	28216264	Lynch et al. (2017)	GABRA3	UBERON_0004535	""
decreased anxiety	central nervous system	activation_acute	EFO_0009874	ENSG00000011677	28216264	Lynch et al. (2017)	GABRA3	UBERON_0001017	""
increased cardiac output	cardiovascular	activation_acute	EFO_0009872	ENSG00000011677	28216264	Lynch et al. (2017)	GABRA3	UBERON_0004535	""
decreased blood pressure	central nervous system	activation_acute	EFO_0005251	ENSG00000011677	28216264	Lynch et al. (2017)	GABRA3	UBERON_0001017	""
decreased convulsions	cardiovascular	activation_acute	EFO_0009853	ENSG00000011677	28216264	Lynch et al. (2017)	GABRA3	UBERON_0004535	""
decreased cardiac contractility	central nervous system	activation_acute	GO_0045822	ENSG00000011677	28216264	Lynch et al. (2017)	GABRA3	UBERON_0001017	""
decreased body temperature	central nervous system	activation_acute	HP_0002045	ENSG00000011677	28216264	Lynch et al. (2017)	GABRA3	UBERON_0001017	""
increased respiratory rate	central nervous system	activation_acute	EFO_0009840	ENSG00000011677	28216264	Lynch et al. (2017)	GABRA3	UBERON_0001017	""
increased respiratory rate	cardiovascular	activation_acute	EFO_0009840	ENSG00000011677	28216264	Lynch et al. (2017)	GABRA3	UBERON_0004535	""
decreased pain	central nervous system	activation_acute	GO_1904057	ENSG00000011677	28216264	Lynch et al. (2017)	GABRA3	UBERON_0001017	""
coronary vasodilation	cardiovascular system	activation_general	""	ENSG00000128271	23197038	Bowes et al. (2012)	ADORA2A	UBERON_0004535	""
potential for stimulation of platelet aggregation	cardiovascular system	inhibition_general	GO_1901731	ENSG00000128271	23197038	Bowes et al. (2012)	ADORA2A	UBERON_0004535	""
increased blood pressure	cardiovascular system	inhibition_general	HP_0032263	ENSG00000128271	23197038	Bowes et al. (2012)	ADORA2A	UBERON_0004535	""
nervousness (tremors, agitation)	cardiovascular system	inhibition_general	NCIT_C74532	ENSG00000128271	23197038	Bowes et al. (2012)	ADORA2A	UBERON_0004535	""
arousal	cardiovascular system	inhibition_general	EFO_0009849	ENSG00000128271	23197038	Bowes et al. (2012)	ADORA2A	UBERON_0004535	""
insomnia	cardiovascular system	inhibition_general	EFO_0004698	ENSG00000128271	23197038	Bowes et al. (2012)	ADORA2A	UBERON_0004535	""
decreased blood pressure	cardiovascular system	activation_general	EFO_0005251	ENSG00000128271	23197038	Bowes et al. (2012)	ADORA2A	UBERON_0004535	""
decreased reflex	cardiovascular system	activation_general	HP_0001265	ENSG00000128271	23197038	Bowes et al. (2012)	ADORA2A	UBERON_0004535	""
increased heart rate	cardiovascular system	activation_general	HP_0001649	ENSG00000128271	23197038	Bowes et al. (2012)	ADORA2A	UBERON_0004535	""
decreased platelet aggregation	cardiovascular system	activation_general	GO_0090331	ENSG00000128271	23197038	Bowes et al. (2012)	ADORA2A	UBERON_0004535	""
decreased leukocyte activation	cardiovascular system	activation_general	GO_0002695	ENSG00000128271	23197038	Bowes et al. (2012)	ADORA2A	UBERON_0004535	""
decreased locomotor activity	cardiovascular system	activation_general	GO_0040013	ENSG00000128271	23197038	Bowes et al. (2012)	ADORA2A	UBERON_0004535	""
sleep induction	cardiovascular system	activation_general	EFO_0009843	ENSG00000128271	23197038	Bowes et al. (2012)	ADORA2A	UBERON_0004535	""
coronary vasodilation	central nervous system	activation_general	""	ENSG00000128271	23197038	Bowes et al. (2012)	ADORA2A	UBERON_0001017	""
potential for stimulation of platelet aggregation	central nervous system	inhibition_general	GO_1901731	ENSG00000128271	23197038	Bowes et al. (2012)	ADORA2A	UBERON_0001017	""
increased blood pressure	central nervous system	inhibition_general	HP_0032263	ENSG00000128271	23197038	Bowes et al. (2012)	ADORA2A	UBERON_0001017	""
nervousness (tremors, agitation)	central nervous system	inhibition_general	NCIT_C74532	ENSG00000128271	23197038	Bowes et al. (2012)	ADORA2A	UBERON_0001017	""
arousal	central nervous system	inhibition_general	EFO_0009849	ENSG00000128271	23197038	Bowes et al. (2012)	ADORA2A	UBERON_0001017	""
insomnia	central nervous system	inhibition_general	EFO_0004698	ENSG00000128271	23197038	Bowes et al. (2012)	ADORA2A	UBERON_0001017	""
decreased blood pressure	central nervous system	activation_general	EFO_0005251	ENSG00000128271	23197038	Bowes et al. (2012)	ADORA2A	UBERON_0001017	""
decreased reflex	central nervous system	activation_general	HP_0001265	ENSG00000128271	23197038	Bowes et al. (2012)	ADORA2A	UBERON_0001017	""
increased heart rate	central nervous system	activation_general	HP_0001649	ENSG00000128271	23197038	Bowes et al. (2012)	ADORA2A	UBERON_0001017	""
decreased platelet aggregation	central nervous system	activation_general	GO_0090331	ENSG00000128271	23197038	Bowes et al. (2012)	ADORA2A	UBERON_0001017	""
decreased leukocyte activation	central nervous system	activation_general	GO_0002695	ENSG00000128271	23197038	Bowes et al. (2012)	ADORA2A	UBERON_0001017	""
decreased locomotor activity	central nervous system	activation_general	GO_0040013	ENSG00000128271	23197038	Bowes et al. (2012)	ADORA2A	UBERON_0001017	""
sleep induction	central nervous system	activation_general	EFO_0009843	ENSG00000128271	23197038	Bowes et al. (2012)	ADORA2A	UBERON_0001017	""
increased anxiety	nervous system	activation_acute	EFO_0005230	ENSG00000147246	28216264	Lynch et al. (2017)	HTR2C	UBERON_0001016	""
decreased anxiety	nervous system	inhibition_acute	EFO_0009874	ENSG00000147246	28216264	Lynch et al. (2017)	HTR2C	UBERON_0001016	""
increased memory	nervous system	inhibition_acute	EFO_0004874	ENSG00000147246	28216264	Lynch et al. (2017)	HTR2C	UBERON_0001016	""
drug abuse/dependence	nervous system	inhibition_acute	EFO_0003890	ENSG00000147246	28216264	Lynch et al. (2017)	HTR2C	UBERON_0001016	""
decreased convulsions	nervous system	inhibition_acute	EFO_0009853	ENSG00000147246	28216264	Lynch et al. (2017)	HTR2C	UBERON_0001016	""
abnormal mouth movements	nervous system	activation_acute	""	ENSG00000147246	28216264	Lynch et al. (2017)	HTR2C	UBERON_0001016	""
decreased eating	nervous system	activation_acute	HP_0100738	ENSG00000147246	28216264	Lynch et al. (2017)	HTR2C	UBERON_0001016	""
decreased locomotor activity	nervous system	activation_acute	GO_0040013	ENSG00000147246	28216264	Lynch et al. (2017)	HTR2C	UBERON_0001016	""
penile erection	nervous system	activation_acute	GO_0043084	ENSG00000147246	28216264	Lynch et al. (2017)	HTR2C	UBERON_0001016	""
decreased memory	nervous system	activation_acute	EFO_0001072	ENSG00000147246	28216264	Lynch et al. (2017)	HTR2C	UBERON_0001016	""
increased convulsions	nervous system	activation_acute	EFO_0009853	ENSG00000147246	28216264	Lynch et al. (2017)	HTR2C	UBERON_0001016	""
increased urinary sodium excretion	nervous system	activation_acute	GO_0035815	ENSG00000108405	28216264	Lynch et al. (2017)	P2RX1	UBERON_0001016	""
neurodegeneration	nervous system	activation_chronic	HP_0002180	ENSG00000108405	28216264	Lynch et al. (2017)	P2RX1	UBERON_0001016	""
decreased pain	nervous system	inhibition_acute	GO_1904057	ENSG00000108405	28216264	Lynch et al. (2017)	P2RX1	UBERON_0001016	""
decreased inflammation	nervous system	inhibition_acute	GO_0050728	ENSG00000108405	28216264	Lynch et al. (2017)	P2RX1	UBERON_0001016	""
decreased convulsions	nervous system	inhibition_acute	EFO_0009853	ENSG00000108405	28216264	Lynch et al. (2017)	P2RX1	UBERON_0001016	""
increased pain	nervous system	activation_acute	GO_1904058	ENSG00000108405	28216264	Lynch et al. (2017)	P2RX1	UBERON_0001016	""
increased pain	renal	activation_acute	GO_1904058	ENSG00000108405	28216264	Lynch et al. (2017)	P2RX1	UBERON_0001008	""
neurodegeneration	renal	activation_chronic	HP_0002180	ENSG00000108405	28216264	Lynch et al. (2017)	P2RX1	UBERON_0001008	""
decreased pain	renal	inhibition_acute	GO_1904057	ENSG00000108405	28216264	Lynch et al. (2017)	P2RX1	UBERON_0001008	""
decreased inflammation	renal	inhibition_acute	GO_0050728	ENSG00000108405	28216264	Lynch et al. (2017)	P2RX1	UBERON_0001008	""
decreased convulsions	renal	inhibition_acute	EFO_0009853	ENSG00000108405	28216264	Lynch et al. (2017)	P2RX1	UBERON_0001008	""
increased pain	immune	activation_acute	GO_1904058	ENSG00000108405	28216264	Lynch et al. (2017)	P2RX1	UBERON_0002405	""
neurodegeneration	immune	activation_chronic	HP_0002180	ENSG00000108405	28216264	Lynch et al. (2017)	P2RX1	UBERON_0002405	""
decreased pain	immune	inhibition_acute	GO_1904057	ENSG00000108405	28216264	Lynch et al. (2017)	P2RX1	UBERON_0002405	""
decreased inflammation	immune	inhibition_acute	GO_0050728	ENSG00000108405	28216264	Lynch et al. (2017)	P2RX1	UBERON_0002405	""
decreased convulsions	immune	inhibition_acute	EFO_0009853	ENSG00000108405	28216264	Lynch et al. (2017)	P2RX1	UBERON_0002405	""
increased urine excretion	immune	activation_acute	HP_0000103	ENSG00000108405	28216264	Lynch et al. (2017)	P2RX1	UBERON_0002405	""
hemolysis	renal	activation_acute	EFO_0009473	ENSG00000108405	28216264	Lynch et al. (2017)	P2RX1	UBERON_0001008	""
increased urinary sodium excretion	immune	activation_acute	GO_0035815	ENSG00000108405	28216264	Lynch et al. (2017)	P2RX1	UBERON_0002405	""
increased urine excretion	renal	activation_acute	HP_0000103	ENSG00000108405	28216264	Lynch et al. (2017)	P2RX1	UBERON_0001008	""
increased urine excretion	nervous system	activation_acute	HP_0000103	ENSG00000108405	28216264	Lynch et al. (2017)	P2RX1	UBERON_0001016	""
hemolysis	nervous system	activation_acute	EFO_0009473	ENSG00000108405	28216264	Lynch et al. (2017)	P2RX1	UBERON_0001016	""
increased urinary sodium excretion	renal	activation_acute	GO_0035815	ENSG00000108405	28216264	Lynch et al. (2017)	P2RX1	UBERON_0001008	""
hemolysis	immune	activation_acute	EFO_0009473	ENSG00000108405	28216264	Lynch et al. (2017)	P2RX1	UBERON_0002405	""
increased pain	renal	activation_acute	GO_1904058	ENSG00000187848	28216264	Lynch et al. (2017)	P2RX2	UBERON_0001008	""
neurodegeneration	renal	activation_chronic	HP_0002180	ENSG00000187848	28216264	Lynch et al. (2017)	P2RX2	UBERON_0001008	""
decreased pain	renal	inhibition_acute	GO_1904057	ENSG00000187848	28216264	Lynch et al. (2017)	P2RX2	UBERON_0001008	""
decreased inflammation	renal	inhibition_acute	GO_0050728	ENSG00000187848	28216264	Lynch et al. (2017)	P2RX2	UBERON_0001008	""
decreased convulsions	renal	inhibition_acute	EFO_0009853	ENSG00000187848	28216264	Lynch et al. (2017)	P2RX2	UBERON_0001008	""
increased urine excretion	immune	activation_acute	HP_0000103	ENSG00000187848	28216264	Lynch et al. (2017)	P2RX2	UBERON_0002405	""
neurodegeneration	immune	activation_chronic	HP_0002180	ENSG00000187848	28216264	Lynch et al. (2017)	P2RX2	UBERON_0002405	""
decreased pain	immune	inhibition_acute	GO_1904057	ENSG00000187848	28216264	Lynch et al. (2017)	P2RX2	UBERON_0002405	""
decreased inflammation	immune	inhibition_acute	GO_0050728	ENSG00000187848	28216264	Lynch et al. (2017)	P2RX2	UBERON_0002405	""
decreased convulsions	immune	inhibition_acute	EFO_0009853	ENSG00000187848	28216264	Lynch et al. (2017)	P2RX2	UBERON_0002405	""
increased urinary sodium excretion	nervous system	activation_acute	GO_0035815	ENSG00000187848	28216264	Lynch et al. (2017)	P2RX2	UBERON_0001016	""
neurodegeneration	nervous system	activation_chronic	HP_0002180	ENSG00000187848	28216264	Lynch et al. (2017)	P2RX2	UBERON_0001016	""
decreased pain	nervous system	inhibition_acute	GO_1904057	ENSG00000187848	28216264	Lynch et al. (2017)	P2RX2	UBERON_0001016	""
decreased inflammation	nervous system	inhibition_acute	GO_0050728	ENSG00000187848	28216264	Lynch et al. (2017)	P2RX2	UBERON_0001016	""
decreased convulsions	nervous system	inhibition_acute	EFO_0009853	ENSG00000187848	28216264	Lynch et al. (2017)	P2RX2	UBERON_0001016	""
increased urinary sodium excretion	immune	activation_acute	GO_0035815	ENSG00000187848	28216264	Lynch et al. (2017)	P2RX2	UBERON_0002405	""
increased urine excretion	nervous system	activation_acute	HP_0000103	ENSG00000187848	28216264	Lynch et al. (2017)	P2RX2	UBERON_0001016	""
increased pain	immune	activation_acute	GO_1904058	ENSG00000187848	28216264	Lynch et al. (2017)	P2RX2	UBERON_0002405	""
hemolysis	renal	activation_acute	EFO_0009473	ENSG00000187848	28216264	Lynch et al. (2017)	P2RX2	UBERON_0001008	""
hemolysis	nervous system	activation_acute	EFO_0009473	ENSG00000187848	28216264	Lynch et al. (2017)	P2RX2	UBERON_0001016	""
increased pain	nervous system	activation_acute	GO_1904058	ENSG00000187848	28216264	Lynch et al. (2017)	P2RX2	UBERON_0001016	""
hemolysis	immune	activation_acute	EFO_0009473	ENSG00000187848	28216264	Lynch et al. (2017)	P2RX2	UBERON_0002405	""
increased urinary sodium excretion	renal	activation_acute	GO_0035815	ENSG00000187848	28216264	Lynch et al. (2017)	P2RX2	UBERON_0001008	""
increased urine excretion	renal	activation_acute	HP_0000103	ENSG00000187848	28216264	Lynch et al. (2017)	P2RX2	UBERON_0001008	""
decreased convulsions	central nervous system	activation_acute	EFO_0009853	ENSG00000163285	28216264	Lynch et al. (2017)	GABRG1	UBERON_0001017	""
convulsions	central nervous system	inhibition_acute	EFO_0009853	ENSG00000163285	28216264	Lynch et al. (2017)	GABRG1	UBERON_0001017	""
decreased sleep	central nervous system	inhibition_acute	EFO_0008568	ENSG00000163285	28216264	Lynch et al. (2017)	GABRG1	UBERON_0001017	""
decreased anxiety	cardiovascular	activation_acute	EFO_0009874	ENSG00000163285	28216264	Lynch et al. (2017)	GABRG1	UBERON_0004535	""
convulsions	cardiovascular	inhibition_acute	EFO_0009853	ENSG00000163285	28216264	Lynch et al. (2017)	GABRG1	UBERON_0004535	""
decreased sleep	cardiovascular	inhibition_acute	EFO_0008568	ENSG00000163285	28216264	Lynch et al. (2017)	GABRG1	UBERON_0004535	""
decreased pain	central nervous system	activation_acute	GO_1904057	ENSG00000163285	28216264	Lynch et al. (2017)	GABRG1	UBERON_0001017	""
increased cardiac output	cardiovascular	activation_acute	EFO_0009872	ENSG00000163285	28216264	Lynch et al. (2017)	GABRG1	UBERON_0004535	""
increased sleep	cardiovascular	activation_acute	EFO_0008568	ENSG00000163285	28216264	Lynch et al. (2017)	GABRG1	UBERON_0004535	""
ataxia	central nervous system	activation_acute	MONDO_0000437	ENSG00000163285	28216264	Lynch et al. (2017)	GABRG1	UBERON_0001017	""
decreased body temperature	central nervous system	activation_acute	HP_0002045	ENSG00000163285	28216264	Lynch et al. (2017)	GABRG1	UBERON_0001017	""
decreased blood pressure	cardiovascular	activation_acute	EFO_0005251	ENSG00000163285	28216264	Lynch et al. (2017)	GABRG1	UBERON_0004535	""
decreased memory	central nervous system	activation_acute	EFO_0001072	ENSG00000163285	28216264	Lynch et al. (2017)	GABRG1	UBERON_0001017	""
decreased anxiety	central nervous system	activation_acute	EFO_0009874	ENSG00000163285	28216264	Lynch et al. (2017)	GABRG1	UBERON_0001017	""
ataxia	cardiovascular	activation_acute	MONDO_0000437	ENSG00000163285	28216264	Lynch et al. (2017)	GABRG1	UBERON_0004535	""
increased respiratory rate	central nervous system	activation_acute	EFO_0009840	ENSG00000163285	28216264	Lynch et al. (2017)	GABRG1	UBERON_0001017	""
decreased convulsions	cardiovascular	activation_acute	EFO_0009853	ENSG00000163285	28216264	Lynch et al. (2017)	GABRG1	UBERON_0004535	""
increased eating	cardiovascular	activation_acute	HP_0100738	ENSG00000163285	28216264	Lynch et al. (2017)	GABRG1	UBERON_0004535	""
drug abuse/dependence	central nervous system	activation_acute	EFO_0003890	ENSG00000163285	28216264	Lynch et al. (2017)	GABRG1	UBERON_0001017	""
decreased locomotor activity	central nervous system	activation_acute	GO_0040013	ENSG00000163285	28216264	Lynch et al. (2017)	GABRG1	UBERON_0001017	""
increased eating	central nervous system	activation_acute	HP_0100738	ENSG00000163285	28216264	Lynch et al. (2017)	GABRG1	UBERON_0001017	""
decreased cardiac contractility	central nervous system	activation_acute	GO_0045822	ENSG00000163285	28216264	Lynch et al. (2017)	GABRG1	UBERON_0001017	""
decreased cardiac contractility	cardiovascular	activation_acute	GO_0045822	ENSG00000163285	28216264	Lynch et al. (2017)	GABRG1	UBERON_0004535	""
decreased body temperature	cardiovascular	activation_acute	HP_0002045	ENSG00000163285	28216264	Lynch et al. (2017)	GABRG1	UBERON_0004535	""
decreased locomotor activity	cardiovascular	activation_acute	GO_0040013	ENSG00000163285	28216264	Lynch et al. (2017)	GABRG1	UBERON_0004535	""
muscle relaxation	central nervous system	activation_acute	""	ENSG00000163285	28216264	Lynch et al. (2017)	GABRG1	UBERON_0001017	""
increased cardiac output	central nervous system	activation_acute	EFO_0009872	ENSG00000163285	28216264	Lynch et al. (2017)	GABRG1	UBERON_0001017	""
muscle relaxation	cardiovascular	activation_acute	""	ENSG00000163285	28216264	Lynch et al. (2017)	GABRG1	UBERON_0004535	""
decreased memory	cardiovascular	activation_acute	EFO_0001072	ENSG00000163285	28216264	Lynch et al. (2017)	GABRG1	UBERON_0004535	""
increased respiratory rate	cardiovascular	activation_acute	EFO_0009840	ENSG00000163285	28216264	Lynch et al. (2017)	GABRG1	UBERON_0004535	""
drug abuse/dependence	cardiovascular	activation_acute	EFO_0003890	ENSG00000163285	28216264	Lynch et al. (2017)	GABRG1	UBERON_0004535	""
increased sleep	central nervous system	activation_acute	EFO_0008568	ENSG00000163285	28216264	Lynch et al. (2017)	GABRG1	UBERON_0001017	""
decreased blood pressure	central nervous system	activation_acute	EFO_0005251	ENSG00000163285	28216264	Lynch et al. (2017)	GABRG1	UBERON_0001017	""
decreased pain	cardiovascular	activation_acute	GO_1904057	ENSG00000163285	28216264	Lynch et al. (2017)	GABRG1	UBERON_0004535	""
increased/decreased blood glucose	renal	activation_acute	HP_0011015	ENSG00000187486	28216264	Lynch et al. (2017)	KCNJ11	UBERON_0001008	""
decreased heart rate	renal	inhibition_acute	HP_0001662	ENSG00000187486	28216264	Lynch et al. (2017)	KCNJ11	UBERON_0001008	""
atrioventricular block	renal	inhibition_acute	MONDO_0000465	ENSG00000187486	28216264	Lynch et al. (2017)	KCNJ11	UBERON_0001008	""
increased blood insulin	renal	inhibition_acute	HP_0000842	ENSG00000187486	28216264	Lynch et al. (2017)	KCNJ11	UBERON_0001008	""
decreased blood glucose	renal	inhibition_acute	HP_0001943	ENSG00000187486	28216264	Lynch et al. (2017)	KCNJ11	UBERON_0001008	""
increased urine excretion	renal	inhibition_acute	HP_0000103	ENSG00000187486	28216264	Lynch et al. (2017)	KCNJ11	UBERON_0001008	""
increased urinary sodium excretion	renal	inhibition_acute	GO_0035815	ENSG00000187486	28216264	Lynch et al. (2017)	KCNJ11	UBERON_0001008	""
decreased blood insulin	renal	activation_acute	HP_0040216	ENSG00000187486	28216264	Lynch et al. (2017)	KCNJ11	UBERON_0001008	""
decreased convulsions	pancreas	activation_acute	EFO_0009853	ENSG00000187486	28216264	Lynch et al. (2017)	KCNJ11	UBERON_0001264	""
decreased heart rate	pancreas	inhibition_acute	HP_0001662	ENSG00000187486	28216264	Lynch et al. (2017)	KCNJ11	UBERON_0001264	""
atrioventricular block	pancreas	inhibition_acute	MONDO_0000465	ENSG00000187486	28216264	Lynch et al. (2017)	KCNJ11	UBERON_0001264	""
increased blood insulin	pancreas	inhibition_acute	HP_0000842	ENSG00000187486	28216264	Lynch et al. (2017)	KCNJ11	UBERON_0001264	""
decreased blood glucose	pancreas	inhibition_acute	HP_0001943	ENSG00000187486	28216264	Lynch et al. (2017)	KCNJ11	UBERON_0001264	""
increased urine excretion	pancreas	inhibition_acute	HP_0000103	ENSG00000187486	28216264	Lynch et al. (2017)	KCNJ11	UBERON_0001264	""
increased urinary sodium excretion	pancreas	inhibition_acute	GO_0035815	ENSG00000187486	28216264	Lynch et al. (2017)	KCNJ11	UBERON_0001264	""
decreased blood pressure	cardiovascular	activation_acute	EFO_0005251	ENSG00000187486	28216264	Lynch et al. (2017)	KCNJ11	UBERON_0004535	""
decreased heart rate	cardiovascular	inhibition_acute	HP_0001662	ENSG00000187486	28216264	Lynch et al. (2017)	KCNJ11	UBERON_0004535	""
atrioventricular block	cardiovascular	inhibition_acute	MONDO_0000465	ENSG00000187486	28216264	Lynch et al. (2017)	KCNJ11	UBERON_0004535	""
increased blood insulin	cardiovascular	inhibition_acute	HP_0000842	ENSG00000187486	28216264	Lynch et al. (2017)	KCNJ11	UBERON_0004535	""
decreased blood glucose	cardiovascular	inhibition_acute	HP_0001943	ENSG00000187486	28216264	Lynch et al. (2017)	KCNJ11	UBERON_0004535	""
increased urine excretion	cardiovascular	inhibition_acute	HP_0000103	ENSG00000187486	28216264	Lynch et al. (2017)	KCNJ11	UBERON_0004535	""
increased urinary sodium excretion	cardiovascular	inhibition_acute	GO_0035815	ENSG00000187486	28216264	Lynch et al. (2017)	KCNJ11	UBERON_0004535	""
abnormal pulse	pancreas	activation_acute	HP_0031860	ENSG00000187486	28216264	Lynch et al. (2017)	KCNJ11	UBERON_0001264	""
increased heart rate	pancreas	activation_acute	HP_0001649	ENSG00000187486	28216264	Lynch et al. (2017)	KCNJ11	UBERON_0001264	""
abnormal pulse	renal	activation_acute	HP_0031860	ENSG00000187486	28216264	Lynch et al. (2017)	KCNJ11	UBERON_0001008	""
cardiac lesions	cardiovascular	activation_acute	""	ENSG00000187486	28216264	Lynch et al. (2017)	KCNJ11	UBERON_0004535	""
abnormal pulse	cardiovascular	activation_acute	HP_0031860	ENSG00000187486	28216264	Lynch et al. (2017)	KCNJ11	UBERON_0004535	""
decreased blood insulin	pancreas	activation_acute	HP_0040216	ENSG00000187486	28216264	Lynch et al. (2017)	KCNJ11	UBERON_0001264	""
cardiac lesions	pancreas	activation_acute	""	ENSG00000187486	28216264	Lynch et al. (2017)	KCNJ11	UBERON_0001264	""
increased/decreased blood glucose	cardiovascular	activation_acute	HP_0011015	ENSG00000187486	28216264	Lynch et al. (2017)	KCNJ11	UBERON_0004535	""
cardiac lesions	renal	activation_acute	""	ENSG00000187486	28216264	Lynch et al. (2017)	KCNJ11	UBERON_0001008	""
decreased blood insulin	cardiovascular	activation_acute	HP_0040216	ENSG00000187486	28216264	Lynch et al. (2017)	KCNJ11	UBERON_0004535	""
increased heart rate	cardiovascular	activation_acute	HP_0001649	ENSG00000187486	28216264	Lynch et al. (2017)	KCNJ11	UBERON_0004535	""
cardiac arrhythmia	pancreas	activation_acute	EFO_0004269	ENSG00000187486	28216264	Lynch et al. (2017)	KCNJ11	UBERON_0001264	""
cardiac arrhythmia	renal	activation_acute	EFO_0004269	ENSG00000187486	28216264	Lynch et al. (2017)	KCNJ11	UBERON_0001008	""
decreased blood pressure	renal	activation_acute	EFO_0005251	ENSG00000187486	28216264	Lynch et al. (2017)	KCNJ11	UBERON_0001008	""
decreased blood pressure	pancreas	activation_acute	EFO_0005251	ENSG00000187486	28216264	Lynch et al. (2017)	KCNJ11	UBERON_0001264	""
increased/decreased blood glucose	pancreas	activation_acute	HP_0011015	ENSG00000187486	28216264	Lynch et al. (2017)	KCNJ11	UBERON_0001264	""
decreased convulsions	cardiovascular	activation_acute	EFO_0009853	ENSG00000187486	28216264	Lynch et al. (2017)	KCNJ11	UBERON_0004535	""
cardiac arrhythmia	cardiovascular	activation_acute	EFO_0004269	ENSG00000187486	28216264	Lynch et al. (2017)	KCNJ11	UBERON_0004535	""
increased heart rate	renal	activation_acute	HP_0001649	ENSG00000187486	28216264	Lynch et al. (2017)	KCNJ11	UBERON_0001008	""
decreased convulsions	renal	activation_acute	EFO_0009853	ENSG00000187486	28216264	Lynch et al. (2017)	KCNJ11	UBERON_0001008	""
emesis	gastrointestinal	activation_general	HP_0002017	ENSG00000166736	23197038	Bowes et al. (2012)	HTR3A	UBERON_0005409	""
constipation	gastrointestinal	inhibition_general	HP_0002019	ENSG00000166736	23197038	Bowes et al. (2012)	HTR3A	UBERON_0005409	""
dizziness	gastrointestinal	inhibition_general	EFO_0009847	ENSG00000166736	23197038	Bowes et al. (2012)	HTR3A	UBERON_0005409	""
gastric emptying	gastrointestinal	activation_general	GO_0035483	ENSG00000166736	23197038	Bowes et al. (2012)	HTR3A	UBERON_0005409	""
hyperglycaemia	gastrointestinal	activation_general	HP_0003074	ENSG00000166736	23197038	Bowes et al. (2012)	HTR3A	UBERON_0005409	""
possible increased heart rate	gastrointestinal	activation_general	HP_0001649	ENSG00000166736	23197038	Bowes et al. (2012)	HTR3A	UBERON_0005409	""
emesis	endocrine	activation_general	HP_0002017	ENSG00000166736	23197038	Bowes et al. (2012)	HTR3A	UBERON_0000949	""
constipation	endocrine	inhibition_general	HP_0002019	ENSG00000166736	23197038	Bowes et al. (2012)	HTR3A	UBERON_0000949	""
dizziness	endocrine	inhibition_general	EFO_0009847	ENSG00000166736	23197038	Bowes et al. (2012)	HTR3A	UBERON_0000949	""
gastric emptying	endocrine	activation_general	GO_0035483	ENSG00000166736	23197038	Bowes et al. (2012)	HTR3A	UBERON_0000949	""
hyperglycaemia	endocrine	activation_general	HP_0003074	ENSG00000166736	23197038	Bowes et al. (2012)	HTR3A	UBERON_0000949	""
possible increased heart rate	endocrine	activation_general	HP_0001649	ENSG00000166736	23197038	Bowes et al. (2012)	HTR3A	UBERON_0000949	""
decreased inflammation	renal	inhibition_acute	GO_0050728	ENSG00000073756	28216264	Lynch et al. (2017)	PTGS2	UBERON_0001008	""
increased blood pressure	renal	inhibition_chronic	HP_0032263	ENSG00000073756	28216264	Lynch et al. (2017)	PTGS2	UBERON_0001008	""
thrombosis	renal	inhibition_chronic	HP_0004936	ENSG00000073756	28216264	Lynch et al. (2017)	PTGS2	UBERON_0001008	""
atherosclerosis	renal	inhibition_chronic	EFO_0003914	ENSG00000073756	28216264	Lynch et al. (2017)	PTGS2	UBERON_0001008	""
decreased pain	renal	inhibition_acute	GO_1904057	ENSG00000073756	28216264	Lynch et al. (2017)	PTGS2	UBERON_0001008	""
decreased urinary sodium excretion	renal	inhibition_acute	GO_0035814	ENSG00000073756	28216264	Lynch et al. (2017)	PTGS2	UBERON_0001008	""
decreased urinary potassium excretion	renal	inhibition_acute	HP_0012364	ENSG00000073756	28216264	Lynch et al. (2017)	PTGS2	UBERON_0001008	""
decreased mitosis	renal	inhibition_acute	GO_0045839	ENSG00000073756	28216264	Lynch et al. (2017)	PTGS2	UBERON_0001008	""
atherothrombosis	renal	inhibition_acute	EFO_1000883	ENSG00000073756	28216264	Lynch et al. (2017)	PTGS2	UBERON_0001008	""
heart attack	renal	inhibition_acute	EFO_0000612	ENSG00000073756	28216264	Lynch et al. (2017)	PTGS2	UBERON_0001008	""
ischemic stroke	renal	inhibition_acute	HP_0002140	ENSG00000073756	28216264	Lynch et al. (2017)	PTGS2	UBERON_0001008	""
decreased inflammation	cardiovascular	inhibition_acute	GO_0050728	ENSG00000073756	28216264	Lynch et al. (2017)	PTGS2	UBERON_0004535	""
increased blood pressure	cardiovascular	inhibition_chronic	HP_0032263	ENSG00000073756	28216264	Lynch et al. (2017)	PTGS2	UBERON_0004535	""
thrombosis	cardiovascular	inhibition_chronic	HP_0004936	ENSG00000073756	28216264	Lynch et al. (2017)	PTGS2	UBERON_0004535	""
atherosclerosis	cardiovascular	inhibition_chronic	EFO_0003914	ENSG00000073756	28216264	Lynch et al. (2017)	PTGS2	UBERON_0004535	""
decreased pain	cardiovascular	inhibition_acute	GO_1904057	ENSG00000073756	28216264	Lynch et al. (2017)	PTGS2	UBERON_0004535	""
decreased urinary sodium excretion	cardiovascular	inhibition_acute	GO_0035814	ENSG00000073756	28216264	Lynch et al. (2017)	PTGS2	UBERON_0004535	""
decreased urinary potassium excretion	cardiovascular	inhibition_acute	HP_0012364	ENSG00000073756	28216264	Lynch et al. (2017)	PTGS2	UBERON_0004535	""
decreased mitosis	cardiovascular	inhibition_acute	GO_0045839	ENSG00000073756	28216264	Lynch et al. (2017)	PTGS2	UBERON_0004535	""
atherothrombosis	cardiovascular	inhibition_acute	EFO_1000883	ENSG00000073756	28216264	Lynch et al. (2017)	PTGS2	UBERON_0004535	""
heart attack	cardiovascular	inhibition_acute	EFO_0000612	ENSG00000073756	28216264	Lynch et al. (2017)	PTGS2	UBERON_0004535	""
ischemic stroke	cardiovascular	inhibition_acute	HP_0002140	ENSG00000073756	28216264	Lynch et al. (2017)	PTGS2	UBERON_0004535	""
decreased inflammation	immune	inhibition_acute	GO_0050728	ENSG00000073756	28216264	Lynch et al. (2017)	PTGS2	UBERON_0002405	""
increased blood pressure	immune	inhibition_chronic	HP_0032263	ENSG00000073756	28216264	Lynch et al. (2017)	PTGS2	UBERON_0002405	""
thrombosis	immune	inhibition_chronic	HP_0004936	ENSG00000073756	28216264	Lynch et al. (2017)	PTGS2	UBERON_0002405	""
atherosclerosis	immune	inhibition_chronic	EFO_0003914	ENSG00000073756	28216264	Lynch et al. (2017)	PTGS2	UBERON_0002405	""
decreased pain	immune	inhibition_acute	GO_1904057	ENSG00000073756	28216264	Lynch et al. (2017)	PTGS2	UBERON_0002405	""
decreased urinary sodium excretion	immune	inhibition_acute	GO_0035814	ENSG00000073756	28216264	Lynch et al. (2017)	PTGS2	UBERON_0002405	""
decreased urinary potassium excretion	immune	inhibition_acute	HP_0012364	ENSG00000073756	28216264	Lynch et al. (2017)	PTGS2	UBERON_0002405	""
decreased mitosis	immune	inhibition_acute	GO_0045839	ENSG00000073756	28216264	Lynch et al. (2017)	PTGS2	UBERON_0002405	""
atherothrombosis	immune	inhibition_acute	EFO_1000883	ENSG00000073756	28216264	Lynch et al. (2017)	PTGS2	UBERON_0002405	""
heart attack	immune	inhibition_acute	EFO_0000612	ENSG00000073756	28216264	Lynch et al. (2017)	PTGS2	UBERON_0002405	""
ischemic stroke	immune	inhibition_acute	HP_0002140	ENSG00000073756	28216264	Lynch et al. (2017)	PTGS2	UBERON_0002405	""
pain	central nervous system	activation_acute	EFO_0003843	ENSG00000273079	28216264	Lynch et al. (2017)	GRIN2B	UBERON_0001017	""
decreased pain	central nervous system	inhibition_acute	GO_1904057	ENSG00000273079	28216264	Lynch et al. (2017)	GRIN2B	UBERON_0001017	""
impaired social interactions	central nervous system	inhibition_chronic	HP_0000735	ENSG00000273079	28216264	Lynch et al. (2017)	GRIN2B	UBERON_0001017	""
stereotypy	central nervous system	inhibition_chronic	HP_0000733	ENSG00000273079	28216264	Lynch et al. (2017)	GRIN2B	UBERON_0001017	""
psychosis	central nervous system	inhibition_chronic	EFO_0005407	ENSG00000273079	28216264	Lynch et al. (2017)	GRIN2B	UBERON_0001017	""
neurodegeneration	central nervous system	inhibition_chronic	HP_0002180	ENSG00000273079	28216264	Lynch et al. (2017)	GRIN2B	UBERON_0001017	""
increased locomotor activity	central nervous system	inhibition_acute	GO_0040017	ENSG00000273079	28216264	Lynch et al. (2017)	GRIN2B	UBERON_0001017	""
ataxia	central nervous system	inhibition_acute	MONDO_0000437	ENSG00000273079	28216264	Lynch et al. (2017)	GRIN2B	UBERON_0001017	""
dizziness	central nervous system	inhibition_acute	EFO_0009847	ENSG00000273079	28216264	Lynch et al. (2017)	GRIN2B	UBERON_0001017	""
decreased memory	central nervous system	inhibition_acute	EFO_0001072	ENSG00000273079	28216264	Lynch et al. (2017)	GRIN2B	UBERON_0001017	""
psychosis	central nervous system	inhibition_acute	EFO_0005407	ENSG00000273079	28216264	Lynch et al. (2017)	GRIN2B	UBERON_0001017	""
decreased convulsions	central nervous system	inhibition_acute	EFO_0009853	ENSG00000273079	28216264	Lynch et al. (2017)	GRIN2B	UBERON_0001017	""
drug abuse/dependence	central nervous system	inhibition_acute	EFO_0003890	ENSG00000273079	28216264	Lynch et al. (2017)	GRIN2B	UBERON_0001017	""
neurotoxicity	central nervous system	inhibition_acute	EFO_0005595	ENSG00000273079	28216264	Lynch et al. (2017)	GRIN2B	UBERON_0001017	""
increased blood pressure	central nervous system	inhibition_acute	HP_0032263	ENSG00000273079	28216264	Lynch et al. (2017)	GRIN2B	UBERON_0001017	""
increased heart rate	central nervous system	inhibition_acute	HP_0001649	ENSG00000273079	28216264	Lynch et al. (2017)	GRIN2B	UBERON_0001017	""
pain	cardiovascular	activation_acute	EFO_0003843	ENSG00000273079	28216264	Lynch et al. (2017)	GRIN2B	UBERON_0004535	""
decreased pain	cardiovascular	inhibition_acute	GO_1904057	ENSG00000273079	28216264	Lynch et al. (2017)	GRIN2B	UBERON_0004535	""
impaired social interactions	cardiovascular	inhibition_chronic	HP_0000735	ENSG00000273079	28216264	Lynch et al. (2017)	GRIN2B	UBERON_0004535	""
stereotypy	cardiovascular	inhibition_chronic	HP_0000733	ENSG00000273079	28216264	Lynch et al. (2017)	GRIN2B	UBERON_0004535	""
psychosis	cardiovascular	inhibition_chronic	EFO_0005407	ENSG00000273079	28216264	Lynch et al. (2017)	GRIN2B	UBERON_0004535	""
neurodegeneration	cardiovascular	inhibition_chronic	HP_0002180	ENSG00000273079	28216264	Lynch et al. (2017)	GRIN2B	UBERON_0004535	""
increased locomotor activity	cardiovascular	inhibition_acute	GO_0040017	ENSG00000273079	28216264	Lynch et al. (2017)	GRIN2B	UBERON_0004535	""
ataxia	cardiovascular	inhibition_acute	MONDO_0000437	ENSG00000273079	28216264	Lynch et al. (2017)	GRIN2B	UBERON_0004535	""
dizziness	cardiovascular	inhibition_acute	EFO_0009847	ENSG00000273079	28216264	Lynch et al. (2017)	GRIN2B	UBERON_0004535	""
decreased memory	cardiovascular	inhibition_acute	EFO_0001072	ENSG00000273079	28216264	Lynch et al. (2017)	GRIN2B	UBERON_0004535	""
psychosis	cardiovascular	inhibition_acute	EFO_0005407	ENSG00000273079	28216264	Lynch et al. (2017)	GRIN2B	UBERON_0004535	""
decreased convulsions	cardiovascular	inhibition_acute	EFO_0009853	ENSG00000273079	28216264	Lynch et al. (2017)	GRIN2B	UBERON_0004535	""
drug abuse/dependence	cardiovascular	inhibition_acute	EFO_0003890	ENSG00000273079	28216264	Lynch et al. (2017)	GRIN2B	UBERON_0004535	""
neurotoxicity	cardiovascular	inhibition_acute	EFO_0005595	ENSG00000273079	28216264	Lynch et al. (2017)	GRIN2B	UBERON_0004535	""
increased blood pressure	cardiovascular	inhibition_acute	HP_0032263	ENSG00000273079	28216264	Lynch et al. (2017)	GRIN2B	UBERON_0004535	""
increased heart rate	cardiovascular	inhibition_acute	HP_0001649	ENSG00000273079	28216264	Lynch et al. (2017)	GRIN2B	UBERON_0004535	""
increased blood pressure	cardiovascular	activation_acute	HP_0032263	ENSG00000273079	28216264	Lynch et al. (2017)	GRIN2B	UBERON_0004535	""
increased then decreased heart rate	cardiovascular	activation_acute	HP_0031860	ENSG00000273079	28216264	Lynch et al. (2017)	GRIN2B	UBERON_0004535	""
increased then decreased heart rate	central nervous system	activation_acute	HP_0031860	ENSG00000273079	28216264	Lynch et al. (2017)	GRIN2B	UBERON_0001017	""
convulsions	cardiovascular	activation_acute	EFO_0009853	ENSG00000273079	28216264	Lynch et al. (2017)	GRIN2B	UBERON_0004535	""
convulsions	central nervous system	activation_acute	EFO_0009853	ENSG00000273079	28216264	Lynch et al. (2017)	GRIN2B	UBERON_0001017	""
increased blood pressure	central nervous system	activation_acute	HP_0032263	ENSG00000273079	28216264	Lynch et al. (2017)	GRIN2B	UBERON_0001017	""
slowed cardiac conduction	cardiovascular system	inhibition_general	EFO_1001497	ENSG00000183873	23197038	Bowes et al. (2012)	SCN5A	UBERON_0004535	""
prolonged QRS interval of ECG	cardiovascular system	inhibition_general	HP_0006677	ENSG00000183873	23197038	Bowes et al. (2012)	SCN5A	UBERON_0004535	""
dysphoria	nervous system	activation_acute	EFO_0009867	ENSG00000118432	28216264	Lynch et al. (2017)	CNR1	UBERON_0001016	""
increased convulsions	nervous system	inhibition_acute	EFO_0009853	ENSG00000118432	28216264	Lynch et al. (2017)	CNR1	UBERON_0001016	""
decreased eating	nervous system	inhibition_acute	HP_0100738	ENSG00000118432	28216264	Lynch et al. (2017)	CNR1	UBERON_0001016	""
dizziness	cardiovascular	activation_acute	EFO_0009847	ENSG00000118432	28216264	Lynch et al. (2017)	CNR1	UBERON_0004535	""
increased convulsions	cardiovascular	inhibition_acute	EFO_0009853	ENSG00000118432	28216264	Lynch et al. (2017)	CNR1	UBERON_0004535	""
decreased eating	cardiovascular	inhibition_acute	HP_0100738	ENSG00000118432	28216264	Lynch et al. (2017)	CNR1	UBERON_0004535	""
drowsiness	cardiovascular	activation_acute	NCIT_C95746	ENSG00000118432	28216264	Lynch et al. (2017)	CNR1	UBERON_0004535	""
drowsiness	nervous system	activation_acute	NCIT_C95746	ENSG00000118432	28216264	Lynch et al. (2017)	CNR1	UBERON_0001016	""
decreased convulsions	nervous system	activation_acute	EFO_0009853	ENSG00000118432	28216264	Lynch et al. (2017)	CNR1	UBERON_0001016	""
decreased convulsions	cardiovascular	activation_acute	EFO_0009853	ENSG00000118432	28216264	Lynch et al. (2017)	CNR1	UBERON_0004535	""
headache	cardiovascular	activation_acute	HP_0002315	ENSG00000118432	28216264	Lynch et al. (2017)	CNR1	UBERON_0004535	""
decreased body temperature	cardiovascular	activation_acute	HP_0002045	ENSG00000118432	28216264	Lynch et al. (2017)	CNR1	UBERON_0004535	""
decreased pain	nervous system	activation_acute	GO_1904057	ENSG00000118432	28216264	Lynch et al. (2017)	CNR1	UBERON_0001016	""
decreased body temperature	nervous system	activation_acute	HP_0002045	ENSG00000118432	28216264	Lynch et al. (2017)	CNR1	UBERON_0001016	""
catalepsy	nervous system	activation_acute	EFO_0009845	ENSG00000118432	28216264	Lynch et al. (2017)	CNR1	UBERON_0001016	""
decreased pain	cardiovascular	activation_acute	GO_1904057	ENSG00000118432	28216264	Lynch et al. (2017)	CNR1	UBERON_0004535	""
nervousness	cardiovascular	activation_acute	NCIT_C74532	ENSG00000118432	28216264	Lynch et al. (2017)	CNR1	UBERON_0004535	""
headache	nervous system	activation_acute	HP_0002315	ENSG00000118432	28216264	Lynch et al. (2017)	CNR1	UBERON_0001016	""
drug abuse/dependence	nervous system	activation_acute	EFO_0003890	ENSG00000118432	28216264	Lynch et al. (2017)	CNR1	UBERON_0001016	""
hallucinations	nervous system	activation_acute	HP_0000738	ENSG00000118432	28216264	Lynch et al. (2017)	CNR1	UBERON_0001016	""
nervousness	nervous system	activation_acute	NCIT_C74532	ENSG00000118432	28216264	Lynch et al. (2017)	CNR1	UBERON_0001016	""
decreased blood pressure	cardiovascular	activation_acute	EFO_0005251	ENSG00000118432	28216264	Lynch et al. (2017)	CNR1	UBERON_0004535	""
decreased locomotor activity	cardiovascular	activation_acute	GO_0040013	ENSG00000118432	28216264	Lynch et al. (2017)	CNR1	UBERON_0004535	""
drug abuse/dependence	cardiovascular	activation_acute	EFO_0003890	ENSG00000118432	28216264	Lynch et al. (2017)	CNR1	UBERON_0004535	""
decreased blood pressure	nervous system	activation_acute	EFO_0005251	ENSG00000118432	28216264	Lynch et al. (2017)	CNR1	UBERON_0001016	""
catalepsy	cardiovascular	activation_acute	EFO_0009845	ENSG00000118432	28216264	Lynch et al. (2017)	CNR1	UBERON_0004535	""
decreased locomotor activity	nervous system	activation_acute	GO_0040013	ENSG00000118432	28216264	Lynch et al. (2017)	CNR1	UBERON_0001016	""
dysphoria	cardiovascular	activation_acute	EFO_0009867	ENSG00000118432	28216264	Lynch et al. (2017)	CNR1	UBERON_0004535	""
increased eating	nervous system	activation_acute	HP_0100738	ENSG00000118432	28216264	Lynch et al. (2017)	CNR1	UBERON_0001016	""
decreased heart rate	nervous system	activation_acute	HP_0001662	ENSG00000118432	28216264	Lynch et al. (2017)	CNR1	UBERON_0001016	""
dizziness	nervous system	activation_acute	EFO_0009847	ENSG00000118432	28216264	Lynch et al. (2017)	CNR1	UBERON_0001016	""
increased eating	cardiovascular	activation_acute	HP_0100738	ENSG00000118432	28216264	Lynch et al. (2017)	CNR1	UBERON_0004535	""
decreased heart rate	cardiovascular	activation_acute	HP_0001662	ENSG00000118432	28216264	Lynch et al. (2017)	CNR1	UBERON_0004535	""
hallucinations	cardiovascular	activation_acute	HP_0000738	ENSG00000118432	28216264	Lynch et al. (2017)	CNR1	UBERON_0004535	""
decreased heart rate	cardiovascular system	activation_general	HP_0001662	ENSG00000181072	23197038	Bowes et al. (2012)	CHRM2	UBERON_0004535	""
tachycardia	cardiovascular system	inhibition_general	HP_0001649	ENSG00000181072	23197038	Bowes et al. (2012)	CHRM2	UBERON_0004535	""
bronchoconstriction	cardiovascular system	inhibition_general	EFO_0009836	ENSG00000181072	23197038	Bowes et al. (2012)	CHRM2	UBERON_0004535	""
tremors	cardiovascular system	inhibition_general	HP_0001337	ENSG00000181072	23197038	Bowes et al. (2012)	CHRM2	UBERON_0004535	""
reflex	cardiovascular system	activation_general	GO_0060004	ENSG00000181072	23197038	Bowes et al. (2012)	CHRM2	UBERON_0004535	""
increased blood pressure	cardiovascular system	activation_general	HP_0032263	ENSG00000181072	23197038	Bowes et al. (2012)	CHRM2	UBERON_0004535	""
negative chronotropy and inotropy	cardiovascular system	activation_general	GO_0045822	ENSG00000181072	23197038	Bowes et al. (2012)	CHRM2	UBERON_0004535	""
decreased cardiac conduction (PR interval)	cardiovascular system	activation_general	EFO_1001497	ENSG00000181072	23197038	Bowes et al. (2012)	CHRM2	UBERON_0004535	""
decreased cardiac action potential duration	cardiovascular system	activation_general	GO_0098901	ENSG00000181072	23197038	Bowes et al. (2012)	CHRM2	UBERON_0004535	""
paralysis	pulmonary	activation_general	HP_0003470	ENSG00000138435	23197038	Bowes et al. (2012)	CHRNA1	UBERON_0002048	""
muscle relaxation	pulmonary	inhibition_general	""	ENSG00000138435	23197038	Bowes et al. (2012)	CHRNA1	UBERON_0002048	""
constipation	pulmonary	inhibition_general	HP_0002019	ENSG00000138435	23197038	Bowes et al. (2012)	CHRNA1	UBERON_0002048	""
apnoea	pulmonary	inhibition_general	HP_0002104	ENSG00000138435	23197038	Bowes et al. (2012)	CHRNA1	UBERON_0002048	""
decreased blood pressure	pulmonary	inhibition_general	EFO_0005251	ENSG00000138435	23197038	Bowes et al. (2012)	CHRNA1	UBERON_0002048	""
decreased heart rate	pulmonary	inhibition_general	HP_0001662	ENSG00000138435	23197038	Bowes et al. (2012)	CHRNA1	UBERON_0002048	""
analgesia	pulmonary	activation_general	EFO_1001484	ENSG00000138435	23197038	Bowes et al. (2012)	CHRNA1	UBERON_0002048	""
increased heart rate	pulmonary	activation_general	HP_0001649	ENSG00000138435	23197038	Bowes et al. (2012)	CHRNA1	UBERON_0002048	""
palpitations	pulmonary	activation_general	HP_0001962	ENSG00000138435	23197038	Bowes et al. (2012)	CHRNA1	UBERON_0002048	""
nausea	pulmonary	activation_general	HP_0002018	ENSG00000138435	23197038	Bowes et al. (2012)	CHRNA1	UBERON_0002048	""
abuse potential	pulmonary	activation_general	EFO_0003890	ENSG00000138435	23197038	Bowes et al. (2012)	CHRNA1	UBERON_0002048	""
paralysis	gastrointestinal	activation_general	HP_0003470	ENSG00000138435	23197038	Bowes et al. (2012)	CHRNA1	UBERON_0005409	""
muscle relaxation	gastrointestinal	inhibition_general	""	ENSG00000138435	23197038	Bowes et al. (2012)	CHRNA1	UBERON_0005409	""
constipation	gastrointestinal	inhibition_general	HP_0002019	ENSG00000138435	23197038	Bowes et al. (2012)	CHRNA1	UBERON_0005409	""
apnoea	gastrointestinal	inhibition_general	HP_0002104	ENSG00000138435	23197038	Bowes et al. (2012)	CHRNA1	UBERON_0005409	""
decreased blood pressure	gastrointestinal	inhibition_general	EFO_0005251	ENSG00000138435	23197038	Bowes et al. (2012)	CHRNA1	UBERON_0005409	""
decreased heart rate	gastrointestinal	inhibition_general	HP_0001662	ENSG00000138435	23197038	Bowes et al. (2012)	CHRNA1	UBERON_0005409	""
analgesia	gastrointestinal	activation_general	EFO_1001484	ENSG00000138435	23197038	Bowes et al. (2012)	CHRNA1	UBERON_0005409	""
increased heart rate	gastrointestinal	activation_general	HP_0001649	ENSG00000138435	23197038	Bowes et al. (2012)	CHRNA1	UBERON_0005409	""
palpitations	gastrointestinal	activation_general	HP_0001962	ENSG00000138435	23197038	Bowes et al. (2012)	CHRNA1	UBERON_0005409	""
nausea	gastrointestinal	activation_general	HP_0002018	ENSG00000138435	23197038	Bowes et al. (2012)	CHRNA1	UBERON_0005409	""
abuse potential	gastrointestinal	activation_general	EFO_0003890	ENSG00000138435	23197038	Bowes et al. (2012)	CHRNA1	UBERON_0005409	""
paralysis	cardiovascular system	activation_general	HP_0003470	ENSG00000138435	23197038	Bowes et al. (2012)	CHRNA1	UBERON_0004535	""
muscle relaxation	cardiovascular system	inhibition_general	""	ENSG00000138435	23197038	Bowes et al. (2012)	CHRNA1	UBERON_0004535	""
constipation	cardiovascular system	inhibition_general	HP_0002019	ENSG00000138435	23197038	Bowes et al. (2012)	CHRNA1	UBERON_0004535	""
apnoea	cardiovascular system	inhibition_general	HP_0002104	ENSG00000138435	23197038	Bowes et al. (2012)	CHRNA1	UBERON_0004535	""
decreased blood pressure	cardiovascular system	inhibition_general	EFO_0005251	ENSG00000138435	23197038	Bowes et al. (2012)	CHRNA1	UBERON_0004535	""
decreased heart rate	cardiovascular system	inhibition_general	HP_0001662	ENSG00000138435	23197038	Bowes et al. (2012)	CHRNA1	UBERON_0004535	""
analgesia	cardiovascular system	activation_general	EFO_1001484	ENSG00000138435	23197038	Bowes et al. (2012)	CHRNA1	UBERON_0004535	""
increased heart rate	cardiovascular system	activation_general	HP_0001649	ENSG00000138435	23197038	Bowes et al. (2012)	CHRNA1	UBERON_0004535	""
palpitations	cardiovascular system	activation_general	HP_0001962	ENSG00000138435	23197038	Bowes et al. (2012)	CHRNA1	UBERON_0004535	""
nausea	cardiovascular system	activation_general	HP_0002018	ENSG00000138435	23197038	Bowes et al. (2012)	CHRNA1	UBERON_0004535	""
abuse potential	cardiovascular system	activation_general	EFO_0003890	ENSG00000138435	23197038	Bowes et al. (2012)	CHRNA1	UBERON_0004535	""
paralysis	central nervous system	activation_general	HP_0003470	ENSG00000138435	23197038	Bowes et al. (2012)	CHRNA1	UBERON_0001017	""
muscle relaxation	central nervous system	inhibition_general	""	ENSG00000138435	23197038	Bowes et al. (2012)	CHRNA1	UBERON_0001017	""
constipation	central nervous system	inhibition_general	HP_0002019	ENSG00000138435	23197038	Bowes et al. (2012)	CHRNA1	UBERON_0001017	""
apnoea	central nervous system	inhibition_general	HP_0002104	ENSG00000138435	23197038	Bowes et al. (2012)	CHRNA1	UBERON_0001017	""
decreased blood pressure	central nervous system	inhibition_general	EFO_0005251	ENSG00000138435	23197038	Bowes et al. (2012)	CHRNA1	UBERON_0001017	""
decreased heart rate	central nervous system	inhibition_general	HP_0001662	ENSG00000138435	23197038	Bowes et al. (2012)	CHRNA1	UBERON_0001017	""
analgesia	central nervous system	activation_general	EFO_1001484	ENSG00000138435	23197038	Bowes et al. (2012)	CHRNA1	UBERON_0001017	""
increased heart rate	central nervous system	activation_general	HP_0001649	ENSG00000138435	23197038	Bowes et al. (2012)	CHRNA1	UBERON_0001017	""
palpitations	central nervous system	activation_general	HP_0001962	ENSG00000138435	23197038	Bowes et al. (2012)	CHRNA1	UBERON_0001017	""
nausea	central nervous system	activation_general	HP_0002018	ENSG00000138435	23197038	Bowes et al. (2012)	CHRNA1	UBERON_0001017	""
abuse potential	central nervous system	activation_general	EFO_0003890	ENSG00000138435	23197038	Bowes et al. (2012)	CHRNA1	UBERON_0001017	""
vascular hypertrophy	cardiovascular	activation_acute	EFO_0009829	ENSG00000120907	28216264	Lynch et al. (2017)	ADRA1A	UBERON_0004535	""
decreased blood pressure	cardiovascular	inhibition_acute	EFO_0005251	ENSG00000120907	28216264	Lynch et al. (2017)	ADRA1A	UBERON_0004535	""
increased heart rate	cardiovascular	inhibition_acute	HP_0001649	ENSG00000120907	28216264	Lynch et al. (2017)	ADRA1A	UBERON_0004535	""
orthostatic hypotension	cardiovascular	inhibition_acute	EFO_0005252	ENSG00000120907	28216264	Lynch et al. (2017)	ADRA1A	UBERON_0004535	""
chronic heart failure	cardiovascular	inhibition_acute	EFO_0000373	ENSG00000120907	28216264	Lynch et al. (2017)	ADRA1A	UBERON_0004535	""
dizziness	cardiovascular	inhibition_acute	EFO_0009847	ENSG00000120907	28216264	Lynch et al. (2017)	ADRA1A	UBERON_0004535	""
retrograde ejaculation	cardiovascular	inhibition_acute	HP_0012877	ENSG00000120907	28216264	Lynch et al. (2017)	ADRA1A	UBERON_0004535	""
increased blood pressure	cardiovascular	activation_acute	HP_0032263	ENSG00000120907	28216264	Lynch et al. (2017)	ADRA1A	UBERON_0004535	""
increased pupil diameter	cardiovascular	activation_acute	HP_0011499	ENSG00000120907	28216264	Lynch et al. (2017)	ADRA1A	UBERON_0004535	""
increased cardiac contractility	cardiovascular	activation_acute	GO_0045823	ENSG00000120907	28216264	Lynch et al. (2017)	ADRA1A	UBERON_0004535	""
cardiac arrhythmia	cardiovascular	activation_acute	EFO_0004269	ENSG00000120907	28216264	Lynch et al. (2017)	ADRA1A	UBERON_0004535	""
increased heart rate	gastrointestinal	activation_general	HP_0001649	ENSG00000043591	23197038	Bowes et al. (2012)	ADRB1	UBERON_0005409	""
decreased blood pressure	gastrointestinal	inhibition_general	EFO_0005251	ENSG00000043591	23197038	Bowes et al. (2012)	ADRB1	UBERON_0005409	""
decreased heart rate	gastrointestinal	inhibition_general	HP_0001662	ENSG00000043591	23197038	Bowes et al. (2012)	ADRB1	UBERON_0005409	""
decreased cardiac output	gastrointestinal	inhibition_general	EFO_0009872	ENSG00000043591	23197038	Bowes et al. (2012)	ADRB1	UBERON_0005409	""
increased cardiac contractility	gastrointestinal	activation_general	GO_0045823	ENSG00000043591	23197038	Bowes et al. (2012)	ADRB1	UBERON_0005409	""
electrolyte disturbances	gastrointestinal	activation_general	HP_0003111	ENSG00000043591	23197038	Bowes et al. (2012)	ADRB1	UBERON_0005409	""
increased renin release	gastrointestinal	activation_general	GO_1900135	ENSG00000043591	23197038	Bowes et al. (2012)	ADRB1	UBERON_0005409	""
relaxation of colon and oesophagus	gastrointestinal	activation_general	""	ENSG00000043591	23197038	Bowes et al. (2012)	ADRB1	UBERON_0005409	""
lipolysis	gastrointestinal	activation_general	EFO_0009876	ENSG00000043591	23197038	Bowes et al. (2012)	ADRB1	UBERON_0005409	""
increased heart rate	cardiovascular system	activation_general	HP_0001649	ENSG00000043591	23197038	Bowes et al. (2012)	ADRB1	UBERON_0004535	""
decreased blood pressure	cardiovascular system	inhibition_general	EFO_0005251	ENSG00000043591	23197038	Bowes et al. (2012)	ADRB1	UBERON_0004535	""
decreased heart rate	cardiovascular system	inhibition_general	HP_0001662	ENSG00000043591	23197038	Bowes et al. (2012)	ADRB1	UBERON_0004535	""
decreased cardiac output	cardiovascular system	inhibition_general	EFO_0009872	ENSG00000043591	23197038	Bowes et al. (2012)	ADRB1	UBERON_0004535	""
increased cardiac contractility	cardiovascular system	activation_general	GO_0045823	ENSG00000043591	23197038	Bowes et al. (2012)	ADRB1	UBERON_0004535	""
electrolyte disturbances	cardiovascular system	activation_general	HP_0003111	ENSG00000043591	23197038	Bowes et al. (2012)	ADRB1	UBERON_0004535	""
increased renin release	cardiovascular system	activation_general	GO_1900135	ENSG00000043591	23197038	Bowes et al. (2012)	ADRB1	UBERON_0004535	""
relaxation of colon and oesophagus	cardiovascular system	activation_general	""	ENSG00000043591	23197038	Bowes et al. (2012)	ADRB1	UBERON_0004535	""
lipolysis	cardiovascular system	activation_general	EFO_0009876	ENSG00000043591	23197038	Bowes et al. (2012)	ADRB1	UBERON_0004535	""
vascular relaxation	cardiovascular system	inhibition_general	GO_0060087	ENSG00000151067	23197038	Bowes et al. (2012)	CACNA1C	UBERON_0004535	""
decreased blood pressure	cardiovascular system	inhibition_general	EFO_0005251	ENSG00000151067	23197038	Bowes et al. (2012)	CACNA1C	UBERON_0004535	""
decreased PR interval	cardiovascular system	inhibition_general	HP_0005165	ENSG00000151067	23197038	Bowes et al. (2012)	CACNA1C	UBERON_0004535	""
possible shortening of QT interval of ECG	cardiovascular system	inhibition_general	HP_0012232	ENSG00000151067	23197038	Bowes et al. (2012)	CACNA1C	UBERON_0004535	""
anti-inflammatory activity	Immune	inhibition_general	GO_0050728	ENSG00000073756	23197038	Bowes et al. (2012)	PTGS2	""	""
anti-mitogenic effects	Immune	inhibition_general	GO_0045839	ENSG00000073756	23197038	Bowes et al. (2012)	PTGS2	""	""
myocardial infarction	Immune	inhibition_general	EFO_0000612	ENSG00000073756	23197038	Bowes et al. (2012)	PTGS2	""	""
increased blood pressure	Immune	inhibition_general	HP_0032263	ENSG00000073756	23197038	Bowes et al. (2012)	PTGS2	""	""
ischaemic stroke	Immune	inhibition_general	HP_0002140	ENSG00000073756	23197038	Bowes et al. (2012)	PTGS2	""	""
atherothrombosis	Immune	inhibition_general	EFO_1000883	ENSG00000073756	23197038	Bowes et al. (2012)	PTGS2	""	""
anti-inflammatory activity	cardiovascular system	inhibition_general	GO_0050728	ENSG00000073756	23197038	Bowes et al. (2012)	PTGS2	UBERON_0004535	""
anti-mitogenic effects	cardiovascular system	inhibition_general	GO_0045839	ENSG00000073756	23197038	Bowes et al. (2012)	PTGS2	UBERON_0004535	""
myocardial infarction	cardiovascular system	inhibition_general	EFO_0000612	ENSG00000073756	23197038	Bowes et al. (2012)	PTGS2	UBERON_0004535	""
increased blood pressure	cardiovascular system	inhibition_general	HP_0032263	ENSG00000073756	23197038	Bowes et al. (2012)	PTGS2	UBERON_0004535	""
ischaemic stroke	cardiovascular system	inhibition_general	HP_0002140	ENSG00000073756	23197038	Bowes et al. (2012)	PTGS2	UBERON_0004535	""
atherothrombosis	cardiovascular system	inhibition_general	EFO_1000883	ENSG00000073756	23197038	Bowes et al. (2012)	PTGS2	UBERON_0004535	""
euphoria	central nervous system	activation_general	HP_0031844	ENSG00000118432	23197038	Bowes et al. (2012)	CNR1	UBERON_0001017	""
increased weight loss	central nervous system	inhibition_general	EFO_0005245	ENSG00000118432	23197038	Bowes et al. (2012)	CNR1	UBERON_0001017	""
emesis	central nervous system	inhibition_general	HP_0002017	ENSG00000118432	23197038	Bowes et al. (2012)	CNR1	UBERON_0001017	""
depression	central nervous system	inhibition_general	MONDO_0002050	ENSG00000118432	23197038	Bowes et al. (2012)	CNR1	UBERON_0001017	""
dysphoria	central nervous system	activation_general	EFO_0009867	ENSG00000118432	23197038	Bowes et al. (2012)	CNR1	UBERON_0001017	""
anxiety	central nervous system	activation_general	EFO_0005230	ENSG00000118432	23197038	Bowes et al. (2012)	CNR1	UBERON_0001017	""
memory impairment	central nervous system	activation_general	EFO_0001072	ENSG00000118432	23197038	Bowes et al. (2012)	CNR1	UBERON_0001017	""
poor concentration	central nervous system	activation_general	HP_0031987	ENSG00000118432	23197038	Bowes et al. (2012)	CNR1	UBERON_0001017	""
analgesia	central nervous system	activation_general	EFO_1001484	ENSG00000118432	23197038	Bowes et al. (2012)	CNR1	UBERON_0001017	""
hypothermia	central nervous system	activation_general	HP_0002045	ENSG00000118432	23197038	Bowes et al. (2012)	CNR1	UBERON_0001017	""
increased gastrointestinal transit	cardiovascular	activation_acute	HP_0410204	ENSG00000164270	28216264	Lynch et al. (2017)	HTR4	UBERON_0004535	""
decreased gastrointestinal transit	cardiovascular	inhibition_acute	HP_0030897	ENSG00000164270	28216264	Lynch et al. (2017)	HTR4	UBERON_0004535	""
decreased anxiety	cardiovascular	inhibition_acute	EFO_0009874	ENSG00000164270	28216264	Lynch et al. (2017)	HTR4	UBERON_0004535	""
increased gastrointestinal transit	gastrointestinal	activation_acute	HP_0410204	ENSG00000164270	28216264	Lynch et al. (2017)	HTR4	UBERON_0005409	""
decreased gastrointestinal transit	gastrointestinal	inhibition_acute	HP_0030897	ENSG00000164270	28216264	Lynch et al. (2017)	HTR4	UBERON_0005409	""
decreased anxiety	gastrointestinal	inhibition_acute	EFO_0009874	ENSG00000164270	28216264	Lynch et al. (2017)	HTR4	UBERON_0005409	""
increased gastric emptying	cardiovascular	activation_acute	GO_0120062	ENSG00000164270	28216264	Lynch et al. (2017)	HTR4	UBERON_0004535	""
increased QTc interval	cardiovascular	activation_acute	HP_0005184	ENSG00000164270	28216264	Lynch et al. (2017)	HTR4	UBERON_0004535	""
increased memory	central nervous system	activation_acute	EFO_0004874	ENSG00000164270	28216264	Lynch et al. (2017)	HTR4	UBERON_0001017	""
decreased gastrointestinal transit	central nervous system	inhibition_acute	HP_0030897	ENSG00000164270	28216264	Lynch et al. (2017)	HTR4	UBERON_0001017	""
decreased anxiety	central nervous system	inhibition_acute	EFO_0009874	ENSG00000164270	28216264	Lynch et al. (2017)	HTR4	UBERON_0001017	""
diarrhea	gastrointestinal	activation_acute	HP_0002014	ENSG00000164270	28216264	Lynch et al. (2017)	HTR4	UBERON_0005409	""
fainting	gastrointestinal	activation_acute	HP_0001279	ENSG00000164270	28216264	Lynch et al. (2017)	HTR4	UBERON_0005409	""
fainting	central nervous system	activation_acute	HP_0001279	ENSG00000164270	28216264	Lynch et al. (2017)	HTR4	UBERON_0001017	""
increased gastrointestinal transit	central nervous system	activation_acute	HP_0410204	ENSG00000164270	28216264	Lynch et al. (2017)	HTR4	UBERON_0001017	""
increased memory	cardiovascular	activation_acute	EFO_0004874	ENSG00000164270	28216264	Lynch et al. (2017)	HTR4	UBERON_0004535	""
increased QTc interval	central nervous system	activation_acute	HP_0005184	ENSG00000164270	28216264	Lynch et al. (2017)	HTR4	UBERON_0001017	""
diarrhea	cardiovascular	activation_acute	HP_0002014	ENSG00000164270	28216264	Lynch et al. (2017)	HTR4	UBERON_0004535	""
decreased blood pressure	central nervous system	activation_acute	EFO_0005251	ENSG00000164270	28216264	Lynch et al. (2017)	HTR4	UBERON_0001017	""
decreased blood volume	cardiovascular	activation_acute	HP_0011106	ENSG00000164270	28216264	Lynch et al. (2017)	HTR4	UBERON_0004535	""
diarrhea	central nervous system	activation_acute	HP_0002014	ENSG00000164270	28216264	Lynch et al. (2017)	HTR4	UBERON_0001017	""
increased memory	gastrointestinal	activation_acute	EFO_0004874	ENSG00000164270	28216264	Lynch et al. (2017)	HTR4	UBERON_0005409	""
fainting	cardiovascular	activation_acute	HP_0001279	ENSG00000164270	28216264	Lynch et al. (2017)	HTR4	UBERON_0004535	""
increased heart rate	central nervous system	activation_acute	HP_0001649	ENSG00000164270	28216264	Lynch et al. (2017)	HTR4	UBERON_0001017	""
increased gastric emptying	gastrointestinal	activation_acute	GO_0120062	ENSG00000164270	28216264	Lynch et al. (2017)	HTR4	UBERON_0005409	""
decreased blood volume	central nervous system	activation_acute	HP_0011106	ENSG00000164270	28216264	Lynch et al. (2017)	HTR4	UBERON_0001017	""
increased QTc interval	gastrointestinal	activation_acute	HP_0005184	ENSG00000164270	28216264	Lynch et al. (2017)	HTR4	UBERON_0005409	""
increased gastric emptying	central nervous system	activation_acute	GO_0120062	ENSG00000164270	28216264	Lynch et al. (2017)	HTR4	UBERON_0001017	""
increased heart rate	cardiovascular	activation_acute	HP_0001649	ENSG00000164270	28216264	Lynch et al. (2017)	HTR4	UBERON_0004535	""
decreased blood pressure	gastrointestinal	activation_acute	EFO_0005251	ENSG00000164270	28216264	Lynch et al. (2017)	HTR4	UBERON_0005409	""
decreased blood volume	gastrointestinal	activation_acute	HP_0011106	ENSG00000164270	28216264	Lynch et al. (2017)	HTR4	UBERON_0005409	""
increased heart rate	gastrointestinal	activation_acute	HP_0001649	ENSG00000164270	28216264	Lynch et al. (2017)	HTR4	UBERON_0005409	""
decreased blood pressure	cardiovascular	activation_acute	EFO_0005251	ENSG00000164270	28216264	Lynch et al. (2017)	HTR4	UBERON_0004535	""
decreased platelet aggregation	central nervous system	activation_acute	GO_0090331	ENSG00000128271	28216264	Lynch et al. (2017)	ADORA2A	UBERON_0001017	""
increased blood pressure	central nervous system	inhibition_acute	HP_0032263	ENSG00000128271	28216264	Lynch et al. (2017)	ADORA2A	UBERON_0001017	""
increased heart rate	central nervous system	inhibition_acute	HP_0001649	ENSG00000128271	28216264	Lynch et al. (2017)	ADORA2A	UBERON_0001017	""
increased platelet aggregation	central nervous system	inhibition_acute	GO_1901731	ENSG00000128271	28216264	Lynch et al. (2017)	ADORA2A	UBERON_0001017	""
increased aggression	central nervous system	inhibition_acute	EFO_0003015	ENSG00000128271	28216264	Lynch et al. (2017)	ADORA2A	UBERON_0001017	""
decreased blood pressure	blood	activation_acute	EFO_0005251	ENSG00000128271	28216264	Lynch et al. (2017)	ADORA2A	UBERON_0000178	""
increased blood pressure	blood	inhibition_acute	HP_0032263	ENSG00000128271	28216264	Lynch et al. (2017)	ADORA2A	UBERON_0000178	""
increased heart rate	blood	inhibition_acute	HP_0001649	ENSG00000128271	28216264	Lynch et al. (2017)	ADORA2A	UBERON_0000178	""
increased platelet aggregation	blood	inhibition_acute	GO_1901731	ENSG00000128271	28216264	Lynch et al. (2017)	ADORA2A	UBERON_0000178	""
increased aggression	blood	inhibition_acute	EFO_0003015	ENSG00000128271	28216264	Lynch et al. (2017)	ADORA2A	UBERON_0000178	""
decreased blood pressure	central nervous system	activation_acute	EFO_0005251	ENSG00000128271	28216264	Lynch et al. (2017)	ADORA2A	UBERON_0001017	""
decreased platelet aggregation	blood	activation_acute	GO_0090331	ENSG00000128271	28216264	Lynch et al. (2017)	ADORA2A	UBERON_0000178	""
decreased blood pressure	cardiovascular	activation_acute	EFO_0005251	ENSG00000128271	28216264	Lynch et al. (2017)	ADORA2A	UBERON_0004535	""
increased blood pressure	cardiovascular	inhibition_acute	HP_0032263	ENSG00000128271	28216264	Lynch et al. (2017)	ADORA2A	UBERON_0004535	""
increased heart rate	cardiovascular	inhibition_acute	HP_0001649	ENSG00000128271	28216264	Lynch et al. (2017)	ADORA2A	UBERON_0004535	""
increased platelet aggregation	cardiovascular	inhibition_acute	GO_1901731	ENSG00000128271	28216264	Lynch et al. (2017)	ADORA2A	UBERON_0004535	""
increased aggression	cardiovascular	inhibition_acute	EFO_0003015	ENSG00000128271	28216264	Lynch et al. (2017)	ADORA2A	UBERON_0004535	""
decreased platelet aggregation	cardiovascular	activation_acute	GO_0090331	ENSG00000128271	28216264	Lynch et al. (2017)	ADORA2A	UBERON_0004535	""
increased heart rate	blood	activation_acute	HP_0001649	ENSG00000128271	28216264	Lynch et al. (2017)	ADORA2A	UBERON_0000178	""
increased heart rate	central nervous system	activation_acute	HP_0001649	ENSG00000128271	28216264	Lynch et al. (2017)	ADORA2A	UBERON_0001017	""
increased heart rate	cardiovascular	activation_acute	HP_0001649	ENSG00000128271	28216264	Lynch et al. (2017)	ADORA2A	UBERON_0004535	""
proconvulsant	central nervous system	activation_general	EFO_0009853	ENSG00000168539	23197038	Bowes et al. (2012)	CHRM1	UBERON_0001017	""
decreased cognitive function	central nervous system	inhibition_general	HP_0100543	ENSG00000168539	23197038	Bowes et al. (2012)	CHRM1	UBERON_0001017	""
decreased gastric acid secretion	central nervous system	inhibition_general	GO_0060455	ENSG00000168539	23197038	Bowes et al. (2012)	CHRM1	UBERON_0001017	""
blurred vision	central nervous system	inhibition_general	HP_0000622	ENSG00000168539	23197038	Bowes et al. (2012)	CHRM1	UBERON_0001017	""
increased gastric acid secretion	central nervous system	activation_general	GO_0060454	ENSG00000168539	23197038	Bowes et al. (2012)	CHRM1	UBERON_0001017	""
hypertension	central nervous system	activation_general	EFO_0000537	ENSG00000168539	23197038	Bowes et al. (2012)	CHRM1	UBERON_0001017	""
tachycardia	central nervous system	activation_general	HP_0001649	ENSG00000168539	23197038	Bowes et al. (2012)	CHRM1	UBERON_0001017	""
hyperthermia	central nervous system	activation_general	HP_0001945	ENSG00000168539	23197038	Bowes et al. (2012)	CHRM1	UBERON_0001017	""
proconvulsant	gastrointestinal	activation_general	EFO_0009853	ENSG00000168539	23197038	Bowes et al. (2012)	CHRM1	UBERON_0005409	""
decreased cognitive function	gastrointestinal	inhibition_general	HP_0100543	ENSG00000168539	23197038	Bowes et al. (2012)	CHRM1	UBERON_0005409	""
decreased gastric acid secretion	gastrointestinal	inhibition_general	GO_0060455	ENSG00000168539	23197038	Bowes et al. (2012)	CHRM1	UBERON_0005409	""
blurred vision	gastrointestinal	inhibition_general	HP_0000622	ENSG00000168539	23197038	Bowes et al. (2012)	CHRM1	UBERON_0005409	""
increased gastric acid secretion	gastrointestinal	activation_general	GO_0060454	ENSG00000168539	23197038	Bowes et al. (2012)	CHRM1	UBERON_0005409	""
hypertension	gastrointestinal	activation_general	EFO_0000537	ENSG00000168539	23197038	Bowes et al. (2012)	CHRM1	UBERON_0005409	""
tachycardia	gastrointestinal	activation_general	HP_0001649	ENSG00000168539	23197038	Bowes et al. (2012)	CHRM1	UBERON_0005409	""
hyperthermia	gastrointestinal	activation_general	HP_0001945	ENSG00000168539	23197038	Bowes et al. (2012)	CHRM1	UBERON_0005409	""
proconvulsant	cardiovascular system	activation_general	EFO_0009853	ENSG00000168539	23197038	Bowes et al. (2012)	CHRM1	UBERON_0004535	""
decreased cognitive function	cardiovascular system	inhibition_general	HP_0100543	ENSG00000168539	23197038	Bowes et al. (2012)	CHRM1	UBERON_0004535	""
decreased gastric acid secretion	cardiovascular system	inhibition_general	GO_0060455	ENSG00000168539	23197038	Bowes et al. (2012)	CHRM1	UBERON_0004535	""
blurred vision	cardiovascular system	inhibition_general	HP_0000622	ENSG00000168539	23197038	Bowes et al. (2012)	CHRM1	UBERON_0004535	""
increased gastric acid secretion	cardiovascular system	activation_general	GO_0060454	ENSG00000168539	23197038	Bowes et al. (2012)	CHRM1	UBERON_0004535	""
hypertension	cardiovascular system	activation_general	EFO_0000537	ENSG00000168539	23197038	Bowes et al. (2012)	CHRM1	UBERON_0004535	""
tachycardia	cardiovascular system	activation_general	HP_0001649	ENSG00000168539	23197038	Bowes et al. (2012)	CHRM1	UBERON_0004535	""
hyperthermia	cardiovascular system	activation_general	HP_0001945	ENSG00000168539	23197038	Bowes et al. (2012)	CHRM1	UBERON_0004535	""
abdominal pain	central nervous system	activation_acute	HP_0002027	ENSG00000134640	28216264	Lynch et al. (2017)	MTNR1B	UBERON_0001017	""
decreased sleep	central nervous system	inhibition_acute	EFO_0008568	ENSG00000134640	28216264	Lynch et al. (2017)	MTNR1B	UBERON_0001017	""
decreased memory	central nervous system	inhibition_acute	EFO_0001072	ENSG00000134640	28216264	Lynch et al. (2017)	MTNR1B	UBERON_0001017	""
nightmares	central nervous system	activation_acute	EFO_0009844	ENSG00000134640	28216264	Lynch et al. (2017)	MTNR1B	UBERON_0001017	""
decreased pain	central nervous system	activation_acute	GO_1904057	ENSG00000134640	28216264	Lynch et al. (2017)	MTNR1B	UBERON_0001017	""
increased memory	central nervous system	activation_acute	EFO_0004874	ENSG00000134640	28216264	Lynch et al. (2017)	MTNR1B	UBERON_0001017	""
decreased blood pressure	central nervous system	activation_acute	EFO_0005251	ENSG00000134640	28216264	Lynch et al. (2017)	MTNR1B	UBERON_0001017	""
increased sleep	central nervous system	activation_acute	EFO_0008568	ENSG00000134640	28216264	Lynch et al. (2017)	MTNR1B	UBERON_0001017	""
decreased anxiety	central nervous system	activation_acute	EFO_0009874	ENSG00000134640	28216264	Lynch et al. (2017)	MTNR1B	UBERON_0001017	""
increased gastrointestinal motility	cardiovascular system	inhibition_general	HP_0030895	ENSG00000108576	23197038	Bowes et al. (2012)	SLC6A4	UBERON_0004535	""
decreased upper gastrointestinal transit	cardiovascular system	inhibition_general	HP_0030897	ENSG00000108576	23197038	Bowes et al. (2012)	SLC6A4	UBERON_0004535	""
decreased plasma renin	cardiovascular system	inhibition_general	GO_1900134	ENSG00000108576	23197038	Bowes et al. (2012)	SLC6A4	UBERON_0004535	""
increased other serotonin-mediated effects	cardiovascular system	inhibition_general	GO_1904014	ENSG00000108576	23197038	Bowes et al. (2012)	SLC6A4	UBERON_0004535	""
insomnia	cardiovascular system	inhibition_general	EFO_0004698	ENSG00000108576	23197038	Bowes et al. (2012)	SLC6A4	UBERON_0004535	""
anxiety	cardiovascular system	inhibition_general	EFO_0005230	ENSG00000108576	23197038	Bowes et al. (2012)	SLC6A4	UBERON_0004535	""
nausea	cardiovascular system	inhibition_general	HP_0002018	ENSG00000108576	23197038	Bowes et al. (2012)	SLC6A4	UBERON_0004535	""
sexual dysfunction	cardiovascular system	inhibition_general	EFO_0004714	ENSG00000108576	23197038	Bowes et al. (2012)	SLC6A4	UBERON_0004535	""
increased gastrointestinal motility	central nervous system	inhibition_general	HP_0030895	ENSG00000108576	23197038	Bowes et al. (2012)	SLC6A4	UBERON_0001017	""
decreased upper gastrointestinal transit	central nervous system	inhibition_general	HP_0030897	ENSG00000108576	23197038	Bowes et al. (2012)	SLC6A4	UBERON_0001017	""
decreased plasma renin	central nervous system	inhibition_general	GO_1900134	ENSG00000108576	23197038	Bowes et al. (2012)	SLC6A4	UBERON_0001017	""
increased other serotonin-mediated effects	central nervous system	inhibition_general	GO_1904014	ENSG00000108576	23197038	Bowes et al. (2012)	SLC6A4	UBERON_0001017	""
insomnia	central nervous system	inhibition_general	EFO_0004698	ENSG00000108576	23197038	Bowes et al. (2012)	SLC6A4	UBERON_0001017	""
anxiety	central nervous system	inhibition_general	EFO_0005230	ENSG00000108576	23197038	Bowes et al. (2012)	SLC6A4	UBERON_0001017	""
nausea	central nervous system	inhibition_general	HP_0002018	ENSG00000108576	23197038	Bowes et al. (2012)	SLC6A4	UBERON_0001017	""
sexual dysfunction	central nervous system	inhibition_general	EFO_0004714	ENSG00000108576	23197038	Bowes et al. (2012)	SLC6A4	UBERON_0001017	""
cardiac valvulopathy	gastrointestinal	activation_acute	""	ENSG00000135914	28216264	Lynch et al. (2017)	HTR2B	UBERON_0005409	""
decreased gastrointestinal transit	gastrointestinal	inhibition_acute	HP_0030897	ENSG00000135914	28216264	Lynch et al. (2017)	HTR2B	UBERON_0005409	""
cardiovascular malformations	gastrointestinal	inhibition_developmental toxicity	EFO_0005269	ENSG00000135914	28216264	Lynch et al. (2017)	HTR2B	UBERON_0005409	""
decreased pain	gastrointestinal	inhibition_acute	GO_1904057	ENSG00000135914	28216264	Lynch et al. (2017)	HTR2B	UBERON_0005409	""
pulmonary hypertension	nervous system	activation_acute	EFO_0001361	ENSG00000135914	28216264	Lynch et al. (2017)	HTR2B	UBERON_0001016	""
decreased gastrointestinal transit	nervous system	inhibition_acute	HP_0030897	ENSG00000135914	28216264	Lynch et al. (2017)	HTR2B	UBERON_0001016	""
cardiovascular malformations	nervous system	inhibition_developmental toxicity	EFO_0005269	ENSG00000135914	28216264	Lynch et al. (2017)	HTR2B	UBERON_0001016	""
decreased pain	nervous system	inhibition_acute	GO_1904057	ENSG00000135914	28216264	Lynch et al. (2017)	HTR2B	UBERON_0001016	""
cardiac valvulopathy	nervous system	activation_acute	""	ENSG00000135914	28216264	Lynch et al. (2017)	HTR2B	UBERON_0001016	""
cardiac valvulopathy	cardiovascular	activation_acute	""	ENSG00000135914	28216264	Lynch et al. (2017)	HTR2B	UBERON_0004535	""
decreased gastrointestinal transit	cardiovascular	inhibition_acute	HP_0030897	ENSG00000135914	28216264	Lynch et al. (2017)	HTR2B	UBERON_0004535	""
cardiovascular malformations	cardiovascular	inhibition_developmental toxicity	EFO_0005269	ENSG00000135914	28216264	Lynch et al. (2017)	HTR2B	UBERON_0004535	""
decreased pain	cardiovascular	inhibition_acute	GO_1904057	ENSG00000135914	28216264	Lynch et al. (2017)	HTR2B	UBERON_0004535	""
increased pain	nervous system	activation_acute	GO_1904058	ENSG00000135914	28216264	Lynch et al. (2017)	HTR2B	UBERON_0001016	""
increased pain	cardiovascular	activation_acute	GO_1904058	ENSG00000135914	28216264	Lynch et al. (2017)	HTR2B	UBERON_0004535	""
increased pain	gastrointestinal	activation_acute	GO_1904058	ENSG00000135914	28216264	Lynch et al. (2017)	HTR2B	UBERON_0005409	""
decreased anxiety	gastrointestinal	activation_acute	EFO_0009874	ENSG00000135914	28216264	Lynch et al. (2017)	HTR2B	UBERON_0005409	""
decreased anxiety	cardiovascular	activation_acute	EFO_0009874	ENSG00000135914	28216264	Lynch et al. (2017)	HTR2B	UBERON_0004535	""
decreased anxiety	nervous system	activation_acute	EFO_0009874	ENSG00000135914	28216264	Lynch et al. (2017)	HTR2B	UBERON_0001016	""
pulmonary hypertension	gastrointestinal	activation_acute	EFO_0001361	ENSG00000135914	28216264	Lynch et al. (2017)	HTR2B	UBERON_0005409	""
pulmonary hypertension	cardiovascular	activation_acute	EFO_0001361	ENSG00000135914	28216264	Lynch et al. (2017)	HTR2B	UBERON_0004535	""
bronchoconstriction	respiratory	activation_acute	EFO_0009836	ENSG00000168398	28216264	Lynch et al. (2017)	BDKRB2	UBERON_0001004	""
decreased pain	respiratory	inhibition_acute	GO_1904057	ENSG00000168398	28216264	Lynch et al. (2017)	BDKRB2	UBERON_0001004	""
decreased urinary sodium excretion	respiratory	inhibition_acute	GO_0035814	ENSG00000168398	28216264	Lynch et al. (2017)	BDKRB2	UBERON_0001004	""
decreased blood pressure	renal	activation_acute	EFO_0005251	ENSG00000168398	28216264	Lynch et al. (2017)	BDKRB2	UBERON_0001008	""
decreased pain	renal	inhibition_acute	GO_1904057	ENSG00000168398	28216264	Lynch et al. (2017)	BDKRB2	UBERON_0001008	""
decreased urinary sodium excretion	renal	inhibition_acute	GO_0035814	ENSG00000168398	28216264	Lynch et al. (2017)	BDKRB2	UBERON_0001008	""
increased urine excretion	renal	activation_acute	HP_0000103	ENSG00000168398	28216264	Lynch et al. (2017)	BDKRB2	UBERON_0001008	""
inflammation	central nervous system	activation_acute	GO_0006954	ENSG00000168398	28216264	Lynch et al. (2017)	BDKRB2	UBERON_0001017	""
decreased pain	central nervous system	inhibition_acute	GO_1904057	ENSG00000168398	28216264	Lynch et al. (2017)	BDKRB2	UBERON_0001017	""
decreased urinary sodium excretion	central nervous system	inhibition_acute	GO_0035814	ENSG00000168398	28216264	Lynch et al. (2017)	BDKRB2	UBERON_0001017	""
increased urinary sodium excretion	central nervous system	activation_acute	GO_0035815	ENSG00000168398	28216264	Lynch et al. (2017)	BDKRB2	UBERON_0001017	""
increased urine excretion	cardiovascular	activation_acute	HP_0000103	ENSG00000168398	28216264	Lynch et al. (2017)	BDKRB2	UBERON_0004535	""
decreased pain	cardiovascular	inhibition_acute	GO_1904057	ENSG00000168398	28216264	Lynch et al. (2017)	BDKRB2	UBERON_0004535	""
decreased urinary sodium excretion	cardiovascular	inhibition_acute	GO_0035814	ENSG00000168398	28216264	Lynch et al. (2017)	BDKRB2	UBERON_0004535	""
increased urinary sodium excretion	renal	activation_acute	GO_0035815	ENSG00000168398	28216264	Lynch et al. (2017)	BDKRB2	UBERON_0001008	""
bronchoconstriction	renal	activation_acute	EFO_0009836	ENSG00000168398	28216264	Lynch et al. (2017)	BDKRB2	UBERON_0001008	""
decreased blood pressure	central nervous system	activation_acute	EFO_0005251	ENSG00000168398	28216264	Lynch et al. (2017)	BDKRB2	UBERON_0001017	""
decreased blood pressure	respiratory	activation_acute	EFO_0005251	ENSG00000168398	28216264	Lynch et al. (2017)	BDKRB2	UBERON_0001004	""
bronchoconstriction	central nervous system	activation_acute	EFO_0009836	ENSG00000168398	28216264	Lynch et al. (2017)	BDKRB2	UBERON_0001017	""
increased urine excretion	central nervous system	activation_acute	HP_0000103	ENSG00000168398	28216264	Lynch et al. (2017)	BDKRB2	UBERON_0001017	""
increased urinary sodium excretion	respiratory	activation_acute	GO_0035815	ENSG00000168398	28216264	Lynch et al. (2017)	BDKRB2	UBERON_0001004	""
inflammation	respiratory	activation_acute	GO_0006954	ENSG00000168398	28216264	Lynch et al. (2017)	BDKRB2	UBERON_0001004	""
bronchoconstriction	cardiovascular	activation_acute	EFO_0009836	ENSG00000168398	28216264	Lynch et al. (2017)	BDKRB2	UBERON_0004535	""
inflammation	cardiovascular	activation_acute	GO_0006954	ENSG00000168398	28216264	Lynch et al. (2017)	BDKRB2	UBERON_0004535	""
inflammation	renal	activation_acute	GO_0006954	ENSG00000168398	28216264	Lynch et al. (2017)	BDKRB2	UBERON_0001008	""
decreased blood pressure	cardiovascular	activation_acute	EFO_0005251	ENSG00000168398	28216264	Lynch et al. (2017)	BDKRB2	UBERON_0004535	""
increased urinary sodium excretion	cardiovascular	activation_acute	GO_0035815	ENSG00000168398	28216264	Lynch et al. (2017)	BDKRB2	UBERON_0004535	""
increased urine excretion	respiratory	activation_acute	HP_0000103	ENSG00000168398	28216264	Lynch et al. (2017)	BDKRB2	UBERON_0001004	""
decreased convulsions	cardiovascular	activation_acute	EFO_0009853	ENSG00000143603	28216264	Lynch et al. (2017)	KCNN3	UBERON_0004535	""
increased atrial refractory period	cardiovascular	inhibition_acute	""	ENSG00000143603	28216264	Lynch et al. (2017)	KCNN3	UBERON_0004535	""
convulsions	cardiovascular	inhibition_acute	EFO_0009853	ENSG00000143603	28216264	Lynch et al. (2017)	KCNN3	UBERON_0004535	""
neurotoxicity	cardiovascular	inhibition_acute	EFO_0005595	ENSG00000143603	28216264	Lynch et al. (2017)	KCNN3	UBERON_0004535	""
decreased convulsions	central nervous system	activation_acute	EFO_0009853	ENSG00000143603	28216264	Lynch et al. (2017)	KCNN3	UBERON_0001017	""
increased atrial refractory period	central nervous system	inhibition_acute	""	ENSG00000143603	28216264	Lynch et al. (2017)	KCNN3	UBERON_0001017	""
convulsions	central nervous system	inhibition_acute	EFO_0009853	ENSG00000143603	28216264	Lynch et al. (2017)	KCNN3	UBERON_0001017	""
neurotoxicity	central nervous system	inhibition_acute	EFO_0005595	ENSG00000143603	28216264	Lynch et al. (2017)	KCNN3	UBERON_0001017	""
decreased locomotor activity	central nervous system	activation_acute	GO_0040013	ENSG00000143603	28216264	Lynch et al. (2017)	KCNN3	UBERON_0001017	""
ataxia	central nervous system	activation_acute	MONDO_0000437	ENSG00000143603	28216264	Lynch et al. (2017)	KCNN3	UBERON_0001017	""
ataxia	cardiovascular	activation_acute	MONDO_0000437	ENSG00000143603	28216264	Lynch et al. (2017)	KCNN3	UBERON_0004535	""
decreased locomotor activity	cardiovascular	activation_acute	GO_0040013	ENSG00000143603	28216264	Lynch et al. (2017)	KCNN3	UBERON_0004535	""
increased heart failure	cardiovascular	activation_acute	EFO_0003144	ENSG00000274286	28216264	Lynch et al. (2017)	ADRA2B	UBERON_0004535	""
decreased blood pressure	cardiovascular	inhibition_acute	EFO_0005251	ENSG00000274286	28216264	Lynch et al. (2017)	ADRA2B	UBERON_0004535	""
decreased survival	cardiovascular	inhibition_developmental toxicity	EFO_0000480	ENSG00000274286	28216264	Lynch et al. (2017)	ADRA2B	UBERON_0004535	""
decreased pain	cardiovascular	activation_acute	GO_1904057	ENSG00000274286	28216264	Lynch et al. (2017)	ADRA2B	UBERON_0004535	""
skeletal muscle tremor	nervous system	activation_acute	HP_0001337	ENSG00000274286	28216264	Lynch et al. (2017)	ADRA2B	UBERON_0001016	""
decreased blood pressure	nervous system	inhibition_acute	EFO_0005251	ENSG00000274286	28216264	Lynch et al. (2017)	ADRA2B	UBERON_0001016	""
decreased survival	nervous system	inhibition_developmental toxicity	EFO_0000480	ENSG00000274286	28216264	Lynch et al. (2017)	ADRA2B	UBERON_0001016	""
increased blood pressure	cardiovascular	activation_acute	HP_0032263	ENSG00000274286	28216264	Lynch et al. (2017)	ADRA2B	UBERON_0004535	""
increased heart rate	cardiovascular	activation_acute	HP_0001649	ENSG00000274286	28216264	Lynch et al. (2017)	ADRA2B	UBERON_0004535	""
increased heart failure	nervous system	activation_acute	EFO_0003144	ENSG00000274286	28216264	Lynch et al. (2017)	ADRA2B	UBERON_0001016	""
cardiac ischemia	nervous system	activation_acute	EFO_1001375	ENSG00000274286	28216264	Lynch et al. (2017)	ADRA2B	UBERON_0001016	""
skeletal muscle tremor	cardiovascular	activation_acute	HP_0001337	ENSG00000274286	28216264	Lynch et al. (2017)	ADRA2B	UBERON_0004535	""
sedation	cardiovascular	activation_acute	EFO_0009868	ENSG00000274286	28216264	Lynch et al. (2017)	ADRA2B	UBERON_0004535	""
increased blood pressure	nervous system	activation_acute	HP_0032263	ENSG00000274286	28216264	Lynch et al. (2017)	ADRA2B	UBERON_0001016	""
sedation	nervous system	activation_acute	EFO_0009868	ENSG00000274286	28216264	Lynch et al. (2017)	ADRA2B	UBERON_0001016	""
decreased pain	nervous system	activation_acute	GO_1904057	ENSG00000274286	28216264	Lynch et al. (2017)	ADRA2B	UBERON_0001016	""
cardiac ischemia	cardiovascular	activation_acute	EFO_1001375	ENSG00000274286	28216264	Lynch et al. (2017)	ADRA2B	UBERON_0004535	""
increased heart rate	nervous system	activation_acute	HP_0001649	ENSG00000274286	28216264	Lynch et al. (2017)	ADRA2B	UBERON_0001016	""
decreased gastrointestinal motility	central nervous system	activation_general	HP_0002579	ENSG00000082556	23197038	Bowes et al. (2012)	OPRK1	UBERON_0001017	""
increased urinary output	central nervous system	activation_general	HP_0000103	ENSG00000082556	23197038	Bowes et al. (2012)	OPRK1	UBERON_0001017	""
sedation	central nervous system	activation_general	EFO_0009868	ENSG00000082556	23197038	Bowes et al. (2012)	OPRK1	UBERON_0001017	""
dysphoria	central nervous system	activation_general	EFO_0009867	ENSG00000082556	23197038	Bowes et al. (2012)	OPRK1	UBERON_0001017	""
confusion	central nervous system	activation_general	HP_0004372	ENSG00000082556	23197038	Bowes et al. (2012)	OPRK1	UBERON_0001017	""
dizziness	central nervous system	activation_general	EFO_0009847	ENSG00000082556	23197038	Bowes et al. (2012)	OPRK1	UBERON_0001017	""
decreased locomotion	central nervous system	activation_general	GO_0040013	ENSG00000082556	23197038	Bowes et al. (2012)	OPRK1	UBERON_0001017	""
tachycardia	central nervous system	activation_general	HP_0001649	ENSG00000082556	23197038	Bowes et al. (2012)	OPRK1	UBERON_0001017	""
decreased gastrointestinal motility	cardiovascular system	activation_general	HP_0002579	ENSG00000082556	23197038	Bowes et al. (2012)	OPRK1	UBERON_0004535	""
increased urinary output	cardiovascular system	activation_general	HP_0000103	ENSG00000082556	23197038	Bowes et al. (2012)	OPRK1	UBERON_0004535	""
sedation	cardiovascular system	activation_general	EFO_0009868	ENSG00000082556	23197038	Bowes et al. (2012)	OPRK1	UBERON_0004535	""
dysphoria	cardiovascular system	activation_general	EFO_0009867	ENSG00000082556	23197038	Bowes et al. (2012)	OPRK1	UBERON_0004535	""
confusion	cardiovascular system	activation_general	HP_0004372	ENSG00000082556	23197038	Bowes et al. (2012)	OPRK1	UBERON_0004535	""
dizziness	cardiovascular system	activation_general	EFO_0009847	ENSG00000082556	23197038	Bowes et al. (2012)	OPRK1	UBERON_0004535	""
decreased locomotion	cardiovascular system	activation_general	GO_0040013	ENSG00000082556	23197038	Bowes et al. (2012)	OPRK1	UBERON_0004535	""
tachycardia	cardiovascular system	activation_general	HP_0001649	ENSG00000082556	23197038	Bowes et al. (2012)	OPRK1	UBERON_0004535	""
decreased gastrointestinal motility	gastrointestinal	activation_general	HP_0002579	ENSG00000082556	23197038	Bowes et al. (2012)	OPRK1	UBERON_0005409	""
increased urinary output	gastrointestinal	activation_general	HP_0000103	ENSG00000082556	23197038	Bowes et al. (2012)	OPRK1	UBERON_0005409	""
sedation	gastrointestinal	activation_general	EFO_0009868	ENSG00000082556	23197038	Bowes et al. (2012)	OPRK1	UBERON_0005409	""
dysphoria	gastrointestinal	activation_general	EFO_0009867	ENSG00000082556	23197038	Bowes et al. (2012)	OPRK1	UBERON_0005409	""
confusion	gastrointestinal	activation_general	HP_0004372	ENSG00000082556	23197038	Bowes et al. (2012)	OPRK1	UBERON_0005409	""
dizziness	gastrointestinal	activation_general	EFO_0009847	ENSG00000082556	23197038	Bowes et al. (2012)	OPRK1	UBERON_0005409	""
decreased locomotion	gastrointestinal	activation_general	GO_0040013	ENSG00000082556	23197038	Bowes et al. (2012)	OPRK1	UBERON_0005409	""
tachycardia	gastrointestinal	activation_general	HP_0001649	ENSG00000082556	23197038	Bowes et al. (2012)	OPRK1	UBERON_0005409	""
decreased noradrenaline release and sympathetic neurotransmission	central nervous system	activation_general	GO_0061533	ENSG00000150594	23197038	Bowes et al. (2012)	ADRA2A	UBERON_0001017	""
increased gastrointestinal motility	central nervous system	inhibition_general	HP_0030895	ENSG00000150594	23197038	Bowes et al. (2012)	ADRA2A	UBERON_0001017	""
increased insulin secretion	central nervous system	inhibition_general	HP_0000842	ENSG00000150594	23197038	Bowes et al. (2012)	ADRA2A	UBERON_0001017	""
decreased blood pressure	central nervous system	activation_general	EFO_0005251	ENSG00000150594	23197038	Bowes et al. (2012)	ADRA2A	UBERON_0001017	""
decreased heart rate	central nervous system	activation_general	HP_0001662	ENSG00000150594	23197038	Bowes et al. (2012)	ADRA2A	UBERON_0001017	""
mydriasis	central nervous system	activation_general	HP_0011499	ENSG00000150594	23197038	Bowes et al. (2012)	ADRA2A	UBERON_0001017	""
sedation	central nervous system	activation_general	EFO_0009868	ENSG00000150594	23197038	Bowes et al. (2012)	ADRA2A	UBERON_0001017	""
decreased noradrenaline release and sympathetic neurotransmission	cardiovascular system	activation_general	GO_0061533	ENSG00000150594	23197038	Bowes et al. (2012)	ADRA2A	UBERON_0004535	""
increased gastrointestinal motility	cardiovascular system	inhibition_general	HP_0030895	ENSG00000150594	23197038	Bowes et al. (2012)	ADRA2A	UBERON_0004535	""
increased insulin secretion	cardiovascular system	inhibition_general	HP_0000842	ENSG00000150594	23197038	Bowes et al. (2012)	ADRA2A	UBERON_0004535	""
decreased blood pressure	cardiovascular system	activation_general	EFO_0005251	ENSG00000150594	23197038	Bowes et al. (2012)	ADRA2A	UBERON_0004535	""
decreased heart rate	cardiovascular system	activation_general	HP_0001662	ENSG00000150594	23197038	Bowes et al. (2012)	ADRA2A	UBERON_0004535	""
mydriasis	cardiovascular system	activation_general	HP_0011499	ENSG00000150594	23197038	Bowes et al. (2012)	ADRA2A	UBERON_0004535	""
sedation	cardiovascular system	activation_general	EFO_0009868	ENSG00000150594	23197038	Bowes et al. (2012)	ADRA2A	UBERON_0004535	""
inflammation	immune	activation_acute	GO_0006954	ENSG00000113749	28216264	Lynch et al. (2017)	HRH2	UBERON_0002405	""
decreased gastric acid secretion	immune	inhibition_acute	GO_0060455	ENSG00000113749	28216264	Lynch et al. (2017)	HRH2	UBERON_0002405	""
decreased gastric emptying	immune	inhibition_acute	GO_0120061	ENSG00000113749	28216264	Lynch et al. (2017)	HRH2	UBERON_0002405	""
decreased eating	immune	inhibition_acute	HP_0100738	ENSG00000113749	28216264	Lynch et al. (2017)	HRH2	UBERON_0002405	""
decreased inflammation	immune	inhibition_acute	GO_0050728	ENSG00000113749	28216264	Lynch et al. (2017)	HRH2	UBERON_0002405	""
decreased pain	immune	inhibition_acute	GO_1904057	ENSG00000113749	28216264	Lynch et al. (2017)	HRH2	UBERON_0002405	""
increased gastric emptying	cardiovascular	activation_acute	GO_0120062	ENSG00000113749	28216264	Lynch et al. (2017)	HRH2	UBERON_0004535	""
decreased gastric acid secretion	cardiovascular	inhibition_acute	GO_0060455	ENSG00000113749	28216264	Lynch et al. (2017)	HRH2	UBERON_0004535	""
decreased gastric emptying	cardiovascular	inhibition_acute	GO_0120061	ENSG00000113749	28216264	Lynch et al. (2017)	HRH2	UBERON_0004535	""
decreased eating	cardiovascular	inhibition_acute	HP_0100738	ENSG00000113749	28216264	Lynch et al. (2017)	HRH2	UBERON_0004535	""
decreased inflammation	cardiovascular	inhibition_acute	GO_0050728	ENSG00000113749	28216264	Lynch et al. (2017)	HRH2	UBERON_0004535	""
decreased pain	cardiovascular	inhibition_acute	GO_1904057	ENSG00000113749	28216264	Lynch et al. (2017)	HRH2	UBERON_0004535	""
increased gastric emptying	immune	activation_acute	GO_0120062	ENSG00000113749	28216264	Lynch et al. (2017)	HRH2	UBERON_0002405	""
increased gastric acid secretion	cardiovascular	activation_acute	GO_0060454	ENSG00000113749	28216264	Lynch et al. (2017)	HRH2	UBERON_0004535	""
increased heart rate	immune	activation_acute	HP_0001649	ENSG00000113749	28216264	Lynch et al. (2017)	HRH2	UBERON_0002405	""
increased gastric acid secretion	immune	activation_acute	GO_0060454	ENSG00000113749	28216264	Lynch et al. (2017)	HRH2	UBERON_0002405	""
increased gastric emptying	gastrointestinal	activation_acute	GO_0120062	ENSG00000113749	28216264	Lynch et al. (2017)	HRH2	UBERON_0005409	""
decreased gastric acid secretion	gastrointestinal	inhibition_acute	GO_0060455	ENSG00000113749	28216264	Lynch et al. (2017)	HRH2	UBERON_0005409	""
decreased gastric emptying	gastrointestinal	inhibition_acute	GO_0120061	ENSG00000113749	28216264	Lynch et al. (2017)	HRH2	UBERON_0005409	""
decreased eating	gastrointestinal	inhibition_acute	HP_0100738	ENSG00000113749	28216264	Lynch et al. (2017)	HRH2	UBERON_0005409	""
decreased inflammation	gastrointestinal	inhibition_acute	GO_0050728	ENSG00000113749	28216264	Lynch et al. (2017)	HRH2	UBERON_0005409	""
decreased pain	gastrointestinal	inhibition_acute	GO_1904057	ENSG00000113749	28216264	Lynch et al. (2017)	HRH2	UBERON_0005409	""
decreased blood pressure	gastrointestinal	activation_acute	EFO_0005251	ENSG00000113749	28216264	Lynch et al. (2017)	HRH2	UBERON_0005409	""
increased drinking	cardiovascular	activation_acute	HP_0001959	ENSG00000113749	28216264	Lynch et al. (2017)	HRH2	UBERON_0004535	""
increased heart rate	gastrointestinal	activation_acute	HP_0001649	ENSG00000113749	28216264	Lynch et al. (2017)	HRH2	UBERON_0005409	""
decreased blood pressure	immune	activation_acute	EFO_0005251	ENSG00000113749	28216264	Lynch et al. (2017)	HRH2	UBERON_0002405	""
increased drinking	gastrointestinal	activation_acute	HP_0001959	ENSG00000113749	28216264	Lynch et al. (2017)	HRH2	UBERON_0005409	""
decreased blood pressure	cardiovascular	activation_acute	EFO_0005251	ENSG00000113749	28216264	Lynch et al. (2017)	HRH2	UBERON_0004535	""
inflammation	gastrointestinal	activation_acute	GO_0006954	ENSG00000113749	28216264	Lynch et al. (2017)	HRH2	UBERON_0005409	""
increased gastric acid secretion	gastrointestinal	activation_acute	GO_0060454	ENSG00000113749	28216264	Lynch et al. (2017)	HRH2	UBERON_0005409	""
inflammation	cardiovascular	activation_acute	GO_0006954	ENSG00000113749	28216264	Lynch et al. (2017)	HRH2	UBERON_0004535	""
increased drinking	immune	activation_acute	HP_0001959	ENSG00000113749	28216264	Lynch et al. (2017)	HRH2	UBERON_0002405	""
increased heart rate	cardiovascular	activation_acute	HP_0001649	ENSG00000113749	28216264	Lynch et al. (2017)	HRH2	UBERON_0004535	""
prolongation of QT interval of ECG	cardiovascular system	inhibition_general	HP_0001657	ENSG00000055118	23197038	Bowes et al. (2012)	KCNH2	UBERON_0004535	""
decreased body temperature	central nervous system	activation_acute	HP_0002045	ENSG00000166148	28216264	Lynch et al. (2017)	AVPR1A	UBERON_0001017	""
myocardial hypertrophy	central nervous system	activation_chronic	EFO_0002503	ENSG00000166148	28216264	Lynch et al. (2017)	AVPR1A	UBERON_0001017	""
decreased urinary sodium excretion	central nervous system	inhibition_acute	GO_0035814	ENSG00000166148	28216264	Lynch et al. (2017)	AVPR1A	UBERON_0001017	""
decreased anxiety	central nervous system	inhibition_acute	EFO_0009874	ENSG00000166148	28216264	Lynch et al. (2017)	AVPR1A	UBERON_0001017	""
decreased aggression	central nervous system	inhibition_acute	EFO_0003015	ENSG00000166148	28216264	Lynch et al. (2017)	AVPR1A	UBERON_0001017	""
decreased body temperature	cardiovascular	activation_acute	HP_0002045	ENSG00000166148	28216264	Lynch et al. (2017)	AVPR1A	UBERON_0004535	""
myocardial hypertrophy	cardiovascular	activation_chronic	EFO_0002503	ENSG00000166148	28216264	Lynch et al. (2017)	AVPR1A	UBERON_0004535	""
decreased urinary sodium excretion	cardiovascular	inhibition_acute	GO_0035814	ENSG00000166148	28216264	Lynch et al. (2017)	AVPR1A	UBERON_0004535	""
decreased anxiety	cardiovascular	inhibition_acute	EFO_0009874	ENSG00000166148	28216264	Lynch et al. (2017)	AVPR1A	UBERON_0004535	""
decreased aggression	cardiovascular	inhibition_acute	EFO_0003015	ENSG00000166148	28216264	Lynch et al. (2017)	AVPR1A	UBERON_0004535	""
decreased body temperature	renal	activation_acute	HP_0002045	ENSG00000166148	28216264	Lynch et al. (2017)	AVPR1A	UBERON_0001008	""
myocardial hypertrophy	renal	activation_chronic	EFO_0002503	ENSG00000166148	28216264	Lynch et al. (2017)	AVPR1A	UBERON_0001008	""
decreased urinary sodium excretion	renal	inhibition_acute	GO_0035814	ENSG00000166148	28216264	Lynch et al. (2017)	AVPR1A	UBERON_0001008	""
decreased anxiety	renal	inhibition_acute	EFO_0009874	ENSG00000166148	28216264	Lynch et al. (2017)	AVPR1A	UBERON_0001008	""
decreased aggression	renal	inhibition_acute	EFO_0003015	ENSG00000166148	28216264	Lynch et al. (2017)	AVPR1A	UBERON_0001008	""
increased urinary sodium excretion	renal	activation_acute	GO_0035815	ENSG00000166148	28216264	Lynch et al. (2017)	AVPR1A	UBERON_0001008	""
increased urinary sodium excretion	cardiovascular	activation_acute	GO_0035815	ENSG00000166148	28216264	Lynch et al. (2017)	AVPR1A	UBERON_0004535	""
increased blood pressure	renal	activation_acute	HP_0032263	ENSG00000166148	28216264	Lynch et al. (2017)	AVPR1A	UBERON_0001008	""
increased urinary sodium excretion	central nervous system	activation_acute	GO_0035815	ENSG00000166148	28216264	Lynch et al. (2017)	AVPR1A	UBERON_0001017	""
increased blood pressure	cardiovascular	activation_acute	HP_0032263	ENSG00000166148	28216264	Lynch et al. (2017)	AVPR1A	UBERON_0004535	""
increased blood pressure	central nervous system	activation_acute	HP_0032263	ENSG00000166148	28216264	Lynch et al. (2017)	AVPR1A	UBERON_0001017	""
increased memory	cardiovascular	activation_acute	EFO_0004874	ENSG00000166148	28216264	Lynch et al. (2017)	AVPR1A	UBERON_0004535	""
increased memory	central nervous system	activation_acute	EFO_0004874	ENSG00000166148	28216264	Lynch et al. (2017)	AVPR1A	UBERON_0001017	""
increased memory	renal	activation_acute	EFO_0004874	ENSG00000166148	28216264	Lynch et al. (2017)	AVPR1A	UBERON_0001008	""
increased cardiac contractility	cardiovascular	inhibition_acute	GO_0045823	ENSG00000018625	28216264	Lynch et al. (2017)	ATP1A2	UBERON_0004535	""
decreased heart rate	cardiovascular	inhibition_acute	HP_0001662	ENSG00000018625	28216264	Lynch et al. (2017)	ATP1A2	UBERON_0004535	""
atrioventricular block	cardiovascular	inhibition_acute	MONDO_0000465	ENSG00000018625	28216264	Lynch et al. (2017)	ATP1A2	UBERON_0004535	""
cardiac arrhythmia	cardiovascular	inhibition_acute	EFO_0004269	ENSG00000018625	28216264	Lynch et al. (2017)	ATP1A2	UBERON_0004535	""
ventricular fibrillation	cardiovascular	inhibition_acute	EFO_0004287	ENSG00000018625	28216264	Lynch et al. (2017)	ATP1A2	UBERON_0004535	""
increased urine excretion	cardiovascular	inhibition_acute	HP_0000103	ENSG00000018625	28216264	Lynch et al. (2017)	ATP1A2	UBERON_0004535	""
increased urinary sodium excretion	cardiovascular	inhibition_acute	GO_0035815	ENSG00000018625	28216264	Lynch et al. (2017)	ATP1A2	UBERON_0004535	""
vomiting	cardiovascular	inhibition_acute	HP_0002017	ENSG00000018625	28216264	Lynch et al. (2017)	ATP1A2	UBERON_0004535	""
increased cardiac contractility	renal	inhibition_acute	GO_0045823	ENSG00000018625	28216264	Lynch et al. (2017)	ATP1A2	UBERON_0001008	""
decreased heart rate	renal	inhibition_acute	HP_0001662	ENSG00000018625	28216264	Lynch et al. (2017)	ATP1A2	UBERON_0001008	""
atrioventricular block	renal	inhibition_acute	MONDO_0000465	ENSG00000018625	28216264	Lynch et al. (2017)	ATP1A2	UBERON_0001008	""
cardiac arrhythmia	renal	inhibition_acute	EFO_0004269	ENSG00000018625	28216264	Lynch et al. (2017)	ATP1A2	UBERON_0001008	""
ventricular fibrillation	renal	inhibition_acute	EFO_0004287	ENSG00000018625	28216264	Lynch et al. (2017)	ATP1A2	UBERON_0001008	""
increased urine excretion	renal	inhibition_acute	HP_0000103	ENSG00000018625	28216264	Lynch et al. (2017)	ATP1A2	UBERON_0001008	""
increased urinary sodium excretion	renal	inhibition_acute	GO_0035815	ENSG00000018625	28216264	Lynch et al. (2017)	ATP1A2	UBERON_0001008	""
vomiting	renal	inhibition_acute	HP_0002017	ENSG00000018625	28216264	Lynch et al. (2017)	ATP1A2	UBERON_0001008	""
increased cardiac contractility	renal	inhibition_acute	GO_0045823	ENSG00000129244	28216264	Lynch et al. (2017)	ATP1B2	UBERON_0001008	""
decreased heart rate	renal	inhibition_acute	HP_0001662	ENSG00000129244	28216264	Lynch et al. (2017)	ATP1B2	UBERON_0001008	""
atrioventricular block	renal	inhibition_acute	MONDO_0000465	ENSG00000129244	28216264	Lynch et al. (2017)	ATP1B2	UBERON_0001008	""
cardiac arrhythmia	renal	inhibition_acute	EFO_0004269	ENSG00000129244	28216264	Lynch et al. (2017)	ATP1B2	UBERON_0001008	""
ventricular fibrillation	renal	inhibition_acute	EFO_0004287	ENSG00000129244	28216264	Lynch et al. (2017)	ATP1B2	UBERON_0001008	""
increased urine excretion	renal	inhibition_acute	HP_0000103	ENSG00000129244	28216264	Lynch et al. (2017)	ATP1B2	UBERON_0001008	""
increased urinary sodium excretion	renal	inhibition_acute	GO_0035815	ENSG00000129244	28216264	Lynch et al. (2017)	ATP1B2	UBERON_0001008	""
vomiting	renal	inhibition_acute	HP_0002017	ENSG00000129244	28216264	Lynch et al. (2017)	ATP1B2	UBERON_0001008	""
increased cardiac contractility	cardiovascular	inhibition_acute	GO_0045823	ENSG00000129244	28216264	Lynch et al. (2017)	ATP1B2	UBERON_0004535	""
decreased heart rate	cardiovascular	inhibition_acute	HP_0001662	ENSG00000129244	28216264	Lynch et al. (2017)	ATP1B2	UBERON_0004535	""
atrioventricular block	cardiovascular	inhibition_acute	MONDO_0000465	ENSG00000129244	28216264	Lynch et al. (2017)	ATP1B2	UBERON_0004535	""
cardiac arrhythmia	cardiovascular	inhibition_acute	EFO_0004269	ENSG00000129244	28216264	Lynch et al. (2017)	ATP1B2	UBERON_0004535	""
ventricular fibrillation	cardiovascular	inhibition_acute	EFO_0004287	ENSG00000129244	28216264	Lynch et al. (2017)	ATP1B2	UBERON_0004535	""
increased urine excretion	cardiovascular	inhibition_acute	HP_0000103	ENSG00000129244	28216264	Lynch et al. (2017)	ATP1B2	UBERON_0004535	""
increased urinary sodium excretion	cardiovascular	inhibition_acute	GO_0035815	ENSG00000129244	28216264	Lynch et al. (2017)	ATP1B2	UBERON_0004535	""
vomiting	cardiovascular	inhibition_acute	HP_0002017	ENSG00000129244	28216264	Lynch et al. (2017)	ATP1B2	UBERON_0004535	""
increased cardiac contractility	cardiovascular	inhibition_acute	GO_0045823	ENSG00000069849	28216264	Lynch et al. (2017)	ATP1B3	UBERON_0004535	""
decreased heart rate	cardiovascular	inhibition_acute	HP_0001662	ENSG00000069849	28216264	Lynch et al. (2017)	ATP1B3	UBERON_0004535	""
atrioventricular block	cardiovascular	inhibition_acute	MONDO_0000465	ENSG00000069849	28216264	Lynch et al. (2017)	ATP1B3	UBERON_0004535	""
cardiac arrhythmia	cardiovascular	inhibition_acute	EFO_0004269	ENSG00000069849	28216264	Lynch et al. (2017)	ATP1B3	UBERON_0004535	""
ventricular fibrillation	cardiovascular	inhibition_acute	EFO_0004287	ENSG00000069849	28216264	Lynch et al. (2017)	ATP1B3	UBERON_0004535	""
increased urine excretion	cardiovascular	inhibition_acute	HP_0000103	ENSG00000069849	28216264	Lynch et al. (2017)	ATP1B3	UBERON_0004535	""
increased urinary sodium excretion	cardiovascular	inhibition_acute	GO_0035815	ENSG00000069849	28216264	Lynch et al. (2017)	ATP1B3	UBERON_0004535	""
vomiting	cardiovascular	inhibition_acute	HP_0002017	ENSG00000069849	28216264	Lynch et al. (2017)	ATP1B3	UBERON_0004535	""
increased cardiac contractility	renal	inhibition_acute	GO_0045823	ENSG00000069849	28216264	Lynch et al. (2017)	ATP1B3	UBERON_0001008	""
decreased heart rate	renal	inhibition_acute	HP_0001662	ENSG00000069849	28216264	Lynch et al. (2017)	ATP1B3	UBERON_0001008	""
atrioventricular block	renal	inhibition_acute	MONDO_0000465	ENSG00000069849	28216264	Lynch et al. (2017)	ATP1B3	UBERON_0001008	""
cardiac arrhythmia	renal	inhibition_acute	EFO_0004269	ENSG00000069849	28216264	Lynch et al. (2017)	ATP1B3	UBERON_0001008	""
ventricular fibrillation	renal	inhibition_acute	EFO_0004287	ENSG00000069849	28216264	Lynch et al. (2017)	ATP1B3	UBERON_0001008	""
increased urine excretion	renal	inhibition_acute	HP_0000103	ENSG00000069849	28216264	Lynch et al. (2017)	ATP1B3	UBERON_0001008	""
increased urinary sodium excretion	renal	inhibition_acute	GO_0035815	ENSG00000069849	28216264	Lynch et al. (2017)	ATP1B3	UBERON_0001008	""
vomiting	renal	inhibition_acute	HP_0002017	ENSG00000069849	28216264	Lynch et al. (2017)	ATP1B3	UBERON_0001008	""
water retention in body	cardiovascular system	activation_general	GO_0003092	ENSG00000166148	23197038	Bowes et al. (2012)	AVPR1A	UBERON_0004535	""
increased blood pressure	cardiovascular system	activation_general	HP_0032263	ENSG00000166148	23197038	Bowes et al. (2012)	AVPR1A	UBERON_0004535	""
decreased heart rate	cardiovascular system	activation_general	HP_0001662	ENSG00000166148	23197038	Bowes et al. (2012)	AVPR1A	UBERON_0004535	""
myocardial fibrosis	cardiovascular system	activation_general	HP_0001685	ENSG00000166148	23197038	Bowes et al. (2012)	AVPR1A	UBERON_0004535	""
cardiac hypertrophy	cardiovascular system	activation_general	EFO_0002503	ENSG00000166148	23197038	Bowes et al. (2012)	AVPR1A	UBERON_0004535	""
hyponatraemia	cardiovascular system	activation_general	HP_0002902	ENSG00000166148	23197038	Bowes et al. (2012)	AVPR1A	UBERON_0004535	""
water retention in body	renal	activation_general	GO_0003092	ENSG00000166148	23197038	Bowes et al. (2012)	AVPR1A	UBERON_0001008	""
increased blood pressure	renal	activation_general	HP_0032263	ENSG00000166148	23197038	Bowes et al. (2012)	AVPR1A	UBERON_0001008	""
decreased heart rate	renal	activation_general	HP_0001662	ENSG00000166148	23197038	Bowes et al. (2012)	AVPR1A	UBERON_0001008	""
myocardial fibrosis	renal	activation_general	HP_0001685	ENSG00000166148	23197038	Bowes et al. (2012)	AVPR1A	UBERON_0001008	""
cardiac hypertrophy	renal	activation_general	EFO_0002503	ENSG00000166148	23197038	Bowes et al. (2012)	AVPR1A	UBERON_0001008	""
hyponatraemia	renal	activation_general	HP_0002902	ENSG00000166148	23197038	Bowes et al. (2012)	AVPR1A	UBERON_0001008	""
increased cardiac contractility	cardiovascular	inhibition_acute	GO_0045823	ENSG00000172572	28216264	Lynch et al. (2017)	PDE3A	UBERON_0004535	""
increased heart rate	cardiovascular	inhibition_acute	HP_0001649	ENSG00000172572	28216264	Lynch et al. (2017)	PDE3A	UBERON_0004535	""
decreased blood pressure	cardiovascular	inhibition_acute	EFO_0005251	ENSG00000172572	28216264	Lynch et al. (2017)	PDE3A	UBERON_0004535	""
ventricular arrhythmia	cardiovascular	inhibition_acute	HP_0004308	ENSG00000172572	28216264	Lynch et al. (2017)	PDE3A	UBERON_0004535	""
decreased platelets	cardiovascular	inhibition_acute	HP_0001873	ENSG00000172572	28216264	Lynch et al. (2017)	PDE3A	UBERON_0004535	""
decreased platelet aggregation	cardiovascular	inhibition_acute	GO_0090331	ENSG00000172572	28216264	Lynch et al. (2017)	PDE3A	UBERON_0004535	""
decreased female fertility	cardiovascular	inhibition_acute	EFO_0008560	ENSG00000172572	28216264	Lynch et al. (2017)	PDE3A	UBERON_0004535	""
increased cardiac contractility	blood	inhibition_acute	GO_0045823	ENSG00000172572	28216264	Lynch et al. (2017)	PDE3A	UBERON_0000178	""
increased heart rate	blood	inhibition_acute	HP_0001649	ENSG00000172572	28216264	Lynch et al. (2017)	PDE3A	UBERON_0000178	""
decreased blood pressure	blood	inhibition_acute	EFO_0005251	ENSG00000172572	28216264	Lynch et al. (2017)	PDE3A	UBERON_0000178	""
ventricular arrhythmia	blood	inhibition_acute	HP_0004308	ENSG00000172572	28216264	Lynch et al. (2017)	PDE3A	UBERON_0000178	""
decreased platelets	blood	inhibition_acute	HP_0001873	ENSG00000172572	28216264	Lynch et al. (2017)	PDE3A	UBERON_0000178	""
decreased platelet aggregation	blood	inhibition_acute	GO_0090331	ENSG00000172572	28216264	Lynch et al. (2017)	PDE3A	UBERON_0000178	""
decreased female fertility	blood	inhibition_acute	EFO_0008560	ENSG00000172572	28216264	Lynch et al. (2017)	PDE3A	UBERON_0000178	""
increased blood pressure	cardiovascular	activation_acute	HP_0032263	ENSG00000151067	28216264	Lynch et al. (2017)	CACNA1C	UBERON_0004535	""
decreased blood pressure	cardiovascular	inhibition_acute	EFO_0005251	ENSG00000151067	28216264	Lynch et al. (2017)	CACNA1C	UBERON_0004535	""
decreased cardiac contractility	cardiovascular	inhibition_acute	GO_0045822	ENSG00000151067	28216264	Lynch et al. (2017)	CACNA1C	UBERON_0004535	""
increased PR interval	cardiovascular	inhibition_acute	HP_0012248	ENSG00000151067	28216264	Lynch et al. (2017)	CACNA1C	UBERON_0004535	""
decreased/increased convulsions	cardiovascular	inhibition_acute	EFO_0009853	ENSG00000151067	28216264	Lynch et al. (2017)	CACNA1C	UBERON_0004535	""
increased blood pressure	central nervous system	activation_acute	HP_0032263	ENSG00000151067	28216264	Lynch et al. (2017)	CACNA1C	UBERON_0001017	""
decreased blood pressure	central nervous system	inhibition_acute	EFO_0005251	ENSG00000151067	28216264	Lynch et al. (2017)	CACNA1C	UBERON_0001017	""
decreased cardiac contractility	central nervous system	inhibition_acute	GO_0045822	ENSG00000151067	28216264	Lynch et al. (2017)	CACNA1C	UBERON_0001017	""
increased PR interval	central nervous system	inhibition_acute	HP_0012248	ENSG00000151067	28216264	Lynch et al. (2017)	CACNA1C	UBERON_0001017	""
decreased/increased convulsions	central nervous system	inhibition_acute	EFO_0009853	ENSG00000151067	28216264	Lynch et al. (2017)	CACNA1C	UBERON_0001017	""
increased convulsions	central nervous system	activation_acute	EFO_0009853	ENSG00000151067	28216264	Lynch et al. (2017)	CACNA1C	UBERON_0001017	""
increased cardiac contractility	central nervous system	activation_acute	GO_0045823	ENSG00000151067	28216264	Lynch et al. (2017)	CACNA1C	UBERON_0001017	""
increased cardiac contractility	cardiovascular	activation_acute	GO_0045823	ENSG00000151067	28216264	Lynch et al. (2017)	CACNA1C	UBERON_0004535	""
decreased locomotor activity	central nervous system	activation_acute	GO_0040013	ENSG00000151067	28216264	Lynch et al. (2017)	CACNA1C	UBERON_0001017	""
increased convulsions	cardiovascular	activation_acute	EFO_0009853	ENSG00000151067	28216264	Lynch et al. (2017)	CACNA1C	UBERON_0004535	""
decreased locomotor activity	cardiovascular	activation_acute	GO_0040013	ENSG00000151067	28216264	Lynch et al. (2017)	CACNA1C	UBERON_0004535	""
decreased body temperature	endocrine	activation_general	HP_0002045	ENSG00000178394	23197038	Bowes et al. (2012)	HTR1A	UBERON_0000949	""
potentially anxiogenic	endocrine	inhibition_general	EFO_0005230	ENSG00000178394	23197038	Bowes et al. (2012)	HTR1A	UBERON_0000949	""
reduced REM sleep	endocrine	activation_general	GO_0042322	ENSG00000178394	23197038	Bowes et al. (2012)	HTR1A	UBERON_0000949	""
increased adrenocorticotropic hormone	endocrine	activation_general	HP_0003154	ENSG00000178394	23197038	Bowes et al. (2012)	HTR1A	UBERON_0000949	""
cortisol secretion	endocrine	activation_general	GO_0043400	ENSG00000178394	23197038	Bowes et al. (2012)	HTR1A	UBERON_0000949	""
growth hormone secretion	endocrine	activation_general	GO_0030252	ENSG00000178394	23197038	Bowes et al. (2012)	HTR1A	UBERON_0000949	""
decreased body temperature	central nervous system	activation_general	HP_0002045	ENSG00000178394	23197038	Bowes et al. (2012)	HTR1A	UBERON_0001017	""
potentially anxiogenic	central nervous system	inhibition_general	EFO_0005230	ENSG00000178394	23197038	Bowes et al. (2012)	HTR1A	UBERON_0001017	""
reduced REM sleep	central nervous system	activation_general	GO_0042322	ENSG00000178394	23197038	Bowes et al. (2012)	HTR1A	UBERON_0001017	""
increased adrenocorticotropic hormone	central nervous system	activation_general	HP_0003154	ENSG00000178394	23197038	Bowes et al. (2012)	HTR1A	UBERON_0001017	""
cortisol secretion	central nervous system	activation_general	GO_0043400	ENSG00000178394	23197038	Bowes et al. (2012)	HTR1A	UBERON_0001017	""
growth hormone secretion	central nervous system	activation_general	GO_0030252	ENSG00000178394	23197038	Bowes et al. (2012)	HTR1A	UBERON_0001017	""
increased urinary sodium excretion	renal	activation_acute	GO_0035815	ENSG00000083454	28216264	Lynch et al. (2017)	P2RX5	UBERON_0001008	""
neurodegeneration	renal	activation_chronic	HP_0002180	ENSG00000083454	28216264	Lynch et al. (2017)	P2RX5	UBERON_0001008	""
decreased pain	renal	inhibition_acute	GO_1904057	ENSG00000083454	28216264	Lynch et al. (2017)	P2RX5	UBERON_0001008	""
decreased inflammation	renal	inhibition_acute	GO_0050728	ENSG00000083454	28216264	Lynch et al. (2017)	P2RX5	UBERON_0001008	""
decreased convulsions	renal	inhibition_acute	EFO_0009853	ENSG00000083454	28216264	Lynch et al. (2017)	P2RX5	UBERON_0001008	""
increased pain	renal	activation_acute	GO_1904058	ENSG00000083454	28216264	Lynch et al. (2017)	P2RX5	UBERON_0001008	""
increased pain	immune	activation_acute	GO_1904058	ENSG00000083454	28216264	Lynch et al. (2017)	P2RX5	UBERON_0002405	""
neurodegeneration	immune	activation_chronic	HP_0002180	ENSG00000083454	28216264	Lynch et al. (2017)	P2RX5	UBERON_0002405	""
decreased pain	immune	inhibition_acute	GO_1904057	ENSG00000083454	28216264	Lynch et al. (2017)	P2RX5	UBERON_0002405	""
decreased inflammation	immune	inhibition_acute	GO_0050728	ENSG00000083454	28216264	Lynch et al. (2017)	P2RX5	UBERON_0002405	""
decreased convulsions	immune	inhibition_acute	EFO_0009853	ENSG00000083454	28216264	Lynch et al. (2017)	P2RX5	UBERON_0002405	""
increased pain	nervous system	activation_acute	GO_1904058	ENSG00000083454	28216264	Lynch et al. (2017)	P2RX5	UBERON_0001016	""
neurodegeneration	nervous system	activation_chronic	HP_0002180	ENSG00000083454	28216264	Lynch et al. (2017)	P2RX5	UBERON_0001016	""
decreased pain	nervous system	inhibition_acute	GO_1904057	ENSG00000083454	28216264	Lynch et al. (2017)	P2RX5	UBERON_0001016	""
decreased inflammation	nervous system	inhibition_acute	GO_0050728	ENSG00000083454	28216264	Lynch et al. (2017)	P2RX5	UBERON_0001016	""
decreased convulsions	nervous system	inhibition_acute	EFO_0009853	ENSG00000083454	28216264	Lynch et al. (2017)	P2RX5	UBERON_0001016	""
hemolysis	immune	activation_acute	EFO_0009473	ENSG00000083454	28216264	Lynch et al. (2017)	P2RX5	UBERON_0002405	""
increased urine excretion	nervous system	activation_acute	HP_0000103	ENSG00000083454	28216264	Lynch et al. (2017)	P2RX5	UBERON_0001016	""
hemolysis	renal	activation_acute	EFO_0009473	ENSG00000083454	28216264	Lynch et al. (2017)	P2RX5	UBERON_0001008	""
increased urinary sodium excretion	immune	activation_acute	GO_0035815	ENSG00000083454	28216264	Lynch et al. (2017)	P2RX5	UBERON_0002405	""
increased urine excretion	renal	activation_acute	HP_0000103	ENSG00000083454	28216264	Lynch et al. (2017)	P2RX5	UBERON_0001008	""
increased urinary sodium excretion	nervous system	activation_acute	GO_0035815	ENSG00000083454	28216264	Lynch et al. (2017)	P2RX5	UBERON_0001016	""
hemolysis	nervous system	activation_acute	EFO_0009473	ENSG00000083454	28216264	Lynch et al. (2017)	P2RX5	UBERON_0001016	""
increased urine excretion	immune	activation_acute	HP_0000103	ENSG00000083454	28216264	Lynch et al. (2017)	P2RX5	UBERON_0002405	""
increased pain	renal	activation_acute	GO_1904058	ENSG00000089041	28216264	Lynch et al. (2017)	P2RX7	UBERON_0001008	""
neurodegeneration	renal	activation_chronic	HP_0002180	ENSG00000089041	28216264	Lynch et al. (2017)	P2RX7	UBERON_0001008	""
decreased pain	renal	inhibition_acute	GO_1904057	ENSG00000089041	28216264	Lynch et al. (2017)	P2RX7	UBERON_0001008	""
decreased inflammation	renal	inhibition_acute	GO_0050728	ENSG00000089041	28216264	Lynch et al. (2017)	P2RX7	UBERON_0001008	""
decreased convulsions	renal	inhibition_acute	EFO_0009853	ENSG00000089041	28216264	Lynch et al. (2017)	P2RX7	UBERON_0001008	""
increased urine excretion	renal	activation_acute	HP_0000103	ENSG00000089041	28216264	Lynch et al. (2017)	P2RX7	UBERON_0001008	""
increased urinary sodium excretion	immune	activation_acute	GO_0035815	ENSG00000089041	28216264	Lynch et al. (2017)	P2RX7	UBERON_0002405	""
neurodegeneration	immune	activation_chronic	HP_0002180	ENSG00000089041	28216264	Lynch et al. (2017)	P2RX7	UBERON_0002405	""
decreased pain	immune	inhibition_acute	GO_1904057	ENSG00000089041	28216264	Lynch et al. (2017)	P2RX7	UBERON_0002405	""
decreased inflammation	immune	inhibition_acute	GO_0050728	ENSG00000089041	28216264	Lynch et al. (2017)	P2RX7	UBERON_0002405	""
decreased convulsions	immune	inhibition_acute	EFO_0009853	ENSG00000089041	28216264	Lynch et al. (2017)	P2RX7	UBERON_0002405	""
increased urine excretion	immune	activation_acute	HP_0000103	ENSG00000089041	28216264	Lynch et al. (2017)	P2RX7	UBERON_0002405	""
increased urinary sodium excretion	renal	activation_acute	GO_0035815	ENSG00000089041	28216264	Lynch et al. (2017)	P2RX7	UBERON_0001008	""
hemolysis	renal	activation_acute	EFO_0009473	ENSG00000089041	28216264	Lynch et al. (2017)	P2RX7	UBERON_0001008	""
increased urinary sodium excretion	nervous system	activation_acute	GO_0035815	ENSG00000089041	28216264	Lynch et al. (2017)	P2RX7	UBERON_0001016	""
neurodegeneration	nervous system	activation_chronic	HP_0002180	ENSG00000089041	28216264	Lynch et al. (2017)	P2RX7	UBERON_0001016	""
decreased pain	nervous system	inhibition_acute	GO_1904057	ENSG00000089041	28216264	Lynch et al. (2017)	P2RX7	UBERON_0001016	""
decreased inflammation	nervous system	inhibition_acute	GO_0050728	ENSG00000089041	28216264	Lynch et al. (2017)	P2RX7	UBERON_0001016	""
decreased convulsions	nervous system	inhibition_acute	EFO_0009853	ENSG00000089041	28216264	Lynch et al. (2017)	P2RX7	UBERON_0001016	""
hemolysis	immune	activation_acute	EFO_0009473	ENSG00000089041	28216264	Lynch et al. (2017)	P2RX7	UBERON_0002405	""
increased pain	nervous system	activation_acute	GO_1904058	ENSG00000089041	28216264	Lynch et al. (2017)	P2RX7	UBERON_0001016	""
increased urine excretion	nervous system	activation_acute	HP_0000103	ENSG00000089041	28216264	Lynch et al. (2017)	P2RX7	UBERON_0001016	""
increased pain	immune	activation_acute	GO_1904058	ENSG00000089041	28216264	Lynch et al. (2017)	P2RX7	UBERON_0002405	""
hemolysis	nervous system	activation_acute	EFO_0009473	ENSG00000089041	28216264	Lynch et al. (2017)	P2RX7	UBERON_0001016	""
cardiac hypertrophy	cardiovascular	activation_acute	EFO_0002503	ENSG00000170214	28216264	Lynch et al. (2017)	ADRA1B	UBERON_0004535	""
decreased blood pressure	cardiovascular	inhibition_acute	EFO_0005251	ENSG00000170214	28216264	Lynch et al. (2017)	ADRA1B	UBERON_0004535	""
decreased blood pressure	renal	activation_acute	EFO_0005251	ENSG00000170214	28216264	Lynch et al. (2017)	ADRA1B	UBERON_0001008	""
decreased blood pressure	renal	inhibition_acute	EFO_0005251	ENSG00000170214	28216264	Lynch et al. (2017)	ADRA1B	UBERON_0001008	""
neurodegeneration	nervous system	activation_acute	HP_0002180	ENSG00000170214	28216264	Lynch et al. (2017)	ADRA1B	UBERON_0001016	""
decreased blood pressure	nervous system	inhibition_acute	EFO_0005251	ENSG00000170214	28216264	Lynch et al. (2017)	ADRA1B	UBERON_0001016	""
cardiac hypertrophy	renal	activation_acute	EFO_0002503	ENSG00000170214	28216264	Lynch et al. (2017)	ADRA1B	UBERON_0001008	""
decreased blood pressure	nervous system	activation_acute	EFO_0005251	ENSG00000170214	28216264	Lynch et al. (2017)	ADRA1B	UBERON_0001016	""
orthostatic hypotension	cardiovascular	activation_acute	EFO_0005252	ENSG00000170214	28216264	Lynch et al. (2017)	ADRA1B	UBERON_0004535	""
neurodegeneration	renal	activation_acute	HP_0002180	ENSG00000170214	28216264	Lynch et al. (2017)	ADRA1B	UBERON_0001008	""
convulsions	renal	activation_acute	EFO_0009853	ENSG00000170214	28216264	Lynch et al. (2017)	ADRA1B	UBERON_0001008	""
decreased locomotor activity	nervous system	activation_acute	GO_0040013	ENSG00000170214	28216264	Lynch et al. (2017)	ADRA1B	UBERON_0001016	""
orthostatic hypotension	renal	activation_acute	EFO_0005252	ENSG00000170214	28216264	Lynch et al. (2017)	ADRA1B	UBERON_0001008	""
decreased blood pressure	cardiovascular	activation_acute	EFO_0005251	ENSG00000170214	28216264	Lynch et al. (2017)	ADRA1B	UBERON_0004535	""
cardiac hypertrophy	nervous system	activation_acute	EFO_0002503	ENSG00000170214	28216264	Lynch et al. (2017)	ADRA1B	UBERON_0001016	""
convulsions	nervous system	activation_acute	EFO_0009853	ENSG00000170214	28216264	Lynch et al. (2017)	ADRA1B	UBERON_0001016	""
orthostatic hypotension	nervous system	activation_acute	EFO_0005252	ENSG00000170214	28216264	Lynch et al. (2017)	ADRA1B	UBERON_0001016	""
decreased locomotor activity	renal	activation_acute	GO_0040013	ENSG00000170214	28216264	Lynch et al. (2017)	ADRA1B	UBERON_0001008	""
neurodegeneration	cardiovascular	activation_acute	HP_0002180	ENSG00000170214	28216264	Lynch et al. (2017)	ADRA1B	UBERON_0004535	""
decreased locomotor activity	cardiovascular	activation_acute	GO_0040013	ENSG00000170214	28216264	Lynch et al. (2017)	ADRA1B	UBERON_0004535	""
convulsions	cardiovascular	activation_acute	EFO_0009853	ENSG00000170214	28216264	Lynch et al. (2017)	ADRA1B	UBERON_0004535	""
gastric bleeding	gastrointestinal	inhibition_general	EFO_0009879	ENSG00000095303	23197038	Bowes et al. (2012)	PTGS1	UBERON_0005409	""
pulmonary bleeding	gastrointestinal	inhibition_general	HP_0040223	ENSG00000095303	23197038	Bowes et al. (2012)	PTGS1	UBERON_0005409	""
dyspepsia	gastrointestinal	inhibition_general	EFO_0008533	ENSG00000095303	23197038	Bowes et al. (2012)	PTGS1	UBERON_0005409	""
renal dysfunction	gastrointestinal	inhibition_general	HP_0012211	ENSG00000095303	23197038	Bowes et al. (2012)	PTGS1	UBERON_0005409	""
gastric bleeding	pulmonary	inhibition_general	EFO_0009879	ENSG00000095303	23197038	Bowes et al. (2012)	PTGS1	UBERON_0002048	""
pulmonary bleeding	pulmonary	inhibition_general	HP_0040223	ENSG00000095303	23197038	Bowes et al. (2012)	PTGS1	UBERON_0002048	""
dyspepsia	pulmonary	inhibition_general	EFO_0008533	ENSG00000095303	23197038	Bowes et al. (2012)	PTGS1	UBERON_0002048	""
renal dysfunction	pulmonary	inhibition_general	HP_0012211	ENSG00000095303	23197038	Bowes et al. (2012)	PTGS1	UBERON_0002048	""
gastric bleeding	renal	inhibition_general	EFO_0009879	ENSG00000095303	23197038	Bowes et al. (2012)	PTGS1	UBERON_0001008	""
pulmonary bleeding	renal	inhibition_general	HP_0040223	ENSG00000095303	23197038	Bowes et al. (2012)	PTGS1	UBERON_0001008	""
dyspepsia	renal	inhibition_general	EFO_0008533	ENSG00000095303	23197038	Bowes et al. (2012)	PTGS1	UBERON_0001008	""
renal dysfunction	renal	inhibition_general	HP_0012211	ENSG00000095303	23197038	Bowes et al. (2012)	PTGS1	UBERON_0001008	""
ataxia	cardiovascular	activation_acute	MONDO_0000437	ENSG00000080709	28216264	Lynch et al. (2017)	KCNN2	UBERON_0004535	""
increased atrial refractory period	cardiovascular	inhibition_acute	""	ENSG00000080709	28216264	Lynch et al. (2017)	KCNN2	UBERON_0004535	""
convulsions	cardiovascular	inhibition_acute	EFO_0009853	ENSG00000080709	28216264	Lynch et al. (2017)	KCNN2	UBERON_0004535	""
neurotoxicity	cardiovascular	inhibition_acute	EFO_0005595	ENSG00000080709	28216264	Lynch et al. (2017)	KCNN2	UBERON_0004535	""
decreased convulsions	central nervous system	activation_acute	EFO_0009853	ENSG00000080709	28216264	Lynch et al. (2017)	KCNN2	UBERON_0001017	""
increased atrial refractory period	central nervous system	inhibition_acute	""	ENSG00000080709	28216264	Lynch et al. (2017)	KCNN2	UBERON_0001017	""
convulsions	central nervous system	inhibition_acute	EFO_0009853	ENSG00000080709	28216264	Lynch et al. (2017)	KCNN2	UBERON_0001017	""
neurotoxicity	central nervous system	inhibition_acute	EFO_0005595	ENSG00000080709	28216264	Lynch et al. (2017)	KCNN2	UBERON_0001017	""
decreased locomotor activity	cardiovascular	activation_acute	GO_0040013	ENSG00000080709	28216264	Lynch et al. (2017)	KCNN2	UBERON_0004535	""
decreased locomotor activity	central nervous system	activation_acute	GO_0040013	ENSG00000080709	28216264	Lynch et al. (2017)	KCNN2	UBERON_0001017	""
decreased convulsions	cardiovascular	activation_acute	EFO_0009853	ENSG00000080709	28216264	Lynch et al. (2017)	KCNN2	UBERON_0004535	""
ataxia	central nervous system	activation_acute	MONDO_0000437	ENSG00000080709	28216264	Lynch et al. (2017)	KCNN2	UBERON_0001017	""
decreased pain	nervous system	activation_acute	GO_1904057	ENSG00000188822	28216264	Lynch et al. (2017)	CNR2	UBERON_0001016	""
increased inflammation	nervous system	inhibition_acute	GO_0050729	ENSG00000188822	28216264	Lynch et al. (2017)	CNR2	UBERON_0001016	""
decreased inflammation	Immune	activation_acute	GO_0050728	ENSG00000188822	28216264	Lynch et al. (2017)	CNR2	""	""
increased inflammation	Immune	inhibition_acute	GO_0050729	ENSG00000188822	28216264	Lynch et al. (2017)	CNR2	""	""
decreased inflammation	nervous system	activation_acute	GO_0050728	ENSG00000188822	28216264	Lynch et al. (2017)	CNR2	UBERON_0001016	""
decreased pain	Immune	activation_acute	GO_1904057	ENSG00000188822	28216264	Lynch et al. (2017)	CNR2	""	""
increased salivation	nervous system	activation_acute	GO_0046878	ENSG00000184984	28216264	Lynch et al. (2017)	CHRM5	UBERON_0001016	""
